Sorush Nik Namian Resume (CV)

Brief Degree and Biography: (MAJ Dr. Sorush Niknamian PhD CRFM PE APA_FPD OMS-IV AICP MWSES MLPI MACRO MTMA MRSB FIMS FChE EMBS FNNECOS FTSCO ANCC, AANP, ACPE, ACHE, ADA CERP APA FMDCSCO FSASS) Ph.D. in Cell and Molecular Biology and Oncology and Professor of Cell and Molecular Biology, Oncology and Biological Attacks. He is a Professional Biologist, Senior Research Scientist, Chartered Scientist and Registered His Science Council ID is: A-0008833. He is one of United Kingdom and Indiana Cancer Consortium (ICC) certified. He is a Registered Researcher in the U.S. Government's System for Award Management, Registered Scientist at National Center for Biotechnology Information. He is studying Medicine/Military Medicine at Liberty University (LU), Lynchburg, VA, United States of America. He holds Bachelor’s Degree in Mechatronics Engineering, applied Mathematics, Civil Engineering and Management. He is a Member of US Government National Science Foundation, Member of Hera Swiss Volunteers (ID: 198036), Member of US Army American College of Physicians Chapter, Ambassador of American Cancer Society (ACS CAN) and former Ambassador of European Association for Cancer Research (EACR), Active Member of Federal Health Professionals at US Army Forces and Certified Member of American Red Cross and Food Regulatory Affairs Professionals. He is an Honorary Board Member and contributor of Weston A Price

Foundation (WAPF) in Washington DC, United States of America. He Holds Honorary Doctorate of Cancer Biology and Doctor of Science from Violet Cancer Institute. He is preserved and nominated for the preserved as Position Title: DIRECTOR OF MILITARY SUPPORT, Agency: Army National Guard Units. Announcement Number: ID: WA-10507254-AR-19-161. Extra Information: DIRECTOR OF MILITARY SUPPORT located at the WASHINGTON J3 DCSOPS. Professor Sorush Niknamian is an ACP Chapter member in United States Army and Air Force. Active Member of IMRTC-USA (International Management Research and Technology Consortium Research) as Advisor, Referee and Professor at IMRTC-USA (International Management Research and Technology Consortium Panel). He is a Service Member of Modern Military Association of America. Certified Member of World Medical Association with ID: 5c7b154b01602 as a Junior Medical Doctor. He is an Active Member of the National Guard Association of the United States of America (Branch: Army, Rank: Major, State Affiliation: Maryland) and Serving Volunteer at the Peace Corps of the United States of America (Ref ID: 10811430) and certified member of The National Bureau of Asian Research. He is a member of Military Officers Association of America (Member Number: 05670401, Rank: Major). He is one of the certified member of Texas Section of the American Physical Society. Active Member of the United Nation (ROSTER NUMBER – 1665156). MAJ Dr. Sorush Niknamian is a Certified and professional in Terrorism Affairs, Terrorism Analysis and Terrorism Counterterrorism from American Military University (AMU). He has been written more than 30 books in different area of science specially Medicine, Evolutionary Biology, Nutrition and Oncology. He has published more than 120 research articles in International and National scientific journals. He is an activist in ASCO Action Network in Virginia, ACS CAN, ACC and FPA and Improving Heart Failure Outcomes Through Personalized Education—Improving HOPE. He is an active Member of Physicians for human rights. He is an active member of Federal Planners' Advocacy Network. Volunteer/Alumni in IRAP (International Refugee Assistance Project) at MSF (Doctors Without Borders). He is an active registered in Advocated of Internal Medicine at ACP (US Army Chapter).

RESEARCH INTERESTS: Cancer Biology, Evolutionary Biology, Biological Sciences, General Biology, Biomedical Sciences, Clinical Oncology, Military Medicine, Infectious Diseases, Internal Medicine, Medical Sciences.

AFFILIATIONS: [1] MAJ Dr. Sorush Niknamian, PE, NSPE US Military Academy Member, Virginia, VA02 Lynchburg, Biomedical Engineering. [2] MAJ Dr. Sorush Niknamian, Military Medicine Dep., Liberty University, USA. [3] Dr. Sorush Niknamian, Honorary Board Member of Weston A Price Foundation (WAPF), Washington DC, USA. [4] Professor of Biology, Chemistry and Mathematics, West Chester University of Pennsylvania, Date of beginning: Summer 2020. Address: 700 S High St, West Chester, PA 19383. https://www.wcupa.edu/. [5] Ambassador of American Planning Association and Federal Planning Association, United States of America. [6] Fellow Member of the Medical Society of the State of New York (MSSNY) The Medical Society of the State of New York (MSSNY), MEMBER ID: 3009762.

Primary Phone: +44(793)7058125 United States Address 1: Weston A. Price Foundation (WAPF) PMB 106-380 4200 Wisconsin Avenue, NW Washington, DC 20016 USA. Phone: +1(703) 820-3333. United States Address 2: Liberty University, 1971 University Blvd, Lynchburg, VA 24515.

Board Member of United Breast Cancer Foundation: Tel.: +1 877 UBC 4CURE Indiana Cancer Consortium (ICC) certified. United Kingdom Personal E-mail Address: [email protected] Office E-mail: [email protected] Office Phone: +1(510)2813388 Website: www.westonaprice.org Website: www.violetcancerinstitute.org www.caringbridge.org/visit/cancertreatment www.caringbridge.org/visit/cancerprevention2 US Government National Science Foundation ID: 000785552

Research ID Badge Code:

Open Researcher and Contributor ID: 0000-0002-2385-8590 Researcher ID: O-8976-2018

Editorial Board and Peer Review Identifier: publons.com/a/1548852/ Social Science Research Network ID: 3007268 Registered Researcher in the U.S. Government's System for Award Management (NAS) AIP Scitation account number: 000001319438 SOPHAS Express ID: 1929115891 NCBI API Key: 500db90507652e3ffaaa38df5afe3990cc09 Elsevier API Key: 42567a7b46a5047235ca40472b7cb44b Alison ID: 11782090 Loop profile: 595506 SSRN Author ID: 3007268 Researchgate link: https://www.researchgate.net/profile/Sorush_Niknamian2

Academic Identifier Websites:

[1] http://liberty.academia.edu/SorushNiknamian

[2] https://www.zotero.org/niknamian/

[3] https://ssrn.com/author=3007268/

[4] National Center for Biotechnology Information: https://www.ncbi.nlm.nih.gov/myncbi/12mmWRuqRsxEQu/cv/286616/.

[5] https://www.researchgate.net/profile/Sorush_Niknamian2/

[6] https://issuu.com/so.niknamian/

[7] academig.com/#/people/sorush_niknamian

[8] https://academia.stackexchange.com/users/104354/dr-sorush-niknamian, User ID: 104354

[9] https://biopharmadealmakers.nature.com/search?utf8=%E2%9C%93&query=sorus h+niknamian/

[10] https://www.ctsnet.org/home/soniknamiangmailcom/

[11] http://alliedacademies.com/profile/Sorush%20Niknamian

[12] https://stackoverflow.com/story/niknamian/

[13] https://helicsgroup.net/index.php/user/member_details/1595/35

[14] https://www.yumpu.com/user/so.niknamian

[15] go.publichealth.yale.edu/SorushNiknamian

[16] https://encyclopedia.pub/author/list/all

[17] https://figshare.com/authors/Sorush_Niknamian/5905778/

[18] https://scholar.google.com/citations?user=g4Sr160AAAAJ&hl=en/

[19] https://publons.com/researcher/1548852/professor-dr-sorush-niknamian/

[20] https://osf.io/gjp9c/

[21] http://alliedacademies.com/profile/Sorush%20Niknamian/

[22] https://www.pulsus.com/author/sorush-niknamian-7843/

Social Media Webpages:

[1] Twitter: https://twitter.com/SNamian

[2] LinkedIn: https://www.linkedin.com/in/sorush-niknamian-038504182/

[3] Pinterest: https://www.pinterest.com/banafshehpira/somayeh-zaminpira-sorushniknamian/

[4] https://github.com/sniknamian/

[5] Site Link: http://www.caringbridge.org/visit/cancertreatment, Site Name: cancer treatment

[6] Site Link: www.caringbridge.org/visit/cancerprevention2, Site Name: cancerprevention2

[7] Member of WebMD: https://member.webmd.com/profile.aspx/

[8] https://disqus.com/by/drsorushniknamian/ DISQUS Identity: @drsorushniknamian

[9] https://www.caringbridge.org/visit/cancerevolution/

[10] https://stackoverflow.com/story/niknamian/

[11] https://vimeo.com/user89057289/

[12] Microsoft Personal Unique ID: 000300001B6B2861

[13] American Cancer Society Personal Fund Raiser (CANRaiser): TR/Events/GeneralACSCAN?px=4444603&pg=personal&fr_id=1252

E-mail: [email protected]

[14] Personal page at ACS CAN Fundraiser, American Cancer Society: TR/Events/GeneralACSCAN?px=4444603&pg=personal&fr_id=1251

[15] https://www.yumpu.com/user/so.niknamian

[16] https://rocketreach.co, API: 2803b2k556fea7c73dbc744e4e0c271327ce499.

Education:

[1] (1999 – 2003) IAUCTB University, BS Degree. Applied Mathematics.

[2] (2005- 2010) - Sharif University of Technology (SUT) BS Degree - Mechatronics Engineering.

[3] Bachelor’s Degree in General Biology, University of Applied Sciences (2010 – 2014)

[4] Ph.D. in Cell and Molecular Biology, University of Applied Sciences (2014 - 2018)

[5] Master’s Degree. And Bachelor’s Degree in Biomedical Sciences. University of Applied Sciences. (2010 – 2014)

[5] Medical Student at Liberty University (LU), Military Medicine Department, Student ID Number: L30349919, United States. (2019 – 2022)

[6] MSc by Research in Molecular and Cellular Medicine at the University of Oxford, Entry in 2019/20 Graduation: 2020/20 (Application in Process)

[7] University of Edinburgh, Cancer (Edinburgh Cancer Research Centre) (PhD) - 3 Years (Full-time), School: Deanery of Molecular, Genetic and Population Health

Sciences 2019/0 Entry, Graduation Date: 31/Aug/2022, (UUN) ID: S1986808. (Application in Process)

[8] Professional Academic Program: Terrorism Affairs, American Military University, ID: 5778625

[9] Student of Engineering for Professionals (EP) at the part-time/online graduate division of the Johns Hopkins University’s Whiting School of Engineering, Summer 2019. reference number: 824722513. (Application in Process)

[10] Certified Terrorism Activities at American Military University (AMU), 111 W Congress St, Charles Town, WV 25414, USA, student ID: 5778625.

[11] 2020 Spring Semester Public Health Certificate to MPH, Loyola University Chicago, USA. Reference Number: 198036527. Website: https://gpem.luc.edu/account/logout?r=https%3a%2f%2fgpem.luc.edu%2fapply%2 fstatus%3fsubmitted%3d1.

[12] Graduate Certificate in Public Health, University of New England Online (UNE), Term: Spring A 2020, Status: Application in Progress, 716 Stevens Ave. Portland, ME 04103, Phone: (855) 325-0895, Fax: (207) 221-4847.

[13] Master of Public Health (MPH), University of New England Online (UNE) Term: Spring A 2020, Status: Application in Progress, 716 Stevens Ave. Portland, ME 04103, Phone: (855) 325-0895, Fax: (207) 221-4847.

[14] Student Member of Baltimore Academy of Defense, United States of America. Traditional Chinese Kung Fu & Historical American Swordsmanship. https://academyofdefence.com/

[15] MBA/MPH, Yale School of Public Health. Personal Web link: go.publichealth.yale.edu/SorushNiknamian.

[16] Resident Member and Doctor of American College of Radiation Oncology (ACRO), URL: https://www.acro.org/, Membership Dates: 1/1/2020 - 12/31/2020.

Supported by: Dr. Shane Hopkins, MD, Chair and Dr. J. Ben Wilkinson, MD, Co- chair ACRO Membership Committee. ID: 50536.

[17] Certified Member of Virginia Military Institute, Virginia Military Institute | (540) 464-7211 Lexington, Virginia 24450, Rank: Major, Specialty: MAJ Dr. of Military Medicine and Clinical Oncology. https://inside.vmi.edu.

[18] Fellow Member of European School of Oncology (ESO), Milan, Italy.

[19] MSc in Clinical Trials (Part-time), University of Oxford, Entry in 2020/21, Granted by European Heart Academy (ESC Educational Grant).

[20] Graduate Member of Mathematical Sciences Research Institute (MSRI), URL: https://www.msri.org/people/45101/. Member Number: 45101.

[21] Fellow/Graduate Member of Institute of Mathematical Statistics (IMS), Founded: 1935, ID: 32896, President: Regina Liu [email protected], The Institute of Mathematical Statistics is an international professional and scholarly society devoted to the development, dissemination, and application of statistics and probability. The Institute currently has about 4,000 members in all parts of the world. Beginning in 2005, the institute started offering joint membership with the Bernoulli Society for Mathematical Statistics and Probability as well as with the International Statistical Institute. The Institute was founded in 1935 with Harry C. Carver and Henry L. Rietz as its two most important supporters.

[22] Student Member of Academy of Communication in Healthcare (ACH), About the Academy: We, the leadership of the ACH (Academy of Communication in Healthcare) and EACH: International Association for Communication in Healthcare, support the free movement of information and of all interested participants across international boundaries to improve our knowledge and practice in communication and healthcare. We are experts in the field of healthcare communication. We recognize the value of diversity and relationship to both individual and public health. We believe strongly in open borders that allow researchers, educators, patients, clinicians, and students to meet for a free exchange of ideas in order to support collaboration with professionals from all countries. We particularly wish to welcome

9 and support scholars and practitioners in communities that are challenged by war, poverty, and inadequate infrastructure. Website: https://www.achonline.org// .

[23] Resident/Post Doc Student Member of the American Academy of Emergency Medicine Resident and Student Association (AAEM/RSA), ID: 85737, Critical Care and Emergency Ultrasound Sections, Virginia Chapter Division. URL: https://www.aaemrsa.org/. 555 E. Wells St. Suite 1100, Milwaukee, WI 53202, Phone: 800-884-2236, Fax: 414-276-3349.

[24] Certified Resident Member and Mentor of American College of Radiation Oncology, Member ID: 50536. https://www.acro.org.

[25] Professional/Fellow Member of Institute for Engineering Research and Publication (IFERP), Institute for Engineering Research and Publication (IFERP) is one of the world's largest Non-profitable professional associations operating under Technoarete Research and Development Association (TRADA) meant for research and development in the field of Engineering, Science & Technology. IFERP is a paramount body which has brought technical revolution and sustainable development in the field of Engineering, science and technology. IFERP is a forum where innovations & research interest could be supported and developed prioritizing our mutual interest. Our forums & Associates constitutes of Professional leaders, Universities, Organizations & Associations connecting each other with a mission to work as wizards of science for defending the earth. URL: https://www.iferp.in/, Fellowship ID: PMIR02714698.

[26] Certified Member of Academy of Communication in Healthcare (ACH), About the Academy: We, the leadership of the ACH (Academy of Communication in Healthcare) and EACH: International Association for Communication in Healthcare, support the free movement of information and of all interested participants across international boundaries to improve our knowledge and practice in communication and healthcare. We are experts in the field of healthcare communication. We recognize the value of diversity and relationship to both individual and public health. We believe strongly in open borders that allow researchers, educators, patients, clinicians, and students to meet for a free exchange of ideas in order to support collaboration with professionals from all countries. We particularly wish to welcome

10 and support scholars and practitioners in communities that are challenged by war, poverty, and inadequate infrastructure. Website: https://www.achonline.org/.

[27] Active Member of American Academy of Pas (AAPA), AAPA ID: 110-704- 206, Website: https://www.aapa.org/, About AAPA: Founded in 1968, the American Academy of PAs is the national professional society for PAs. It represents a profession of more than 131,000 PAs across all medical and surgical specialties in all 50 states, the District of Columbia, U.S. territories, and the uniformed services. AAPA advocates and educates on behalf of the profession and the patients PAs serve. We work to ensure the professional growth, personal excellence and recognition of PAs. We also enhance their ability to improve the quality, accessibility and cost-effectiveness of patient-centered healthcare. Address: 2318 Mill Rd., Ste. 1300, Alexandria, VA 22314.

[28] Resident/Post Doc Student Member of the American Academy of Emergency Medicine Resident and Student Association (AAEM/RSA), ID: 85737, Critical Care and Emergency Ultrasound Sections, Virginia Chapter Division. URL: https://www.aaemrsa.org/,

[29] Member of Learning & Performance Institute, Awarded by: Michael Strawbridge FLPI, Head of Global Content, Networks & Member Services, Learning and Performance Institute, p: +44 (0)2476 496215 m: 07584 992885 w: www.thelpi.org. Rank: MLPI.

[30] Medical Military Post Doc Student Member of MEDSCAPE PHYSICIAN BUSINESS ACADEMY, About Medscape: Medscape is the leading online global destination for physicians and healthcare professionals worldwide, offering the latest medical news and expert perspectives; essential point-of-care drug and disease information; and relevant professional education and CME. Medscape, LLC, 395 Hudson Street, 3rd Floor, New York, NY 10014. By phone: 212-301-6700.

[31] Professional/Fellow Member of Institute for Engineering Research and Publication (IFERP), Institute for Engineering Research and Publication (IFERP) is one of the world's largest Non-profitable professional associations operating under Technoarete Research and Development Association (TRADA) meant for research

11 and development in the field of Engineering, Science & Technology. IFERP is a paramount body which has brought technical revolution and sustainable development in the field of Engineering, science and technology. IFERP is a forum where innovations & research interest could be supported and developed prioritizing our mutual interest. Our forums & Associates constitutes of Professional leaders, Universities, Organizations & Associations connecting each other with a mission to work as wizards of science for defending the earth. URL: https://www.iferp.in/, Fellowship ID: PMIR02714698.

[32] Post Doc Student Member of the American College of Obstetricians and Gynecologists ACOG, ACOG ID: 001278959I.

[33] Certified Terrorism Analysis Professional, American Military University (AMU), USA. ID: 5778625.

[34] Certified Terrorism Counterterrorism Professional, American Military University (AMU), USA. ID: 5778625.

[35] Post Doc Student Member and of The American Academy of Emergency Medicine Resident and Student Association (AAEM/RSA), Member ID: 85737, Member type: Student/Resident, Member since: 12/20/2019, Membership expires: 06/30/2020. URL: https://aaemrsa.execinc.com/.

[36] Senior Member of The International Academy of Science and Engineering for Development (IASED), http://www.iased.org/. A IASED Senior Member candidate can be either: 1. A professional title of associate professor or above. 2. Obtained a doctoral-level degree. 3. Significant performance in IASED-designated field for at least 2 years, or 5 years’ professional practice. *A senior member can be invited to join IASED editorial board, to review papers, to be a session chair, or invited speaker, etc.

[47] Student Member of Virginia Military Institute (VMI), Virginia Military Institute | (540) 464-7211 Lexington, Virginia 24450.

[48] Woodrow Wilson Teaching Fellow, 5 Vaughn Drive, Suite 300 Princeton, New Jersey 08540, PHONE 609.452.7007 | FAX 609.452.0066. URL: https://woodrow.elluciancrmrecruit.com/Admissions/Pages/Login.aspx.

[49] Post Doc Student Member of Academy of Communication in Healthcare ACH, 201 E. Main Street, Suite 1405 Lexington, KY 40507 Phone: 859-514-9211 Fax: 859-514-9207. Website: https://www.achonline.org/. Mission Statement: ACH is the professional home for all those who are committed to improving communication and relationships in healthcare. ACH accomplishes this through: Welcoming researchers, educators, clinicians, patients, patient advocates, and all members of the healthcare team. Providing opportunities for collaboration, support and personal and professional development. Identifying strengths, resources and needs of patients, their family members and healthcare professionals, both as unique individuals and in relationship to one another. Developing skills that integrate biological, psychological and social domains. Applying existing scholarship from multiple disciplines and developing new knowledge through research. Promoting collaborative relationships between clinicians and patients, teachers and learners, and all members of the health care team. Incorporating core values of respect, empathy and genuineness in human relationships and the importance of self- awareness in all activities. Vision Statement: A health care system where all patients, healthcare professionals, trainees and researchers feel valued, are treated equitably with respect, compassion, understanding, and are actively engaged in healthcare processes and decisions. Basic Beliefs We Share as an Organization ACH believes that the healing human relationship among healthcare professionals, patients and their families is a critical aspect of healthcare. We believe that highly performing interpersonal and inter-professional delivery systems are necessary to achieve the greatest benefit from our biotechnical services. ACH believes in the highest quality, most fully accessible and cost-effective health care for all. ACH believes that relationship skills, communication skills, and teaching skills are learnable and teachable. ACH believes that improved relationships and communication enhance team and patient satisfaction, reduce errors and grievances, improve efficacy, efficiency and safety, and enhance health outcomes, as documented in the peer- reviewed literature. ACH believes that organizational investment in the continuous quality improvement of relationships and communication rewards the organization in many dimensions. ACH believes in learner-centered methods of teaching and

13 coaching, facilitating discovery of learning needs and preferred learning styles. ACH leaders and teachers live the relationship-centered human values we teach, with each other in the organization and in our interactions with patients, family members, colleagues on the health care team, clients, and interested others; we strive to remain curious about and respectful of all forms of diversity that our individual experiences bring to our relationships. ACH is committed to evidence-based practice in healthcare and teaching, grounded in highest quality research that continually informs our work. ACH is committed to promoting diversity in its membership and leadership, including but not limited to diversity in profession, seniority, interests, gender, race/ethnicity, and sexual orientation. It believes that such diversity is critical to attaining the best research, scholarship, teaching, health care and other strategic goals of the Academy. Accordingly, ACH believes it essential to assertively recruit under-represented minorities into our organization. ACH is committed to assisting in the training of under-represented minority healthcare professionals and to reducing healthcare disparities. ACH is committed to human relationships grounded in integrity, congruence, transparency, empathy and unconditional positive regard. As a non-profit human service organization, ACH adheres to a clear mission and assures that resources are used on mission-centered activities. [Our basic beliefs were developed by participants at the 2009 Winter Course and edited by the Executive Committee. The mission, vision, and beliefs were updated by the Board in February 2014 and October 2015.]

[50] Fellow/Physician Member of Haymarket Medical Network. The Haymarket Medical Network reaches healthcare practitioners through a multichannel environment that includes more than a dozen unique brands offered across multiple formats (web, app, print, live event). The network benefits from its inter- connectivity, allowing users to move from brand to brand to discover the relevant content they need to make practice-related decisions. Included in the network is MPR, a renowned drug database used by healthcare practitioners of all professions and specialties to view concise drug information and stay up-to-date on the latest news in pharmacology. myCME delivers a broad range of continuing medical education courses for most healthcare professions and clinical specialties. The network also features an expanding portfolio of websites and apps that deliver news and feature content for all healthcare practitioners targeting a specific therapeutic area (cardiology, endocrinology, infectious diseases, oncology, neurology, pain, and

14 psychiatry) and primary care content delivered to a particular audience (physician assistants, nurse practitioners, and nurses). Website URL: https://www.haymarketmedicalnetwork.com/.

Continued Professional Degree (CPD)

[1] Antibiotic Resistance the Silent Tsunami, Uppsala University, Sweden, 2016

[2] Exploring Our Oceans, University of Southampton's, England, 2016

[3] Talking About Cancer, Cancer Research UK, England, 2016

[4] Good Brain, Bad Brain, Parkinson's Disease, University of Birmingham, England, 2016

[5] Genomic Medicine, University of Exeter, England, 2016

[6] Influenza, How The Flu Spreads and Evolves, Lancaster University, England, 2016.

[7] The Evolution of Human Mind, Kyoto University, Japan, 2016

[8] Non-Small Cell Lung Cancer MET Molecular Alterations: Molecular Oncology Tumor Boards, American Society of Clinical Oncology, March 29, 2017 – March 29, 2020

[9] Continuing Medical Education Credit, Disparities in Cancer Care: Do You Know…? December 11, 2016 – December 11, 2019, ASCO University, American Society of Clinical Oncology.

[10] Introduction to the Biology of Cancer, Johns Hopkins University, Instructed by Kenneth J. Pienta, M.D.

[11] The Genomics Era: The Future of Genetics in Medicine St George's, University of London.

[12] Exploring Cancer Medicines University of Leeds.

[13] Digital Health for Cancer Management: Smart Health Technologies in Complex Diseases Taipei Medical University

[14] Describe the pharmacologic profiles of benzodiazepines, opiates and other controlled drugs, Identify the diagnostic criteria for acute and chronic pain, anxiety disorder, insomnia, depression and substance abuse, Discuss beliefs, attitudes and stereotypes about controlled substance prescribing, controlled drug abusers and chemical dependence and consider the therapeutic implications of treatments based upon these beliefs, Event: Prescribing of Controlled Substances Course, 09/26/2018 5:30 PM - 8:00 PM, Location: UAB Huntsville School of Medicine, Registration type: PA, The Medical Foundation of Alabama designates this live activity for a maximum of 2 AMA PRA Category 1 Credits™. Madison County Medical Society.

[15] CE - A Retrospective, Epidemiological Review of Hemiplegic Migraines in a Military Pop.... Society of Federal Health Professionals

[16] CE Article The Transcendental Meditation. Society of Federal Health Professionals

[17] CE - MilMed Article Outcomes of Genitourinary Injury. Society of Federal Health Professionals

[18] CE - MilMed Article Risk of Exertional Heat Illnesses Associated with Sickle Cell Trait in US Military. Society of Federal Health Professionals

[19] CE - Military Health Provider Training and Evaluation of a Problem Solving. Society of Federal Health Professionals

[20] CE - Impact of TBI, PTSD, and Hearing Loss on Tinnitus Progression in a US Marine Cohort. Society of Federal Health Professionals

[21] CE - Development of a Perceived Access Inventory. Society of Federal Health Professionals

[22] CE - The Incidence of Dental Needs During Isolated Missions Compared to Non-Isolated Missions. Society of Federal Health Professionals

[23] CE - A Model for Supporting Grief Recovery Following Traumatic Loss. Society of Federal Health Professionals.

[24] ASSESSMENT TITLE: Medical Receptionist Skills, INCLUDED MODULES: Medical Receptionist Skills, TIMESTAMP: Mon, 30 Sep 2019 10:27:41 PM CDT, Completed: 09-30-2019.

[25] Telemedicine: Can It Help Your Practice? PHYSICIAN BUSINESS ACADEMY. Course material developed by Medscape, LLC, December 27, 2019, WebMD, LLC, 395 Hudson St, New York, NY 10014, www.medscape.com.

[26] Medscape Physician Business Academy, Telemedicine, Course material developed by Medscape, LLC, December 28, 2019.

[27] Medscape Physician Business Academy. How to Become an Effective Medical Leader. Course material developed by Medscape, LLC. December 28, 2019.

[28] CONTINUING MEDICAL EDUCATION CERTIFICATE, 2019 Updates in Hematologic Malignancies and Disorders, December 28, 2019, and is awarded 1.00 AMA PRA Category 1 Credit(s)™. Medscape, LLC designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board. Certificate Number: 76587826.

[39] Resident Member of American College of Radiation Oncology (ACRO), ID: 50536American College of Radiation Oncology, 2001 6th Ave., Suite 2700, Seattle, WA 98121, Phone: (206) 956-3642 Email: [email protected]. Member Since 11/5/2019, Expires: 12/31/2022. About ACRO: The College is managed by a volunteer Board of Chancellors elected by the membership and guided by the By- laws. The Board consists of 11 elected Chancellors made up of the Chair, the President (Chair Elect), the Vice-President (President Elect), the Secretary- Treasurer, the three (3) Chairs of select ACRO Standing Committees (Governmental & Economic Affairs Committee, Standards Committee, and Membership Committee), and four (4) At-large members of the Board. The Board meets twice

17 each year, at the Annual Meeting and at a mid-year meeting in October. The Executive Committee meets monthly by telephone conference call. Elections are held annually prior to the College’s Annual Meeting. Each chancellor serves a 4- year term but not more than two consecutive terms. The chief executive officer of the College is the President of the College who automatically ascends to the position of Chairman. Programming is by committees whose members are appointed by the Board of Chancellors. The Board of Chancellors adheres to guidelines of tenure for committee personnel to ensure periodic rotation. The Board of Chancellors, through a contract with an association management company (WSMA Association Management Services), is supported by an Executive Director who, with other assigned staff members, is responsible for all functions related to management direction, administrative services, membership administration, publications, conference management, financial management, continuing medical education, and committee support. The strength of the College lies in the careful appointment of committees for the varied assignments and in the broad participation of members in the educational activities.

[40] Candidate for Postdoc Fellowship in Neural Circuits, Basal Ganglia, National Institute of Neurological Disorder and Stroke, 02/11/2020.

[41] Candidate for Postdoctoral fellowship, Emory University, 02/11/2020.

Work and Experience:

[1] (2014 - 2017) Executive Manager, Research & Commercial Manager at Saina Medical Monthly Magazine at Saina Medical Clinic.

[2] (1999 - 2019) Shareholder & Stakeholder of Manzoumeh Sanat Co., Teheran, Iran.

[3] (2015 – 2019) Ambassador of European Association for Cancer Research in Iran.

[4] (2016 – Present) Honorary Board Member and Member of the Board of Directors in Weston A. Price Foundation, Washington DC, United States of America.

[5] (2017 – Present) Executive Manager, CEO and Founder of Iran Chapter at Weston A. Price Foundation, Washington DC, United States of America.

[6] (2008 – 2019) Research Manager at Manzoumeh Sanat Co., Tehran, Iran.

[7] Volunteer Corps of Health Volunteers Overseas (HVO) - Founded: 1986 - Headquarters: Washington, D.C. - Number of employees: 13 - Type of business: Humanitarian Health Aid - Areas served: Africa, Asia – Volunteer from 2018.

[8] Executive Manager and Funder of Violet Cancer Institute (VCI) certified and indexed in Indiana Cancer Consortium (ICC).

[9] Member of Federal Health Professionals in United States Marine Forces, Army Forces and Military Medicine. Federal Membership ID: 98581

[10] Member and Volunteer Corps at American Cancer Society (ACS), American Cancer Society Cancer Action Network.

[11] The North Alabama Medical Reserve Corps, 3330 L&N Drive, Suite I, Huntsville, AL 35801, Brooke Rawlins, NAMRC Director, +1(256) 457-1906

[12] Registered Researcher in the U.S. Government's System for Award Management (NAS).

[13] Member of The Global Tracheostomy Collaborative, we are a global Quality Improvement Collaborative (QIC) for tracheostomy patients consisting of a multidisciplinary team of physicians, nurses, allied health clinicians and patients/caregivers from a global community working together to disseminate best practices and improve outcomes. Dr. David Roberson, ENT specialist, from Harvard is the lead on the Collaborative.

[14] Registered Scientist at National Center for Biotechnology Information.

[15] Guest Editor of Nature Medicine Journal, 2018 – 2019.

[16] Professional Reviewer at National Institute for Health Research (NIHR), United Kingdom, https://www.nihr.ac.uk/.

[17] Editor of the Publishing Research Group, American Society of Clinical Oncology, 2318 Mill Road, Suite 800, Alexandria, VA 22314, Phones: 888-282- 2552, 703-299-0158, Licensed by asco.org • cancer.net • conquer.org • cancerlinq.org

[13] Editorial Board and member of Global Oncology Interest Group, American Society of Clinical Oncology. USA.

[14] Senior Research Scientist at Science Council. ID: A-0008833

[15] Campaigns Ambassador of Cancer Research UK: Campaigns Ambassadors save lives by persuading politicians to support better cancer policies. Just by talking to their politicians, Ambassadors help change Government policy. They campaign on cancer prevention, early diagnosis, science research and access to treatments. Elected Date: 2019. Website: https://www.cancerresearchuk.org.

[16] Volunteer Corp of Memorial Sloan Kettering Cancer Center, 1275 York Avenue, between 67th and 68th Streets, in Manhattan. Requisition ID: 2018-23677.

[17] Full-Time Member of American Red Cross - National Capital Area, Membership Number: 17249835, Website: https://www.redcross.org.

[18] Nominee of Assistant Management Accountant (Fixed Term Contract), Buckingham Palace, London, United Kingdom.

[19] Nominee of Summer Duty Manager (Buckingham Palace 2019), Household / Department: Royal Collection Trust, Section / Branch: Visitor Experience. Location: Buckingham Palace, Contract/recruitment type: Summer position, Start date: June 2019, End date: October 2019, Starting salary: £25,116 per annum, pro-rata, plus lunch and training provided, Hours of work: 37.5 per week, over 5 days, Monday to Sunday, About the role: It's leading the team to deliver a remarkable visitor experience. It’s the collaboration and the community spirit. And it’s helping millions

20 enjoy magnificent buildings and beautiful art. This is what makes working for Royal Collection Trust so different. When the doors of Buckingham Palace’s glorious State Rooms are opened to the public each August and September, hundreds of thousands of people come to visit. Our outstanding and friendly summer team welcome, delight and inspire every one of our visitors. Joining our enthusiastic Visitor Services team as Duty Manager, your challenge will be to ensure the delivery of an exceptional visitor experience. Each day, you’ll oversee the daily operations of the Summer Opening whilst inspiring your team to deliver their very best. You’ll train and guide our front-of-house staff before the Palace opens, making sure they’re ready to meet the daily demands of this busy operation. And, when the doors are open, you’ll engage, support and motivate them, and act as a trusted source of advice for our Team Leaders and Supervisors. Whether you're dealing with customer queries or overseeing the visitor route, you'll be the final point of call, resolving any issues that may arise. And, as you liaise closely with the other Duty Managers, you’ll champion collaboration across the operation to ensure continuity at all of our London locations. Above all, you'll aim for the highest levels of care and security for staff, visitors and the Royal Collection in all that you do, and be the driving force behind a truly memorable visitor experience.

[20] Nominee of Senior Buyer, Household / Department: Royal Collection Trust Section / Branch: Retail, Location: St. James’s Palace, Contract/recruitment type: Fixed Term Contract, start date: May 2019, End date: May 2020, Salary band: c. £45,000 per annum, Hours of work: 37.5 per week, Monday to Friday, About the role: It’s finding inspiration for the next top seller. It's never standing still. And it’s playing your part in the team helping millions enjoy magnificent buildings and beautiful art. This is what makes a career at Royal Collection Trust so exceptional. Through permanent and seasonal shops, as well as a growing eCommerce platform, Royal Collection Trust's retail operations generate a revenue that is directly invested into the care and conservation of the Royal Collection. As Senior Buyer, your challenge will be to source and develop approximately 200 new items each year for sale online and across our sites. You’ll be involved in all aspects of retail buying, from planning and sourcing products, through to marketing and display. Our retail range is as varied as our international customer base. You’ll develop products that are bespoke to Royal Collection Trust, ensuring new lines appeal to our customers and resonate with the visitor experience and exhibitions at each of our sites. You’ll

21 need to be on the pulse. As a source of expert advice, you’ll be relied upon to keep up to date with current and emerging trends to drive through new initiatives that will keep improving our retail offering at every opportunity. We place a great emphasis on UK manufacturing and you will look to build and maintain a core base of suppliers in all product areas. Working closely with each supplier, you’ll ensure all trade is in line with our ethical and sustainable standards. You'll also collaborate and build strong relationships with colleagues across the Retail department to ensure appropriate stock levels are maintained and all products are consistent with our style and brand. And you’ll monitor our sales, continuously looking for new opportunities to improve performance. Creative thinking will be key, and you’ll be encouraged to grow your expertise, whilst developing our product range. And knowing you play an integral part in an exceptional retail service will motivate you to deliver the exceptional.

[21] Nominee and elected for Summer Operations Supervisor (Buckingham Palace 2019), Household / Department: Royal Collection Trust, Section / Branch: Visitor Experience, Location: Buckingham Palace, Contract/recruitment type: Summer position, Start date: June 2019, End date: October 2019, Starting salary: £22,717.50 per annum (pro-rata) plus lunch and training provided, Hours of work: 37.5 per week, over 5 days, Monday to Sunday.

[21] Personal Campaign, The Oral Cancer Foundation, Website: https://donate.oralcancer.org/campaign/Prime-cause-and-treatment-of-cancer, Campaign Title: Prime cause and treatment of cancer.

[22] Certified nominee of Senior Research Associate, University of Cambridge, ID Number: SW17809.

[23] Certified Nominee of CCI/CCF Public Engagement Coordinator, University of Cambridge, UK, ID: NS17600.

[24] Volunteer and Member of HERA • Swiss Volunteers, HERA ® • Version 3.90 © deimos.ch 2005-2019. Erdgas. www.swissvolunteers.ch.

[25] Volunteer of Cancer Research Wales, Cancer Research Wales, Velindre Hospital Whitchurch, Cardiff CF14 2TL. https://www.cancerresearchwales.co.uk.

[26] volunteer opportunity offered by Discussion Central, Time Commitment: 5-8 Hour Commitment, AIChE Publication Committee, volunteered by: Arthur Baulch, Managing Editor, Journals, AIChE.

[27] Volunteer at Young Professional Committee Industry Liaison, Offered by: Monica Mellinger, Senior Membership Associate & Engage Community Lead, AIChE.

[29] Judges/Alumni Volunteer 2019 Mid-Atlantic AIChE Regionals Conference for Saturday, April 6th. Volunteering Roles - Chem-E-Car Poster & Safety Inspection: Description: 9 AM - 11 AM: For this, you will have to look at the posters each school team has created for their competition car they have built. You will be given a judging form and have to make sure that every school competing is following the rules, i.e. dress appropriately, the car itself is not in hazardous form, information on poster follows requirements, etc. - Student Poster Competition: Description: 11:00 am - 1:00 pm. Student members present posters on their findings in sustainability, catalysis and reaction engineering, computing and process control, environmental aspects of chemical engineering, as well as food, pharmaceutical, bioengineering, fuels, petrochemicals, energy, materials, separations, among other topics. Your role for this is to ask questions and judge each student. Top 3 students will be given reward money. - Student Paper Competition: Description: 10:00 am - 12:00 pm: Students are given the opportunity to discuss what they want to. Presentations often focus on recent advances in some branch of chemical engineering, original research, or plant design. For this event, we will need 3 chemical engineers (faculty, industry representative, or AIChE local section member) to judge paper presentations. the setting for this will be in a classroom setting where we will place about 3-5 students in each room to present and you, the judges will then get to see their presentation approx 15 min each and rank them. The top 3 students will get prize money and the top winner will be submitted for the National Student Paper Competition.

[31] Member of Swiss Volunteers. Verlosung Swiss Volunteers Weltklasse Zürich 2019. HERA • Swiss Volunteers, 222.swissvoluneers.ch. @ Swiss Volunteers | Impressum | Contatto | FAQ | Condizioni.

[33] Candidate for the Director of Revenue Analysis position within the Stand Together philanthropic community. © Freedom Partners Shared Services, LLC; 1310 N. Courthouse Rd; Suite 700; Arlington, VA 22201; USA.

[34] preserved as Position Title: DIRECTOR OF MILITARY SUPPORT, Agency: Army National Guard Units. Announcement Number: WA-10507254-AR-19-161. Extra Information: DIRECTOR OF MILITARY SUPPORT located at the WASHINGTON J3 DCSOPS.

[35] Certified Volunteer at 2019 International Conference on Frontiers of Neural Networks, ICFNN 2019, DATE: 26 July, 2019 - 28 July, 2019 VENUE: Rome, Italy.

[36] Technical Committee-Roles and Responsibility, INTERNATIONAL ACADEMY OF SCIENCE AND ENGINEERING FOR DEVELOPMENT, Hong Kong, Website: www.iased.org.

[37] Ambassador of Lung Cancer Community, Lung Cancer Registry, USA.

[38] Volunteer/member of the Abstract Review Board/Poster Judge for the 2019 National Abstract and Poster Competitions, 2019 National Abstract Competitions, ACP, Los Angeles, CA, April 23-25, 2020.

[39] Nominee for Sanger Institute as Advanced Research Assistant. ID: 83488. Institute Summary: We use genome sequences to advance understanding of the biology of humans and pathogens to improve human health. Website: https://www.sanger.ac.uk/

[40] Lead Guest Editor of Cancer Research Journal, (http://www.sciencepublishinggroup.com/specialissue/specialissueinfo?journalid= 158&specialissueid=158011/ Introduction: Oncology and Molecular Biology Research (OMBR) is an internationally peer-reviewed journal that aspires to publish eminent quality papers in all the arenas of cancer and Molecular Biology related fields. The special issue main focus is on the novel concepts, new methodologies, advanced regimens, novel therapeutic agents and also alternative approaches for

24 early detection and intervention of cancer. Aims and Scope: Cancer Molecular Biology, Cellular Biology, Military Medicine (Oncology), Cancer Biology, Oncology.

[41] Selected Executive Director - Digital Research (OTV), The Walt Disney Company of the United States of America.

[42] Director of Infection Prevention position at Virginia Hospital Center, Arlington, VA 22204, $90,957 - $130,978 a year, (Virginia Hospital Center is a 394-bed not- for-profit teaching facility with multiple, independently recognized Centers of Excellence including: Cardiology & Cardiovascular Surgery, The Reinsch Pierce Family Center for Breast Health, The Hitt Family Center for Radiation Oncology, Neuroscience/Stroke, Oncology, Orthopedics (Total Joint Replacement Services), Palliative Care, Advanced Inpatient Diabetes Program, Inpatient Rehabilitation, Wound Healing & Hyperbaric Medicine, Emergency Services, Women & Infant Health and Urology.]

[43] Assistant Editor, Disney Publishing Worldwide, Employee ID: 692588BR. Formerly: The Disney Publishing Group (1992 - 1998), Buena Vista Publishing (1998 - 1999), Type: Subsidiary, Industry: Publishing, Founded: 1991; 28 years ago, Founder: Michael Lynton, Headquarters: Glendale, California[1], Number of locations: 2 creative centers (2009), Area served: Worldwide, Key people: Andrew Sugerman (EVP) Jeff Sellinger (SVP, Learning) Jeanne Mosure Raj Murari (SVPs, Group Publishers) Lyle Underkoffler (VP, Digital), Parent: Disney Parks, Experiences and Products, (The Walt Disney Company), Divisions: Core Publishing, Digital Publishing, Subsidiaries: Disney Book Group, LLC, Disney Learning, Disney Magazine Publishing, Inc.

[44] Executive Director - Digital Research (OTV), ID: 666246BR, Disney Publishing Worldwide, (The Walt Disney Company).

[45] Candidate for Assistant/Associate Professor of Clinical Medicine - Department of Medicine, Division of Hematology/Oncology. UIC.

[46] Candidate of Director, Quality - Hospital Cancer Programs, UIC.

[47] Candidate of Criminal Intelligence Officer - Forestry Crime at INTERPOL

[48] Senior Editor of EC Clinical and Experimental Anatomy Journal.

[49] Nominee of the Director of Curriculum and Instruction, U.S. Naval Sea Cadet Corps - Arlington, VA 22201.

[50] Assistant Director, Political and Security Affairs, The National Bureau of Asian Research - Washington, District of Columbia, Position Description: Assistant Director, Political and Security Affairs (PSA) Overall responsibilities: Assistant project directors work on project teams to support directors in accomplishing specif...

[51] AIChE Volunteer of company recruiter of American Institute of Chemical Engineers. 120 Wall Street, 23rd Floor, New York, NY 10005, Phone: +1-646-495- 1361, Website: www.aiche.org, E-mail: [email protected].

[52] Public Affairs Specialist, GS-1035-13 (FBI), Director's Office, National Press Office, Washington, DC, ID: 27931,

[53] Editor-In-Chief for the Journal of Multidisciplinary Research and Reviews, Journal of Multidisciplinary Research and Reviews is an international, peer reviewed, open access, scientific and scholarly journal which publishes Research papers, Review papers, Mini reviews, Case reports, Case studies, Short communications, Letters, Editorials, Books, Thesis, Dissertation works, etc., from all the aspects of Agricultural Science, Biological Science, Business, Chemical Science, Education Science, Engineering and Technology, Humanities, Life Science, Physical Science, Marine Science, Social science. After publishing, articles are freely available through online without any restrictions or any other subscriptions to researchers and readers worldwide. Area – Multidisciplinary, Frequency – Biannual, Language – English, Review Process – Double Blinded, Publication Timeline: 21 Days peer review process, Available online by 45 days from the date of submission. URL: https://www.innovationinfo.org/index.php/journal/Editor_in_Chief/Dr-Sorush- Niknamian

[54] Criminal Intelligence Officer - Forestry Crime, INTERPOL recruitment – External Candidates. https://interpol.recruitmentplatform.com/Q22FK026203F3VBQBV7V4V4EW/EN/

26 index.php?ID=Q22FK026203F3VBQBV7V4V4EW&LG=EN&mask=interext&Jo bAdlg=EN/

[26] Volunteer at Sterling Volunteers, URL: https://app.verifiedvolunteers.com/en/Mains/Home,

[27] Peace Corps Volunteer (April 2020 - September 2020) of the United States of America, URL: https://www.peacecorps.gov/volunteer/, Member ID: 10811430.

[28] Organizing Committee Member of Neurology and Neurosurgery-2020, website: http://neurology.madridge.com/. 2nd International Conference on Neurology and Neurosurgery held during May 04-05, 2020 at Chicago, USA.

[29] Search Angel of Sterling Volunteer, Account ID: 8303, Website: https://app.verifiedvolunteers.com/en/Mains/Home/.

[30] Organizing Committee Member of 2nd International Conference on Medical Sciences, November 01 – 02, 2019 Denver, Colorado | USA, Theme: Enhance The Knowledge of Medicine and Surgery. URL: https://biomedconferences.org/biomedical-sciences/organizing-committee.php.

[31] Board Member of Current Research in Oncology, https://kosmospublishers.com/board-members-oncology-research-and-therapy/, Kosmos Publishers, Current research in Oncology is an online open access scientific journal which publishes peer reviewed articles from all the subjects of Cancer research and topics related to Oncology essentially for all those with an active interest in the treatment of cancer. Focus: Oncology Research and Therapy deals with diagnosis, treatment of cancerous tumours of different types. It mainly focuses on the progress of clinical and basic research for cancer which promotes to understand the causes and their cure with best possible advancements. This journal works to accelerate the advanced clinical research for cancer patients and its prevention towards it by publishing original research articles, review articles, case reports, brief reports, communications, image articles, commentaries, etc. Mostly diagnosis techniques like Biopsy, Endoscopy, X-rays, MRI, CT scan, Blood tests can be followed to determine malignancy are realms of high interest for the journal publications. There is tremendous ongoing research on the treatment of different categories of cancer like chemotherapy, radiotherapy and surgery, where our journal

27 plays a vital role in focusing the improvements in treatment and cancer detection thereby enhances the quality of life. All published articles are permanently archived and available at Kosmos Publishers website in HTML and PDF formats.

[32] Nominee of Executive Assistant to the Chief Operations Officer GPM, Corp - Asheville, NC (Geriatric Practice Management), Devoted to the support of LTPAC medical practices, Address: 16 Biltmore Ave, Suite 300 | Asheville, NC 28801, Website: https://gpm.md/

[33] Mission Support Analyst, GS 11/12 (External) (Detroit), ID: 29499, Location: DETROIT

[34] Organizing Committee Member, https://www.boffinaccesssynod.com/patient- safety. World Congress on Patient Safety and Quality Health care, March 19-20, 2020 Abu Dhabi, United Arab Emirates.

[35] Editorial Board Member of SunKrist Public Health and Research Journal, https://publichealth.sunkristpublishing.com/editorial-board-members.php.

[35] Organizing Committee Member at 2nd International Conference on Neurology and Neurosurgery held during May 04-05, 2020 at Miami, USA. Madridge Conferences invites all the participants from all over the world to attend 2nd International Conference on Neurology and Neurosurgery during May 4-5, 2020 at Orlando, USA. The annual Neurology conference provide opportunity for direct communication between the Young Researchers and highly affiliated personalities in medical field whether they are working in the similar field and also provides an opportunity to explore the innovative ideas of the other communities, companies and associations. The First International Conference on Neurology has gathering of neuron research experts from 18 different countries all over the world. Neurology- 2020 conference brings Research Institutions, Neurosurgeons, Neuron specialists, Physicians, Neuroscientists, Psychiatrist, Health Care Personnel, CEO's, Presidents of Industries, Business Delegates, Young Researchers and talented Student populations under a solitary gable catalyzing information exchange for the advancement of research in the field of Neurology from around the world in addition to contributed papers both oral and poster presentations. We look forward to welcoming participants from all over the world to the sparkling country of USA and

28 are highly optimistic of making this event a cherishable experience for our participants and collaborator. URL: https://neurology.madridge.com/

[36] Presidential Editorial Board of International Journal of Nursing and Health Care, International Journal of Nursing and Health Care is an online-only, broad based, peer reviewed open access journal with a global focus on scientific research in all related areas of Clinical Cytology and Pathology. The main objective of the journal is to serve a forum for scientists, researchers, physicians, Surgeons and other health professionals to find current advances in the areas of Clinical Cytology and Pathology. International Journal of Nursing and Health Care, an Open Access peer reviewed Journal welcomes varied article types such as Original Articles, Research Articles, Review Articles, Short Reports, Case Reports, Perspectives (Editorials). URL: http://www.scitechz.com/nursing/eb.php.

[37] Volunteer Member at United Nations, URL: https://vmam.unv.org/

[38] volunteering with Diabetes Canada. prospective volunteer, Diabetes Canada, 235 Yorkland Blvd, Suite 200, Toronto, ON M2J 4Y8, P: 416-408-7155, diabetes.ca | 1-800-banting | Leading the fight to end diabetes. Manager: Renan Passatore - Coordinator, Volunteer Engagement.

[39] Member of the CareFirst Medical Management Talent Network. CareFirst BlueCross BlueShield is a regional leader in providing health care insurance coverage and related services throughout Maryland, Washington, D.C. and Northern Virginia. In addition to our offices all around the region, we are also hiring subsidiary companies located in Baltimore, MD, Alexandria, VA and Charleston, WV.

[40] Associate Member of Institute of Consultants/Southern Africa, Membership number: A00405, Referral Link: http://www.iocsa.org/Register/A00405, The Institute of Consultants Southern Africa (IOCSA) was formed to represent all professionals who consult to, advise or counsel clients in business, government, SOE’s, NGO’s and society in general. These professionals can provide services on a permanent, interim or freelance basis. Purpose: The purpose of the Institute is to create a flourishing, competitive consulting marketplace in which business solutions are delivered ethically for the benefit of all key stakeholders, namely the Consultant,

29 the Client and Society. Code of Conduct: All members of the Institute are required and agree, as a condition of membership, to adhere to a Code of Conduct.

[41] planning advocate of APA (American Planning Association), (1) urging the members of Congress to increase funding for federal transportation and community development programs that would strengthen and better connect communities and residents to opportunity. Investing in our nation’s infrastructure is one of APA’s top policy priorities in 2019. The Confidential message for "Congress: Prioritize communities in final FY2020 Transportation, Housing and Urban Development spending bill" was sent on 11/23/2019 07:20 PM to the following recipients: Sen. Mark Warner (D-VA), Sen. Tim Kaine (D-VA), Rep. Ben Cline (R-VA). (2) urging the representative to co-sponsor legislation that would strengthen and better prepare coastal communities for extreme flooding, storms, and rising seas. Promoting healthy and safe communities through good planning and strategic investments is one of APA’s top policy priorities in 2019. The Confidential message for "Urge your elected officials to co-sponsor the bipartisan Digital Coast Act" was sent on 11/23/2019 07:21 PM to the following recipients: Sen. Mark Warner (D-VA), Sen. Tim Kaine (D-VA), Rep. Ben Cline (R-VA).

[42] Organizing Committee Member, International Conference on Immunology and Vaccines” Paris, France, 22-24 September 2020. The Conference deliberation would be on the Theme: Innovative approaches and Recent Advancements in Vaccination & Immunology Research. web site: https://immunology.magnuscorpus.com/.

[43] Board member at Human Resource Department, Chevron Corporation. 1 Westferry Circus, Canary Wharf, London E14 4HA, United Kingdom. Invited by: James Armitage EMEA Recruitment Team Lead. Email: [email protected]/.

[44] Executive Editor and Board Member - Journal of Cancer Research Reviews & Reports, Journal Website: http://www.onlinescientificresearch.com/index.php, Members URL: http://www.onlinescientificresearch.com/members.php, Scientific Research and Community is Independent Open Access Publishers and encourages all the academic disciplines to publish their research globally. Scientific Research and Community finds the people from worldwide as community for publishing research in the arena of science and Technology. It is a Platform for all the Scientific

30 researchers and Young researchers to promote their research values through this organization. Scientific Research and Community is an Independent and Non Profitable Organization encourages people from Medical, Clinical, Health care, Engineering, Life sciences, Pharmacy research backgrounds. Scientific Research & Community is team with well qualified people as community and advisory board members who discovers new research and development for this organization. Test Scientific Research and Community aims to publish original research work that contributes significantly to enhance the scientific knowledge in Medical Sciences Clinical Research, Health Care, Engineering and Technology, Pharmacy, Life sciences, Environmental Sciences. Scientific Research and Community focus on Clinical Research, Epidemiology, Oncology, Biomedicine, Dentistry, Medical Education, Physiotherapy, Pulmonology, Nephrology, Gynaecology, Dermatology, Dermatoepidemiology, Otorhinolaryngology, Ophthalmology, Sexology, Osteology, Kinesiology, Neuroscience, Haematology, Psychology, Paediatrics, Angiology/Vascular Medicine, Critical care Medicine, Cardiology, Endocrinology, Gastroenterology, Infectious Diseases and Vaccinology, Hepatology, Geriatric Medicine, Bariatrics, Pharmacy and Nursing, Pharmacognosy and Phytochemistry, Radiobiology, Pharmacology, Toxicology, Clinical immunology, Clinical and Hospital Pharmacy, Cell Biology, Genomics and Proteomics, Pharmacogenomics, Bioinformatics and Biotechnology, Earth & Environmental sciences, Pharmaceutical research, Engineering and Technology.

[45] Organizing Committee of OCM for EPIGENETICS Series Conferences, Epigenetics and Chromosome, June 24-25, 2020 Zurich, Switzerland, Theme: Exceeding the Vision in the Field of Epigenetics and Molecular Biology, URL: https://epigenetics.europeannualconferences.com/organizing-committee.php/, Conferenceseries LLC Ltd and its subsidiaries including iMedPub Ltd and Conference Series Organise 3000+ Conferences across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members. Conferenceseries LLC Ltd is an amalgamation of Open Access Publications and worldwide international science conferences and events. Established in the year 2007 with the sole aim of making the information on Sciences and technology "Open Access", Conferenceseries LLC Ltd publishes scholarly journals in all aspects of Science, Engineering, Management and Technology

31 journals. Conferenceseries LLC Ltd has been instrumental in taking the knowledge on Science & technology to the doorsteps of ordinary men and women. Research Scholars, Students, Libraries, Educational Institutions, Research centers and the industry are main stakeholders that benefitted greatly from this knowledge dissemination. Conferenceseries LLC Ltd also organizes 3000+ International conferences across the globe, where knowledge transfer takes place through debates, round table discussions, poster presentations, workshops, symposia and exhibitions.

[46] Senior Editor at the Journal of Cancer Research and Cellular Therapeutics (JCRCT), Web link: https://www.auctoresonline.org/journals/cancer-research-and- cellular-therapeutics/editorial-board/, AUCTORES PUBLISHING LLC, 16192 Coastal Highway, Lewes , DE 19958, USA, Phone : +1-(302)-313-1778, Email : [email protected], About AUCTORES: Auctores is an emerging international open access publisher aimed at development and rapid dissemination of scientific knowledge to the global community without any restrictions. Auctores encompasses journals on discipline of science, technology and engineering, publishes the work in a manner that represents the highest standards and integrity. We run the operation in accordance with (COPE) guidelines which is universally acceptable. We are steadfast to safeguard the highest standards of publication ethics and take all probable actions contrary to publication misconduct, as stated in the Code of Conduct and for resolving the case suspected malpractice in publication ethics we follow COPE Flowcharts. We encourage the academics all over the globe of various fields to get connected with Auctores and publicize their findings. We follow rigorous standard peer review process and accept papers from all parts of the globe and there is no demographic, racial, and socioeconomic barriers. Auctores facilitate the dissemination of research discoveries to the global community without restriction. Thus, all articles published in Auctores journals are freely available online. Another slogan behind the establishment of Auctores is to act as a connecting link among researchers, academia, industry and policy makers. We planned a display place to emphasize quality innovative work and to encourage move towards to serve the scientific community with 30 worldwide open access, peer reviewed journals via the academics who focus on science, technology and engineering discipline through the work they publish with us. Auctores encompasses the time and quality consequently drives us on the way to the achievement and development of our ideas; broadening in our excellence services to guide our associates and figure out our

32 commitment. Our opinion is welcoming Novelties and a vision to authorize the existing researchers to enlighten the scientific world, expanding its support in guiding the academics and researchers in all parts of the globe.Auctores is ardent supporter to The Budapest Open Access Initiative (BOAI). In accordance with the (BOAI): All articles published by Auctores journals are under the terms of Creative Commons Attribution License. This permits anyone read, download, copy, share, print or use them for any other legalized determination, without asking permission from the publisher or the author, the original work and source is appropriately cited.

[47] Organizing Committee Member of the International Conference on Pharmacy and Pharma Network held on August 25-27, 2020 in Germany/Munich. Details: ICPPN Germany 2020 welcomes all participants throughout the world to attend the International Conference on Pharmacy and Pharma Network held on August 25-27, 2020 in Germany. The Conference deals with the theme on "Recent Innovations and Advances in Pharmacy and Pharma Networks" and it has a branch of Scientific Sessions concerned with the departments of Pharmacology, Pharmacognosy, Toxicology, Pharmaceutical Sciences, Clinical Pharmacy, Biopharmaceutics and which included with subdivisions they are Hospital Pharmacy, Industrial Pharmacy, Pharmaceutical Biotechnology, Medicinal Chemistry, Pharmaceutical Nanotechnology, Pharmaceutical Microbiology. Pharma Conference 2020 is a chance to extend and exhibit your ideas and explore the new innovations with experts from everywhere throughout the globe. The Conference serves researchers from academia and industry and intended to be of interest to a broad audience of Pharmaceutical, Medical and Health professionals, Worldwide pharmacists, Professors, researchers, they will present their novel research and provide an insight to the current research and future expansions in pharmacy and pharma network.

[48] Organizing Committee Member of an Organizing Committee Member for the 4th World Congress on Biotechnology and Healthcare which has been scheduled for the month of September 28 - 29, 2020 San Diego, USA. Invited by: Brenda Marshal, Program Facilitator | BioHe2020, CPG Scientific Events | USA. Website: http://www.biohealthconference.org/. Scope of the conference: The idiopathic goal of the conference is to promote research and developmental activities in Biotechnology and Healthcare and to encourage scientific information interchange between researchers, developers, students, and practitioners working around the

World. This will also provide you an opportunity to share knowledge and channels for extending businesses between industry and academia.

[49] Top Nominee of Committee Coordinator II at Social and Scientific Systems (SSS), Social & Scientific Systems (SSS) works to improve public health worldwide by providing technical, research, and program management services to government, nonprofit, and commercial clients. Our research and support for domestic and international health programs enable policymakers, medical professionals, communities, and citizens to improve public health. Please join our dedicated staff of employee owners in an environment that values diversity and supports health, wellbeing, and professional growth. This position is responsible for coordinating and facilitating activities for scientific, resource, community, and/or leadership/executive committees in support of Clinical Research and Bioscience projects and programs. Tasks include arranging teleconferences, drafting agendas, tracking action items, and drafting summaries and communications. The coordinator may also assist with other project-related activities that do not directly fall under committee support. The coordinator provides administrative and technical support with moderate supervision. Broad priorities are established by the supervisor with regular review. Responsibilities: Communicates effectively and continuously with committee leadership and members to coordinate and facilitate committee business, serving as a point of contact and guiding the committee on responsibilities, actions, and timelines with assistance from the supervisor and/or designee. Demonstrates good knowledge of internal and external procedures and, with assistance from the supervisor and/or designee, provides guidance to the committee. Proposes call/meeting agenda items to committee leadership. Schedules, coordinates, and participates in committee conference calls and face-to-face meetings. Drafts review/decision letters, conference call and meeting discussion summaries, and memoranda and communications that are timely, technically accurate, and grammatically correct for leadership review with moderate to minimal guidance and editing from the supervisor and/or designee. Distributes approved call and meeting summaries and correspondence as appropriate in a timely manner. Independently tracks and facilitates completion of action items from calls and meetings and ensures accomplishment. Coordinates, accurately generates, or creates necessary documents for timely distribution to the committee with input and review by the supervisor and/or designee as needed. Develops, maintains, quality assures, and distributes

34 standard or ad hoc reports with guidance from the supervisor and/or designee, interacting with internal project staff as necessary to ensure accurate and timely information. Facilitates committee membership elections if applicable. Performs information management including organization of electronic files; updates on internal and external project websites for membership rosters, resource documents, and status comments for study proposals (as needed); and maintenance of email distribution lists. Ensures the supervisor and/or designee is aware of all issues, including the status of action items and communicates with the supervisor and/or designee to identify committee leadership needs for information and materials. Identifies concerns of internal project staff that may need to be shared with committee leadership in conjunction with and approval by the supervisor and/or designee. Communicates independently and effectively with internal project staff to coordinate routine committee-related activities but consults with supervisor and/or designee on non-routine items. Proposes ideas and actively participates in meetings and activities with other group members to improve overall quality of work and work processes. May assist with independent data safety monitoring board committees in support of CRB projects and programs. Provides backup and/or supplemental support for other similar committees and tasks as needed. May support more than one committee. Performs additional duties as required and assigned. Website: https://careers-s-3.icims.com/jobs/logout?logout=1&hashed=843373731/.

[49] Organizing Committee Member of International Conference and Exhibition on Nanotechnology (ICENT), June 8-10, 2020, Seoul, South Korea, About Nano Seoul 2020: International Conference and Exhibition on Nanotechnology will be held at Seoul, South Korea during June 8-10, 2020. Nanotechnology 2020 features the theme "A Disruptive Innovation Shaping the Future Technology". Nanotechnology Conference deals with a branch of scientific sessions concerned with the departments of Nanotechnology, Nanomaterials, Molecular Engineering, Biotechnology, Pharmaceuticals, Nanophotonics, Tissue Engineering, Nanochemistry, Neuro Engineering, and Cancer Nanotechnology. Nano conference 2020 is an opportunity to enlarge and flaunt your thoughts and study the new advancements with researchers from all around the globe. Nano Seoul 2020 assembles world-recognized nanotechnology specialists, researchers, professors, industrialists, Business Delegates and students from the research fields of Nanotechnology, Materials Science, Medical Science, Chemistry and Physics. Nano

35 conference in South Korea helps researchers to share their research experience and indulge in interactive discussions. Conference Website: https://www.seoulnanoconf.com/#header/,

[50] Organizing committee Member, 3rd European congress on Material Science & Nanotechnology" scheduled on September 24-25, 2020 in Paris, France. The theme of the conference is "Developing Innovations and Challenges in Material Science & Nanotechnology". Euro Material Science 2020 presents a multifarious platform: Keynote/Plenary/Poster/ E-poster /Video/Workshop/Expo. URL: https://coalesceresearchgroup.com/conferences/materialresearch.

[51] Honorary Member of PMI Project, Program and Portfolio Management.

[52] Organizing Committee Member of World Congress on Glycobiology (WCG- 2020), May 28-29, 2020, Brussels, Belgium, website: https://conferenceera.com/glycobiology-conference/, World Congress on Glycobiology (WCG-2020) is an International Conference organized by ConferenceEra on May 28-29, 2020,at Brussels, Belgium. WCG-2020 invitesand unites researchers, scholar’s, students, academicians, research organizations, and making the congress a perfect platform to share most happeningscientific advancements, progressive research in Glycobiologyover the globe.WCG-2020 allows multiple opportunities for scientific networking and knowledge sharing interaction. As well as the activeposter discussion sessions, panel discussions for speakers and participants to engage beyond discussing the data, into envisioning a future that integrates rapidly evolving therapies, procedures in Glycobiology.WCG- 2020 will be a communicating environment to share deliberate current challenges and ways to move the field forward. The conference will foster the exchange of ideas and spur multidisciplinary collaborations.

[53] Associate Editor and Editorial Board Member of The Applied Medical Research Journal, E-ISSN 2149-2018, URL: http://www.ejmamr.com/index.php, The "Applied Medical Research" is a peer-reviewed publication, aims to publish all the latest and outstanding research articles, reviews and letters in all areas of medical sciences from molecules to organ systems. The journal aims to provide the most complete and reliable source of information on current developments in the field. Both experimental and clinical research and studies are welcome. By this way, one

36 of the main aims of the journal is to supply original information from bench to bedside. Thus, submitted manuscripts should provide a significant advance to the field supported by evident data.

[54] Organizing Committee Member of the 2nd World Congress On Cardiology and Cardiovascular Diseases, Theme: Emerging Procedures and Transpiring research in Cardiology and Cardiovascular Diseases, 21-22 September 2020, Paris, France, URL: https://www.phronesisonline.com/cardiology-congress/, WCCD-2020 has a great scholarly Scientific Program with 2 days of methodical sessions. This program will feature new research findings, chances to learn from world famous connoisseurs and discussions with contemporaries WCCD-2020 is a unique platform to bring together worldwide distinguished academicians in the field of Cardiology, cardiovascular & cardiac researchers, public health & business professionals, scientists, industry researchers and scholars to exchange about growing research and technologies. Expert faculties will discuss the relevant progress in Cardio research and will explore the latest trends to reduce the effects of cardiovascular risk factors. WCCD-2020 Conference provide a worldwide stage for trading most recent developments in the field of Cardiology and cardiovascular and offering opportunities to listen the presentations conveyed by eminent experts from everywhere throughout the globe. Participating at WCCD-2020 give an approach to meet, cooperate with, and make contacts with different specialists in your claim to frame region.

[54] Organizing Committee Member of International Conference on Pharmacy and Pharma Networks, August 25-27, 2020, Munich, Germany, ICPPN Germany 2020 welcomes all participants throughout the world to attend the International Conference on Pharmacy and Pharma Network held on August 25-27, 2020 in Germany. The Conference deals with the theme on "Recent Innovations and Advances in Pharmacy and Pharma Networks" and it has a branch of Scientific Sessions concerned with the departments of Pharmacology, Pharmacognosy, Toxicology, Pharmaceutical Sciences, Clinical Pharmacy, Biopharmaceutics and which included with subdivisions they are Hospital Pharmacy, Industrial Pharmacy, Pharmaceutical Biotechnology, Medicinal Chemistry, Pharmaceutical Nanotechnology, Pharmaceutical Microbiology. URL: https://pharma2020networks.com/.

[55] Executive Editor of Scientific Research & Community (SRC), URL: http://www.onlinescientificresearch.com/members.php. Scientific Research and Community is Independent Open Access Publishers and encourages all the academic disciplines to publish their research globally. Scientific Research and Community finds the people from worldwide as community for publishing research in the arena of science and Technology. It is a Platform for all the Scientific researchers and Young researchers to promote their research values through this organization. Scientific Research and Community is an Independent and Non Profitable Organization encourages people from Medical, Clinical, Health care, Engineering, Life sciences, Pharmacy research backgrounds. Scientific Research & Community is team with well qualified people as community and advisory board members who discovers new research and development for this organization. Scientific Research and Community aims to publish original research work that contributes significantly to enhance the scientific knowledge in Medical Sciences Clinical Research, Health Care, Engineering and Technology, Pharmacy, Life sciences, Environmental Sciences. Scientific Research and Community focus on Clinical Research, Epidemiology, Oncology, Biomedicine, Dentistry, Medical Education, Physiotherapy, Pulmonology, Nephrology, Gynecology, Dermatology, Dermatoepidemiology, Otorhinolaryngology, Ophthalmology, Sexology, Osteology, Kinesiology, Neuroscience, Hematology, Psychology, Pediatrics, Angiology/Vascular Medicine, Critical care Medicine, Cardiology, Endocrinology, Gastroenterology, Infectious Diseases and Vaccinology, Hepatology, Geriatric Medicine, Bariatrics, Pharmacy and Nursing, Pharmacognosy and Phytochemistry, Radiobiology, Pharmacology, Toxicology, Clinical immunology, Clinical and Hospital Pharmacy, Cell Biology, Genomics and Proteomics, Pharmacogenomics, Bioinformatics and Biotechnology, Earth & Environmental sciences, Pharmaceutical research, Engineering and Technology.

[56] Program Committee Member of World Congress on Public Health May 21-22, 2020, Berlin, Germany. URL: https://conferenceera.com/public-health- conference/program-committee, World Congress on Public Health (WCPH-2020): World Congress on Public Health (WCPH-2020) is an International Conference organized by Conference Era on May 21-22, 2020, at Berlin, Germany. WCPH- 2020invitesand unites researchers, scholar’s, students, academicians, research organizations, and making the congress a perfect platform to share most happening

38 scientific advancements, progressive research in Public Health over the globe. WCPH-2020 allows multiple opportunities for scientific networking and knowledge sharing interaction. As well as the active poster discussion sessions, panel discussions for speakers and participants to engage beyond discussing the data, into envisioning a future that integrates rapidly evolving procedures in Public Health.WCPH-2020 will be a communicating environment to share deliberate current challenges and ways to move the field forward. The conference will foster the exchange of ideas and spur multidisciplinary collaborations.

[57] Program Committee Member of Global Conference on Biotechnology and Bioinformatics, June 18-19, 2020 Boston, USA. (GCBB-2020), URL: https://moraft.com/biotechnology-and-bioinformatics-2020, About GCBB -2020: MORAFT welcomes you to attend the Global Conference on Biotechnology and Bioinformatics. GCBB -2020 is scheduled on June18-19, 2020 in Boston, USA. This conference specifically designed to bring subject matter professionals together to exchange and discuss current research findings in the field globally. Moraft is an international scientific conference-organizing group involved in promoting global current research through high profile conferences. We enable like-minded people to connect for sharing information, ideas, and opportunities for networking by providing the attendees platform to participate, enrich and discover innovation and future research. Well-known speakers all over the globe are invited to present their latest research updates and share findings, able to discuss the new techniques, procedures involved. Participants can have breakout sessions to have in-depth discussions, B2B meetings poster symposia, video presentations and workshops.

[58] First Nominee of Principal Researcher/Senior Researcher, Employer: The International Institute for Environment and Development (IIED), URL: https://isw.changeworknow.co.uk/iied/vms/e/careers/positions/c3LDy72LXfqA5O LczmEg0f. Location: Central London, Salary: £46,178 - £61,760p.a. (up to £69,744 for exceptional candidates depending on experience), plus benefits, Hours: 35, Contract Type: Permanent, Closing Date: 13 January 2020, Interview: 3rd OR 4th February 2020.

[59] First Candidate of Principal Researcher/Senior Researcher, Location: Central London, Salary: £46,178 - £61,760p.a. (up to £69,744 for exceptional candidates depending on experience), plus benefits, Hours: 35, Contract Type: Permanent, The

International Institute for Environment and Development (IIED) is a policy and action research organ. application ref. EG-M7M-DJI, https://isw.changeworknow.co.uk/iied/vms/e/careers/settings.

[60] First Candidate of Associate or Senior Editor, Nature Cancer Journal. Impact factor: 51.848 (2018), ISO 4: Nat. Rev. Cancer, History: Oct. 2001–present, ISSN: 1474-175X (print); 1474-1768 (web), Publishers: United Kingdom, Nature Research. URL: https://www.nature.com/natcancer/, Location: Shanghai. Job Code: (27859).

[61] Editor in Chief at Britain International of Exact Sciences Journal (BIoEx – Journal), ISSN: 2686-1208 (online) | 2686-1216 (print) |, Britain International of Exact Sciences (BioEx) Journal is a peer-reviewed journal published in January, May and September by Britain International for Academic Research (BIAR) Publisher. BioEx Journal welcome research paper in mathematics, physic, chemistry, biology, engineering, medical, Agriculture and other sciences related areas and it is published in both online and printed versions. Website: http://biarjournal.com/index.php/bioex/index.

[62] First Candidate and Elected for Chief, Division of Immunology, Boston Children’s Hospital, Professor of Pediatrics, HMS, Employer: Boston Children’s Hospital, Division of Gastroenterology, Location: Boston Children's Hospital, Posted: Dec 30, 2019, Specialty: Allergy & Clinical Immunology,Position Type: Permanent. Job Description: Division of Immunology, Department of Pediatrics, Boston Children’s Hospital, Immunology has been a central focus of the Department since Charles A. Janeway, MD took the position of Physician-in-Chief in 1946 and, with David Gitlin, pioneered the use of intravenous immune globulin. The Division of Immunology was created in 1968, led by Fred Rosen, MD with a separate Division of Allergy that was headed since 1976, by Raif Geha, MD. The two merged in 1986 under Geha, now the longest-serving Division Chief in Boston Chidren’s Hospital (BCH) history. Since its inception, the Division has been an international front-runner in the field of Pediatric Allergy & Immunology, credited with groundbreaking advances in the molecular, cellular, and genetic delineation of a wide range of immunodeficiency syndromes. The Division has attained distinction

40 in Allergy as well. Its investigators have identified dysfunction of regulatory T cells as the basis of tolerance breakdown in food allergy, demonstrated interactions of the microbiome with the gut immune system and dissected pathways of pathogenesis of atopic dermatitis. The Division’s leadership in scientific discovery is matched by its preeminence in clinical care. It is the largest clinical Division of Immunology in the nation with 35,000 patient visits annually. Patients with complex disorders of immune function are referred from around the world for evaluation by its physicians, who are also leaders in NIH-sponsored multicenter studies of the pathogenesis and treatment of allergic and immunologic disorders. A robust educational program, centered around an NIH T32 training grant, fills out the missions of the Division. The incumbent of the Chief position will assume responsibility for leadership, strategic coordination and advancement of all of the clinical, research, and training activities in the Division. Clinical Programs: Unique within the Department of Pediatrics at BCH in covering three independent clinical subspecialties (Allergy & Immunology, Pediatric Rheumatology, and Dermatology), the Division provides care for about 35,000 ambulatory visits annually along with inpatient care and consultation for 500 patients, making this, by a wide margin, the biggest such Division in Pediatrics nationally ($22M Annual Clinical Revenues). Under the leadership of Hans Oettgen, MD, PhD (Associate Chief), along with Andrew MacGinnitie, MD, PhD (Clinical Director), the clinical programs have seen dramatic expansion over the past three decades and now, in addition to offering services at the Longwood campus of BCH, offer full service clinics at six satellite locations ranging from Peabody in the North to Milford in the West and New Bedford on the South coast. Further extending the geographic range of service, rheumatologists provide care for children at the University of Massachusetts Medical Center and dermatologists cover consultations at Bay State Medical center via telemedicine. On the Longwood campus, clinics are now open three Saturdays and several evenings every month. Each of the subspecialties has grown over the past decade, notably including an increase from 2 to 7 FTE in Dermatology for which pediatric-trained subspecialists are quite rare and recruitment is particularly challenging. The clinical staff includes 45 MDs, 4 RN-PNPs, 15 RNs, and 30 administrative and support personnel. Several specialized integrated multispecialty clinics are offered by the Division, many developed recently. These include a Food Allergy Center, Aerodigestive Disorders Program, Eosinophilic Gastrointestinal Diseases Center, High Risk Asthma Clinic, Atopic Dermatitis Center, Samara Turkel Rheumatology

Center, Immune Dysregulation Clinic, Autoimmunity and Dermatology clinic, Pediatric Oncology Dermatology clinic (DFCI), Autoinflammatory Diseases clinic and, under development, a multispecialty lupus clinic. Basic Research: The laboratories of the Division occupy the 10th floor of the Karp Family research building. In contrast to the many other less clinically-oriented Immunology programs at HMS, the unifying theme of the research groups in the BCH Division of Immunology is a focus on the most important research questions seeded by clinical challenges in Allergy, Immunology, Rheumatology, and Dermatology. Areas of investigation under the senior PIs include 1) mechanisms of tolerance breakdown, host- microbiome interactions and effector cell function in food allergy (Chatila, Oettgen, Geha), 2) genomics and mechanisms of primary immunodeficiency disorders (Geha, Chatila), 3) mechanisms of skin inflammation in atopic dermatitis (Geha) and 4) innate immune system receptors and signaling (Zanoni). Several Assistant Professors, most currently on or recently funded by NIH K-awards, are being supported to develop independent research programs. Their main themes are 1) the genetic basis of immunodeficiency (Chou), 2) monocyte development and function (Lee), 3) pathogenesis of atopic dermatitis and its connection with food allergy (Leyva-Castillo), 4) genomics of arthritis and lupus (Janssen), and 5) synovial regulatory T cell function in arthritis (Henderson). The Karp 10 Immunology investigators, who have overlapping areas of interest and complementary areas of technical expertise, are highly collaborative and the new investigators receive tremendous support and guidance from the senior PIs. Division scientists have made a number of high impact discoveries. Some representative examples are cited here. Talal Chatila, MD and his team recently reported that a defined consortium of gut microbiota acts on intestinal immune cells in a Toll like receptor- mediated pathway, to induce a specialized RORgT+ type of regulatory T cells that control food allergy (Nat Immunology, 2019). The same investigators also recently uncovered the basis of the severe asthma phenotype conferred by the Q576R genetic variant of the IL-4 receptor alpha chain (also originally discovered by Chatila, N Engl J Med, 1997). They found that Q576R introduces a consensus Grb2-binding site, linking the receptor to transcriptional induction of genes leading to proinflammatory IL-17-dominated phenotype (Nat Medicine, 2016). In a series of elegant studies, Raif Geha, MD and colleagues have defined the cellular and molecular events in which a combination of skin injury (scratching) and cutaneous allergen exposure leads to atopic dermatitis. Many children with atopic dermatitis

42 also have food allergy and the Geha group recently provided the first demonstration of a compelling immunological basis for this link, showing that IL-33 from injured keratinocytes acts together with IL-25 from intestinal tuft cells to activate innate immune cells (ILC2) which, in turn, promote mast cell expansion (Immunity, 2019). The Geha and Chou groups have led the field in identifying novel genetic mutations underlying immunodeficiency including recently a TFR1 mutation (combined immunodeficiency) 4-1BB (EBV driven lymphoproliferation) IFNRA (CMV infection) RAC2 gain of function mutation, RELA (autoinflammatory disease) PI3KCD loss of function (hypogammaglobulinemia) (combined immunodeficiency) MYD88 truncation (BCG adenitis and neutropenia), c-Rel deficiency (combined immunodeficiency) STAT2 mutation (hemophagocytic lymphohistiocytosis) and ITPKB (severe combined immunodeficiency). The Oettgen lab has demonstrated that IgE-mediated mast cell activation not only results in immediate allergic reactions, as has long been understood, but also provides a critical pool of IL-4 that consolidates and sustains type 2 immune responses in mucosal tissues (Immunity, 2014). The clinical impact of this allergy- amplifying role of IgE is now being evaluated in humans by Oettgen together with Wanda Phipatanakul in the NIH PARK study in which young children are given anti-IgE to prevent allergic sensitization and the onset of asthma. Michiko Oyoshi, PhD’s lab investigates mechanisms of maternal à fetal tolerance transmission in food allergy and has recently found that IgG:allergen immune complexes transmitted via breast milk and transported by the neonatal Fc receptor, FcRN, confer tolerance to mouse pups (J Exp Med, 2018). Ivan Zanoni, PhD and colleagues have reported several high impact observations regarding innate immunity, including a demonstration that CD14 controls endocytosis of TLR4 and facilitates TLR-independent cellular activation by LPS (Cell, 2011). More recently Zanoni has focused on the roles of type III interferons in intestinal immune homeostasis and has described IFN-l regulation of neutrophil functions by non- transcriptional mechanisms (Nat Immunology, 2017). Clinical and Translational Research: Clinical research has blossomed in the Division over the past two decades especially in the areas of asthma, food allergy and rheumatologic disorders. Wanda Phipatanakul MD, MPH, has developed a leading center of asthma research ($6.9M annual NIH support, including 3 U01’s and 1 R01). Having skillfully fostered a strong alliance with the Boston Public School system, she and her team have gained access to students’ classrooms as well as their homes, allowing large-scale groundbreaking studies on the contributions of defined

43 urban home and school allergen and toxin exposures on asthma onset and morbidity. The center is a site for numerous NIH multi-center studies including the AsthmaNet and SICAS (School Inner City Asthma Study) programs. In addition, several large NIH sponsored treatment and prevention trials have been run from this center. This has benefited the entire Division, providing fruitful opportunities for mechanistic translational studies by basic science PI’s in the Division. One such first-of-kind trial in the prevention of asthma applies a strategy of IgE blockade (Oettgen, mechanistic studies). Other innovative and high-impact studies include an ongoing trial of IL-4 receptor blockade in a genotype-stratified trial enrolling children harboring a genetic variant of the receptor (Q576R) associated with severe disease, originally discovered by Talal Chatila, MD in the Division (Chatila, mechanistic studies), and investigations of the association of the same variant with atopic dermatitis (Geha and Leyva-Castillo, mechanistic studies). In food allergy research, Division investigators have pioneered strategies for oral immunotherapy, including adjunctive use of anti-IgE (omalizumab) (Schneider and Umetsu) and establishing safety and efficacy of the first peanut allergy products likely to receive FDA approval including an OIT formulation (Rachid, Chatila, mechanistic studies) and an epicutaneous patch (Schneider). A highly innovative strategy for reversing established food allergy, fecal microbial transfer, is now in the clinic in Phase I trials (Rachid, Chatila) in a Harvard- Broad-MIT sponsored project. This is an offshoot of studies by Rachid and Chatila with collaborators at the BWH Microbiome Center showing that a defined consortium of bacteria can prevent and/or reverse food allergy in mice. The first pediatric trials of IL-4 receptor blockade in atopic dermatitis are being done in the Division (Schneider). In Rheumatology, ongoing translational investigations include studies to characterize regulatory T (Treg) cell dysfunction in systemic JIA and oligoarticular JIA (Henderson, Chatila, Nigrovic) and mechanistic characterization of a recently described cause of CNS vasculitis and stroke in children, adenosine deaminase 2 deficiency (Lee). Scholarship: An overview of the published output of its investigators during the preceding five years prepared for last year’s Scientific Advisory Committee (SAC) Review of the Division demonstrated the aggregate impact of their research with numerous papers in the most influential journals including NEJM (6), JAMA (4), Nature (2), Science (3), Immunity (8), Nature Medicine (2), Nature Immunology (2), JCI (6), Blood (12), JEM (11), and PNAS (5). In addition, more than 100 papers were published in the most prestigious journal of the subspecialty, the Journal of Allergy and Clinical

Immunology (impact factor 14.2). In terms of published output, this division is without peer in Pediatric Immunology Divisions in the U.S. Training and Education: The Division of Immunology offers three clinical fellowships: Pediatric Dermatology (Liang, PD), Allergy & Immunology (Schneider, PD), and Pediatric Rheumatology (Lo, PD). Each is viewed as among the preeminent training programs in its specialty in the U.S. In addition, Jennifer Huang in the Division serves as overall PD for the Harvard Combined Dermatology residency, anchoring that nationally highly-ranked residency in the Division as well. The Allergy & Immunology and Pediatric Rheumatology fellowships each include 2-3-year research components during which trainees’ salaries are funded by a 9-slot NIH T32 (Oettgen, PI) now in its 35th year (Geha, founding PI). The T32 attracts the most talented and research-oriented applicants, many holding MD, PhD degrees. While many trainees are paired with mentors within the Division, the grant encourages training with T32 faculty members throughout Harvard, so far including, HMS, BIDMC, MGH, HSPH, and BWH. More than 90% of the graduates of this program have remained in academia, many now serving in major leadership positions including Division and Department Chiefs as well as Editors-in-Chief in the U.S. and internationally. Faculty plays a major role in the training of residents in the Boston Combined Residency in Pediatrics and serve as faculty and/or leaders in several HMS courses. International outreach and collaborations: In an effort to identify novel genetic causes of immunodeficiency the Division established ten years ago the International Consortium for Immune Deficiency (ICID). ICID is co- directed by Raif Geha and Janet Chou. It has 36 collaborating centers spread over North Africa, The Middle East, Southern Europe, and South America. These collaborations foster scientific discovery, and make referrals to BCH of patients with rare immunodefciencies who may undergo bone marrow transplantation or become subjects in gene therapy programs. Patients encountered via CID are an invaluable resource for our training program. Clinical and Molecular Immunology Laboratories: Craig Platt, MD, PhD, an immunologist in the Division trained in the Geha lab, oversees the execution and strategic development of complex laboratory tests including flow cytometric and functional analyses run in the BCH Department of Laboratory Medicine’s CLIA-certified Immunology lab. For patients with uncharacterized immunodeficiency syndromes, the Division under the leadership of Dr. Janet Chou offers state-of-the-art genetic and functional evaluation in a research setting with a pipeline starting with rapid sequencing of more than 300 genes known

45 to be linked to immunodeficiency followed, if the screen is negative, by whole exome sequencing and in-house bioinformatic analysis of the exome. For all mutations identified in the research lab, CLIA-approved Sanger sequencing (for positive DNA variants) or whole exome analysis is sent out to verify the results. This capability for efficient yet deep immunological evaluation has been a major draw for international referrals, and variants identified in this lab account for six of twelve new mutations reported in the international literature just this past year. Budget: The wide scope of clinical, scientific, and educational activities of the Division is supported by a diverse array of resources. Total operating funds are $37M, distributed among $22M clinical revenue, $12M Grants, and $3M endowment income. The NIH research grant portfolio includes 13 R01, 4 U01, and 1 U19 grants. NIH training grants in the portfolio include a T32 (9 slots, $601K) along with 2 K08 and 2 K23 awards. Pharma awards from Genentech, Aimmune, ThermoFisher, and others support ongoing clinical and related mechanistic studies. The Division has actively cultivated relationships with philanthropists from individuals and foundations including the David and Denise Bunning Foundation for Food Allergy Research, The Food Allergy Science Initiative, The Perkin Fund, The Samara Turkel Fund, and others. Four HMS chairs and one BCH chair support senior Division faculty. Four investigatorships, smaller endowed funds awarded for two-year periods, help promote the emerging research programs of young investigators in the Division. The division has also accumulated a substantial surplus from its clinical income that has been instrumental in recruiting faculty. Qualifications: The incumbent Chief will be an internationally recognized senior physician investigator specialized in Allergy & Immunology. S/he will have demonstrated an outstanding record in basic or translational research and have the breadth of scientific knowledge and insight to shepherd the academic mission of the Division. It will be critical for the incoming leader to also have deep experience and demonstrated proficiency in administration as well as the ability to align goals among the diverse clinical programs and to integrate the clinical, research, and educational activities of the Division. The incumbent should have the skills needed to sustain and expand the current federal funding portfolio while actively fostering relationships with private philanthropists, foundations, and pharma sources. Finally, the successful candidate must be an outstanding individual who is able to work collegially with the clinicians and scientists in his or her charge and to foster collaborations and interactions among Division faculty members as well as with the broader Boston Children’s and Harvard

Medical School faculties. URL: https://www.nejmcareercenter.org/job/308407/chief-division-of-immunology- boston-children-s-hospital-professor-of-pediatrics- hms/?Action=ShowConfirmation&UserState=ExistingUserWithProfile&Applicati onId=235704#apply-form.

[64] Honorary Editorial Board of Journal of Clinical Research and Reports : Open Access, Journal DOI: 10.31579/JCRR/2019, Website: https://www.auctoresonline.org/journals/journal-of-clinical-research-and-reports, About the Journal: Journal of Clinical Research and Reports (JCRR) is an international peer reviewed scholarly journal whose primary aim is to dissemination and development of knowledge on all aspects of clinical trial design, management, legal, ethical and regulatory issues, case record form design, data collection, quality assurance and data auditing methodologies. The journal has a broad coverage for articles are clinical trial methodology, traditional results papers, clinical trial design, conduct, decision analysis, synthesis, history, statistical methods, data management, legal, ethical and regulatory issues, case record form design, data collection, quality assurance, data auditing methodologies, risk-benefit, cost-effectiveness, clinical or policy impact of all types of clinical trials and related medical research methodologies. All the articles submitted to JCRR subject to rigorous double-blind peer review process under the guidance of an international editorial board consisting of a distinguished team of Addiction researchers and reviewers. Call for submissions: Journal of Clinical Research and Reports editor welcomes all types of articles like Research, Case Report, Short Communication, Review, Hypothesis, Method and protocol, Editorials, Perspectives, Letter to the editor from every corner of the globe. All published articles will be assigned DOI provided by CrossRef. Open Access Policy: This journal is an open access journal which provides immediate, worldwide, boundary-free access to the full content of every distributed article without charging readers or their institutions for access. Readers are given the authorization to read, circulate, copy, print, download, search, or link to the full texts of all articles in JCRR. JCRR implements the Creative Commons Attribution License to all works published providing instant and permanent access for free to all types of original works. The license grants copyright to the author concerned and makes the articles available for their dissemination. Anyone can use the articles in

47 any constructive way as long as the credit is given to the author and citation to the original source.

[65] Senior Nominee of Senior Director, Federal Affairs, Government Affairs & Policy (GA&P), Company Name: Gilead Sciences, Company Location: Washington D.C. Metro Area. Gartner, Inc. (NYSE: IT), is the world’s leading research and advisory company and a member of the S&P 500. We equip business leaders with indispensable insights, advice and tools to achieve their mission-critical priorities today and build the successful organizations of tomorrow. Our unmatched combination of expert-led, practitioner-sourced and data-driven research steers clients toward the right decisions on the issues that matter most. We are a trusted advisor and objective resource for more than 15,000 organizations in more than 100 countries — across all major functions, in every industry and enterprise size. https://www.gartner.com/en.

[66] Nominee of 41636 Conference Associate, Rotational Program – Stamford, Gartner, Inc. (NYSE: IT), is the world’s leading research and advisory company and a member of the S&P 500. We equip business leaders with indispensable insights, advice and tools to achieve their mission-critical priorities today and build the successful organizations of tomorrow. Our unmatched combination of expert-led, practitioner-sourced and data-driven research steers clients toward the right decisions on the issues that matter most. We are a trusted advisor and objective resource for more than 15,000 organizations in more than 100 countries — across all major functions, in every industry and enterprise size. https://www.gartner.com/en.

[67] Senior Candidate for Chief of Staff, United Nations Foundation Washington D.C. Metro Area, Position Overview: The United Nations Foundation is seeking a dynamic and proven professional to serve as Chief of Staff to the President & CEO as the Foundation embarks on its next generation of innovation, advocacy, and partnership to support the United Nations and UN causes. The Chief of Staff will function as a strategic partner to the President & CEO, supporting the P/CEO’s management of the Foundation’s leadership team, working to align organizational mission and goals with high quality execution across the Foundation, fostering inclusive and productive relationships between the P/CEO and staff throughout the organization, facilitating timely decision-making and a productive balance between

48 short-term execution and long-term priorities, and ensuring strategic use of the P/CEO’s time. The Chief of Staff will also serve as principal liaison for the UN Foundation Board of Directors and oversee preparation and follow-up of Board meetings. The Chief of Staff serves as a member of the Foundation’s Leadership team and is a member of the Executive Office, reporting to the P/CEO. The successful candidate will have a track record of excellence operating in similar roles in complex organizations and have a reputation for exceptional judgment, emotional intelligence, personal integrity, and results.

[68} Nominee of Parks, Experiences and Products for the Editorial Assistant position (ID: 736966BR). The Walt Disney Company, Disney Parks, Experiences and Products is the global hub that brings Disney’s stories, characters, and franchises to life through theme parks and resorts, cruise and vacation experiences, and consumer products—everything from toys to apparel, and books to video games. https://dpep.disney.com/.

[69] Nominee of Senior Editorial Assistant 2 yrs. exp. req. AASA, The School Superintendents Association - Alexandria, VA 22314. SUMMARY: The incumbent works closely with the Editor of School Administrator magazine to produce, curate and/or edit magazine content, as well as provide administrative support. This individual also has a principal role managing Conference Daily Online.ID: 035589.

[70] Prime Nominee of Chief Scientist, Air Force Office of Scientific Research (AFOSR), Company Location: Arlington County, Virginia, United States, The Chief Scientist is a key individual in the Air Force Research Laboratory/Air Force Office of Scientific Research (AFRL/AFOSR) organization and is a part of the Air Force Materiel Command. AFOSR is headquartered in Arlington, VA. AFOSR is the basic research manager for AFRL and manages a worldwide exchange program for scientists and engineers. AFOSR invests in long-term, broad-based research into Air Force-related science and engineering. Through grants to universities, contracts for industry research, and support for basic research in AFRL, AFOSR strengthens the national knowledge base and research infrastructure in support of the Air Force goals. Guided by the National Defense Strategy and the Air Force Science and Technology Strategy, AFOSR has identified core Science and Technology directions. These directions support the Transformational Strategic Capabilities outlined in the Air Force Science and Technology Strategy and represent approaches

49 for fostering basic research that can lead to technology advancements through coordinated research in several disciplines. Some of these research areas include aerospace, chemical and materials sciences, math, information and life sciences and physics and electronics. The Chief Scientist Provides Input in the Following Areas: Scientific advice and guidance on research plans and programs in accordance to the core science and technologies. Advises on the status of scientific and technical competence within AFOSR, the employment of consultants and experts; and plans and conducts efforts including symposia colloquia and technical training. A broad range of technical expertise to fine-tune the direction of engineering, scientific, physical and biological sciences, and human systems research projects and help identify emerging areas of research for the Air Force. Key Responsibilities: As AFOSR's principal scientific/technical advisor and primary authority for the technical content of the basic research program the Chief Scientist is responsible for the following broad areas: Evaluate the scope of the technical research program to determine its adequacy and efficiency in meeting national, DoD, USAF, AFMC, and AFRL objectives in core area technologies. Identify research gaps and analyzes advancements in a broad range of scientific fields including human cognition, collective behavior, social-cultural modeling, etc., advising on their impact on AF programs and objectives. Lead the transition of basic research results to more mature programs such as synthetic biology development, cyber development, and hypersonic technologies. Recommend new initiatives and adjustments to current programs required to meet current and future Air Force needs. Programs judged by incumbent to be worthy of intensive and extensive exploration are those of national and/or international significance and involve many major and exceptionally critically scientific and engineering problems. Explore novel interdisciplinary/multidisciplinary approaches as required.

[71] Official Ambassador of American Osteopathic Society of Rheumatic Diseases (AOSRD), Reno, Nevada.

[72] Associate Editor of Archives of Nanomedicine: Open Access Journal, Editorial Manager: Jessica Rose, Email: [email protected], [email protected], URL: https://lupinepublishers.com/nano-science-nanotechnology-journal/editorial-committee.php, Archives of Nanomedicine: Open Access Journal (ANOAJ) is a peer reviewed scientific journal meant for professionals and researchers in Nanomedicine and Nanotechnology. This journal

50 publishes high quality original articles, review articles, case reports, short communications, etc. It is an international, peer-reviewed journal presenting significant, novel, interdisciplinary theoretical and experimental results related to nanoscience and nanotechnology in the life sciences. Content includes basic, clinical research addressing diagnosis, treatment, monitoring, prediction, translational and prevention of diseases. This journal covers a wide range of categories such as molecular nanotechnology, Nano sensors, nano particles, Nano drugs, drug delivery, nanomaterials, Nano biotechnology, Nano biopharmaceutics, Nano electronics, nano-devices, nanorobotics etc. The potential scope of nanomedicine is broad, and we expect it to eventually involve all aspects of medicine. Sub-categories include synthesis, bioavailability and biodistribution of nanomedicines; delivery, pharmacodynamics, and pharmacokinetics of nanomedicines; imaging; diagnostics; improved therapeutics; innovative biomaterials; interactions of nanomaterials with cells, tissues, and living organisms; regenerative medicine; public health; toxicology; point of care monitoring; nutrition; Nano medical devices; prosthetics; biomimetics; and bioinformatics. It invites all type of High Quality articles such as Editorial, Research Articles, Short Communications, Opinion Articles, Review Articles, Case Reports. We invite authors to submit original manuscripts in these categories. Lupine Publishers, LLC, 57 West 57th Street, 3rd floor, New York - NY 10019, USA, +1 (914) 407-6109, Fax - +1 (914) 465-7596, [email protected], ISSN: 2637-6660, Linking ISSN (ISSN-L): 2637- 6660.

[73] Certified Volunteer and Member of the ASCO Ed Book expert panel, The STEM International Organization (STEMIO) is a platform for professionals, who contribute meaningfully to STEM research around the world through their scientific investigations and research projects. The United States recognizes the need for investment in STEM education in order for young people to be competitive in the jobs market. In September 2017 President Donald Trump signed a presidential memorandum to expand access to high-quality STEM education for young people. It will put STEM education, particularly computer science, at the forefront of the Department of Education’s priorities. It also aims to devote at least $200 million a year in grant funds towards this area. Our Organization recognizes the importance of encouraging students from an early age to have an appreciation and a growing understanding of science. In an increasingly global society, as an initiative to support

51 the STEM research, we have established this society to create and expand opportunities for all researchers that will enable them to navigate and lead the 21st century. About STEM: The STEM International Organization is a platform for professionals, who contribute meaningfully to STEM research around the world through their scientific, tecnological, engineering and mathematical investigations and research projects. The United States recognizes the need for investment in STEM education in order for young people to be competitive in the jobs market. In September 2017 President Donald Trump signed a presidential memorandum to expand access to high-quality STEM education for young people. It will put STEM education, particularly computer science, at the forefront of the Department of Education’s priorities. It also aims to devote at least $200 million a year in grant funds towards this area. Our Organization recognizes the importance of encouraging Researchers, Scientist and students from an early age to have an appreciation and a growing understanding of STEM. In an increasingly global society, as an initiative to support the STEM research, we have established this organization to create and expand opportunities for all STEM researchers that will enable them to navigate and lead the 21st-century. The STEM Board of directors thrive for-Become a bridge between Educators and students for their research breakthrough investigations. Seek the Sponsors for grants approvals to promote their research through STEM Research Funding. Form a global community of dedicated and passionate STEM professionals for advisory roles. Encourage and research sharing through scientific events worldwide and STEM Expo. Empower the skilled and leading women professionals by Women in STEM. Conduct stem tours for the STEM researchers to explore real- world applications of their research via STEM Tours. Our Mission: Our mission is to promote the research and disseminate and encourage the researchers by channelizing their knowledge through different outreach programs and events. Our Vision: Our Vision stands to broaden the horizons of STEM and become a unique platform for researchers, scientists, physicians where they could get the solution for all their stem-related problems.

[74] WW Teaching Fellow and Woodrow Wilson Graduate School of Teaching and Learning of the Woodrow Wilson National Foundation. The Woodrow Wilson National Fellowship Foundation identifies and develops leaders and institutions to meet the nation’s critical challenges. 5 Vaughn Drive | Suite 300 | Princeton, NJ 08540-6313 | Phone: 609-452-7007 | Fax: 609-452-0066. (In Process).

[75] Professor of Biology, Chemistry and Mathematics, West Chester University of Pennsylvania, Date of beginning: Summer 2020. Address: 700 S High St, West Chester, PA 19383.

[76] Being the session chair for “Pharmaceutical Research & Development” at “International Conference on Pharmaceutics and Drug Delivery Systems”, September 24-26, 2020 at Rome, Italy. https://irisscientificgroup.com/conferences/pharmaceutics-and-drug-delivery- systems/. ICPD 2020.

[77] Editorial Board Member of Journal of Medical Case Reports and Reviews, an Open Access Publication ISSN: 2589-8655 | 2589-8647, About the Journal: JMCRR invites original research and review articles not published/submitted for publications anywhere. The journal accepts review articles only if author (s) has included his/her own research work and is an authority in the particular field. Invited or submitted review articles on current medical research developments will also be included. Medical practitioners are encouraged to contribute interesting case reports. The journal publishes special features like and book reviews clinical trials which are registered in the Clinical Trial Registry of India or Clinical trials.gov. We publish innovative original research papers, review articles, case reports and short communications dealing with all the medical specialties like Anatomy, Physiology, Biochemistry, Pharmacology, Pathology, Forensic medicine, Microbiology, Community Medicine, Ophthalmology, Otorhinolaryngology, Internal Medicine, General Surgery, Paediatrics, Obstetrics and Gynecology, Orthopedics, Psychiatry, Radiology, Pulmonary Medicine, Dermatology and Venereal diseases, Infectious Diseases, Anaesthesia, Cardiology, Diabetes, Cancer research, Endocrinology, Urology, Neurosurgery, Geriatric Medicine, Gastroenterology, Neurology, Nephrology, Dentistry and Medical education. About US: We also accept research articles in the field of Medical Research, Free radical biology, Immunology, Infertility, Hematology, Medical Genetics, Laboratory Medicine, Medical Statistics and Biotechnology Welcome to the Journal of Medical Case Reports and Reviews, Rapid publication of original medical and allied research articles, reviews, case reports, preliminary and pilot studies. Symposium proceedings, summaries of presentations or collections of medical data on a specific topic are also welcome, for publication as supplements/special issues. Journal Editorial Board members oversee the peer review process for the journal, including evaluating submissions, selecting

53 reviewers and assessing their comments, and making editorial decisions. Together with Advisory Editorial Board Members they are involved in the development of journal policies and ethics standards and work to promote the Demo Journal mission to provide resources, support and advice for early stage researchers in their journey from writing to publishing their scientific papers while at the same time making free public access to scientific research. URL: http://jmcrr.info/index.php/jmcrr/about/editorialTeam.

[78] Organizing Committee Member of 2nd International Congress on Cancer Research and Therapy 2020, 18-19, June 2020 Valencia, Spain, About the Conference: The 2nd International Conference on Cancer research and Therapy is scheduled for June 18-19 2020, Valencia, Spain. Impact Cancer 2020 invites all the participants from all over the world which includes prompt Keynote talks, Oral talks, Poster presentations, Sponsor Ships and Exhibitions. The aim of this conference is " Inspiring Innovations and Advanced Practice in Cancer Care ". Impact Cancer 2020 is comprised of many interactive scientific sessions as well as various diagnostic and therapeutic advancements in cancer. It is an initiative to unite the diverse research and business communities working in this field under a one roof to explore every single aspect of oncology. Importance & Scope: Impact Cancer 2020 will be the best platform for all the oncologists, hematologist's, research scholars, students who are working in this field to exchange their knowledge related to Oncology Research. This international event is an effort to understand the underlying biological procedures which are amended to increase effectiveness, precision, survivability and quality of life. Impact Cancer 2020 is the premier event that brings together international experts, Training Institutes, Manufacturing Medical Devices Companies, Business Entrepreneurs, Medical Colleges, Researchers, Academicians, Physicians, Post Docs, Students, Pharmacy Industries, Academic scientists, Industry professionals, Diagnostic laboratory professionals and decision makers across the globe to exchange their knowledge, experience and research innovations to build Cancer Research scientists to reduce the global burden of cancer. Why To Attend? You do not need to be a member International Conference on Oncology {IMPACT Cancer Research and Therapy 2020} attend the conference. Our conference invite to Leading World Doctors, registered Nurses, Professors, Research fellows and many more from leading universities, companies and medical research institutions, hospitals sharing their novel researches in the arena of Oncology. Attendees will

54 include: Academicians, Oncologists, Radiologists, Chemotherapists, scientists, clinicians, researchers, world Doctors, Health practitioners, Pharmaceutical organizations, Clinical Research organizations. Associations and Societies sponsoring the meeting and looking for collaborative partners. hospitals sharing their novel researches in the arena of Nursing (exhibiting). Policy and decision makers with disciplines in the field of Radiation Therapy and chemotherapy Nursing stakeholders including academic researchers and entrepreneurs, industry policy makers. IMPACT conferences attract participants representing more than 53 countries around the world. IMPACT Executive Program: If you are a young scientist who is interested in dementia care and wishes to exchange ideas with industry experts, the IMPACT EXECUTIVE PROGRAM may well be the event for you. It is a 2 days’ event held in parallel to the conference, tailored around Stem cell and its advances. This program provides a unique opportunity to meet like-minded individuals and share the insights of the world's foremost specialists in Oncology innovators. Conference Benefits: International Summit on Cancer conference is comprised of scientific sessions, keynote forums, Exhibitions, workshops, symposia and poster presentations where the most recent developments in Oncology research will be discussed. Website: https://www.impactcancer2020.com/.

[79] Volunteer at International Volunteer HQ (IHVQ), Project: Childcare, Duration: 12 weeks, Start Date: Apr. 1, 2020. Service Country: Kenya. Our mission is to change the face of volunteer travel. Established in 2007, we have grown to become the world’s leading volunteer travel company, working in over 50 destinations around the world and placing thousands of volunteers abroad every year. We believe in a future where any traveler, anywhere in the world is empowered to make a meaningful difference in the community they are visiting, and we take pride in making this happen. We’re focused on providing affordable volunteer travel experiences that are responsible, safe and high quality. Our programs heighten global awareness and cultural understanding through the skills and expertise taken by volunteers to their host communities, and through the experiences and lessons that volunteers take back to their own countries and cultures. We’re a values-led organization and there is a lot that we stand for, but four values in particular sit above all others. These are what make us tick: Responsible: Being responsible in everything we do is a fundamental value at IVHQ. For us it’s about more than just running safe volunteer programs, and we work hard to to create and run ethical

55 programs that prioritize community needs and the protection of children. Our programs are designed to deliver sustainable value for communities and for the environment, and we talk openly about the issues and challenges of responsible tourism. We believe in always doing the right thing and having a long-term mindset, and we work hard to ensure volunteers develop realistic expectations about the impact they’ll have. Innovative: Innovation has always been central to our success as an organization. We’ve challenged the status quo and changed the face of volunteer travel by making it affordable and accessible to everyone. We know that to keep our fees low and remain a positive contributor to communities around the world, we have to constantly innovate, be smarter about how we serve communities and volunteers, and take a fresh approach to addressing the issues that are important to our sector. Since the beginning, we’ve been an entrepreneurial young start-up that’s proudly youthful, non-corporate and tech-focused. We understand that every volunteer dollar is hard-earned and we work tirelessly to deliver value. Trusted: Being trusted is important to IVHQ. We think globally and we demonstrate respect for all volunteers, communities and everyone we interact with. We are honest, open and transparent about how we operate and volunteers can count on us to keep them informed, to keep them safe and to always follow through when we make a commitment. We’re not afraid to work hard for our volunteers and we're fiercely loyal to them, and to every community we operate in. Awesome: Always striving to be awesome is something that truly sets IVHQ apart. For us, being awesome means being passionate about volunteer travel, the communities we work with and the individual volunteers we interact with every day. We’re an organization made up of real people with diverse ideas and personalities and we never forget that our volunteers are just as unique. For us, being awesome also means being youthful, ambitious and tenacious, and ensuring that we use our size and scale to have a significant global impact. We believe that staying nimble helps us to adapt and respond to volunteer and community needs in the best possible way. Website: https://my.volunteerhq.org/login. [email protected], +64-6-758-7949 (International), 1-877-342-6588 (USA/Canada Call Free), 0-808-234-1621 (UK Call Free), 1-800-557-380 (Australia Call Free).

[80] Organizing Committee Member at 3rd International Conference on Physical and Theoretical Chemistry, May 18-19, 2020 Budapest, Hungary. About Conference: Physical Chemistry 2020 Conference Series is now proud to announce

56 the “3rd International Conference on Physical and Theoretical Chemistry” during May 18-19, 2020 Budapest, Hungary. Organizing Committee was inviting the participants from all over the globe to take part in this annual conference with the theme “changing the World by Exploring the Emerging Trends in Physical and Theoretical Chemistry”. Physical Chemistry 2020 aims at sharing new technologies and new ideas amongst the students, professionals and industrialists from research areas of Physical chemistry, thermochemistry, surface science, geochemistry, astrochemistry to share their recent changes and applications in various fields and indulge in interactive discussions and technical sessions at the event. The Conference was also providing a space for institutions and/or companies to present their research results, services, products and their innovations. Theme: "Changing the World by Exploring the Emerging Trends in Physical and Theoretical Chemistry" - Physical Chemistry 2020. Website: https://physicalchemistry.alliedacademies.com/.

[81] First Candidate of GLO001BJ Senior Editor (Part-Time) - The Lancet Oncology. 2020, The Lancet began as an independent, international weekly general medical journal founded in 1823 by Thomas Wakley. Since its first issue (October 5, 1823), the journal has strived to make science widely available so that medicine can serve, and transform society, and positively impact the lives of people. Over the past two centuries, The Lancet has sought to address urgent topics in our society, initiate debate, put science into context, and influence decision makers around the world. The Lancet has evolved as a family of journals (across Child & Adolescent Health, Diabetes & Endocrinology, Digital Health, Gastroenterology & Hepatology, Global Health, Hematology, HIV, Infectious Diseases, Neurology, Oncology, Planetary Health, Psychiatry, Public Health, Respiratory Medicine, Biomedicine, Clinical Medicine), but retains at its core the belief that medicine must serve society, that knowledge must transform society, that the best science must lead to better lives. https://www.thelancet.com/journals/lanonc/home. About the journal: The Lancet Oncology was launched in September, 2000, as a lively and informative monthly journal covering international issues relevant to clinical cancer specialists worldwide. The journal is now the world-leading clinical oncology periodical publishing high-quality, peer-reviewed research (especially reports from clinical trials), reviews, comment and opinion, weekly news, and Commissions (typically in partnership with societies, governments, NGOs, and academic centres). Content

57 covers topics that advance clinical practice, challenge the status quo, advocate change in health policy, and tackle issues related to global oncology. Much of the journal’s articles are published Online First for enhanced timeliness prior to print publication. Uniquely, all original research is peer-reviewed via a fast-track service, and successful papers are published within 8 weeks of submission. The journal also regularly features podcasts, video, infographics, and curated web content. The Lancet Oncology has also fostered a reputation for hosting events for oncologists, cancer researchers, and policymakers. The Lancet Oncology convenes many conferences, either alone or in collaboration with partners. Events include branded plenary lectures and sessions at conferences worldwide; the long-running Asian Oncology Summit series; Oncology At The Limits; Frontiers of Oncology; Advancing Cancer Immunotherapy; and The Lancet Summit, to name just a few. Reputation and Impact: The Lancet Oncology has an Impact Factor of 35·386®. The journal ranks third out of 229 oncology journals worldwide, and is the leading clinical oncology research journal (2018 Journal Citation Reports®, Clarivate Analytics 2019). Articles published in The Lancet Oncology regularly receive coverage in the mainstream print, online, and broadcast media.

[82] ID: GLO001DF, Elsevier Scientific Editor Candidate.

[83] ID: R2412 Director of Evidence-Based Medicine and Medical Editor Candidate.

[84] International Organizing Committee Member and keynote speaker at 7th International Conference on Global Healthcare, Sep 14-15,2020, Vienna, Austria. Website: https://globalhealthcare.pulsusconference.com/research-excellence- awards#. OCM URL: https://globalhealthcare.pulsusconference.com/organizing-committee. Pulsus Group is an internationally renowned peer-review publisher in scientific, technical, and medical journals established in the year 1984 with offices in Ontario, Canada and Hyderabad, India has acquired Andrew John Publishing and openaccessjournals.com to expand its Open Access Publishing through its 50+ journals in association with 20+ International medical and scientific societies. Pulsus through its cmesociety.com is been very instrumental to provide an invaluable channel for scientists and researchers to exchange ideas and research by creating a forum for discussing the possibilities of future collaborations between universities,

58 institutions, research bodies and organizations from different countries through international CME/CPD accredited conferences and meetings.

[85] Volunteer of Cystic Fibrosis Foundation as a teamMATE (The “MATE” stands for “Make Adding Tomorrows Easier). Email: [email protected].

[86] Volunteer for Chem-E-Car Competition EDP Reviewer (Online), Selected by: Sarah Ewing, Senior Membership Associate, AIChE, Duties: Volunteers will receive a copy of the safety rules, and are asked to review their assigned EDPs for compliance with safety rules and completeness. Volunteers are asked to provide general comments regarding the safety of the vehicle and the completeness of the package, which are passed along to the students who will have a chance to remedy any safety concerns before their car is judged onsite by a live safety inspector. A safety evaluation form will be provided to guide the entire review process. URL: https://engage.aiche.org/volunteeropportunities/volunteer-opportunity- details?VolunteerOpportunityKey=dd39a4d9-ef19-4a6a-9cb9- c7de6f5ae0a4&CommunityKey=de21ae11-bfdc-41b4-851d- 84c7293f0d99&ssopc=1. Starts: 02-07-2020.

[87] Organizing Committee Member of 2nd International Conference on Traditional Medicine and Nutrition, 22-24, September 2020, Theme: Contemporary Advancements and research in Traditional Medicine and Nutrition, https://traditionalmedicine.magnuscorpus.com/organizing-committee. Hotel Name: Hyatt Regency Paris - Charles de Gaulle, Address: 351 Av. Du Bois De La Pie Cs 42048 Paris, Nord 2 Cedex, 95912 Roissy-en-France, France.

[88] Board Member of Mangwende Orphan Care Trust, https://mangwendeorphancaretrust.org/. The Mangwende Orphan Care Trust– is a locally driven project which seeks to reverse family disintegration resulting from the devastating effects of HIV/AIDS, poverty and diseases consequently leading to countless numbers of orphans and child headed families. The project is thus driven by the community itself where the project coordinator and board meet with local community leadership to ascertain their needs and work to facilitate provision of those needs. The project is a non-denominational and non-governmental charity project which has no formal relationship with any grouping, but seeks to interact with all churches as well as bodies and individuals who share the same vision. It will

59 help children regardless of race, color, religion or sex especially in areas of providing education, health care, counseling, supplementary feeding, spiritual and moral guidance and life survival skills. We have come to the conclusion that sustainable farming is the backbone of our project. The Mangwende Orphan Care Trust is a project founded in memory of the life of the late Chief Jonathan Tafirenyika Chibanda Mangwende. We believe that the rural areas, the ignored villagers, vulnerable and the needy can rise again. The project was initiated end of 2013 as a partnership project linking faith based organizations, the community, traditional leadership, the farming as well as business community. The chief was well known for his passion to the less privileged and patronage to supportive organizations during his lifetime. The Mangwende Orphan Care Trust encompasses our core beliefs, our vision and our mission. Through the Trust we establish our strategic direction, our policies and procedures for the sustainable projects. The Trust facilitates financial and legal management and provides core project oversight and protection whilst instilling integrity and accountability. OUR VISION: To facilitate the socioeconomic transformation of Zimbabwe and Africa as a whole, by educating, assisting and advocating for widows, orphans, vulnerable and under- privileged. Our actions are guided by kingdom principles and under the auspices of the Council of Chiefs and local government we encourage the use of innovative technology and cutting edge methodology. Our aims are underpinned by sustainability, food security and green – skill development with the aid of renewable green energy and information technology. OUR MISSION: Centered on Christ Jesus, we will share the Fathers heart by maximizing the effectiveness of the three Zunde raMambo Pillars in the community –Zunde Community center, Zunde RaMambo plots and Master Farmer/Hurudza, facilitated through the Mangwende Orphan Care Trust. We hope to restore the family unity, through a paradigm shift, from the begging bowl mentality to one of civic engagement, by raising a generation of socially responsible leaders grounded in stewardship, service and entrepreneurial self- sufficiency. By sharing the Father’s heart, we seek to bring hope and a future to those previously without hope.

[89] Volunteer at Cystic Fibrosis Foundation volunteer, Virginia Chapter, https://www.cff.org/, Cystic Fibrosis Foundation, 4550 Montgomery Ave. Suite 1100 N, Bethesda, MD 20814, 301-951-4422, 800-344-4823 (toll free). The mission of the Cystic Fibrosis Foundation is to cure cystic fibrosis and to provide all people

60 with CF the opportunity to lead long, fulfilling lives by funding research and drug development, partnering with the CF community, and advancing high-quality, specialized care.

[90] Nominee of Job title: SENIOR RESEARCH ANALYST, Job link: https://jobs.washingtonpost.com/job/40736635/senior-research-analyst/, Employer: The American Academy of Actuaries, Application date: 2/19/2020. The Washington Post Jobs Team 1301 K Street, NW Washington, DC 20071.

[91] Volunteer at Pancreatic Cancer Action Network, Pancreatic Cancer Action Network®, PanCAN®, PurpleStride®, Wage Hope®, Know Your Tumor®, Powerful Knowledge. Personal Treatment. ®, Precision Promise℠ and Demand Better For Patients. For Survival. ℠ are the trademarks of the Pancreatic Cancer Action Network, Inc. The Pancreatic Cancer Action Network is registered as a 501©3 nonprofit organization. Contributions to the Pancreatic Cancer Action Network are tax-deductible to the extent permitted by law. The Pancreatic Cancer Action Network’s tax identification number is #33-0841281. http://volunteercentral.pancan.org/home?badlogin=1. Pancreatic Cancer Action Network®, PanCAN®, PurpleStride®, Wage Hope®, Know Your Tumor®, Powerful Knowledge. Personal Treatment.®, Precision Promise℠ and Demand Better For Patients. For Survival.℠ are the trademarks of the Pancreatic Cancer Action Network, Inc. The Pancreatic Cancer Action Network is registered as a 501©3 nonprofit organization. Contributions to the Pancreatic Cancer Action Network are tax-deductible to the extent permitted by law. The Pancreatic Cancer Action Network’s tax identification number is #33-0841281.

[92] Nominee of Lead Oncology Medical Expert, Philadelphia, Pennsylvania; Collegeville, Pennsylvania, Medical and Clinical, Req ID: 239668. Job description: Site Name: USA - Pennsylvania - Upper Providence, USA - Pennsylvania – Philadelphia Posted Date: Jan 22 2020, The Medical Expert (ME) Lead is a trained disease area expert in Oncology with a credible voice of Medical with external customers. The ME Lead engages external stakeholders representing GSK in engagements where first-hand clinical expertise and experience in the field is necessary and is responsible at the therapy area level for providing high-value Oncology expertise to the internal organization, and leading external communications and engagement designed to educate, gain external expert insight

61 and advocacy. The ME Lead is the direct tie between the team and VP and TAH for Oncology and Senior Medical Lead for the assets, and indirectly to the medical and scientific directors, field leaders and US VEO. The position provides an essential bridge to GSK that will enable the delivery of medicines of value to the market and patient. The education and experience required for this position is essential to ensure credibility to facilitate engagement with external medical community, to ensure accuracy and appropriateness of interpretation and integration of information within GSK. The incumbent will establish and maintain ongoing long-term collaborative peer-to-peer relationships with key thought leaders and may manage certain KOL activities like Advisory Boards. Key Responsibilities; Lead other MEs to ensure consistency & clear KPIs for the organization: Content and strategic input, including; Medical unmet need development; Pipeline/R&D input; and, Other key strategic areas. Engagement of top EEs, physician and patient associations, other key healthcare stakeholders (AMCs, etc.); Appropriate documentation of associated field related activities. Engage with of US EEs, physician associations, other key healthcare stakeholders (AMCs, etc.) and treating HCPs partnering with medical field leadership based on geographic location and existing relationships, engaging them on: Medico-scientific exchange, relevant to the MA asset strategy. Potential research interests, Other collaboration opportunities, Collaborate with, teach, and network USMA including the Field with external stakeholders, Engage with Payer and Policy decision makers as necessary, Contribute to the development of US Asset strategy and tactics, Drive product and/or disease area knowledge for medico- scientific, Provide input to R&D and help inform trial designs and endpoint prioritization, Advise organization through active and continuous involvement in key USP customer activities (e.g., Ad Boards, customer meetings), Participate in USP speaker programs for medico-scientific exchange at an expert level, Maintains clinical, scientific and technical expertise in specific therapeutic areas; reviews scientific journals; attend scientific and key technical meetings; participate in internal training programs; collects and communicates medical and scientific insights and intelligence relevant to lifecycle and product portfolio. © 2001-2020 GlaxoSmithKline plc. All rights reserved. Trademarks are owned by or licensed to the GSK group of companies. GlaxoSmithKline plc. Registered in England and Wales No. 3888792.

Registered office: 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom. Website URL: https://jobs.gsk.com/en-gb/jobs/239668?lang=en- us&source=LinkedIn.

[92] Nominee of Medical Editor, Elsevier, Company Location: Philadelphia, Pennsylvania, United States, this role is available as a Remote Position anywhere in the USA - Elsevier is a leading provider of information solutions for healthcare and research professionals around the world and operates within the company RELX Group. Elsevier’s mission is to lead the way in advancing science, technology, and health. It provides over 25% of the world’s clinical content, serving 9,000 hospitals globally and over 20 million healthcare professionals, including health executives, nurses, physicians, and pharmacists, by integrating evidence-based content into the care delivery process, driving better clinical decisions and improved patient outcomes. Elsevier's ability to consistently provide its high level of evidence- based content and resources is made possible by strong partnerships with the science and health communities and leading Societies & Associations, HIT vendors, resellers, and suppliers. Elsevier is part of RELX group, a world‐leading provider of information and analytics for professional and business customers across industries. The group serves customers in more than 180 countries and has offices in about 40 countries. It employs approximately 30,000 people of whom half are in North America. Clinical Solutions: Clinical Solutions is a division of Elsevier that is focused on innovation in helping healthcare professionals globally to improve clinical outcomes by reducing unwarranted variability in care. Our products align with all stages of the longitudinal patient journey, offering providers and patients integrated decision support and information solutions. We offer reference solutions to help providers make better, more informed clinical decisions in all care settings. Our team is building the next-generation of integrated clinical workflow solutions with clinical pathways, leveraging our industry leading evidence-based content. Elsevier’s Clinical Solutions is looking for a Physician for the position of Medical Editor as part of our Content Team. The Medical Editor serves a key role in creating and maintaining clinical excellence in our evidence-based clinical decision support content. Duties & Responsibilities: Write, edit, and update clinical content for a digital point-of-care clinical decision resource. Keep current with and appropriately evaluate the medical literature, guidelines, and other clinical information sources. Ensure that content is current, clinically accurate, and supported by the best available

63 evidence. Collaborate with commissioned physician authors and reviewers and critically review content they produce for (i) scientific and clinical accuracy and appropriateness (ii) compliance with editorial policies and processes and (iii) consistency in content across related topics within the content portfolio. Focus on users’ needs across different use cases. This includes staying current with practicing clinicians’ information needs and workflow: changes in clinical practice, electronic medical records, regulatory and quality standards, and continuing medical education requirements. This also includes being innovative and flexible regarding content format to meet different use cases. Ensure that content is clearly written and well organized. Create, maintain, and ensure quality of point of care content and data, in adherence with Elsevier editorial policies, industry standard ontologies/clinical terminologies, and interoperable/integratable with Clinical Solutions products as well as current electronic medical record systems. Execute the editorial workflow and roadmap to continuously maintain and publish current content across the Clinical Solutions Portfolio. Collaborate with other Medical Editors, pharmacist and nursing editors, and other members of the editorial team. Collaborate with other content teams. This may include review and quality assurance of order set content, patient education content, clinical pathways, or other types of clinical content. Collaborate with other teams within Clinical Solutions (e.g., Product, Commercial, Informatics, Marketing, Sales, etc.) and Elsevier to provide insight based on clinical experience and expertise. Occasional travel to attend approved conferences, other internal Elsevier meetings, or other meetings will be required. Active participation (participation in workgroups, committees, collaboration groups) in thought leadership organizations within area of specialty is supported and encouraged. Other duties or tasks as assigned.

[93] Nominee of the position of Deputy Director of Operations, Office of Generic Drugs (601), This position is being filled under an excepted hiring authority, Title 21, Section 3072 of the 21st Century Cures Act. The candidate selected for this position will serve under a career or career-conditional appointment and be paid under the provisions of the authority. Additional information on 21st Century Cures Act can be found here: https://www.fda.gov/regulatory-information/selected- amendments-fdc-act/21st-century-cures-act, The Food and Drug Administration (FDA or Agency) is the regulatory, scientific, public health and consumer protection agency responsible for ensuring all human and animal drugs, medical devices,

64 cosmetics, foods, food additives, drugs and medicated feeds for food producing animals, tobacco and radiation emitting devices safe, and effective. The Office of Generic Drugs is responsible for the development and implementation of standards for the safety and effectiveness of generic drugs; reviews and evaluates Abbreviated New Drug Applications (ANDAs) and their amendments or supplements and determines approvability; establishes bioequivalence specifications for drug products and develops guidelines for bioequivalence reviews, industry protocols, and studies; and oversees all aspects of labeling submissions for ANDAs. Assists with implementing the Executive Performance Reporting and implementation. In addition, the incumbent has oversight as a major orchestrator of the development and implementation of programs, processes, and strategic initiatives to support important Office, Center, and Agency priorities. Oversees efforts for ensuring robust, efficient, and effective operations of all OGD elements. Provides leadership and expert advice on processes and procedures, organization structures, and change management within OGD. Evaluates the effectiveness of complex regulatory programs in meeting established goals and objectives across CDER and FDA Offices and with a broad range of organizational sub-units developing and executing a plan for improvement based on evaluation results. Advises and supports various leadership positions within OGD in development and implementation of business processes, quality management systems, administrative activities, and training and development activities within OGD. Independently evaluates and monitors program initiatives and their effectiveness. Develops solutions and implements new operational programs, processes, and systems where needed. Operates effectively and collaboratively across CDER organizational boundaries to identify and address issues of variability in all OGD operational elements, making recommendations for consideration by the OGD Director and/or the OGD Senior Leadership Team to ensure alignment and coordination of key OGD activities with Center and Agency priorities. Provides technical direction, oversight, and leadership to OGD’s Associate Director for Knowledge Management (ADKM) and Generic Regulatory Affairs Team (GReAT) to execute program operations and processes that integrate and enhance the efficiency and consistency of OGD. Oversees the development of knowledge management tools, smart forms, and procedures with other Offices, including but not limited to the Office of Strategic Programs, Office of New Drugs, Office of Pharmaceutical Quality, and the Office of Computational Sciences.

Provides direction and leadership on projects/studies which advance the state-of-the- art oversight of scientific and regulatory informatics, ensuring best practices and approaches are utilized in the development, delivery, enterprise resource planning, and business intelligence of all data management initiatives within OGD. Provides technical direction, oversight, and leadership to OGD’s Senior Management Officer (SMO) who oversees the Program Management and Analysis Staff (PMAS) in the development and implementation of all administrative functions within OGD. PMAS oversees human resource management and budgetary management, with emphasis on developing and implementing robust administrative procedures and plans to recruit, hire, and retain a world-class regulatory workforce in the Office. Represents and acts as the advocate for the Office on various Agency and Center- level management committees that influence day-to-day operations of the Center and Office. Participates in working groups at all levels in the Agency. Represents the Office in crosscutting regulations on policy development for administrative operations. Maintains cooperative relationship with key individuals in other Centers to obtain their input on administrative operations and program initiatives. Works with stakeholders to appropriately inform and advise FDA as needed. Also coordinates and collaborates with officials related to fiscal year spending. Monitors, coordinates, and provides authoritative advice on revised or new legislations impacting fiscal year spending, budget allowance and execution. Identifies and handles sensitive, controversial, and critical problems that are complex and precedent setting in nature. Advises OGD senior management on potential impacts. Maintains current knowledge about new and/or revised legislation, guidance, policies and procedures that affect administrative operations. Uses subject matter expertise to set appropriate policy and regulations impacting program operations. Area of Consideration: United States Citizens or Nationals. Professional Experience/Desirable Qualifications: Executive leadership experience with an established track record in leading organizations of significant size and complexity. Knowledge of Generic Drug development and knowledge of regulatory standards for safety and effectiveness of human drugs. Effective communicator who can drive collaboration, empower staff, and is committed to the Public Health mission. Key requirements will include: Meets the Office of Personnel Management (OPM) Individual Occupational Requirements (IOR) for General Medical and Healthcare Series, 0601. This series requires at the minimum a Bachelor’s level degree that focuses on the medical filed, health sciences or allied sciences. Please review the

66 entire IOR to confirm the minimum education requirements: (Bachelor’s or graduate/higher level degree: major study in an academic field related to the medical field, health sciences or allied sciences appropriate to the work of the position. This degree must be from an educational program from an accrediting body recognized by the U.S. Department of Education (external link) at the time the degree was obtained.)

National Newspaper Publications:

1. Good Fats, Bad Fats (In Persian) – Iran National Daily Newspaper, 2016 2. The Dangers of Soy (In Persian) – Iran National Daily Newspaper, 2016 3. Animal Saturated Fats, Eat or Not to eat (In Persian) – Iran National Daily Newspaper, 2016 4. Beauty in What Price (In Persian) – Iran National Daily Newspaper, 2016 5. Fatty Liver Epidemic and The Forgotten Treatment (In Persian) – Iran National Daily Newspaper, 2016 6. Whitefly Crisis in Tehran (In Persian) – Iran National Daily newspaper, 2016 7. Diabetes and weather temperature (In Persian) – Iran National Daily Newspaper, 2016.

Published Books (Author, Editor, Co-Author)

[1] Fat & Cholesterol Myths, Soroush Niknamian, V.H. Djenab, royan Pazhouh Publication, ISBN: 978-600-408-183-2, FIPA: 4414611, 2016.

[2] Evolution of Human Nutrition, Soroush Niknamian, V.H. Djenab, Royan Pazhouh Publication, ISBN: 978-600-408-182-5, FIPA: 4414242, 2016.

[3] Ketogenic Diet, Soroush Niknamian, V.H. Djenab, Royan Pazhouh Publication, ISBN: 9786004081801, FIPA: 4401508, 2016.

[4] Occupational Health & Diseases, Sh. Tofighi MD, B. Farzinrad MD, Soroush Niknamian BSc., P. Banihashemi BSc., Royan Pazhouh Publication, ISBN: 978- 600-408-032-3, FIPA: 3928783, 2016.

[5] Notes on Women Diseases, Soroush Niknamian, V.H. Djenab, B. Farzinrad, Royan Pazhouh Publication, ISBN: 978-600-408-032-3, FIPA: 3928783, 2016.

[6] Exercise & Health, F. Engar, N. Daneshbakhsh, Soroush Niknamian, Royan Pazhouh Publication, ISBN: 978-600-408-032-3, FIPA: 3928783, 2016.

[7] Crisis Management in Megacities, P. Zafarghandi, H. Yazdimehr, S. Azizi, Editor: Soroush Niknamian, Royan Pazhouh Publication, ISBN: 978-600-408-198- 6, FIPA: 4443571, 2016.

[8] Mental Health in the Workplace, Somayeh Zaminpira, Soroush Niknamian, Royan Pazhouh Publication, ISBN: 978-600-408341-6, FIPA: 4856278, 2017.

[9] Quantum Medicine, the Medicine of the 21st Century, Somayeh Zaminpira, Soroush Niknamian, Arvij Iranian Publications, ISBN: 978-964-504-479-2, FIPA: 4880789, 2017.

[10] Nanomedicine, Somayeh Zaminpira, Soroush Niknamian, Arvij Iranian Publication, ISBN: 978-964-504-480-8, FIPA: 4880809, 2017.

[11] Cholesterol & Obesity Myths, Somayeh Zaminpira, Soroush Niknamian, ISBN: 978-600-408-339-3, FIPA: 4856161.

[12] Effect of Nutrition in Evolution of Cancer, Somayeh Zaminpira, Soroush Niknamian, Royan Pazhouh Publications, 2017, ISBN: 978-600-408-338-6, FIPA: 4855933.

[13] Women Diseases and Cures, Somayeh Zaminpira, Soroush Niknamian, 2017, Royan Pazhouh Publications, ISBN: 978-600-408-340-9, FIPA: 4856452.

[14] Ketogenic Diet in Cancer Treatment, Somayeh Zaminpira, Soroush Niknamian, Royan Pazhouh publications, 2017, ISBN: 978-600-408-342-3, FIPA: 4856282.

[15] The Prime Cause, Prevention and Treatment of Cancer, Somayeh Zaminpira, Soroush Niknamian, Stephanie Seneff, Tahan Publications, 2017, ISBN: 978-600- 758-157-5, FIPA: 4761729.

[16] Prime Cause and Treatment of Cancer, Somayeh Zaminpira, Sorush Niknamian, LAP LAMBERT Academic Publishing Groups, 2017, ISBN-13: 978- 620-2-05082-1, ISBN-10: 6202050829, EAN: 9786202050821.

[17] The Ultimate Treatment of Cancer, Soroush Niknamian, V.H Djenab, Arvij Iranian Publications, ISBN: 978-964-504-492-1, FIPA: 4719578, 2017.

[18] Essential and Supplies of Work in High, A.K., R.R., N.M., Soroush Niknamian, Royan Pazhouh Publications, 2016, ISBN: 978-600-408-230-3, FIPA: 4546159.

[19] Perfectionism and Coronary Heart Disease, Mina Nazari Kamal, K.G., Soroush Niknamian, Arvij Iranian Publications, 2017, ISBN: 978-964-504-486-0, FIPA: 4701743.

[20] Disaster Damage Assessment, M.S., S.K., A.Z., Soroush Niknamian, 2016, Royan Pazhouh Publications, ISBN: 978-600-408-187-0, FIPA: 4402975.

[21] Social Considerations in Disasters, A.K., H.N., A.B., Soroush Niknamian, Royan Pazhouh Publications, 2016, ISBN: 978-600-408-216-7, FIPA: 4503290.

[22] Healthy Fun at Home and School, N.D., M.N., Soroush Niknamian, Arvij Iranian Publications, 2017, ISBN: 978-964-504-472-3, FIPA: 4669387.

[23] Climate Change in Iran and the World, M.P., Soroush Niknamian, M.S., Royan Pazhouh Publications, 2016, ISBN: 978-600-408-186-3, FIPA: 4402329.

[24] Lesson Planning, N.D., M.N., Soroush Niknamian, Arvij Iranian Publications, 2017, ISBN: 978-964-504-474-7, FIPA: 4669398.

[25] Fear, Anxiety and Depression Relation to Cancer incidence in Humans, Prof. Dr. Sorush Niknamian, Dr. Somayeh Zaminpira, Professor Sptephanie Seneff, Project ID: #1791, ISBN: 978-613-8-24867-5, Editor: mmelnic Contributor: Sorush Niknamian, Status: Quality Assurance. Publisher: GlobeEdit is an imprint of: SIA OmniScriptum Publishing Brivibas gatve 197, LV-1039, Riga Latvia, European Union.

[26] Sorush Niknamian, Designing a Hybrid Brain Computer Interface System, ISBN: 978-0-359-27646-2, ID: 24044872, Category: Medicine & Science, Publisher: Lulu Bookstore.

[27] Sorush Niknamian, Teaching English as a Foreign Language, The Comparative Effect of Dictogloss and Processing Instruction Tasks on EFL Learners’ Writing Accuracy, ISBN: 978-620-0-09326-4, Editor: ecaterina focsa, LAP LAMBERT Academic Publishing Group.

[28] Sorush Niknamian, The Key to Success, ISBN: 978-620-0-25259-3, Editor: kballiu, PUBLISHER: LAMBERT ACADEMIC PUBLISHING GROUP – URL: https://www.weltbild.at/artikel/buch/the-key-to-success_26647076-1/

[29] Sorush Niknamian and Somayeh Zaminpira, Cancer Treatment (The Last Key) [Positive Cancer Treatment Results], Positive Cancer Treatment Results, ISBN: 978- 620-0-10857-9, Editor: efocsa, Project ID: #2631, LAP LAMBERT PUNLICATION GROUP.

[30] Cancer Treatment (The Last Key), ISBN: 978-613-8-91743-4, Editor: efocsa, Contributor: Sorush Niknamian. Pubcation: Scholar’s Press.

[31] Comparative Analysis on Corruption in Iran and Japan: Details on Corruption in Iran and Japan Paperback – February 22, 2020, by Sorush Niknamian (Author), Paperback: 51 pages, Publisher: Eliva Press (February 22, 2020), Language: English, ISBN-10: 9975339654, ISBN-13: 978-9975339650, Product Dimensions: 6 x 0.1 x 9 inches. Amazon URL: https://www.amazon.com/dp/9975339654. Summary: The corruption is a phenomenon with which some countries have been today grappled, especially developing nations. It has multiple causes and consequences and its range starts from an individual action (e.g. bribe) and covers all cornerstones of political and economic system and is developed. Despite complexity, difficulty and sensitivity of involvement with this symptom, the extensive studies have been conducted for measurement of corruption, expression of reasons for perpetration of such criminal activity and presentation of deterrent solutions by international communities during recent years. This study aims to conduct comparative analysis on corruption in Iran and Japan and the findings suggest that Iran has acquired rank 130 in received corruption while Japan received rank 74 in this regard.

Published Research Articles in International Journals (ISI):

[1] *Soroush Niknamian, 1 Vahid Hosseini Djenab2 MD, Sora Niknamian3 M.Sc., Continued Folic Acid Supplementation Throughout Pregnancy, May Cause Colorectal Cancer In The Future, International Science and Investigation Journal, ISSN: 2251-8576 2016, 5(4), Journal homepage: www.isijournal.info.

[2] *Soroush Niknamian, Somayeh Zaminpira Ph.D., High Untreated Phytic-Acid in The Diet, May Lead to Mineral Deficiencies, Specifically, During Pregnancy., Journal of Multidisciplinary Engineering Science and Technology (JMEST) ISSN: 2458-9403 Vol. 3 Issue 10, October – 2016.

[3] *Soroush Niknamian, Sora Niknamian, Sulfur Deficiency in Human Body, May Be the Link to the Rise of Obesity in Men and Women. International Science and Investigation Journal. ISSN: 2251-8576 2016, 5(5). Journal homepage: www.isijournal.info.

[4] Soroush Niknamian , Nutritional Ketosis Condition and Specific Ketogenic Diet, May Benefit Cancer Patients as an Alternative Treatment by Sudden Change in the Metabolic State of Cancer Cells. International Science and Investigation Journal. ISSN: 2251-8576 2016, 5(5). Journal homepage: www.isijournal.info.

[5] Soroush Niknamian1, Sora Niknamian2 M.Sc., Dodecanoic-Acid in Extra Virgin Coconut Oil, May Reduce the Incidence of Heart Disease and Cancer in Humans, International Journal of Science and Research (IJSR) ISSN (Online): 2319-7064.

[6] Soroush Niknamian, et al., Reactive Oxygen Species along with Reactive Nitrogen Species (ROS/RNS) as the Main Cause of Multiple Sclerosis. International Science and Investigation Journal, ISSN: 2251-8576 2016, 5(5), Journal homepage: www.isijournal.info.

[7] Somayeh Zaminpira, Sorush Niknamian, The Role of vitamin k2 in reducing the incidence of osteoporosis and heart disease., Available online at http://www.journalcra.com, International Journal of Current Research, Vol. 8, Issue, 11, pp.41730-41735, November, 2016.

[8] Soroush Niknamian, Iran’s Traditional Foods: A Heritage Worth Renewing, Weston A Price Foundation Journal. Winter 2017.

[9] Soroush Niknamian et al., On the Cancer of Wild Animals, International Science and Investigation Journal, ISSN: 2251-8576, 2016, 5(5), Journal homepage: www.isijournal.info.

[10] Sorush Niknamian, Miriam Kalamian, EdM, MS, CNS, Vegetable Oils Consumption as One of the Leading Cause of Cancer and Heart Disease, International Science and Investigation Journal, ISSN: 2251-8576, 2016, 5(5), Journal homepage: www.isijournal.info.

[11] Sorush Niknamian, Somayeh Zaminpira (2017). “CONSUMPTION OF SATURATED ANIMAL FATS IN THE DIET OF HUMANS MAY DECREASE THE RATE OF HEART DISEASE IN THE FUTURE.” International Journal of Research - Granthaalayah, 5(1), 295-303. https://doi.org/10.5281/zenodo.265222.

[12] Sorush Niknamian, Somayeh Zaminpira, Synthetic Folic Acid Supplementation During Pregnancy Increases the Risk of Neonatal Jaundice in Newborns, Journal of Multidisciplinary Engineering Science and Technology (JMEST), ISSN: 2458-9403 Vol. 3 Issue 12, December – 2016.

[13] Somayeh Zaminpira, Sorush Niknamian. (2017). “AGRICULTURAL REVOLUTION IN THE LINE OF HUMAN EVOLUTION IS THE ONSET OF NUTRITIONAL METABOLIC DISEASES, EPIDEMIC OF CANCER AND THE INFECTIOUS DISEASES.” International Journal of Research - Granthaalayah, 5(3), 88-103. https://doi.org/10.5281/zenodo.439556.

[14] Somayeh Zaminpira, Sorush Niknamian, Comparison of Cancer Incidence in Domesticated Versus Wild Animals, as the New Insight into the Cause and Prevention of Cancer in Humans, Journal of Multidisciplinary Engineering Science and Technology (JMEST) ISSN: 2458-9403 Vol. 4 Issue 7, July – 2017.

[15] Somayeh Zaminpira, Sorush Niknamian. The Main Treatment of Cancer. Open Access J Surg. 2017; 6(3): 555687., Submission: September 28, 2017; Published: October 16, 2017.

[16] Sorush Niknamian, Nutritional Ketosis Condition and Specific Ketogenic Diet, May Benefit Cancer Patients as an Alternative Treatment by Sudden Change in the Metabolic State of Cancer Cells, International Journal of Biochemistry & Physiology., Research Article, Volume 1 Issue 1, Received Date: November 08, 2016 Published Date: November 15, 2016.

[17] Somayeh Zaminpira, Sorush Niknamian, Introducing the Evolutionary Cell Memory (ECM) Hypothesis, International Journal of Biochemistry & Physiology, Research Article, Volume 3 Issue 1, Received Date: December 11, 2017 Published Date: January 08, 2018.

[18] Sorush Niknamian, Nutritional ketosis condition and specific ketogenic diet, may benefit cancer patients as an alternative treatment by sudden change in the metabolic state of cancer cells, International Journal of Development Research, Vol. 06, Issue, 11, pp.10355-10363, November, 2016.

[19] Soroush Niknamian* and Somayeh Zaminpira, Introducing the Prodotis M1- Macrophage Hypothesis of Cancer Metastasis (PMMH), EC Cancer 2.6 (2018): 261-285.

[20] Somayeh Zaminpira and Sorush Niknamian. “Evolutionary Metabolic Hypothesis of Cancer (EMHC)”. EC Pulmonology And. Respiratory Medicine 5.4 (2017): 167-179.

[21] Dr. Somayeh Zaminpira and Dr. Sorush Niknamian. “How Bohr Effect Admits the Ozone Therapy Plus Specific Keto-Diet in the Treatment of Cancer”. EC Pulmonology and Respiratory Medicine SI.01 (2017): 06-09.

[22] Somayeh Zaminpira and Sorush Niknamian. “The Main Cause and Prevention of Multiple Sclerosis and its Relation to Cancer”. EC Cancer 2.5 (2017): 217-226.

Received: November 11, 2017; Published: November 22, 2017. Introducing the Evolutionary Metabolic Hypothesis of Multiple Sclerosis (Emhms).

[23] Dr. Somayeh Zaminpira and Dr. Sorush Niknamian., Introduction to the Evolutionary Metabolic Medicine Based on Mitochondrial Dysfunction, EC Pulmonology and Respiratory Medicine, Special Issue, SI.01 (2017): 25-30. Published: November 27, 2017.

[24] Dr. Somayeh Zaminpira and Dr. Sorush Niknamian., How Bohr Effect Admits the Ozone Therapy Plus Specific Keto-Diet in the Treatment of Cancer, EC Pulmonology and Respiratory Medicine, Special Issue: Mini Review, SI.01 (2017): 06-09. Published: November 09, 2017. [25] Somayeh Zaminpira and Sorush Niknamian, How Butterfly Effect or Deterministic Chaos Theory in Theoretical Physics Explains the Main Cause of Cancer, 2(5): 227-238., Published: November 22, 2017. [26] Dr. Somayeh Zaminpira* and Professor Dr. Sorush Niknamian, How Chronic Fear Results in Hypoxia in Tissues and Cancer in Humans through Bohr Effect, Canc Sci Onchol, 2018; Volume 2, Issue 1.

[27] Somayeh Zaminpira, Sorush Niknamian, Anti-carcinogenic and therapeutic properties of curcumin, Journal of Cancer Research and Metastasis, Vol 1 No 2 December 2018. This open-access article is distributed under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC) (http:// creativecommons.org/licenses/by-nc/4.0/), which permits reuse, distribution and reproduction of the article, provided that the original work is properly cited and the reuse is restricted to noncommercial purposes. For commercial reuse, contact [email protected]. [28] Sorush Niknamian and Somayeh Zaminpira, The Hybrid Causes for the High Cancer Incidences in Cold Climates in Humans, Page 266-271. Volume 8 Issue 3 – 2019, EC Pulmonology and Respiratory Medicine, Publisher: ECronicon Open Access.

[29] Sorush Niknamian Ph.D., "Explanation of how do individuals with multiple sclerosis cope with social isolation, Journal of Clinical Practice, ISSN 2044-9038, 2018 16 (4), DOI:10.4172/clinical-practice.1000460, Pages: 1179-1187. [30] Sorush Niknamian*, The Introduction of Designing a Hybrid Brain Computer Interface System, BIOMEDICAL Journal of Scientific and Technical Research, ISSN: 2574 -1241, DOI: 10.26717/BJSTR.2019.16.002828. Copyright@ Sorush Niknamian | Biomed J Sci & Tech Res| BJSTR. MS.ID.002828. Volume 16- Issue 2. [31] Sorush Niknamian* and Spmayeh Zaminpira, Quantum entanglement in theoretical physics as a new insight into cancer biology, Eniade Abiodun Adeyemi et al. / Af.J.Bio.Sc. 1(2) (2019) 1-11. ISSN: 2663-2187, African Journal of Biological Sciences. [32] Sorush Niknamian, Explanation of how do individuals with multiple sclerosis cope with social isolation, Clin. Pract. (2018) 16(4), 1179-1187, DOI: 10.4172/clinical-practice.1000460. [33] Somayeh Zaminpira* and Sorush Niknamian, The Prime Cause of Type-2 (T2D), Type-1 Diabetes (T1D) and the Relation between Diabetes and Cancer, Received Date: 03-14-2019 Accepted Date: 03-18-2019 Published Date: 03-21- 2019. Copyright: © 2019 Somayeh Zaminpira – Citation: Citation: Zaminpira S and Niknamian S. The Prime Cause of type-2 (T2D), Type-1 Diabetes (T1D) And The Relation Between Diabetes and Cancer. JJ Cell Mol Bio 2019; 4(1): 014. [34] Somayeh Zaminpira, Sorush Niknamian, Stephanie Seneff, Dominic D’Agostino (2019) The Positive Effect of Skd Plus Iot and Hbo2t In The Treatment Of Cancer [Introducing Sorush Cancer Treatment Protocol (Sctp)]. Cancer Stud Ther J Volume 4(1):1–6. (Journal: Cancer Studies and Therapeutics (ISSN: 2002- 7184). Web link: http://researchopenworld.com/the-positive-effect-of-skd-plus-iot- and-hbo2t-in-the-treatment-of-cancer-introducing-sorush-cancer-treatment- protocol-sctp/

[35] MicroRNAs Biomarkers Profiling in Diagnosis and Therapeutic Management of Hepatitis B Virus Infection, Sorush Niknamian, Online: 28 March 2019, DOI: 10.20944/preprints201903.0265.v1, Web Link: https://www.preprints.org/search/scilit?search1=niknamian&field1=title_keywords

&clause=OR&search2=niknamian&field2=assigned_doi&search_subject_area=&s earch_subject_sub_area=&date_from=&date_to=&search_scilit=

[36] Assessment of Risk Factors in Patients with Chronic Hepatitis B, Sorush Niknamian, Online: 28 March 2019, DOI: 10.20944/preprints201903.0266.v1, Web Link: https://www.preprints.org/search/scilit?search1=niknamian&field1=title_keywords &clause=OR&search2=niknamian&field2=assigned_doi&search_subject_area=&s earch_subject_sub_area=&date_from=&date_to=&search_scilit=

[37] Identifying the Mental Pattern of Housing Demand by grounded Theory: The Cognitive Science Approach, Sorush Niknamian, Online: 8 April 2019, DOI: 10.20944/preprints201904.0074.v1, Web Link: https://www.preprints.org/search/scilit?search1=niknamian&field1=title_keywords &clause=OR&search2=niknamian&field2=assigned_doi&search_subject_area=&s earch_subject_sub_area=&date_from=&date_to=&search_scilit=

[38] Organizational Justice, Job Stress, and Work-family Conflict: Their Interrelationships in Universities' Personnel, Sorush Niknamian, Online: 8 April 2019, DOI: 10.20944/preprints201904.0099.v1, Web Link: https://www.preprints.org/search/scilit?search1=niknamian&field1=title_keywords &clause=OR&search2=niknamian&field2=assigned_doi&search_subject_area=&s earch_subject_sub_area=&date_from=&date_to=&search_scilit=

[39] Resource–Economic Growth Nexus, Role of Governance, Financial Development, Globalisation and War: Dynamic Approach, Sorush Niknamian, Online: 8 April 2019, DOI: 10.20944/preprints201904.0096.v1, Web Link: https://www.preprints.org/search/scilit?search1=niknamian&field1=title_keywords &clause=OR&search2=niknamian&field2=assigned_doi&search_subject_area=&s earch_subject_sub_area=&date_from=&date_to=&search_scilit=

[40] Estimation of Exchangeable Sodium Percentage with the Aid of Sodium Adsorption Ratio in Sedimentary Soils, Sorush Niknamian, Online: 8 April 2019, DOI: 10.20944/preprints201904. 0101.v1, Web Link: https://www.preprints.org/search/scilit?search1=niknamian&field1=title_keywords

&clause=OR&search2=niknamian&field2=assigned_doi&search_subject_area=&s earch_subject_sub_area=&date_from=&date_to=&search_scilit=

[41] Investigation on the Effect of Cold Drawing Process on Mechanical Properties and Structure of Seamless Steel (Ck60) Tube, Sorush Niknamian, Online: 8 April 2019, DOI: 10.20944/preprints201904. 0097.v1, Web Link: https://www.preprints.org/search/scilit?search1=niknamian&field1=title_keywords &clause=OR&search2=niknamian&field2=assigned_doi&search_subject_area=&s earch_subject_sub_area=&date_from=&date_to=&search_scilit=

[42] Real Time Control Strategy for Hybrid Electric Vehicles, Sorush Niknamian, Online: 8 April 2019, DOI: 10.20944/preprints201904. 0100.v1, Web Link: https://www.preprints.org/search/scilit?search1=niknamian&field1=title_keywords &clause=OR&search2=niknamian&field2=assigned_doi&search_subject_area=&s earch_subject_sub_area=&date_from=&date_to=&search_scilit=

[43] The Dumping-Based Unfair Trade in World Trade Organization WTO, Sorush Niknamian, Online: 8 April 2019, DOI: 10.20944/preprints201904.0098.v1, Web Link: https://www.preprints.org/search/scilit?search1=niknamian&field1=title_keywords &clause=OR&search2=niknamian&field2=assigned_doi&search_subject_area=&s earch_subject_sub_area=&date_from=&date_to=&search_scilit=

[44] Professor Dr. Sorush Niknamian, Effect of Stemregenin1 and SB431542 small molecules on ex vivo expansion of umbilical cord blood hematopoietic stem cells on biocompatible polyethersulfone nanofiber scaffolds, received 14 May 2019; Accepted 13 June 2019; Publish Online 15 June 2019, Journal of Medical Case Reports and Reviews 2:6 (2019), ISSN (O) 2589-8655| (P) 2589-8647, Available online at www.jmcrr.info, Corresponding Author: Professor Dr. Sorush Niknamian, PhD, Military Medicine, Liberty University, USA.

[45] Sorush Niknamian Ph.D. in Cell and Molecular Biology, CSci (Chartered Scientist), RSciTech (Registered Science Technician), RSci (Registered Scientist) ID: A0008833, Science Council, United Kingdom and Indiana Cancer Consortium

(ICC) certified. Liberty University, United States of America, Military Medicine, UK.K, *Author for correspondence: [email protected], "Explanation of how do individuals with multiple sclerosis cope with social isolation”, Journal of Clinical Practice (2018) 16(4) 1179-1187, ISSN 2044-9038, DOI: 10.4172/clinical- practice.1000460.

[46] Sorush Niknamian, Spmayeh Zaminpira and Sprephanie Seneff (2019). Quantum entanglement in theoretical physics as a new insight into cancer biology, African Journal of Biological Sciences. 1 (2), 1-12. [or Sorush Niknamian et al. / Afr.J.Bio.Sc. 1(2) (2019) 1-12, ISSN: 2663-2187]. https://doi.org/10.33472/AFJBS.1.2.2019.1-12.

[47] Sorush Niknamian*, The Impact of Stress, Anxiety, Fear and Depression in The Cause of Cancer in Humans, received: June 08, 2019 | Published: June 25, 2019, [To Cite This Article: Sorush Niknamian. The Impact of Stress, Anxiety, Fear and Depression in The Cause of Cancer in Humans. Am J Biomed Sci & Res. 2019 - 3(4). AJBSR.MS.ID.000696. DOI: 10.34297/AJBSR.2019.03.000696.] American Journal of Biomedical Science & Research, ISSN: 2642-1747, www.biomedgrid.com.

[48] Sorush Niknamian, Assessment of Risk Factors in Patients with Chronic Hepatitis B, AMRR-1219004_OA, Asclepius Medical Research and Reviews • Vol 2 • Issue 1 • 2019.

[49] Sorush Niknamian, Evaluation of Serum Vitamin D Levels in Patients with Hepatitis B Virus, AMRR-1219005_OA, Asclepius Medical Research and Reviews • Vol 2 • Issue 1 • 2019.

[50] Sorush Niknamian, MicroRNAs Biomarkers Profiling in Diagnosis and Therapeutic Management of Hepatitis B Virus Infection, AMRR-1219006_OA, Asclepius Medical Research and Reviews • Vol 2 • Issue 1 • 2019.

[51] Somayeh Zaminpira, Sorush Niknamian, Anti-carcinogenic and therapeutic properties of curcumin, J Can Res Metastasis Vol 1 No 2 December 2018.

[52] Sorush Niknamian*, The Introduction of Designing a Hybrid Brain Computer Interface System, Journal of Scientific and Technical Research, Received: March 12, 2019 | Published: March 21, 2019, DOI: 10.26717/BJSTR.2019.16.002828, Web

Link: https://biomedres.us/fulltexts/BJSTR.MS.ID.002828.php, ISSN: 2574 -1241, NLM ID: 101723284, OCoLC: 999826537, LCCN: 2017202541.

[54] Dr. Somayeh Zaminpira* and Professor Sir Sorush Niknamian, How Chronic Fear Results In Hypoxia in Tissues and Cancer in Humans through Bohr Effect, Journal of Cancer Science and Oncology, Global Access Publishers, Canc Sci Onchol, 2018; Volume 2, Issue 1, [Citation: Zaminpira S (2018) How Chronic Fear Results In Hypoxia in Tissues and Cancer in Humans through Bohr Effect.]

[55] Somayeh Zaminpira1, Sorush Niknamian2*, Stephanie Seneff3, Dominic D’Agostino4, Thomas N Seyfried5 and Angela Poff, The Positive Effect of Skd Plus Iot and Hbo2t In The Treatment Of Cancer [Introducing Sorush Cancer Treatment Protocol (Sctp)], Received: March 12, 2019; Accepted: March 21, 2019; Published: March 25, 2019; *Corresponding author: Sorush Niknamian, Cancer Studies and Therapeutics Volume 4 Issue 1, Cancer Stud Ther J, Volume 4(1): 1–6, 2019, RESEARCH OPEN, [Citation: Somayeh Zaminpira, Sorush Niknamian, Stephanie Seneff, Dominic D’Agostino, Thomas N Seyfried and Angela Poff (2019) The Positive Effect of Skd Plus Iot and Hbo2t In The Treatment Of Cancer [Introducing Sorush Cancer Treatment Protocol (Sctp)]. Cancer Stud Ther J Volume 4(1):1–6.]

[56] Sir Sorush Niknamian1*and, Somayeh Zaminpira1, The Hybrid Causes for the High Probabilities of Cancer Incidences in Cold Climates in Humans, Received Date: 12th October 2018 Accepted Date: 22nd April 2019 Published Date: 27th April 2019, Copyright: @ 2019 Sorush Niknamian. This is an Open Access article published and distributed under the terms of the Creative Commons Attribution Licen, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited, [Citation: Niknamian S (2019) The Hybrid Causes for the High Probabilities of Cancer Incidences in Cold Climates in Humans. Enliven: Challenges Cancer Detect Therv 4(1): 001.] Journal: Enliven: Challenges in Cancer Detection and Therapy, ISSN: 2376-046X, www.enlivenarchive.org.

[57] Sorush Niknamian1* and Somayeh Zaminpira2, The Hybrid Causes for the High Cancer Incidences in Cold Climates in Humans, [Citation: Sorush Niknamian and Somayeh Zaminpira. “The Hybrid Causes for the High Cancer Incidences in Cold Climates in Humans”. EC Pulmonology and Respiratory Medicine 8.2 (2019).

[58] Professor Dr. Sorush Niknamian, Effect of Stemregenin1 and SB431542 small molecules on ex vivo expansion of umbilical cord blood hematopoietic stem cells on biocompatible polyethersulfone nanofiber scaffolds, Journal of Medical Case Reports and Reviews 2:6 (2019), ISSN (O) 2589-8655| (P) 2589-8647, Available online at www.jmcrr.info.

[59] Sorush Niknamian*, Effects of High Iodine Containing Low Osmolar Contrast Agent (Visipaque) on Thyroid Function Tests, [Citation: Sorush Niknamian. “Effects of High Iodine Containing Low Osmolar Contrast Agent (Visipaque) on Thyroid Function Tests”. EC Endocrinology and Metabolic Research 4.4 (2019)].

[60] Sorush Niknamian, Evaluation of Serum Tumor Markers Variation, Following the Radioactive Iodine Therapy in Patients with Differentiated Thyroid Cancer, OAJ Otorhinolaryngol 2019; 6(1):050. ISSN: 2469-3073.

[61] Sorush Niknamian*, Evaluation of Serum Vitamin D Levels in Patients with Hepatitis B Virus (HBV), EC ENDOCRINOLOGY AND METABOLIC RESEARCH [Citation: Sorush Niknamian. “Evaluation of Serum Vitamin D Levels in Patients with Hepatitis B Virus (HBV)”. EC Endocrinology and Metabolic Research 4.4 (2019).

[62] Introducing the Sorush Cancer Treatment Protocol (SCTP), International Journal of Cancer and Treatment, Int J Cancer Tremnt 2019, Volume 2: 1, Article Type: Research Article Number: IJCT114 Received Date: 03May, 2019 Accepted Date: 26 May, 2019 Published Date: 29 May, 2019, *Corresponding author: Dr. Sorush Niknamian, [Citation: Niknamian S (2019) Introducing the Sorush Cancer Treatment Protocol (SCTP). Int J Cancer Tremnt Vol: 2, Issu: 1 (24-40).] Copyright: © 2019 Niknamian S. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

[63] Niknamian Sa*, Zaminpira Sb, Seneff Sc, Seyfried TNd, Agostino DDe and Gonzalez MJf, Introducing the Sorush Cancer Treatment Protocol (SCTP), Journal of Cancer Research & Clinical Practice, received: 17 April, 2019 Accepted: 26 April, 2019 Published: 30 April, 2019, [Citation: Niknamian S, Zaminpira S, Seneff S, Seyfried TN, Agostino DD, Gonzalez MJ (2019). Introducing the Sorush Cancer Treatment Protocol (SCTP). J Cancer Res Clin Pract 2(1): 110].

[64] Sorush Niknamian, New Approaches to the Design of Automatic Diagnostic Systems and Math Algorithms of Breast Cancer, submitted: 07 May 2019; Accepted: 11 May 2019; Published: 18 May 2019, Volume 4 | Issue 5 | 1 of 6, Journal of Clinical Review & Case Reports, ISSN: 2573-9565, Copyright: ©2019 Sorush Niknamian. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

[65] Dr. Sorush Niknamian*, Determining the Predictive Power of Vitamin D Levels in Iron Deficiency Anemia, Journal of Medical - Clinical Research & Reviews, received: 02 May 2019; Accepted: 30 May 2019, [Citation: Dr. Sorush Niknamian. Determining the Predictive Power of Vitamin D Levels in Iron Deficiency Anemia. J Med - Clin Res & Rev. 2019; 3(2): 1-5.] J Med - Clin Res & Rev; 2019, Volume 3 | Issue 2 | 1 of 5.

[66] Dr. Sorush Niknamian, OCT4 Expression Regulated Apoptosis and Cell Cycle in Myeloma Cells, Corresponding Author - Dr. Sorush Niknamian, Received 30 May 2019; Accepted 14 June 2019; Published -- June 2019, International Journal of Innovative Research in Medical Science (IJIRMS) Volume 04, Issue 06, June 2019, https://doi.org/10.23958/ijirms/vol04-i06/678.

[67] Sorush Niknamian*, Systematic review on tele-wound-care in spinal cord injury (SCI) patients and the impact of telemedicine in decreasing the cost, Physical Medicine and Rehabilitation Research, ISSN: 2398-3353, Received: June 03, 2019; Accepted: June 11, 2019; Published: June 14, 2019, Phys Med Rehabil Res, 2019 doi: 10.15761/PMRR.1000199 Volume 4: 1-6.

[68] Niknamian S*, Valproic Acid Inhibit Non-Small-Cell Lung Cancer (A549 Cell Line) Metastasis via Inhibition of CD44v6 and Nm23H1, received: 17 April, 2019 Accepted: 14 May, 2019 Published: 20 May, 2019, Journal of Medical and

Clinical Studies, Pubtexto Publishers | www.pubtexto.com, [Citation: Niknamian S (2019). Valproic Acid Inhibit Non-Small-Cell Lung Cancer (A549 Cell Line) Metastasis via Inhibition of CD44v6 and Nm23H1. J Med Clin stud 2(2): 115].

[69] Somayeh Zaminpira1* and Sorush Niknamian2, The Prime Cause of Type-2 (T2D), Type-1 Diabetes (T1D) and the Relation between Diabetes and Cancer, Received Date: 03-14-2019 Accepted Date: 03-18-2019 Published Date: 03-21- 2019, [Citation: Zaminpira S and Niknamian S. The Prime Cause of type-2 (T2D), Type-1 Diabetes (T1D) And The Relation Between Diabetes and Cancer. JJ Cell Mol Bio 2019; 4(1): 014.]

[70] Sorush Niknamian*, Fuzzy Logic Controller for Parallel Plug-in Hybrid Vehicle, Scholar Journal of Applied Sciences and Research, Sch J Appl Sci Res 2019, Volume 2: 9, Article Type: Research Article Number: SJASR252 Received Date: 22 July, 2019 Accepted Date: 27 July, 2019 Published Date: 30 July, 2019, Copyright: © 2019 Niknamian S. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. [Citation: Niknamian S (2019) Fuzzy Logic Controller for Parallel Plug-in Hybrid Vehicle. Sch J Appl Sci Res Vol: 2, Issu: 9 (19-26).]

[71] Sorush Niknamian*, Organizational justice, job stress, and work-family conflict: their interrelationships in universities’ personnel, Physical Medicine and Rehabilitation Research, ISSN: 2398-3353, Received: June 04, 2019; Accepted: June 12, 2019; Published: June 17, 2019, Phys Med Rehabil Res, 2019, doi: 10.15761/PMRR.1000200, Volume 4: 1-5, Copyright: ©2019 Niknamian S. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

[72] Sorush Niknamian*, Systematic review on tele-wound-care in spinal cord injury (SCI) patients and the impact of telemedicine in decreasing the cost, Physical Medicine and Rehabilitation Research, ISSN: 2398-3353, Received: June 03, 2019; Accepted: June 11, 2019; Published: June 14, 2019, Phys Med Rehabil Res, 2019 doi: 10.15761/PMRR.1000199, Volume 4: 1-6, Copyright: ©2019 Niknamian S. This is an open-access article distributed under the terms of the Creative Commons

Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

[73] Sorush Niknamian, Papillary Thyroid Cancer With Low Serum Thyroglobulin And No Thyroid Malignant Focus, Received Date: 04-25-2019 Accepted Date: 05- 02-2019, OAJ Otorhinolaryngol Journal, 2019; 6(1):049.

[74] Dr. Sorush Niknamian, OCT4 Expression Regulated Apoptosis and Cell Cycle in Myeloma Cells, International Journal of Innovative Research in Medical Science (IJIRMS) Volume 04, Issue 06, June 2019, Received 30 May 2019; Accepted 14 June 2019; Published -- June 2019, https://doi.org/10.23958/ijirms/vol04-i06/678. www.ijirms.in,

[75] Sorush Niknamian*, The Climate Change Impacts on Water Resources and Crop Yield, Research Article Volume 1 Issue 2 - August 2019, Ecol Conserv Sci 1(2): ECOA.MS.ID.555559 (2019), [How to cite this article: Sorush Niknamian. The Climate Change Impacts on Water Resources and Crop Yield . Ecol Conserv Sci. 2019; 1(2): 555559]. Ecology & Conservation Science Journal: Open Access, Juniper Publishers. This work is licensed under Creative Commons Attribution 4.0 License,

[76] Niknamian, Sorush (2019): Realization of Strategic Planning in Iran's Higher Education System. figshare. Dataset. DOI: https://doi.org/10.6084/m9.figshare.9947504.v1.

[77] Niknamian, Sorush (2019): The Electronic City, Smart Urban Growth and the Barriers against Realization of it in Iranian Cities’ [Case Study: Dezful City]. figshare. Journal contribution. https://doi.org/10.6084/m9.figshare.9947519.v1.

[78] Niknamian, Sorush (2019): The Isolation and Identification of Mycoplasmas Which cause Contagious Agalactia from Sheep and Goat in Tehran Province.docx. figshare. Presentation. https://doi.org/10.6084/m9.figshare.9947537.v1.

[79] Niknamian, Sorush (2019): Identification of internal and external factors affecting the optimal implementation of government policies. figshare. Journal contribution., https://doi.org/10.6084/m9.figshare.9968897.v1

[80] Sorush Niknamian, The Position for Right to Health and Right of Access to Drug in International law, received date: June 25, 2019: Accepted date: September 19, 2019: Published date: November 04, 2019 Citation: Sorush N (2019) The Position for Right to Health and Right of Access to Drug in International law, 2(2) DOI: 10.31579/ 26394162/038 Copyright: ©2019. Sorush N. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

[81] Sorush Niknamian, Supplementation with N-Acetyl-Cysteine (NAC) increases the amounts of γL-Glutamyl-L-Cystein-Yl-Glycine, which reduces the amounts of Reactive Oxygen Species (ROS) in normal cells and is effective in the Prevention of Cancer, Journal of Orthopaedics and Skeletal Medicine, Volume 3 Issue 1, Citation: Sorush Niknamian (2019) Supplementation with N-Acetyl-Cysteine (Nac) Increases the Amounts of Γ-LGlutamyl-L-Cystein-Yl-Glycine, Which Reduces the Amounts of Reactive Oxygen Species (Ros) In Normal Cells and is Effective in the Prevention of Cancer J Orthop Skeletal Med 3(1): 103.

[82] Sorush Niknamian, Application of Modern Methods: Modeling of Sedimentary Soil ESP Content, Vol 1 No (2019): Britain International of Humanities and Social Sciences, September, Published: 2019-08-20, DOI: https://doi.org/10.33258/bioex.v1i1.22.

[83] Sorush Niknamian, Organizational justice, job stress, and work-family conflict: their interrelationships in universities' personnel, Physical Medicine and Rehabilitation Research DOI: 10.15761/PMRR.1000200, Volume 4: 1-5 https://www.oatext.com/organizational-justice-job-stress-and-work-family- conflict-their-interrelationships-in-universities-personnel.php.

ACCEPTED AND PUBLISHED PREPRINTS

[1] Article ID: 10.20944/preprints201904. 0096.v1, Title: Resource–Economic Growth Nexus, Role of Governance, Financial Development, Globalization and War: Dynamic Approach, Author: Sorush Niknamian, Submitted: 2019-04-05. Preprints.org, MDPI.

[2] Article ID: 10.20944/preprints201904. 0097.v1, Title: Investigation on the Effect of Cold Drawing Process on Mechanical Properties and Structure of Seamless Steel (Ck60) Tube, Author: Sorush Niknamian, Submitted: 2019-04-05, Preprints.org, MDPI.

[3] Article ID: 10.20944/preprints201904. 0098.v1. Title: The Dumping-Based Unfair Trade in World Trade Organization WTO, Author: Sorush Niknamian, Submitted: 2019-04-05, Preprints.org, MDPI.

[4] Article ID: 10.20944/preprints201904. 0099.v1, Title: Organizational Justice, Job Stress, and Work-family Conflict: Their Interrelationships in Universities' Personnel. Author: Sorush Niknamian, Submitted: 2019-04-05. Preprints.org, MDPI.

[5] Article ID: 10.20944/preprints201904.0100.v1, Title: Real Time Control Strategy for Hybrid Electric Vehicles. Author: Sorush Niknamian. Submitted: 2019- 04-05, Preprints.org, MDPI.

[6] Article ID: 10.20944/preprints201904. 0101.v1, Title: Estimation of Exchangeable Sodium Percentage with the Aid of Sodium Adsorption Ratio in Sedimentary Soils, Author: Sorush Niknamian, Submitted: 2019-04-05, Preprints.org, MDPI.

[7] Article ID: 10.20944/preprints201903. 0266.v1, Title: Assessment of Risk Factors in Patients with Chronic Hepatitis B. Author: Sorush Niknamian, Submitted: 2019-03-27, Preprints.org, MDPI.

[8] Article ID: 10.20944/preprints201903. 0265.v1, Title: MicroRNAs Biomarkers Profiling in Diagnosis and Therapeutic Management of Hepatitis B Virus Infection, Author: Sorush Niknamian. Submitted: 2019-03-27, Preprints.org, MDPI.

[9] APA: Niknamian, S. (2019, April 20). Application of modern methods: modeling of sedimentary soil ESP content. https://doi.org/10.31219/osf.io/f9zbw

MLA: Niknamian, Sorush. “Application of Modern Methods: Modeling of Sedimentary Soil ESP Content.” OSF Preprints, 20 Apr. 2019. Web.

Chicago: Niknamian, Sorush. 2019. “Application of Modern Methods: Modeling of Sedimentary Soil ESP Content.” OSF Preprints. April 20. doi:10.31219/osf.io/f9zbw.

[10] APA: Niknamian, S. (2019, April 20). Determination of soil properties using of spectroscopic method. https://doi.org/10.31219/osf.io/b6jvr

MLA: Niknamian, Sorush. “Determination of Soil Properties Using of Spectroscopic Method.” OSF Preprints, 20 Apr. 2019. Web.

Chicago: Niknamian, Sorush. 2019. “Determination of Soil Properties Using of Spectroscopic Method.” OSF Preprints. April 20. doi:10.31219/osf.io/b6jvr.

[11] APA: Niknamian, S. (2019, April 20). Scattered Point Cloud Data Reconstruction Algorithm Based on Local Convexity. https://doi.org/10.31219/osf.io/6qt9w

MLA: Niknamian, Sorush. “Scattered Point Cloud Data Reconstruction Algorithm Based on Local Convexity.” OSF Preprints, 20 Apr. 2019. Web.

Chicago: Niknamian, Sorush. 2019. “Scattered Point Cloud Data Reconstruction Algorithm Based on Local Convexity.” OSF Preprints. April 20. doi:10.31219/osf.io/6qt9w.

[12] APA: Niknamian, S. (2019, April 20). Abnormal Vehicle Load Identification Method Based on Genetic Algorithm and Wireless Sensor Network. https://doi.org/10.31219/osf.io/426na

MLA: Niknamian, Sorush. “Abnormal Vehicle Load Identification Method Based on Genetic Algorithm and Wireless Sensor Network.” OSF Preprints, 20 Apr. 2019. Web.

Chicago: Niknamian, Sorush. 2019. “Abnormal Vehicle Load Identification Method Based on Genetic Algorithm and Wireless Sensor Network.” OSF Preprints. April 20. doi:10.31219/osf.io/426na.

[13] APA: Niknamian, S. (2019, April 20). Secretory Expression of YY (3-36) Peptide in E. coli. https://doi.org/10.31219/osf.io/rn586

MLA: Niknamian, Sorush. “Secretory Expression of YY(3-36) Peptide in E. Coli.” OSF Preprints, 20 Apr. 2019. Web.

Chicago: Niknamian, Sorush. 2019. “Secretory Expression of YY(3-36) Peptide in E. Coli.” OSF Preprints. April 20. doi:10.31219/osf.io/rn586.

[14] APA: Niknamian, S. (2019, April 20). Spermatogonia apoptosis induction as a possible mechanism of toxoplasma gondii induced male infertility. https://doi.org/10.31219/osf.io/2f3wy

MLA: Niknamian, Sorush. “Spermatogonia Apoptosis Induction as a Possible Mechanism of Toxoplasma Gondii Induced Male Infertility.” OSF Preprints, 20 Apr. 2019. Web.

Chicago: Niknamian, Sorush. 2019. “Spermatogonia Apoptosis Induction as a Possible Mechanism of Toxoplasma Gondii Induced Male Infertility.” OSF Preprints. April 20. doi:10.31219/osf.io/2f3wy.

[15] APA: Niknamian, S. (2019, April 20). Effect of Stemregenin1 and SB431542 small molecules on ex vivo expansion of umbilical cord blood hematopoietic stem cells on biocompatible polyethersulfone nanofiber scaffolds. https://doi.org/10.31219/osf.io/dwqg5

MLA: Niknamian, Sorush. “Effect of Stemregenin1 and SB431542 Small Molecules on Ex Vivo Expansion of Umbilical Cord Blood Hematopoietic Stem Cells on Biocompatible Polyethersulfone Nanofiber Scaffolds.” OSF Preprints, 20 Apr. 2019. Web.

Chicago: Niknamian, Sorush. 2019. “Effect of Stemregenin1 and SB431542 Small Molecules on Ex Vivo Expansion of Umbilical Cord Blood Hematopoietic Stem Cells on Biocompatible Polyethersulfone Nanofiber Scaffolds.” OSF Preprints. April 20. doi:10.31219/osf.io/dwqg5.

[16] APA: Niknamian, S. (2019, April 25). Identification of internal and external factors affecting the optimal implementation of government policies. https://doi.org/10.31219/osf.io/5j2ps

MLA: Niknamian, Sorush. “Identification of Internal and External Factors Affecting the Optimal Implementation of Government Policies.” OSF Preprints, 25 Apr. 2019. Web.

Chicago: Niknamian, Sorush. 2019. “Identification of Internal and External Factors Affecting the Optimal Implementation of Government Policies.” OSF Preprints. April 25. doi:10.31219/osf.io/5j2ps.

[17] APA: Niknamian, S. (2019, April 25). Investigating tax culture of the tax payers of the Iranian Tax Administration. https://doi.org/10.31219/osf.io/g98x2

MLA: Niknamian, Sorush. “Investigating Tax Culture of the Tax Payers of the Iranian Tax Administration.” OSF Preprints, 25 Apr. 2019. Web.

Chicago: Niknamian, Sorush. 2019. “Investigating Tax Culture of the Tax Payers of the Iranian Tax Administration.” OSF Preprints. April 25. doi:10.31219/osf.io/g98x2.

[18] APA: Niknamian, S. (2019, April 25). Identification and explanation of the factors related to knowledge management in Supreme Audit Court. https://doi.org/10.31219/osf.io/kqaxm

MLA: Niknamian, Sorush. “Identification and Explanation of the Factors Related to Knowledge Management in Supreme Audit Court.” OSF Preprints, 25 Apr. 2019. Web.

Chicago: Niknamian, Sorush. 2019. “Identification and Explanation of the Factors Related to Knowledge Management in Supreme Audit Court.” OSF Preprints. April 25. doi:10.31219/osf.io/kqaxm.

[19] APA: Niknamian, S. (2019, April 25). Explanation of valuation criteria based on maturity level of Knowledge management. https://doi.org/10.31219/osf.io/s987c

MLA: Niknamian, Sorush. “Explanation of Valuation Criteria Based on Maturity Level of Knowledge Management.” OSF Preprints, 25 Apr. 2019. Web.

Chicago: Niknamian, Sorush. 2019. “Explanation of Valuation Criteria Based on Maturity Level of Knowledge Management.” OSF Preprints. April 25. doi:10.31219/osf.io/s987c.

[20] APA: Niknamian, S. (2019, April 25). DESIGNING A MODEL TO INVESTIGATE THE ROLE OF THE FACTORS FORMUIATION PUBLIC POLICIES IN THE IMPLEMENTATION OF THE ADMINISTRATIVE SYSTEM HEALTH POLICY. https://doi.org/10.31219/osf.io/56xjg

MLA: Niknamian, Sorush. “DESIGNING A MODEL TO INVESTIGATE THE ROLE OF THE FACTORS FORMUIATION PUBLIC POLICIES IN THE IMPLEMENTATION OF THE ADMINISTRATIVE SYSTEM HEALTH POLICY.” OSF Preprints, 25 Apr. 2019. Web.

Chicago: Niknamian, Sorush. 2019. “DESIGNING A MODEL TO INVESTIGATE THE ROLE OF THE FACTORS FORMUIATION PUBLIC POLICIES IN THE IMPLEMENTATION OF THE ADMINISTRATIVE SYSTEM HEALTH POLICY.” OSF Preprints. April 25. doi:10.31219/osf.io/56xjg.

[21] APA: Niknamian, S. (2019, April 25). Realization of Strategic Planning in Iran's Higher Education System. https://doi.org/10.31219/osf.io/2k835

MLA: Niknamian, Sorush. “Realization of Strategic Planning in Iran's Higher Education System.” OSF Preprints, 25 Apr. 2019. Web.

Chicago: Niknamian, Sorush. 2019. “Realization of Strategic Planning in Iran's Higher Education System.” OSF Preprints. April 25. doi:10.31219/osf.io/2k835.

[22] APA: Niknamian, S. (2019, April 25). The Analysis of Relationship among Transformational Leadership Style and Performance of Personnel by Mediation Role of Organizational Culture’ [Case study]. https://doi.org/10.31219/osf.io/9frc2

MLA: Niknamian, Sorush. “The Analysis of Relationship Among Transformational Leadership Style and Performance of Personnel by Mediation Role of Organizational Culture’ [case Study].” OSF Preprints, 25 Apr. 2019. Web.

Chicago: Niknamian, Sorush. 2019. “The Analysis of Relationship Among Transformational Leadership Style and Performance of Personnel by Mediation

Role of Organizational Culture’ [case Study].” OSF Preprints. April 25. doi:10.31219/osf.io/9frc2.

[23] APA Niknamian, S. (2019, April 25). Investigation on the effect of cold drawing process on mechanical properties and structure of seamless steel (Ck60) tube. https://doi.org/10.31219/osf.io/2e9cy

MLA: Niknamian, Sorush. “Investigation on the Effect of Cold Drawing Process on Mechanical Properties and Structure of Seamless Steel (ck60) Tube.” OSF Preprints, 25 Apr. 2019. Web.

Chicago: Niknamian, Sorush. 2019. “Investigation on the Effect of Cold Drawing Process on Mechanical Properties and Structure of Seamless Steel (ck60) Tube.” OSF Preprints. April 25. doi:10.31219/osf.io/2e9cy.

[24] APA: Niknamian, S. (2019, April 28). CANCER INCIDENCE IN WILD ANIMALS AND THE REJECTION OF PETO’S PARADOX THEORY. https://doi.org/10.31219/osf.io/54z82

MLA: Niknamian, Sorush. “CANCER INCIDENCE IN WILD ANIMALS AND THE REJECTION OF PETO’S PARADOX THEORY.” OSF Preprints, 28 Apr. 2019. Web.

Chicago: Niknamian, Sorush. 2019. “CANCER INCIDENCE IN WILD ANIMALS AND THE REJECTION OF PETO’S PARADOX THEORY.” OSF Preprints. April 28. doi:10.31219/osf.io/54z82.

[25] APA: Niknamian, S. (2019, April 28). MEDICAL OZONE THERAPY AS THE EFFECTIVE TREATMENT FOR EBOLA AND AIDs. https://doi.org/10.31219/osf.io/j42xf

MLA: Niknamian, Sorush. “MEDICAL OZONE THERAPY AS THE EFFECTIVE TREATMENT FOR EBOLA AND Aids.” OSF Preprints, 28 Apr. 2019. Web.

Chicago: Niknamian, Sorush. 2019. “MEDICAL OZONE THERAPY AS THE EFFECTIVE TREATMENT FOR EBOLA AND Aids.” OSF Preprints. April 28. doi:10.31219/osf.io/j42xf.

[26] APA: Niknamian, S. (2019, April 28). SUPPLEMENTATION WITH N- ACETYL-CYSTEINE (NAC) INCREASES THE AMOUNTS OF γ-L-Glutamyl- L-cystein-yl-glycine, WHICH REDUCES THE AMOUNTS OF REACTIVE OXYGEN SPECIES (ROS) IN NORMAL CELLS AND IS EFFECTIVE IN THE PREVENTION OF CANCER. https://doi.org/10.31219/osf.io/aq5j3

MLA: Niknamian, Sorush. “SUPPLEMENTATION WITH N-ACETYL- CYSTEINE (NAC) INCREASES THE AMOUNTS OF Γ-l-glutamyl-l-cystein-yl- glycine, WHICH REDUCES THE AMOUNTS OF REACTIVE OXYGEN SPECIES (ROS) IN NORMAL CELLS AND IS EFFECTIVE IN THE PREVENTION OF CANCER.” OSF Preprints, 28 Apr. 2019. Web.

Chicago: Niknamian, Sorush. 2019. “SUPPLEMENTATION WITH N-ACETYL- CYSTEINE (NAC) INCREASES THE AMOUNTS OF Γ-l-glutamyl-l-cystein-yl- glycine, WHICH REDUCES THE AMOUNTS OF REACTIVE OXYGEN SPECIES (ROS) IN NORMAL CELLS AND IS EFFECTIVE IN THE PREVENTION OF CANCER.” OSF Preprints. April 28. doi:10.31219/osf.io/aq5j3.

[27] APA

Niknamian, S. (2019, April 28). The Prime Cause of type-2 (T2D), Type-1 Diabetes (T1D) And The Relation Between Diabetes and Cancer. https://doi.org/10.31219/osf.io/nhwfe

MLA

Niknamian, Sorush. “The Prime Cause of Type-2 (T2D), Type-1 Diabetes (T1D) and the Relation Between Diabetes and Cancer.” OSF Preprints, 28 Apr. 2019. Web.

Chicago

Niknamian, Sorush. 2019. “The Prime Cause of Type-2 (T2D), Type-1 Diabetes (T1D) and the Relation Between Diabetes and Cancer.” OSF Preprints. April 28. doi:10.31219/osf.io/nhwfe.

[28] APA

Niknamian, S. (2019, April 28). THE IMPACT OF STRESS, ANXIETY, FEAR AND DEPRESSION IN THE CAUSE OF CANCER IN HUMANS. https://doi.org/10.31234/osf.io/47fus

MLA

Niknamian, Sorush. “THE IMPACT OF STRESS, ANXIETY, FEAR AND DEPRESSION IN THE CAUSE OF CANCER IN HUMANS.” PsyArXiv, 28 Apr. 2019. Web.

Chicago

Niknamian, Sorush. 2019. “THE IMPACT OF STRESS, ANXIETY, FEAR AND DEPRESSION IN THE CAUSE OF CANCER IN HUMANS.” PsyArXiv. April 28. doi:10.31234/osf.io/47fus.

[29] APA

Niknamian, S. (2019, April 28). Centrifuge model tests for investigation of fiber reinforced soil walls. https://doi.org/10.31219/osf.io/fyqgx

MLA

Niknamian, Sorush. “Centrifuge Model Tests for Investigation of Fiber Reinforced Soil Walls.” OSF Preprints, 28 Apr. 2019. Web.

Chicago

Niknamian, Sorush. 2019. “Centrifuge Model Tests for Investigation of Fiber Reinforced Soil Walls.” OSF Preprints. April 28. doi:10.31219/osf.io/fyqgx.

[30] APA

Niknamian, S. (2019, April 28). The comparison and analysis on optimal status of Best Management Practice (BMP) mixed technique to reduce urban flood discharge in Tehran District 4. https://doi.org/10.31219/osf.io/rt49y

MLA

Niknamian, Sorush. “The Comparison and Analysis on Optimal Status of Best Management Practice (BMP) Mixed Technique to Reduce Urban Flood Discharge in Tehran District 4.” OSF Preprints, 28 Apr. 2019. Web.

Chicago

Niknamian, Sorush. 2019. “The Comparison and Analysis on Optimal Status of Best Management Practice (BMP) Mixed Technique to Reduce Urban Flood Discharge in Tehran District 4.” OSF Preprints. April 28. doi:10.31219/osf.io/rt49y.

[31] APA

MLA

Chicago

[32] APA

Niknamian, S. (2019, April 28). Abnormal Vehicle Load Identification Method Based on Genetic Algorithm and Wireless Sensor Network. https://doi.org/10.31219/osf.io/x93mr

MLA

Niknamian, Sorush. “Abnormal Vehicle Load Identification Method Based on Genetic Algorithm and Wireless Sensor Network.” OSF Preprints, 28 Apr. 2019. Web.

Chicago

Niknamian, Sorush. 2019. “Abnormal Vehicle Load Identification Method Based on Genetic Algorithm and Wireless Sensor Network.” OSF Preprints. April 28. doi:10.31219/osf.io/x93mr.

[33] APA

Niknamian, S. (2019, April 28). Accurate Identification Technique of Access Path Information for Hierarchical Geographic Traffic Network under Big Data Construction. https://doi.org/10.31219/osf.io/phv7a

MLA

Niknamian, Sorush. “Accurate Identification Technique of Access Path Information for Hierarchical Geographic Traffic Network Under Big Data Construction.” OSF Preprints, 28 Apr. 2019. Web.

Chicago

Niknamian, Sorush. 2019. “Accurate Identification Technique of Access Path Information for Hierarchical Geographic Traffic Network Under Big Data Construction.” OSF Preprints. April 28. doi:10.31219/osf.io/phv7a.

[34] APA

Niknamian, S. (2019, April 28). Design of Digital Aerial Photography System for UAV based on Wireless Sensor Network. https://doi.org/10.31219/osf.io/zq7fv

MLA

Niknamian, Sorush. “Design of Digital Aerial Photography System for UAV Based on Wireless Sensor Network.” OSF Preprints, 28 Apr. 2019. Web.

Chicago

Niknamian, Sorush. 2019. “Design of Digital Aerial Photography System for UAV Based on Wireless Sensor Network.” OSF Preprints. April 28. doi:10.31219/osf.io/zq7fv.

[35] APA

Niknamian, S. (2019, April 28). Federal Synergy Computing Model Based on Network Interconnection. https://doi.org/10.31219/osf.io/q7t6d

MLA

Niknamian, Sorush. “Federal Synergy Computing Model Based on Network Interconnection.” OSF Preprints, 28 Apr. 2019. Web.

Chicago

Niknamian, Sorush. 2019. “Federal Synergy Computing Model Based on Network Interconnection.” OSF Preprints. April 28. doi:10.31219/osf.io/q7t6d.

[36] APA

Niknamian, S. (2019, April 28). Data Fast Transmission Method in Wireless Vehicle Ad-hoc Network. https://doi.org/10.31219/osf.io/2nbym

MLA

Niknamian, Sorush. “Data Fast Transmission Method in Wireless Vehicle Ad-hoc Network.” OSF Preprints, 28 Apr. 2019. Web.

Chicago

Niknamian, Sorush. 2019. “Data Fast Transmission Method in Wireless Vehicle Ad- hoc Network.” OSF Preprints. April 28. doi:10.31219/osf.io/2nbym.

[37] APA

Niknamian, S. (2019, April 29). Analysis of the Concepts of Plaster Decorations and Epigraphs in the Altar of the Great Mosque of Urmia. https://doi.org/10.31219/osf.io/jwcvu

MLA

Niknamian, Sorush. “Analysis of the Concepts of Plaster Decorations and Epigraphs in the Altar of the Great Mosque of Urmia.” OSF Preprints, 29 Apr. 2019. Web.

Chicago

Niknamian, Sorush. 2019. “Analysis of the Concepts of Plaster Decorations and Epigraphs in the Altar of the Great Mosque of Urmia.” OSF Preprints. April 29. doi:10.31219/osf.io/jwcvu.

[38] APA

Niknamian, S. (2019, April 29). SEPARATION OF COLLECTION CONCERN. https://doi.org/10.31219/osf.io/tasdy

MLA

Niknamian, Sorush. “SEPARATION OF COLLECTION CONCERN.” OSF Preprints, 29 Apr. 2019. Web.

Chicago

Niknamian, Sorush. 2019. “SEPARATION OF COLLECTION CONCERN.” OSF Preprints. April 29. doi:10.31219/osf.io/tasdy.

[39] APA

Niknamian, S. (2019, April 29). Non-Delimitation of Incompetency Denotations in Jurisprudence and Law and the Contradiction of some of its Titles to the Law on Non-Litigious Matters. https://doi.org/10.31219/osf.io/vzeut

MLA

Niknamian, Sorush. “Non-delimitation of Incompetency Denotations in Jurisprudence and Law and the Contradiction of Some of Its Titles to the Law on Non-litigious Matters.” OSF Preprints, 29 Apr. 2019. Web.

Chicago

Niknamian, Sorush. 2019. “Non-delimitation of Incompetency Denotations in Jurisprudence and Law and the Contradiction of Some of Its Titles to the Law on Non-litigious Matters.” OSF Preprints. April 29. doi:10.31219/osf.io/vzeut.

[40] APA

Niknamian, S. (2019, April 29). The Use of Customer value changing trends in business analysis. https://doi.org/10.31219/osf.io/nm732

MLA

Niknamian, Sorush. “The Use of Customer Value Changing Trends in Business Analysis.” OSF Preprints, 29 Apr. 2019. Web.

Chicago

Niknamian, Sorush. 2019. “The Use of Customer Value Changing Trends in Business Analysis.” OSF Preprints. April 29. doi:10.31219/osf.io/nm732.

[41] APA

Niknamian, S. (2019, April 29). Discovering Hidden Patterns in Loan Reimbursement. https://doi.org/10.31219/osf.io/qfcms

MLA

Niknamian, Sorush. “Discovering Hidden Patterns in Loan Reimbursement.” OSF Preprints, 29 Apr. 2019. Web.

Chicago

Niknamian, Sorush. 2019. “Discovering Hidden Patterns in Loan Reimbursement.” OSF Preprints. April 29. doi:10.31219/osf.io/qfcms.

[42] APA

Niknamian, S. (2019, June 17). On the Mathematical Models for Cancer Growth. Retrieved from osf.io/qbp5t

MLA

Niknamian, Sorush. “On the Mathematical Models for Cancer Growth.” OSF Preprints, 17 June 2019. Web.

Chicago

Niknamian, Sorush. 2019. “On the Mathematical Models for Cancer Growth.” OSF Preprints. June 17. osf.io/qbp5t.

Niknamian, S., 2019. On the Mathematical Models for Cancer Growth [WWW Document]. doi:10.31219/osf.io/qbp5t

[43] APA

Niknamian, S. (n.d.). Investigating tax culture of the tax payers of the Iranian Tax Administration. Retrieved from osf.io/preprints/socarxiv/2dhb3

MLA

Niknamian, Sorush. “Investigating Tax Culture of the Tax Payers of the Iranian Tax Administration.” SocArXiv, n.d. Web.

Chicago

Niknamian, Sorush. n.d. “Investigating Tax Culture of the Tax Payers of the Iranian Tax Administration.” SocArXiv. osf.io/preprints/socarxiv/2dhb3.

[44] APA

Niknamian, S. (2019, December 26). Explanation of valuation criteria based on maturity level of Knowledge management. Retrieved from osf.io/jqg2r

MLA

Niknamian, Sorush. “Explanation of Valuation Criteria Based on Maturity Level of Knowledge Management.” OSF Preprints, 26 Dec. 2019. Web.

Chicago

Niknamian, Sorush. 2019. “Explanation of Valuation Criteria Based on Maturity Level of Knowledge Management.” OSF Preprints. December 26. osf.io/jqg2r.

[45] DESIGNING A MODEL TO INVESTIGATE THE ROLE OF THE FACTORS FORMUIATION PUBLIC POLICIES IN THE IMPLEMENTATION OF THE ADMINISTRATIVE SYSTEM HEALTH POLICY.

APA

Niknamian, S. (2019, December 26). DESIGNING A MODEL TO INVESTIGATE THE ROLE OF THE FACTORS FORMUIATION PUBLIC POLICIES IN THE IMPLEMENTATION OF THE ADMINISTRATIVE SYSTEM HEALTH POLICY. Retrieved from osf.io/8tmch

MLA

Niknamian, Sorush. “DESIGNING A MODEL TO INVESTIGATE THE ROLE OF THE FACTORS FORMUIATION PUBLIC POLICIES IN THE IMPLEMENTATION OF THE ADMINISTRATIVE SYSTEM HEALTH POLICY.” OSF Preprints, 26 Dec. 2019. Web.

Chicago

Niknamian, Sorush. 2019. “DESIGNING A MODEL TO INVESTIGATE THE ROLE OF THE FACTORS FORMUIATION PUBLIC POLICIES IN THE IMPLEMENTATION OF THE ADMINISTRATIVE SYSTEM HEALTH POLICY.” OSF Preprints. December 26. osf.io/8tmch.

[46] Realization of Strategic Planning in Iran's Higher Education System.

Citations:

APA

Niknamian, S. (2019, December 26). Realization of Strategic Planning in Iran's Higher Education System. Retrieved from osf.io/vkgz2

MLA

Niknamian, Sorush. “Realization of Strategic Planning in Iran's Higher Education System.” OSF Preprints, 26 Dec. 2019. Web.

Chicago

Niknamian, Sorush. 2019. “Realization of Strategic Planning in Iran's Higher Education System.” OSF Preprints. December 26. osf.io/vkgz2.

[47] Non-Delimitation of Incompetency Denotations in Jurisprudence and Law and the Contradiction of some of its Titles to the Law on Non-Litigious Matters.

Citations:

APA

Niknamian, S. (2019, December 26). Non-Delimitation of Incompetency Denotations in Jurisprudence and Law and the Contradiction of some of its Titles to the Law on Non-Litigious Matters. Retrieved from osf.io/7vpyg

MLA

Chicago

[48] Citations

APA

Niknamian, S. (2019, December 31). ‘The optimization of a jet turbojet engine by PSO and searching algorithms’. https://doi.org/10.31219/osf.io/xh7s9

MLA

Niknamian, Sorush. “‘the Optimization of a Jet Turbojet Engine by PSO and Searching Algorithms’.” OSF Preprints, 31 Dec. 2019. Web.

Chicago

Niknamian, Sorush. 2019. “‘the Optimization of a Jet Turbojet Engine by PSO and Searching Algorithms’.” OSF Preprints. December 31. doi:10.31219/osf.io/xh7s9.

100

[49] APA

Niknamian, S. (2019, December 31). The Use of Customer value changing trends in business analysis. https://doi.org/10.31219/osf.io/mk38c

MLA

Niknamian, Sorush. “The Use of Customer Value Changing Trends in Business Analysis.” OSF Preprints, 31 Dec. 2019. Web.

Chicago

Niknamian, Sorush. 2019. “The Use of Customer Value Changing Trends in Business Analysis.” OSF Preprints. December 31. doi:10.31219/osf.io/mk38c.

[50] APA

Niknamian, S. (2019, December 31). The Isolation and Identification of Mycoplasmas Which cause Contagious Agalactia from Sheep and Goat in Tehran Province. https://doi.org/10.31219/osf.io/s8efc

MLA

Niknamian, Sorush. “The Isolation and Identification of Mycoplasmas Which Cause Contagious Agalactia from Sheep and Goat in Tehran Province.” OSF Preprints, 31 Dec. 2019. Web.

Chicago

Niknamian, Sorush. 2019. “The Isolation and Identification of Mycoplasmas Which Cause Contagious Agalactia from Sheep and Goat in Tehran Province.” OSF Preprints. December 31. doi:10.31219/osf.io/s8efc.

[51] Niknamian, S. (2019, December 31). ‘The Electronic City, Smart Urban Growth and the Barriers against Realization of it in Iranian Cities’ [Case Study: Dezful City]. https://doi.org/10.31219/osf.io/sdny3

MLA

101

Niknamian, Sorush. “‘the Electronic City, Smart Urban Growth and the Barriers Against Realization of It in Iranian Cities’ [case Study: Dezful City].” OSF Preprints, 31 Dec. 2019. Web.

Chicago

Niknamian, Sorush. 2019. “‘the Electronic City, Smart Urban Growth and the Barriers Against Realization of It in Iranian Cities’ [case Study: Dezful City].” OSF Preprints. December 31. doi:10.31219/osf.io/sdny3.

[52] APA

Niknamian, S. (2019, December 31). Realization of Strategic Planning in Iran's Higher Education System. https://doi.org/10.31219/osf.io/z6cqg

MLA

Niknamian, Sorush. “Realization of Strategic Planning in Iran's Higher Education System.” OSF Preprints, 31 Dec. 2019. Web.

Chicago

Niknamian, Sorush. 2019. “Realization of Strategic Planning in Iran's Higher Education System.” OSF Preprints. December 31. doi:10.31219/osf.io/z6cqg.

[53] Niknamian, S. (2019, December 31). ‘Presentation of a Model for a Competency-Based Succession Planning Model with Respect to Adjusting Role of Organizational Culture in Telecommunication Infrastructure Company of Iran (TICIR) ‘. https://doi.org/10.31219/osf.io/g8umb

MLA

Niknamian, Sorush. “‘presentation of a Model for a Competency-based Succession Planning Model with Respect to Adjusting Role of Organizational Culture in Telecommunication Infrastructure Company of Iran (TICIR) ‘.” OSF Preprints, 31 Dec. 2019. Web.

Chicago

Niknamian, Sorush. 2019. “‘presentation of a Model for a Competency-based Succession Planning Model with Respect to Adjusting Role of Organizational

102

Culture in Telecommunication Infrastructure Company of Iran (TICIR) ‘.” OSF Preprints. December 31. doi:10.31219/osf.io/g8umb.

[54] Niknamian, S. (2019, December 31). Conceptualization of business excellence model with a grand theory approach. https://doi.org/10.31219/osf.io/p74yh

MLA

Niknamian, Sorush. “Conceptualization of Business Excellence Model with a Grand Theory Approach.” OSF Preprints, 31 Dec. 2019. Web.

Chicago

Niknamian, Sorush. 2019. “Conceptualization of Business Excellence Model with a Grand Theory Approach.” OSF Preprints. December 31. doi:10.31219/osf.io/p74yh.

[55] Niknamian, S. (2019, December 31). Resource–Economic Growth Nexus, Role of Governance, Financial Development, Globalisation and War: Dynamic Approach. https://doi.org/10.31219/osf.io/akhsr

MLA

Niknamian, Sorush. “Resource–economic Growth Nexus, Role of Governance, Financial Development, Globalisation and War: Dynamic Approach.” OSF Preprints, 31 Dec. 2019. Web.

Chicago

Niknamian, Sorush. 2019. “Resource–economic Growth Nexus, Role of Governance, Financial Development, Globalisation and War: Dynamic Approach.” OSF Preprints. December 31. doi:10.31219/osf.io/akhsr.

[56] Niknamian, S. (2019, December 31). Investigation on the effect of cold drawing process on mechanical properties and structure of seamless steel (Ck60) tube. https://doi.org/10.31219/osf.io/9nxtf

MLA

103

Niknamian, Sorush. “Investigation on the Effect of Cold Drawing Process on Mechanical Properties and Structure of Seamless Steel (ck60) Tube.” OSF Preprints, 31 Dec. 2019. Web.

Chicago

Niknamian, Sorush. 2019. “Investigation on the Effect of Cold Drawing Process on Mechanical Properties and Structure of Seamless Steel (ck60) Tube.” OSF Preprints. December 31. doi:10.31219/osf.io/9nxtf.

[57] APA

Niknamian, S. (2019, December 31). The comparison and analysis on optimal status of Best Management Practice (BMP) mixed technique to reduce urban flood discharge in Tehran District 4. https://doi.org/10.31219/osf.io/kfdyz

MLA

Chicago

[58] Niknamian, S. (2019, December 31). Non-Delimitation of Incompetency Denotations in Jurisprudence and Law and the Contradiction of some of its Titles to the Law on Non-Litigious Matters. https://doi.org/10.31219/osf.io/cf3hw

MLA

Chicago

104

[59] APA

Niknamian, S. (2019, December 31). Fuzzy Logic Controller for Parallel Plug-in Hybrid Vehicle. https://doi.org/10.31219/osf.io/nx9q2

MLA

Niknamian, Sorush. “Fuzzy Logic Controller for Parallel Plug-in Hybrid Vehicle.” OSF Preprints, 31 Dec. 2019. Web.

Chicago

Niknamian, Sorush. 2019. “Fuzzy Logic Controller for Parallel Plug-in Hybrid Vehicle.” OSF Preprints. December 31. doi:10.31219/osf.io/nx9q2.

[60] Niknamian, S. (2019, December 31). EFFECT OF WIND-STRUCTURE INTERACTION ON LONGITUDINAL RESPONSE OF TALL BUILDINGS. https://doi.org/10.31219/osf.io/qktfe

MLA

Niknamian, Sorush. “EFFECT OF WIND-STRUCTURE INTERACTION ON LONGITUDINAL RESPONSE OF TALL BUILDINGS.” OSF Preprints, 31 Dec. 2019. Web.

Chicago

Niknamian, Sorush. 2019. “EFFECT OF WIND-STRUCTURE INTERACTION ON LONGITUDINAL RESPONSE OF TALL BUILDINGS.” OSF Preprints. December 31. doi:10.31219/osf.io/qktfe.

[61] APA

Niknamian, S. (2019, December 31). Discovering Hidden Patterns in Loan Reimbursement. https://doi.org/10.31219/osf.io/qm8hb

MLA

105

Niknamian, Sorush. “Discovering Hidden Patterns in Loan Reimbursement.” OSF Preprints, 31 Dec. 2019. Web.

Chicago

Niknamian, Sorush. 2019. “Discovering Hidden Patterns in Loan Reimbursement.” OSF Preprints. December 31. doi:10.31219/osf.io/qm8hb.

[62] APA

Niknamian, S. (2019, December 30). Corporate social responsibility and value creation. https://doi.org/10.31219/osf.io/bj7xr

MLA

Niknamian, Sorush. “Corporate Social Responsibility and Value Creation.” OSF Preprints, 30 Dec. 2019. Web.

Chicago

Niknamian, Sorush. 2019. “Corporate Social Responsibility and Value Creation.” OSF Preprints. December 30. doi:10.31219/osf.io/bj7xr.

[63] Niknamian, S. (2019, December 30). comparative analysis on corruption in Iran and Japan. https://doi.org/10.31219/osf.io/mpurj

MLA

Niknamian, Sorush. “Comparative Analysis on Corruption in Iran and Japan.” OSF Preprints, 30 Dec. 2019. Web.

Chicago

Niknamian, Sorush. 2019. “Comparative Analysis on Corruption in Iran and Japan.” OSF Preprints. December 30. doi:10.31219/osf.io/mpurj.

[64] Niknamian, S. (2019, December 30). The effect of wind- soil- structure interaction on the longitudinal response of high-rise buildings. https://doi.org/10.31219/osf.io/q34sk

MLA

106

Niknamian, Sorush. “The Effect of Wind- Soil- Structure Interaction on the Longitudinal Response of High-rise Buildings.” OSF Preprints, 30 Dec. 2019. Web.

Chicago

Niknamian, Sorush. 2019. “The Effect of Wind- Soil- Structure Interaction on the Longitudinal Response of High-rise Buildings.” OSF Preprints. December 30. doi:10.31219/osf.io/q34sk.

[65] Niknamian, S. (2019, December 30). SEPARATION OF COLLECTION CONCERN. https://doi.org/10.31219/osf.io/m7bya

MLA

Niknamian, Sorush. “SEPARATION OF COLLECTION CONCERN.” OSF Preprints, 30 Dec. 2019. Web.

Chicago

Niknamian, Sorush. 2019. “SEPARATION OF COLLECTION CONCERN.” OSF Preprints. December 30. doi:10.31219/osf.io/m7bya.

[66] Niknamian, S. (2019, December 28). Investigating tax culture of the tax payers of the Iranian Tax Administration. https://doi.org/10.31235/osf.io/2dhb3

MLA

Niknamian, Sorush. “Investigating Tax Culture of the Tax Payers of the Iranian Tax Administration.” SocArXiv, 28 Dec. 2019. Web.

Chicago

Niknamian, Sorush. 2019. “Investigating Tax Culture of the Tax Payers of the Iranian Tax Administration.” SocArXiv. December 28. doi:10.31235/osf.io/2dhb3.

[67] Niknamian, S., 2020. Abnormal Vehicle Load Identification Method Based on Genetic Algorithm and Wireless Sensor Network [WWW Document]. doi:10.31219/osf.io/6yrv5.

107

[68] Niknamian, S. (2020) Accurate Identification Technique of Access Path Information for Hierarchical Geographic Traffic Network under Big Data Construction. OSF Preprints. doi: 10.31219/osf.io/mj7zv.

[69] Niknamian, S. (2020), “Data Fast Transmission Method in Wireless Vehicle Ad-hoc Network”, OSF Preprints, 14 January, available at: https://doi.org/10.31219/osf.io/tjhw3.

[70] Niknamian, S. (2020), “Design of Digital Aerial Photography System for UAV based on Wireless Sensor Network”, OSF Preprints, 14 January, available at: https://doi.org/10.31219/osf.io/98vwg.

[71] Niknamian, S. (2020), “Federal Synergy Computing Model Based on Network Interconnection”, OSF Preprints, 14 January, available at: https://doi.org/10.31219/osf.io/vjdba.

[72] Niknamian, S. (2020), “Scattered Point Cloud Data Reconstruction Algorithm Based on Local Convexity”, OSF Preprints, 14 January, available at: https://doi.org/10.31219/osf.io/4rznk.

National Conferences

[1] National Mind Management Olympiad Congress of the Top Elite Researchers and Inventors of Islamic Azad University of Iran. 2017. [2] Top Elite Researchers and Inventors Conference of the Elite Researcher Foundation of Islamic Azad University in Iran. 2017.

[3] Electing the Top Elite Researchers Congress, Islamic Azad University, Central Tehran Branch, Tehran, Iran, 2016.

International Conferences

[1] 4th International Congress On Integrative Medicine, Ketogenic Diet and Immunotherapy in Cancer and Neurological Diseases, 01.04. / 02.04.2017,

108

Fulda/Germany, Speakers: Dr. H.Reinwald, Prof. M. Ruggiero, Dr. D. Kinghardt, Prof. T. Seyfried, Dr. D. D'Agostino, Prof. A. Scheck, Dr. A. Poff, Dr. J. Mikovits, Dr. A. Brigida, Dr. A. Davaroukas, Dr. M. Schwalb, Dr. T. Peter, Dr. N. Antonucci, Dr. D. Sinisalco – Dr. Reinwald/Partner Academy.

[2] American Association for Cancer Research Annual Meeting, Washington DC, 2017.

[3] Webinar, The Chemical Safety Board: Who We Are and What We Do, Co- sponsored by the American Institute of Chemical Engineers (AIChE) and the, American Chemical Society (ACS), Originally delivered Apr 25, 2017, Developed by: AIChE, Presenter(s): Vanessa Allen Sutherland, Phillip R. Westmoreland, Vanessa Allen Sutherland was nominated by President Barack Obama to the U.S. Chemical Safety and Hazard Investigation in March of 2015 and confirmed by the Senate in August of 2015.

[4] Chemical Reactivity Management Webinar, sponsored by ioKinetic and reflects their views, opinions, and insights. Wednesday, May 10, 2017, 2:00pm-3:00pm EDT, American Institute of Chemical Engineers, PO Box 4429, Danbury, CT, 06813-4429, USA Understanding OSHA standards related to highly hazardous chemicals, Experimental design concepts and data analysis with instruments, an introduction to thermal hazard, chemical reactivity and basic calculations, Mitigating the hazards of handling reactive chemicals: Determining your next steps. Presenter: Michelle Murphy.

[5] E-Poster presentation, abstract: The Positive Effect of SKD Plus IOT and HBO2T in the Treatment of Cancer [Introducing Sorush Cancer Treatment Protocol (SCTP)], The 2018 Pennsylvania Society of Oncology and Hematology Annual Scientific Meeting, October 5, 2018, at the Milton S. Hershey Medical Center in Hershey, PA.

[6] International Meeting on Emerging Diseases and Surveillance - IMED 2018 - November 9-November 12, 2018, Vienna, Austria, CME Activity IMED 2018 - November 9 – November 12, 2018, Vienna, Austria. Congress language: English, CME Provider International Society for Infectious Diseases, 9 Babcock Street, Unit

109

3, Brookline, MA 02446, USA. European Union of Medical Specialists (UEMS) European Accreditation Council on CME (EACCME®). 09/11/2018-12/11/2018 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 18 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity. The EACCME® is an institution of the European Union of Medical Specialists (UEMS).

[7] Metabolic Health Summit Conference, MHS 2020 Where keto science meets society, 4th annual scientific experience in Los Angeles, California, Bridging the gap between research and the real world The world's most respected scientists and clinicians will share their work on the ketogenic diet and metabolic therapies, and top keto influencers. Key Speakers: David Ludwig, MD, PhD Harvard University, Dominic D'Agostino, PhD University of South Florida, Mark Sisson (Mark's Daily Apple), Suzanne Ryan (Keto Karma), Dale Bredesen, MD University of California, Los Angeles. Jeff Volek, RD, PhD The Ohio State University.

[8] International Meeting on Emerging Diseases and Surveillance - IMED 2018 - This is to certify that Dr. Sorush Niknamian attended the IMED 2018 in Vienna, Austria from November 9 - November 12, 2018, Vienna, Austria. The above named delegate spent 15 hours on educational activities. Larry Madoff, Britta Lassmann Executive Directors, ISID, CME Activity IMED 2018 - November 9 – November 12, 2018, Vienna, Austria. Congress language: English. CME Provider: International Society for Infectious Diseases, 9 Babcock Street, Unit 3, Brookline, MA 02446, USA. (European Union of Medical Specialists (UEMS) European Accreditation Council on CME (EACCME®)). Credits: 18 European CME credits.

[9] POSTER SESSION A Wednesday, November 28, 2018 1:00 PM – 3:30 PM Americana 4, Tumor Immunology and Immunotherapy, AACR, Poster Presentation, A61 The positive effect of SKD plus IOT and HBO2T in the treatment of cancer. Sorush Niknamian. Sponsor: Weston A. Price Foundation, Washington, DC.

[10] 2019 Giants of Cancer Care®, Date & Time: Thursday, May 30, 2019 7:00 PM- 10:00 PM CST, Location: Adler Planetarium Museum Campus 1300 S. Lake Shore Drive Chicago, IL 60605, Event Overview: The Giants of Cancer Care® recognition program honors renowned physicians and researchers who have devoted their time,

110 talent, and resources to improving the care for patients and families who are affected by cancer. Their discoveries have propelled the field forward and established the building blocks for future advances. Recipients demonstrate the qualities that distinguish this award from others: unlimited selflessness, compassion for their patients, and a desire to understand and develop life changing treatments against a disease that affects so many.

[11] Webinar, Elsevier, Rapid analysis of inclusions in steel with advanced Scanning Electron Microscopy and Optical Emission Spectroscopy (UK), Date: March 27, 2019, Time: 3.00pm GMT, 4.00pm CET, 11.00am EDT, Steel producers are concerned with inclusions that are present during the steel making process because these inclusions can significantly compromise the product quality and productivity of their process. Inclusion contamination in steel such as spinel, alumina, and slag impact product quality and productivity, ultimately resulting in lost revenue and time. Seldom does a single small inclusion pose a problem, but the agglomeration of inclusions is directly linked to downgraded product. In this webinar, researchers from ArcelorMittal in Gent will present how they use SEM/EDX technology for the automated analysis of >1500 steelmaking samples per year, allowing them to more efficiently and effectively control their process and reduce defects. On a similar track, ArcelorMittal also uses OES technology to quantify a variety of inclusion types in seconds. The combination of both instruments offers great possibility for faster and more accurate control of non-metallic inclusions, and to solve or prevent cost and quality problems caused by inclusions in steel. Benefits of attendance/Reasons to join the webinar: Find out how to rapidly assess steel cleanliness based on quantity, morphology, and chemical composition of non- metallic inclusions, hear from expert speakers how to make quality control decisions faster and more economically than ever before, all in your lab or directly on the production floor, Participate in a live question and answer session with expert speakers from ArcelorMittal and Thermo Fisher Scientific.

[12] 20 May 2019, 2019 Stevens lecture: Simon Stevens, CEO of NHS England (for Sorush Niknamian), 6:00pm Meeting, The Royal Society of Medicine. Registered charity no: 206219, UK.

111

[13] Webcast, Immune cell organization in the lupus kidney, Using tools such as single cell RNAseq and spatial mapping, researchers can determine the presence and distribution of monocytes - and their possible roles - in human autoimmune disease. Tuesday, March 26, 2019, 9AM PDT | 12PM EDT | 4PM GMT | 5PM CET.

[14] Rapid analysis of inclusions in steel with advanced Scanning Electron Microscopy, 3pm (UK) on Wednesday 27th March 2019, Materials Today, Elsevier Webinar.

[15] How mechanical properties of polymers change with temperature, 9 April 2019, 4.00pm BST, 5.00pm CEST, 11.00am EDT, Materials Today, Elsevier Webinar.

[16] 2019 April Office Manager Roundtable Meeting, 04/16/2019, 11:30 AM - 1:00 PM, Location: The Ledges, 32 Castle Down Dr, Huntsville, AL 35802, Registration: MCMS Annual Sponsor, Practice Administrator of Member Physicians or Member Physicians. Madison County Medical Society.

[17] Webinar, Subject: Rapid analysis of inclusions in steel with advanced Scanning Electron Microscopy and Optical Emission Spectroscopy, Sponsor: MaterialsToday.

[18] Webinar, Evaluating expression patterns of multiple inhibitory and stimulatory receptors on natural killer cells, April 30, 2019 2:00 PM EDT, 11:00 AM PDT. © Copyright 2015 - 2019. All Rights Reserved, Online event delivered through the WorkCast Online Events and Presentation Platform.

[10] Webinar, Evaluating expression patterns of multiple inhibitory and stimulatory receptors on natural killer cells, April 30, 2019 2:00 PM EDT, 11:00 AM PDT. WorkCast Online Event Platform.

[11] Webinar, Neoantigen Discovery: Realizing the Promise of Personalized Treatment, April 18, 2019, 12pm ET, CellPress Webcasts, Speakers: Nicholas McGranahan Group Leader, Cancer Genome Evolution Research Group University College London, Gerald P. Linette Parker Institute for Cancer Immunotherapy Center for Cellular Immunotherapies Perelman School of Medicine University of Pennsylvania, Moderator: Jiaying Tan Senior Scientific Editor Cell.

112

[12] Wiley Webinars, Evaluating expression patterns of multiple inhibitory and stimulatory receptors on natural killer cells, April 30, 2019 2:00 PM EDT, 11:00 AM PDT. © Copyright 2015 - 2019. All Rights Reserved. Online event delivered through the WorkCast Online Events and Presentation Platform. Speaker: Mirko Corselli, Ph.D. R&D Staff Scientist – Immunology Applications BD Biosciences Moderator: Jeremy Petravicz, Ph.D. Editor: Current Protocols Wiley Moderator. Webinar Details: Natural killer (NK) cells are an important component of the innate immune system and constitute a frontline defense in the killing of virally infected and malignant cells. NK cell function is tightly regulated by stimulatory and inhibitory receptors that recognize cellular stress ligands as well as human leucocyte antigen class I (HLA class I). A series of stimulatory and inhibitory receptors are expressed in a stochastic, variegated and overlapping way on the surface of NK cells, as there are estimated to be over 30,000 NK-cell phenotypes in a given individual. In addition, NK cells display extensive phenotypic diversity between individuals. To investigate multiple NK-cell phenotypes in a single individual, we used a modular panel-design strategy. This approach enabled us to characterize many functionally and developmentally distinct NK-cell subsets using a 6-color backbone panel. The expression of either stimulatory or inhibitory receptors was assessed using two alternative 6-color drop-in panels. We then combined the stimulatory and inhibitory markers into one single 18-color panel to assess all the receptors simultaneously. This enabled the analysis of multiple phenotypes of NK cells across individuals and provided a more comprehensive understanding of NK cell diversity in a single tube.

[13] Nature Webcast, Motor neuron size dependent mechanisms of neuroplasticity following spinal cord injury, Tuesday, 14th May, 2019, 9am PDT | 12pm EDT | 5pm BST | 6pm CEST.

[14] Giants of Cancer Care 2019 Ceremony, Invited by Kayla Collins ([email protected]) and George D. Demetri, MD, Dana-Farber Cancer Institute, Harvard Cancer Center, Boston, MA. Event: OncLive®'s Giants of Cancer Care® Winners' Reception, Date & Time: Thursday, May 30, 2019 7:00 PM-10:00 PM CST, Location: Adler Planetarium, Museum Campus, 1300 S. Lake Shore Drive, Chicago, IL 60605, Event Overview: The Giants of Cancer Care® recognition program honors renowned physicians and researchers who have devoted their time, talent, and resources to improving the care for patients and families who

113 are affected by cancer. Their discoveries have propelled the field forward and established the building blocks for future advances. Recipients demonstrate the qualities that distinguish this award from others: unlimited selflessness, compassion for their patients, and a desire to understand and develop life changing treatments against a disease that affects so many.

[15] Wiley Webinar, Initial Evaluation of the ClearLLab 10C System in the Immunophenotyping of Leukemia and Lymphoma* (*Non-Hodgkin Lymphoma only), Wednesday, May 15th 11am EDT / 4pm BST, Detail: Mike Keeney from Lawson Health Research Institute, Ontario, will present "Initial evaluation of the ClearLLab 10C System in the Immunophenotyping of Leukemia and Non Hodgkin Lymphoma". The presentation will introduce the new ClearLLab 10 Color System and the ClearLLab Control Cells, the first application-specific IVD control cells for leukemia and lymphoma* immunophenotyping as part of a validated system. He will then demonstrate the applicability of the system in evaluation of leukemia & Non- Hodgkin Lymphoma and will evaluate the results of the clinical accuracy study. Casebook: ClearLLab 10C is also supported by a unique, training resource, the ClearLLab 10C case book. This provides 24 diagnostic vignettes giving characteristic findings after flow cytometric analysis, with expert assessment by haematopathologists. Labs can also compare the interpretation of their own findings with the analysis in the casebook.

[16] Wiley Webinar, Evaluating expression patterns of multiple inhibitory and stimulatory receptors on natural killer cells, Originally Aired April 30, 2019. Details: Speaker: Mirko Corselli, Ph.D. R&D Staff Scientist – Immunology Applications BD Biosciences, Moderator: Jeremy Petravicz, Ph.D. Editor: Current Protocols, Wiley Moderator. Natural killer (NK) cells are an important component of the innate immune system and constitute a frontline defense in the killing of virally infected and malignant cells. NK cell function is tightly regulated by stimulatory and inhibitory receptors that recognize cellular stress ligands as well as human leucocyte antigen class I (HLA class I). A series of stimulatory and inhibitory receptors are expressed in a stochastic, variegated and overlapping way on the surface of NK cells, as there are estimated to be over 30,000 NK-cell phenotypes in a given individual. In addition, NK cells display extensive phenotypic diversity between individuals. To investigate multiple NK-cell phenotypes in a single individual, we used a modular

114 panel-design strategy. This approach enabled us to characterize many functionally and developmentally distinct NK-cell subsets using a 6-color backbone panel. The expression of either stimulatory or inhibitory receptors was assessed using two alternative 6-color drop-in panels. We then combined the stimulatory and inhibitory markers into one single 18-color panel to assess all the receptors simultaneously. This enabled the analysis of multiple phenotypes of NK cells across individuals and provided a more comprehensive understanding of NK cell diversity in a single tube. This webinar will provide insights into the design of modular panels and how the expansion of laser options and increased dye availability allow the characterization of cell types with high heterogeneity and phenotypic complexity.

[17] Royal Society of Medicine Conference, 22 May 2019, Global Health Innovations: Bias, Barriers and Breakthroughs. 2:30pm Meeting.

[18] TIPH Graduate School Fair July 2019, George Washington University - Marvin Center Continental Ballroom, 800 21st St. NW, 3rd floor. Association of Schools and Programs of Public Health, This event is co-sponsored with The George Washington University Milken Institute School of Public Health. The Marvin Center is located a block from the Foggy Bottom Metro Station (Orange and Blue lines) and has an attached garage located at 2125 H St. NW.

[19] Title: Identification and Prioritization of the Components of the Entrepreneurship Education System in Technical and Vocational Schools, December 4-6, 2019, Hyatt Regency Boston, Boston, MA, ORGANIZED BY:for Biological Engineering. Invited by: AIChE® • 120 Wall Street, 23 FL • New York, NY 10005, William Blake/Sherlock Biosciences, Michael Jewett/Northwestern University, Vincent Noireaux/University of Minnesota. AICHE Abstract #580385 - Cell Free Systems Conference.

[20] Keynote Speaker, International Conference and Exhibition on Cancer & Therapeutics, Cancer Houston 2019, September 27-28 2019, Houston, TX, USA, Innovations and furtherance Cancer Care.

[21] Certified Volunteer at 2019 International Conference on Frontiers of Neural Networks, ICFNN 2019, DATE: 26 July, 2019 - 28 July, 2019 VENUE: Rome, Italy.

115

[22] Internal Medicine Meeting 2020, Los Angeles, CA, April 23-25, 2020, Pre- Courses April 21-22, Order Number: 8003178480, American College of Physicians, US Army Forces. ACP ID: 03860312.

[23] ACP Internal Medicine Meeting 2020: Los Angeles, CA, Location: Los Angeles Convention Center, 1201 S Figueroa St, Los Angeles, CA, 90015-1308, Date: April 23-25, 2020. ACP ID: 03860312.

[24] The Climate Change Conference, organized by the United Nations Framework Convention on Climate Change (UNFCCC) will take place on 2-13 December in Santiago (Chile). The conference will work, amongst other things, on the implementation of the Paris agreement.

[25] Key Speaker at Healthcare and Hospital Management Conference 2019, Event to be held at the following time, date, and location: Wednesday, November 13, 2019 at 10:30 AM - to - Thursday, November 14, 2019 at 4:00 PM (Gulf Standard Time United Arab Emirates Time), Dubai, UAE, United Arab Emirates.

[26] Honorary Lecturer at SFRR-E Meeting 2020 that will take place in Belgrade, Serbia, on the 9th-12th June 2020. - SFRR-E Annual Award Lecture - SFRR- Europe Basic Science Award Lecture - SFRR-Europe Clinical Award Lecture - SFRR-E Catherine Pasquier Memorial Lecture - SFRR-E Leopold Flohé Redox Pioneer Young Investigator Award.

[27] Honorary Speaker at 3rd Edition of International Cancer Conference, September 23-25, 2019, London, UK, Title: Introducing Sorush Cancer Treatment Protocol (SCTP).

[28] Keynote Speaker at the 3rd International Biotechnology Congress (IBC-2019), Singapore on October 25-27, 2019, Track 602: Pharmaceutical/Medical Biotechnology about Explanation of how do individuals with multiple sclerosis cope with social isolation. IBC-2019, Singapore. Invited by Dr. Xiaodan Mei Executive Chair of SDS2020, Director of National Foreign Experts Databank of MOST (Dalian Branch). Hosting Organization: National Foreign Experts Databank of MOST (Dalian Branch), Concurrent Conference: BIT's 9th Annual World Congress of Molecular & Cell Biology(CMCB-2019).

116

[29] Webinar, Understanding TORCH Infections from both a Clinical and Personal Perspective, SUPPORTED BY: Siemens Healthineers, Credit: 1.0 ACCENT, Duration: 1 hr, Date: SEP.18.2019 1:00 PM - 02:00 PM, AACC (American Association for Clinical Chemistry.

[30] Keynote Speaker at 8th World Conference and Expo on Nanoscience and Nanotechnology, Theme: Latest Innovations in Nanotechnology for the Next Generation, Date: February 17-18, 2020 Venue: Philadelphia, USA. About Conference: On behalf of the Organizing and Advisory Committee we take great pleasure in welcoming Nanoscience and Nanotechnology experts, Professors, Scientists, Eminent Speakers for the 8th World Conference and Expo on Nanoscience and Nanotechnology to foster the progress in the field by contributing with your expertise to what promises to be a very comprehensive and exciting meeting, and to enjoy the immense unique artistic heritage and wonderful landscape of Philadelphia, USA. 8th World Conference and Expo on Nanoscience and Nanotechnology (Nanoscience-Conferences-2020), which will be held during February 17-18, 2020 in Philadelphia, USA is now an established event, attracting global participants’ intent on sharing, exchanging and exploring new avenues of Nanoscience and Nanotechnology and related research and latest developments. The event will have 5-6 world level (Highly cited class) Plenary speakers, established Keynote speakers, active Invited speakers and fresh contributed speakers. In addition, variety of poster presentations along with workshops and special sessions would be interested in audience. Progress in Nanoscience and Nanotechnology is always linked to the progress and welfare of human civilization. A future advance in multiple fields of Nanaoscience critically depends on the availability of superior achievements. The aim of the Nanoscience-Conferences-2020 is to promote quality research and real-world impact in an atmosphere of true international cooperation between scientists and engineers by bringing together world class researchers, international communities and industrial heads to discuss the latest developments and innovations in the fields of Nanoscience and Nanotechnology. We sincerely hope that Nanoscience-Conferences-2020 serves as an international platform for meeting researchers from around the world, widen professional contact and create new opportunities, including establishing new collaborations.

117

[31] The Role of Human Microbiome in the Cause and Prevention of Cancer, Session Selection: Keynote Speaker, Abstract ID: 584552, 2nd International Conference on Microbiome Engineering (ICME 2019) – taking place December 2- 4, 2019, in Boston, Ma, keynote speakers Christopher Voigt (Massachusetts Institute of Technology), Wenyuan Shi (Forsyth Institute) and Wendy Garrett (Harvard School of Public Health) as well as other experts in this field. Conference Chairs: Rachel Haurwitz, Caribou Biosciences, Inc. and Ophelia Venturelli, University of Wisconsin-Madison.

[32] AACC webinar supported by LabLeaders.com. Title: What Labs Can Do to Address the Opioid Crisis, Speaker: Prentiss Jones, PhD, Date: September 4, 2019, Time: 1 PM ET.

[33] Keynote Speaker at Women and Child Nutrition Conference ", December 02- 03, 2019 at Dubai, UAE.

[34] 2019 Annual General Meeting (AGM) held on Thursday 31st October 2019 at the Council Chambers, Chamberlain Room, Council House, Victoria Square, Birmingham B1 1BB in conjunction with a half day Midlands Branch meeting, including technical corrosion presentations by corrosion experts from across Europe. Invited by The Trustees and Council of the Institute, 5 St Peters Gardens, Marefair, Northampton, NN1 1SX Tel: +44 (0)1604 438222 Email: [email protected] Website: www.icorr.org, Institute of Corrosion (EIC), Honorary invited by: Dr Jane Lomas Institute of Corrosion Honorary Secretary.

[35] Honorary attendee of 2019 Dr. Paul Janssen Award Symposium, Friday, October 4th, 2019, Protein Folding in Health and Disease: The 2019 Dr. Paul Janssen Award Symposium, This year's Janssen Award honors Franz-Ulrich Hartl of the Max Planck Institute of Biochemistry and Arthur Horwich of the Yale School of Medicine. These pioneering scientists are being celebrated for their discovery of cellular machinery that facilitates protein folding, which is important to human health. Defects in folding are associated with aging and diseases including Alzheimer’s, Parkinson’s, Huntington’s disease, and prion disease, Invited by: Alison Carley, PhD, Senior Program Manager, Life Sciences, The New York Academy of Sciences, LOCATION: New York Academy of Sciences, 7 World Trade Center, NYC

118

[36] Honorary Speaker at International Awards conference On Children's Rights In Education, Child Health, and Poverty Reduction Strategy ( C.R.I.E.C.H.P.R.S 2019 ), AMA New York Executive Conference Center United States of America from November 17th to 20th 2019 while the second phase will be held In St Louis Senegal from 23rd to 27th November 2019. NOTE: (each of our noble participant will be awarded in the second phase of our event in St Louis Senegal with a whopping (5- ounce gold medal awards) sponsored by our donors.

[37] Keynote and Honorary Speaker at International Conference on Medical Pathology, February 17-19, 2020 | Houston, TX, Doubletree by Hilton, Houston Intercontinental Airport, URL: https://unitedscientificgroup.com/conferences/medical-pathology/featured- speakers, About MedPath-2020: MedPath-2020 hosts an important gathering and foster connections that will spur the innovations in Anatomical, Clinical and Molecular Pathology. It is a three-day event with an assemblage of inspirational keynote addresses, theoretical presentations, interactive panels and valuable real- world case studies from across the academia and industry spectrum of Pathology & Allied areas. It paves ideal layout for Pathologists, Scientists, Molecular Biologists, Geneticists, Physicians, Researchers, Professors and Business People to meet and share advances that offers diagnostic, prognostic and predictive information essential for best patient care. The key lectures will sketch vistas from higher up in the basic research discoveries, linking pathology with its firm science roots. We hope MedPath-2020 will be the best platform to explore and address Pathology issues and beyond at located capital for art of Medicine-Texas.

[38] APA WEBINAR "Sea Level Rise 101: How to Select and Use Sea Level Rise Data for Planning and Policy Decisions". This is the first in a series of webinars on sea level change. This session focuses on different choices for practitioners trying to use the best available sea-level change science for adaptation planning needs. Our panel will discuss the components of changing sea-levels, and identify areas where scientists are working to reduce uncertainty around major contributing factors like melting ice-sheets. Then, we will walk through some questions that users need to think about when planning for future inundation and using sea level projections: 1.

119

What if the nearest tide gauge is 75 miles up the coast. Will sea-level change in my community be similar? 2. When we say we want to plan for the future, how far into the future should we look? 3. Do our assumptions about future emissions matter? 4. What exactly does “likely” sea-level change mean? Do we know the “worst-case”? How do we think about probabilities and scenarios in the context of sea level change? 5. How will sea-level change impact flooding in our community? 6. Do I have the right tool for the job? The panel will use examples from Washington, New Jersey, and elsewhere to illustrate different ways communities are answering the questions above, along with others that come up during our discussion. Webinar participants will leave with tools and examples for using the best available sea-level change science to suit a variety of exposure mapping and adaptation planning approaches. This webcast is hosted by APA's HMDR Division. Webinar ID: 629- 552-227.

[39] NCCN LIVE MEETING, Name: Sorush Niknamian, Email: [email protected], Title: MAJ Dr., Address: 1971 University Blvd, Lynchburg, VA 2451, Lynchburg, Virginia 24515, USA, Confirmation Number: Event Title: NCCN 2020 Congress Series™: Breast Cancer with Updates from 2019 San Antonio Breast Cancer Symposium, Location: Prentice Women's Hospital, 250 East Superior Street, Conference Room L, 3rd Floor, Chicago, Illinois 60611, USA, Date: 02/07/2020, Time: 7:45 AM. Event: NCCN 2020 Congress Series™: Breast Cancer with Updates from 2019 San Antonio Breast Cancer Symposium, Date: Friday, February 7, 2020, Registration, Breakfast, and Exhibits: 7:45 - 8:30 AM, Exhibits will be available all day. Program Time: 8:30 AM - 4:00 PM, Location: Prentice Women's Hospital, Address: 250 East Superior Street, Conference Room L, 3rd Floor, Chicago, Illinois, 60611, USA, Parking: Daily discounted parking is available at the 321 E. Erie Self-Park Garage (Parking C) at the corner of Erie St. & Fairbanks Ct. The early-bird flat rate is $17.00 if you arrive between 5:00 AM and 9:00 AM and depart by 7:30 PM (minimum of 4 hours). Discounted parking is not available at any other garage. No validation of tickets is needed from the conference staff or the hospital. Public transportation is encouraged.

[40] Webinar, Implementing Wellness Techniques to Achieve Work-life Balance, Presented by: Dian Ginsberg, Sr. Director of Career Development; Lynne Peterson, Director of Physician Recruitment; & Lisa Herbert, MD, Physician Success Coach

120

Thursday, November 14, 2019 at 11 a.m. EST, 45 Minutes. Physicians Leadership. Webinar Information: Burnout has been defined as emotional exhaustion, a lack of feeling personal accomplishment, and de-personalization. One major cause of burnout is a lack of work-life balance and personal alignment in the healthcare industry. You may be spending excessive hours working and neglecting your hobbies, family, and friends. Even when you’re not actively working, you’re still fretting about what needs to be done to the point where it’s affecting your sleep and overall wellness. In this webinar, our careers expert and a work-life balance coach will discuss: What questions to ask at an interview to gauge if you and the company are aligned, The importance of personal/organizational values alignment when making important career decisions, How to define what work-life balance means to you individually, and how to find more balance in your current role, Career as it relates to the eight-part Wheel of Life Survey. Host: American Association for Physician Leadership, 400 North Ashley Drive, Suite 400, Tampa, FL, +1 (800) 562- 8088.

[41] Green Cards for Scientific Researchers: How to win your EB-1A/NIW Case – Webinar, Presenter: Brian H. Getson, Esq., November 12, 2019 2:00 PM EST, About the Webinar: learn about the U.S. immigration process and how to maximize your chances of immigration success during this webinar presented by the law firm of Getson & Schatz, P.C. For more information, visit researchergreencard.com.

[42] Next Gen PhD: Where PhDs Land and What the Data Say – Webinar, March 9, 2017, 2:00 PM Eastern, Presenter: Melanie Sinche, this workshop will provide an up-to-date assessment of the current career landscape facing science PhDs. Author Melanie Sinche will share proven strategies for landing potential occupations for advanced degree candidates, along with her research and profiles of science PhDs across a wide range of disciplines.

[43] UNE’s Virtual Office Hour on November 20th, 5:30pm – 6:30pm EST. Topic: Faculty Office Hour, Time: Nov 20, 2019 05:30 AM in Eastern Time (US and Canada), Meeting ID: 729-405-729. Invited by: Tomisa Emerson - Enrollment Counselor, Public Health, College of Graduate & Professional Studies, UNE Online | University of New England, 716 Stevens Avenue | Portland, ME 04103, Phone (207) 221-4838 | online.une.edu.

121

[44] Keynote Speaker at World Congress on Pain Research & Management "scheduled on 26-27 March 2020 in Barcelona, Spain. The theme of the conference is "Interdisciplinary approach towards quality of life in Pain Management ".

[45] Prospective Student Webinar: Department of Nutrition MPH, The Harvard T.H. Chan School of Public Health Admissions Office, Copyright © 2019 Harvard T.H. Chan School of Public Health, all rights reserved. mailing address: 158 Longwood Ave, Boston, MA, 02115-5810, US. Tue, Nov 12, 2019 1:00 PM - 2:00 PM EST.

[46] Rutgers School of Public Health, annual Fall Open House on Wednesday November 20th from 11am to 1pm and learn about the 30+ masters', post- baccalaureate certificate, doctoral, dual-degree, and accelerated BA/BS - MPH programs, the School Offers Fall Open House, MPH - PhD - Certificates – DrPH, Rutgers School of Public Health, 683 Hoes Lane West Piscataway, NJ 08854, invited by: Kamal Kornegay, Rutgers School of Public Health, 732-235-4327, [email protected].

[47] Honorary Attendee invited by Targeted Oncology (TO). A TO roundtable dinner meeting, Dallas, November 12th for Medical Oncologists: A Roundtable Discussion on Non-Hodgkin’s Lymphoma. Speaker: Dr. Luhua (Michael) Wang (The University of Texas MD Anderson Cancer Center), Date: November 12, 2019, Time: 7:00 PM, Location: Ocean Prime Restaurant, 2101 Cedar Springs Road, Dallas, TX 75201.

[48] Nature Webinar, improving proteome coverage and peptide identification rates in short LC gradients, Wednesday, December 18, 2019, 7AM PST | 10AM EST | 3PM GMT | 4PM CET, This webcast has been produced for the sponsor, Thermo Fisher Scientific, who retains sole responsibility for content.

[49] Honorary Speaker at International Conference and Exhibition on Cancer and Therapeutics (ICECT), 6 - 8 July 2020, London, UK, 2020 will build on the phenomenal success of the 2019 meeting in Houston. the program activities shall be led by experts and distinguished speakers from different leading institutions worldwide. This conference is the primary opportunity for practicing Oncologists,

122

Radiologists, Chemotherapists, Cancer Researchers, scientists and cancer related health care workers to participate in a conference focusing on “Cancer Current Research and Treatments”. The ICECT 2020 will also include scientific exhibition, where leading companies will display state-of-the-art products that have found clinical acceptance with particular relevance to the delivery of quality patient care. Conference URL: https://www.icecancerlondon.com/#header.

[50] Organizing Committee Member of International Conference and Exhibition on Cancer and Therapeutics (ICECT), 6 - 8 July 2020, London, UK, 2020 will build on the phenomenal success of the 2019 meeting in Houston. the program activities shall be led by experts and distinguished speakers from different leading institutions worldwide. This conference is the primary opportunity for practicing Oncologists, Radiologists, Chemotherapists, Cancer Researchers, scientists and cancer related health care workers to participate in a conference focusing on “Cancer Current Research and Treatments”. The ICECT 2020 will also include scientific exhibition, where leading companies will display state-of-the-art products that have found clinical acceptance with particular relevance to the delivery of quality patient care. Conference URL: https://www.icecancerlondon.com/#header,

[51] Honorary Keynote Speaker at WGC meeting, Japan during June 7-9, 2020. Introduction to WGC-2020. Following the great success of past ten years, BIT’s 11th World Gene Convention-2020 (WGC-2020) will be held on June 7-9, 2020 in Osaka, Japan. WGC had been successfully organized in Singapore, Macau, Shanghai, Qingdao and Haikou in last ten years. To update the frontiers of life sciences and Industrial Biotechnology, WGC-2020 comes to Osaka. WGC-2020 is a dedicated event where you will have the opportunity to learn about new developments in the field of gene, biotechnology and life sciences, share aspects of your own work by submitting a oral presentation or poster. With the participation of outstanding international experts, we hope productive discussions would stimulate new creative ideas to translate new discoveries into better practice and application. We hope your participation would contribute to your professional development and relationships.

[53] Keynote Speaker and Organizing Committee at 7th World Congress on Epigenetics and Chromosome during June 24-25, 2020 in Zurich, Switzerland. The conference is focused on the theme “Exceeding the Vision in the Field of Epigenetics

123 and Molecular Biology” which covers a broad array of vitally key sessions. This event is approved for CME Credits, Conference Details: https://epigenetics.europeannualconferences.com/, Invited by: Lucy Watson, Conference Manager | Epigenetics 2020, Email: [email protected], Email: [email protected], M: UK - 0-800-014-8923, What’s App: +44-7403-187952.

[54] Registration Number: STO/0/29900047, Participant's Name: Doctor Niknamian Sorush [email protected], ESC organised Event: All About Clinical Trials - EuroCVP 2019, European Society of Cardiology (ESO).

[55] Honorary Speaker at 2nd World Congress On Cardiology and Cardiovascular Diseases, Theme: Emerging Procedures and Transpiring research in Cardiology and Cardiovascular Diseases. On behalf of the organizing committee, we cordially welcome all to participate in the 2nd World Congress on Cardiology and Cardiovascular Diseases (WCCD-2020). We are very proud to host this prestigious event during 21-22 September 2020 at Paris, France. Our theme will be “Emerging Procedures and Transpiring research in Cardiology and Cardiovascular Diseases” We hope to see a lively exchange between colleagues from every part of the world, and especially between fellow Cardiologists from all over the world. WCCD-2020 has a great scholarly Scientific Program with 2 days of methodical sessions. This programme will feature new research findings, chances to learn from world famous connoisseurs and discussions with contemporaries WCCD-2020 is a unique platform to bring together worldwide distinguished academicians in the field of Cardiology, cardiovascular & cardiac researchers, public health & business professionals, scientists, industry researchers and scholars to exchange about growing research and technologies. Expert faculties will discuss the relevant progress in Cardio research and will explore the latest trends to reduce the effects of cardiovascular risk factors. WCCD-2020 Conference provide a worldwide stage for trading most recent developments in the field of Cardiology and cardiovascular and offering opportunities to listen the presentations conveyed by eminent experts from everywhere throughout the globe. Participating at WCCD-2020 give an approach to meet, cooperate with, and make contacts with different specialists in your claim to frame region.

124

[56] Organizing Committee Member of World Congress on Glycobiology (WCG- 2020), May 28-29, 2020, Brussels, Belgium, website: https://conferenceera.com/glycobiology-conference/, World Congress on Glycobiology (WCG-2020) is an International Conference organized by ConferenceEra on May 28-29, 2020,at Brussels, Belgium. WCG-2020 invitesand unites researchers, scholar’s, students, academicians, research organizations, and making the congress a perfect platform to share most happeningscientific advancements, progressive research in Glycobiologyover the globe.WCG-2020 allows multiple opportunities for scientific networking and knowledge sharing interaction. As well as the activeposter discussion sessions, panel discussions for speakers and participants to engage beyond discussing the data, into envisioning a future that integrates rapidly evolving therapies, procedures in Glycobiology.WCG- 2020 will be a communicating environment to share deliberate current challenges and ways to move the field forward. The conference will foster the exchange of ideas and spur multidisciplinary collaborations.

[57] Invited Speaker at International Conference and Expo on Applied Science, Engineering and Technology, June 15-16, 2020 in Montreal, Canada, Website: https://www.olcinternational.com/applied-science-2020/, URL: https://www.olcinternational.com/applied-science-2020/committee.php, About Conference: Research in the field of engineering not only presents highly original ideas and advanced technology but also focuses on practical applications of appropriate technology in different fields. Using engineering as a means to customize innovations that have been tested and formalized by science and applying them for different industries help in accommodating new technologies and in addressing local and global challenges on any given field of research. To contribute to ongoing research and present novel research results in all the aspects of applied science, engineering and technology, OLC International is organizing International Conference and Expo on Applied Science, Engineering and Technology and invites you to join in the mission to find great approaches to make a lasting difference in the world of Engineering and Science. The conference will be held from June 15-16, 2020 in Montreal, Canada with the theme "Latest Scientific Advances and Contemporary Challenges in Applied Science" The conference seeks to contribute

125 to presenting novel research results in all aspects of Engineering Technology and Applied Sciences while bringing together leading scientists, researchers, students, professionals from the industry, academia, and government to discourse on research and development in applied sciences and engineering technology to exchange and share their experiences about different aspects of these fields. This event provides the opportunity for the attendees to join hands with the global scholarly community in concerned fields and get connected with influential peers who can be potential mentors in your field. In addition to prompt keynote lectures and plenary talks focusing on the latest research findings, it also offers various academic and learning activities including poster and video presentations, workshops, exhibition and brain- storming discussions in the field. It will be a perfect platform for students to present their unique research work and express innovative thoughts on a global platform and gain informative insights from eminent scholars in your field. For members of scientific associations, policymakers, and industry leaders, this will be the right platform to develop new network opportunities for the advancement of science and humanity.

[58] Organizing Committee Member and Keynote Speaker “Introducing Sorush Cancer Treatment Protocol”, "International Conference and Exhibition of Cancer & Therapeutics" (ICECT 2020), July 6 - 8, 2020, About Cancer London 2020: "International Conference and Exhibition of Cancer & Therapeutics" (ICECT 2020) invites all the delegates to our upcoming conference which is going to be held in London, UK during July 6 - 8, 2020. The theme of our conference is “Cancer Current Research & Treatments" which will provide an international platform for discussion and sharing the advancements in the Cancer Science research for present and future expansions in various types of Cancer. Leading Oncologist, Health practitioners, educators, researchers and students will present their novel research and provide an insight to the current research and future expansions in Cancer London 2020. Your presence at ICECT 2020 will be a rewarding experience and we look forward to welcome you for Conference in London. URL: https://www.icecancerlondon.com/#header/.

[59] Organizing Committee Member of World Congress on Genetics and Molecular Biology, Theme: Modernization and Discoveries in the field of Genetics will lead to better future. 12-Apr-2021 - 13-Apr-2021 Prague, Czech Republic. The World

126

Congress on Genetics and Molecular Biology will be held from April 12-13, 2021 in Prague, Czech Republic. The Conference provides a unique platform for eminent biologists, biochemists, molecular biologists, bio-technologists, students, researchers in the field, educators, scientists and industry experts to come together on a single stage and provide answers for the upcoming challenges in the respective areas of Genetics and Molecular Biology. Current challenges, achievements in the field and possible suggestions for new technological advances will be discussed by the participants. Keynote presentations by eminent researchers in the field, poster presentations, research results and suggestions for developing new scientific equipment will be discussed at the event paving a new way of opportunities for professionals in the field. Molecular biology is the study of biology at molecular level and it overlaps with the areas of chemistry, biology, biochemistry and genetics and is concerned with the understanding of the various systems of a cell. The conference further seeks to understand how molecules which make up cells play a key role in determining the behavior of things. The event will cover a broad range of challenges related to molecular and cell biology including proteomics, functional genomics, bio-medicine, bio-informatics, molecular virology, immunology and enzymology. The gather will discuss on various scientific sessions and tracks related to the field of genetics and molecular biology including, but not limited to, genomics, diabetes and obesity, clinical genetics, cancer genetics, cytogenetics, genetic disorders, neuro developmental disorders, anthropology, drug discovery, transplantation, pharmacogenetics, bio-informatics in human genetics, evolutionary and population genetics, molecular genetics, immunogenetics, genetic testing, and DNA sequencing. The conference provides a platform for students and researchers in the field to participate in brain storming sessions related to the subject and gain insights with discussions aimed around the subject by professionals in the field including scientists, researchers, professors and academic professionals. Associations and societies related to molecular biology, industry leaders and medical device manufacturing personnel will be able to foster new partnerships and collaborations that will help in enhancing their goals. URL: https://www.axiomaticconferences.com/conferences/genetics-and-molecular- biology.

[60] Keynote Speaker and Organizing Committee Member of World Congress on Glycobiology, May 28-29, 2020, Brussels, Belgium. World Congress on

127

Glycobiology (WCG-2020) is an International Conference organized by ConferenceEra on May 28-29, 2020, at Brussels, Belgium. WCG-2020 invitesand unites researchers, scholar’s, students, academicians, research organizations, and making the congress a perfect platform to share most happeningscientific advancements, progressive research in Glycobiologyover the globe. WCG-2020 allows multiple opportunities for scientific networking and knowledge sharing interaction. As well as the activeposter discussion sessions, panel discussions for speakers and participants to engage beyond discussing the data, into envisioning a future that integrates rapidly evolving therapies, procedures in Glycobiology.WCG- 2020 will be a communicating environment to share deliberate current challenges and ways to move the field forward. The conference will foster the exchange of ideas and spur multidisciplinary collaborations. Website: https://conferenceera.com/glycobiology-conference/.

[61] Webinar: Conquering mental health demons in my STEM journey, In this hour- long session, Prasha will reveal some of her personal struggles during her STEM journey. While sharing her own experiences, she will talk about how she defeated some real demons like depression and anxiety. She will also share some great advice on how you can stay strong and motivated during your PhD journey as well as be prepared to deal with tough situations and take care of your mental health. Topic: Conquering mental health demons in my STEM journey, Date: January 11, 2020, Time: 8:00 AM EST, Speaker: Prasha Sarwate Dutra grew up in New Delhi, India and earned a Bachelor’s in Chemical Engineering followed by a Master’s in Mechanical Engineering from UT Arlington, Texas. She currently works in a leadership role in manufacturing in Rhode Island, USA. She believes that STEM Needs Women, Women Need STEM and to support that she created her podcast, Her STEM Story. Through one on one interviews with people from around the world, her mission is to close the voice-gap in STEM professions. In 2020, Prasha will be launching her coaching program called Conquer Your Career for women in STEM. URL: https://www.editage.com/insights/conquering-mental-health-demons- in-my-stem-journey.

[62] Honorary Keynote Speaker (Lecture: MEDICAL OZONE THERAPY AS THE EFFECTIVE TREATMENT FOR EBOLA AND AIDs) at World Congress on Infectious Diseases - WCID 2020, Start: Mon, 22 Jun 2020, 09:00, End: Wed, 24

128

Jun 2020, 17:00, Website: https://iii.hm/zbh, Venue: Holiday Inn Rome – Aurelia, S.S. 1 – Via Aurelia, Rome 00165, Italy. Infectious Disease conference will provide all the attendees, the opportunity to network with experts, present their research findings to an international audience and notify the latest scientific developments from world’s eminent speakers and contribute to various discussions that will shape future health policies and a proper patient care all around the world. The Conference will have a mix of lectures of keynote addresses, panel discussions, case discussions, current reports of scientific progress featured in oral abstracts and posters. The chosen topics will be of great benefit to practicing clinicians and academicians in the field of infectious diseases, medicine, microbiology, epidemiology, public health, critical care, pulmonology, pharmacology, pathology, pharmacy, nursing, and clinical research. This conference offers an opportunity for faculty, postgraduates, fellows, residents, and undergraduates to present their work, learn and network with the experts.

[63] Honorable Keynote Speaker (ISCTP Speech) at 19th International Conference on Structural Biology, September 28-29, 2020 Barcelona, Spain. On behalf of Scientific Organizing Committee, we are overwhelmed to welcome all the interested participants to attend 19th International Conference on Structural Biology during September 28-29, 2020 at Barcelona, Spain. The conference will be organized around the theme: An Insight into Every Dimension of Advanced Structural Biology Research. Structural Biology 2020 is a three day event consisting of a lettered scientific program, laudable talks by the top notch of the global scientific community, that brings together active researchers, intellectuals, academicians, students, contributors and industrialists to exchange ideas communicate and discuss research findings on new advancements in all kinds of available research worldwide innovative research products which can be exhibited for further development in Biochemistry. This Biochemistry Congress is going to be the largest and most promising international conference that specifically focuses on the Structural Biology by bringing all renowned researchers under one roof. This is a three day multidisciplinary meeting covering all aspects of novel research and contributions in the field of structural biology and biophysics. URL: https://structuralbiology.expertconferences.org/.

129

[64] Keynote Speaker about Explanation of how do individuals with multiple sclerosis cope with social isolation, The 4th International Biotechnology Congress (IBC-2020), Time: Nov. 9-11, 2020, Place: Dubai, UAE. IBC-2020 is a dedicated event where you will have the opportunity to learn about new developments in the field of Biotechnology, Gene and Life Sciences, and share aspects of your own work by submitting a poster or oral presentation. With the participation of outstanding international experts, we hope productive discussions would stimulate new creative ideas to translate new discoveries into better practice and application. IBC-2020 continues to expand with magnificent scientific and social programs to maximize your network in a free communication meeting environment. We create a great platform to researches, scientists, academicians and industry experts to share experiences, discuss research findings and acquire the desired knowledge for practical exercise. Invited by: Ms. Sophie Yu, Organizing Committee of IBC-2020, Tel: 0086-411-84799606, Fax: 0086-411-84799629, Email: [email protected], https://www.bitcongress.com/ibc2020.

[102] Keynote Speaker at SciTech Central Pharma 2020 Abstract and Speech URL: https://www.scitcentralconferences.com/accepted/pharmacology-drug- development-congress. Speaker URL: https://www.scitcentralconferences.com/experts/pharmacology-drug-development- congress. Pharmacology & Drug Development Congress, SciTech Central Pharma 2020 | April 27-28, 2020 | Palms Hotel | Mauritius, SciTech Nanoscience-Pharma 2019 | 14-15 October 2019 | Hotel Sunroute Plaza Shinjuku, Tokyo, Japan, https://www.scitcentralconferences.com/. WHO WE ARE: SciTech Central Inc. was founded with an aim to provide an International platform to the scientific community. SciTech Central Conferences believe that conferences and events are the perfect places to acquire knowledge and make wide business relations with the most advanced technology in the market. SciTech Central Conferences is an online platform where you can get the details about the conferences, seminars, workshops and other related events. These are the events where the best minds can share knowledge and their research outcomes and help the modern world to get the maximum utilization of knowledge. WHAT WE DO: SciTech Central Conferences invites participants for the events related to various fields across the world to get their research work showcased at an International platform. The SciTech Central Conferences is making its mark in the world of researchers and analyst, inventors

130 and inventions, science and education, business and economics, health and medicine and many more by providing details of related events, seminars and conferences. The concept of these events is basically to exchange knowledge and share the research experience on a stage where scientists & researchers from different parts of the world gather to aware the society regarding the recent advancements & breakthroughs in the field of science and technology. SciTech Central Conferences’ uniqueness is manifested in its technological flexibility and the implementation of innovative technologies. WHY SCITECH: Lead by young and innovative team, the company has a winning combination of people with vast experience in the field of research and development. The result is a path-breaking knowledge that provides participants, the most organized and easy ways to learn and explore. More than that, the attendees in the conferences and events will acquire knowledge that will potentially improve the benefits of their participation in the event, or making business connections. Our conferences include an abstract collection and conference plan building system, coordination of meeting calendars between participants, a conference application for management optimization, pre-registration via registration forms & landing pages and maximizing conference guests' benefits. SciTech Central Conferences, Address: SciTech Central Inc. 340 S Lemon Ave # 2725, Walnut, CA 91789, United States. For Asian & Middle East Conferences: SciTech Central Global, India, Phone: +1- 909-245-1470, Email: [email protected] and [email protected],

[65] Honorable Speaker at, 2nd International Conference on Traditional Medicine and Nutrition being held at Paris, France in the month of September from 22-24, 2020. Website: https://cellscience.magnuscorpus.com/organizing-committee. Speech: Comparison of classical and ultrasound-assisted extraction methods on antioxidant activities of pharmaceutically active compounds from Valeriana officinalis.

[66] Organizing Committee Member of 2nd International Conference on Traditional Medicine and Nutrition being held at Paris, France in the month of September from 22-24. URL: https://cellscience.magnuscorpus.com/organizing-committee.

[67] Topic: Corporate Comms Webinar with Olsson, Description: Do you want to reach and engage employees with an enhanced reading experience for company

131 content and/or collateral? Tune into this free webinar on February 26th at 10am PT — Issuu Content Manager Megan Breukelman and special guest Alicia Krieger, Corporate Communications Coordinator at Olsson will discuss: ● How to achieve your comms goals with the Issuu platform, ● How Olsson gained better informed and more engaged employees, ● PLUS, a live Q&A at the end! Time: Feb 26, 2020 10:00 AM in Pacific Time (US and Canada), Webinar ID: 540-970-282.

[68] Honorary Speaker at 2nd International Conference on Clinical & Pharmaceutical Microbiology, 22-24, September 2020, Theme: Fostering the Advances in Clinical Microbiology and Pharmaceutical Science, Magnus Corpus has come into being with the mission to promote conference, events, seminars, and open discussions based on different fields of science and technologies globally. This conference discusses how best the benefits and fruits be carried over to every human being across nations and make the world a better place to live in. After a warm and glorious completion of Microbiology 2019, it takes immense pleasure in honoring you back to cherish your moments. In 2nd International Conference on Clinical and Pharmaceutical Microbiology which is to be slated in September 22nd -24th , 2020 at Paris, France We welcome all the participants across the globe with the theme Fostering the Advances in Clinical Microbiology and Pharmaceutical Science to widen your scientific research in the field. Our conference provides you with the platform to witness the lead gathering of presidents, vice presidents, head of the departments, scientists, researchers, faculties, business entrepreneurs, delegates, industrialists, students and young researchers across the world. It fabricates the best opportunity to propose your research in the form of keynote presentations, poster presentations, oral talks and exhibitions and to explore information with current potential and eminent scientists. Microbiology 2020 also adheres the industrialists and academicians in the field of Microbiology, pharmaceutics, Molecular Biology, Pathology, Infectious Diseases, Immunology and more to transverse your brainstorm and impression. The major focus of this congress is to enhance and support the research work and to exchange the ideas and methodologies among eminent speakers and researchers. URL: http://clinicalmicrobiology.magnuscorpus.com/.

Accepted Abstracts Submitted to Conferences

132

[1] HOW BUTTERFLY EFFECT OR DETERMINISTIC CHAOS THEORY IN THEORICAL PHYSICS EXPLAINS THE MAIN CAUSE OF CANCER, (Introducing the Chaos Theory in Cancer Biology), Goodbye Flat Biology: In Vivo Inspired Cancer Biology and Therapy, Berlin, Germany, 07.05.2018.

[2] The Positive Effect of SKD Plus IOT and HBO2T in the Treatment of Cancer [Introducing SCTP Cancer Treatment Protocol], 36th World Cancer Conference, October 11-13, 2018 Venue: Hilton Zurich Airport, Hohenbühlstrasse 10, 8152 Opfikon, Switzerland, Theme: Interchanging the scientific enlightenment about cancer research. Oral

[3] The Positive Effect of SKD Plus IOT and HBO2T in the Treatment of Cancer [Introducing SCTP Cancer Treatment Protocol], International Conference on Cancer Research and Diagnostics, August 15-16, 2018 Singapore, Theme: Cancer survived is a life revived. Oral

[4] The Positive Effect of SKD Plus IOT and HBO2T in the Treatment of Cancer [Introducing SCTP Cancer Treatment Protocol], International Conference on Cancer Diagnosis & Treatment, August 2-3 2018 Oslo, Norway, Theme: Torch Your Light to Develop Cancer-free World, Venue: Quality Airport Hotel Gardermoen, Oral

[5] The Positive Effect of SKD Plus IOT and HBO2T in the Treatment of Cancer [Introducing SCTP Cancer Treatment Protocol], 4th World Congress on Cancer Research and Radiation Oncology May 20-22, 2019, Barcelona, Spain, Oral Presentation.

[6] The Positive Effect of SKD Plus IOT and HBO2T in the Treatment of Cancer [Introducing SCTP Cancer Treatment Protocol], 35th Annual Miami Breast Cancer Conference, to be held March 8-11, 2018 at the Fontainebleau Miami Beach Hotel in Miami Beach, Florida.

[7] The Positive Effect of SKD Plus IOT and HBO2T in the Treatment of Cancer [Introducing SCTP Cancer Treatment Protocol], 25th Global Meet on Cancer Research & Oncology (Cancer 2019), May 20-21, 2019, Rome, Italy.

133

[8] Designing a Hybrid Brain Computer Interface System, Biomimetics in Bioengineering Conference 2018, Brisbane, Australia, 2-4 December 2018, Presented by: Queensland University of Technology, Nature Protocols, Nature Materials and Nature Reviews Materials, Oral Presentation, Nature Conferences.

[9] The Positive Effect of SKD Plus IOT and HBO2T in the Treatment, ESMO Immuno-Oncology Congress 2018, 13-16 December, Geneva, Switzerland. Category: Clinical practice (including toxicities), CTI Meeting Technology, on behalf of the ESMO Immuno-Oncology 2018 team.

[10] The Positive Effect of SKD Plus IOT and HBO2T in the Treatment, 2018 Tumor Immunology and Immunotherapy Special Conference, Reference ID: A- 54814804, AACR Conferences.

[11] The Positive Effect of SKD Plus IOT and HBO2T in the Treatment, 2019 Pezcoller Foundation-AACR International Award for Extraordinary Achievement in Cancer Research, Reference ID: A-89467145.

[12] Abstract Title: The Positive Effect of SKD Plus IOT and HBO2T in the Treatment, Presenting Author for an abstract that has been submitted for the upcoming 2018 AACR Special Conference on Targeting RAS-Driven Cancers, being held from December 9-12, 2018 at Hilton San Diego Bayfront in San Diego, CA.

[13] Abstract Title: The Positive Effect of SKD Plus IOT and HBO2T in the Treatment of Cancer, The Tumor Cell: Plasticity, Progression and Therapy, March 3-6, 2019, Zuckerman Research Center at Memorial Sloan Kettering Cancer Center, New York, NY, USA, Nature Conferences, www.nature.com/natureconferences/ttc19/index.html, Conference hashtag: #tumour19, Twitter: @NatureConf, @sloan_kettering, @NatureCellBio, @NatureRevCancer.

[14] he relation between the quantum entanglement in theoretical physics as a new insight into the cancer biology, has been selected by the ENA 2018 Executive Scientific Committee for Poster Presentation at the 30th EORTC/AACR/NCI symposium in Dublin (13-16 November 2018).

134

[15] THE RELATION BETWEEN THE QUANTUM ENTANGLEMENT IN THEORETICAL PHYSICS AS A NEW INSIGHT INTO THE CANCER BIOLOGY, 4th International Conference on Quantum Physics and Quantum Technology, November 05-06, 2018 London, UK, Theme: Co-relating the Physics of Quantum to the Wholeness of the Universe.

[16] DESIGNING A HYBRID BRAIN COMPUTER INTERFACE SYSTEM, Advanced Biomedical Engineering and Instrumentation Summit, June 3-5, 2019 | San Francisco, CA, USA. Oral Presentation under "Biomedical Signal and Image Processing" Session.

[17] The Tumor Cell: Plasticity, Progression and Therapy, New York, NY, Poster Presenter, Nature Conferences, March 3-6, 2019, Zuckerman Research Center at Memorial Sloan Kettering Cancer Center, New York, NY, USA, Website: https://www.eventsforce.net/nature/frontend/reg/thome.csp?pageID=52953&ef_sel _menu=340&eventID=131. Presented by: Geoffrey Beene Cancer Research Center at Memorial Sloan Kettering Cancer Center, Nature, Nature Cell Biology and Nature Reviews Cancer, this conference aims to highlight the plasticity of tumors from the early stages of tumor initiation, through disease progression and in response to therapy. Experts will come together with distinct views on the plasticity and heterogeneity of cancer to discuss how cancer-cell-intrinsic attributes and adaptive responses are integrated with the tumour microenvironment and the immune system, and how best to translate our current knowledge into therapeutic modalities.

[18] The Positive Effect of SKD Plus IOT and HBO2T in the Treatment of Cancer [Introducing SCTP Cancer Treatment Protocol] 36th Annual Miami Breast Cancer Conference, March 7-10, 2019, Fontainebleau Miami Beach, 4441 Collins Avenue, Miami Beach, FL 33140. The optimal care of patients with breast cancer is rapidly changing and becoming increasingly complex as a result of advances in all aspects of management, including screening, molecular/genetic testing, detection, primary treatments (ie, surgery, radiation therapy, and systemic therapies), and patient support strategies. For 36 years, the multidisciplinary Miami Breast Cancer Conference® has been bringing together surgical, medical, and radiation oncologists, as well as geneticists, pathologists, radiologists, and supportive care specialists, with the aim of fostering your awareness of state-of-the-art treatments

135 for all stages and subtypes of breast cancer, providing you with expert perspectives on areas of clinical uncertainty or controversy, and encouraging you to engage in cross-team cooperation in your clinic.

[19] CONSUMPTION OF SATURATED ANIMAL FATS IN THE DIET OF HUMANS MAY DECREASE THE RATE OF HEART DISEASE IN THE FUTURE, Control # 19-A-124-ISMICS, 2019 Annual Scientific Meeting | 29 May - 1 June, Marriott Marquis | New York, New York. Sponsor: International Society for Minimally Invasive Cardiothoracic Surgery, 500 Cummings Center, Suite 4400, Beverly, MA 01915, meetings.ismics.org Tel: 978-927-8330 Fax: 978-524-0461.

[20] OCT4 EXPRESSION REGULATED APOPTOSIS AND CELL CYCLE IN MYELOMA CELLS, Nature Conferences, In Vitro Diagnostics, March 22-23, 2019, Nanchang, China, Presented by: Shanghai Jiao Tong University | Experimental Medicine Professional Committee | China Association of In-Vitro Diagnostics | Nature Biomedical Engineering, #InVitro19.

[21] SUPPLEMENTATION WITH N-ACETYL-CYSTEINE (NAC) INCREASES THE AMOUNTS OF γ-L-Glutamyl-L-cystein-yl-glycine, WHICH REDUCES THE AMOUNTS OF REACTIVE OXYGEN SPECIES (ROS) IN NORMAL CELLS AND IS EFFECTIVE IN THE PREVENTION OF CANCER, Nature Conferences, Cellular Metabolism, April 8-11, 2019, Xiamen, China, Presented by: Xiamen University | Nature | Nature Metabolism, NCCM2019.

[22] OCT4 EXPRESSION REGULATED APOPTOSIS AND CELL CYCLE IN MYELOMA CELLS, 3rd Annual Metabolic Health Summit in Los Angeles, CA., Date and Time: Thu, Jan 31, 2019, 3:00 PM – Sun, Feb 3, 2019, 6:00 PM PST, Location: Renaissance Long Beach Hotel, 111 East Ocean Boulevard, Long Beach, CA 90802. Accepted for Poster Presentation by Metabolic Health Summit Planning Committee: Dr. Dominic D'Agostino, Dr. Angela Poff, & Victoria Field.

[23] THE RELATION BETWEEN THE QUANTUM ENTANGLEMENT IN THEORETICAL PHYSICS AS A NEW INSIGHT INTO THE CANCER BIOLOGY, Submission ID: APR19-000520, Submission Category: Q. MEDICAL PHYSICS (GMED), Submission Sub-Category: Q04. Physics of disease states (e.g., modeling of cancer, neuro-degenerative), Submission Presentation Type: Oral,

136

Submission Category Type: Theoretical April Meeting 2019, American Physics Society, April 13-16, Denver, Co, USA.

[24] Design and simulation of Plasmonic nanoparticle solar cells for efficiency increasing, Elsevier Conferences: Design and simulation of Plasmonic nanoparticle solar cells for efficiency increasing, Next-Generation Materials for Energy Applications, November 17 to 19 in Xiamen, China. Abstract No: 0006, Abstract ID: CAPP2019 0006.

[25] THE RELATION BETWEEN THE QUANTUM ENTANGLEMENT IN THEORETICAL PHYSICS AS A NEW INSIGHT INTO THE CANCER BIOLOGY, CPD Accredited, 2nd International Conference on Physical and Theoretical Chemistry, Bangkok, Thailand, July 29-30, 2019.

[26] The Impact of Human Microbiome in the Cause and Prevention of Cancer, Physical Chemistry 2019 | Bangkok, Thailand. Role: Key Speaker.

[27] The positive effect of SKD plus IOT and HBO2T in the treatment of cancer, Clinical Research and Clinical Trials Summit Venice, Italy, September 13-14, 2019, Role: Session Speaker. Invited by: Amelia Smith| Event Manager, Clinical Research 2019, Lexis Conferences, Avenue Roger Vandendriessche 18, 1150 Brussels, Belgium.

[28] MicroRNAs biomarkers profiling in diagnosis and therapeutic management of hepatitis B virus infection, SFRR-E Annual Meeting 2019, which will be held in Ferrara, Italy, on June 19-21, Society for Free Radical Research – Europe.

[29] THE IMPACT OF STRESS, ANXIETY, FEAR AND DEPRESSION IN THE CAUSE OF CANCER IN HUMANS, Abstract ID: 14344978, FENS, Regional Meeting, Belgrade, Serbia, July 10-13 2019.

[30] THE RELATION BETWEEN THE QUANTUM ENTANGLEMENT IN THEORETICAL PHYSICS AS A NEW INSIGHT INTO THE CANCER BIOLOGY, Conference on Equity for Discipline-Based Education Researchers in the Mathematical and Physical Sciences. Abstract ID: CEDBER19-2019-000002.

137

[31] The Role of Human Microbiome in the Cause and Prevention of Cancer, Abstract No. 0003, Cell Symposia, Hallmarks of Cancer, November 17-19 2019, Seattle, WA, USA. Elsevier Conferencers. Abstract ID: CHAL2019 0003. Registration handled on behalf of Elsevier Ltd by Oxford Abstracts. Copyright © 2018 Elsevier Limited.

[32] 8th International Conference on Bioengineering and Nanotechnology Presented by the Society for Biological Engineering (SBE), May 28-31 2019, Hyatt Regency, Baltimore Inner Harbor, Baltimore MD. this conference will bring together leaders and trainees from cutting edge fields of bioengineering and nanotechnology. Topics to be presented include: biomolecular engineering, translational medicine, cell engineering, immunoengineering, and mechanobiology. The global objective of the conference is to bring to the forefront truly transformational development in bionanotechnology. Title: The Introduction of Designing a Hybrid Brain Computer Interface System, Abstract ID: 54952. AICHE Abstract #554952 - 8th International Conference on Bioengineering and Nanotechnology.

[33] Agricultural Revolution in the LINE of Human Evolution Is the Onset of Nutritional Metabolic Diseases, Epidemic of Cancer and the Infectious Diseases, Preferred Presentation Format: Oral Preferred, 2019 Synthetic Biology: Engineering, Evolution & Design (SEED), June 23-27, 2019. Abstract ID: 555155.

[34] Medical Ozone Therapy As the Effective Treatment for Ebola and Aids, Preferred Presentation Format: Oral Preferred, Abstract ID: 555158, 2019 Synthetic Biology: Engineering, Evolution & Design Conference (SEED 2019).

[35] EFFECT OF WIND-STRUCTURE INTERACTION ON LONGITUDINAL RESPONSE OF TALL BUILDINGS, Monday, 16th September, 2019 - Thursday, 19th September, 2019, CIVIL-COMP 2019: The Sixteenth International Conference on Civil, Structural and Environmental Engineering Computing and CIVIL-COMP OPTI 2019 The Fifth International Conference on Soft Computing and Optimization in Civil, Structural and Environmental Engineering. (Fifth International Conference on Soft Computing & Optimization in Civil, Structural and Environmental Engineering, 16-19 September 2019 | Riva del Garda, near Lake Garda, Italy.

138

[36] Valproic acid inhibit non-small-cell lung cancer (A549 cell line) metastasis via inhibition of CD44v6 and Nm23H1, REDOX HOMEOSTASIS: FROM SIGNALLING TO DAMAGE, 19-21 June, Ferrara Italy, Sponsor: SFRRE 2019.

[37] SYSTEMATIC REVIEW ON TELE-WOUND-CARE IN SPINAL CORD INJURY (SCI) PATIENTS AND THE IMPACT OF TELEMEDICINE IN DECREASING THE COST, Global Conference on Nursing and Health Care Management (GCNH 2019)’’ which is going to held during September 02-04, 2019 at Valencia, Spain, Oral Presentation. Sponsor: GCNH 2019 covers a wide range of critically important sessions from basic research to recent innovations and continues to lead the way in providing a platform for partnerships to be made which will move the sector forward. The theme of the conference is ' Multifaceted Current Challenges and Advanced Innovations in Nursing and Health Care' covers a wide range of critically important sessions.

[38] The effect of wind- soil- structure interaction on the longitudinal response of high-rise buildings, CIVIL-COMP 2019: The Sixteenth International Conference on Civil, Structural and Environmental Engineering Computing and CIVIL-COMP OPTI 2019: The Fifth International Conference on Soft Computing and Optimization in Civil, Structural and Environmental Engineering.

[39] Resource–Economic Growth Nexus, Role of Governance, Financial Development, Globalisation and War: Dynamic Approach. CIVIL-COMP 2019: The Sixteenth International Conference on Civil, Structural and Environmental Engineering Computing and CIVIL-COMP OPTI 2019: The Fifth International Conference on Soft Computing and Optimization in Civil, Structural and Environmental Engineering.

[40] OCT4 EXPRESSION REGULATED APOPTOSIS AND CELL CYCLE IN MYELOMA CELLS, 2019 Army/Air Force ACP Conference second call for Resident, Fellow, and Early Career Physician (ECP) abstracts, ACP, US Army Chapter.

[41] The positive effect of SKD plus IOT and HBO2T in the treatment of cancer, 2019 ASCO Annual Meeting (May 31 - June 4, 2019), Paper ID: 247185, Paper Password: 892346.

139

[42] THE RELATION BETWEEN THE QUANTUM ENTANGLEMENT IN THEORETICAL PHYSICS AS A NEW INSIGHT INTO THE CANCER BIOLOGY ,61st Annual Meeting of the APS Division of Plasma Physics, number for submission is DPP19-2019-000002.

[43] New Approaches to the Design of Automatic Diagnostic Systems and Math Algorithms of Breast Cancer, Micro physiological Systems and Bio Analytics Conference, September 4-6 in Jerusalem, Israel. AICHE Abstract #580386 - Microphysiological Systems and Bioanalytics Conference, Oral Presentation, Organizing Committee: Georges Belfort, Rensselaer Polytechnic Institute, , Dana Levy, Hebrew University of Jerusalem, Ben Moaz, Tel Aviv University, Gad Vatine, Ben Gurion University, Martin L. Yarmush, Rutgers University.

[44] Keynote Speaker, International Conference and Exhibition on Cancer & Therapeutics, Cancer Houston 2019, September 27-28 2019, Houston, TX, USA, Innovations and furtherance Cancer Care.

[45] THE RELATION BETWEEN THE QUANTUM ENTANGLEMENT IN THEORETICAL PHYSICS AS A NEW INSIGHT INTO THE CANCER BIOLOGY, Cancer Research UK-AACR Joint Conference: Engineering and Physical Sciences in Oncology, Oct. 15-17, 2019 • London, United Kingdom.

[46] Keynote Speaker at Speaker Invitation | Healthcare Conference 2019 | Nov 13 - 14 | Dubai, UAE, Subject: OCT4 Expression Regulated Apoptosis and Cell Cycle in Myeloma Cells.

[47] Key Speaker at Annual Meeting of SFRR-Europe. Belgrade, Serbia, on the 9th- 12th June 2020. Society for Free Radical Research – Europe.

[48] Keynote Speaker at International Conference on Orphan Drugs & Rare Diseases” scheduled in Berlin, Germany on March 16-17, 2020. The Conference is specifically related with the subject “A STEP TOWARDS ADVANCEMENT IN THE RESEARCH AND TREATMENT OF RARE DISEASES” which focusses on extensive type of sessions. Based totally to your work and research in the field of Pharmaceutics, we would like to honour you via inviting you as an Organizing Committee Member of Orphan Drugs 2020. Orphan Drugs 2020 offers an excellent

140 platform for the interaction amongst experts, administrators, Professors, faculties, professionals, and studies fellows round the arena reputed studies institutes, universities and companies, agencies, affiliation & societies and mainly accelerating the clinical discoveries inside the subject of Pharmaceutics and Novel Drug transport structures to trade statistics at the contemporary studies progress. Invited by: David Roy - Program Manager| Orphan Drugs 2020| Berlin, Germany| March 16-17, 2020, Meetings International Pvt. Ltd, 28 Maxwell Road, #03-05 Red Dot Traffic, Singapore (069120), Phone: +65-31080483, +1-302-231-6756, Toll Free: +800- 852-6126, E-mail 1: [email protected], E-mail 2: [email protected].

[49] Keynote Speaker at Euroscicon conference on Physical Chemistry 2019 (CPD Accredited), which is going to be held from October 30 - 31, 2019 in Paris, France. Invited by: Alice Stephen | Meeting Producer, +44-2033182512 (TEL), +13154447146 (WHATSAPP).

[50] Advisor at Cardinal Health Specialty Solutions September 2019 Oncology Summit Understanding Patients’ and Providers’ Quality of Life in Oncology Care, September 13-14, 2019 | Westin Denver International Airport, Time Commitment: 30-minute pre-meeting survey and a live 2-day meeting. Cardinal Health Specialty Solutions is conducting a market research activity for oncology/hematology physician assistants and nurse practitioners and cordially invites you to participate as an advisor. During the course of the September Oncology Summit, Cardinal Health Specialty Solutions will seek to: Discuss strategies employed by practices to gather feedback from patients on their quality of life and overall cancer experience. Gain insight into the collateral impact of a cancer diagnosis on patients and their caregivers. Obtain feedback on providers’ perceptions on factors impacting a cancer patient’s quality of life. Gain insight into providers’ perceptions of their own quality of life and career satisfaction. Gather information on the benefits and challenges of participating in a patient-reported-outcome network. Invited by: Ajeet Gajra, MD, Vice President/Chief Medical Director, Cardinal Health.

[51] Honorary Speaker at 3rd Edition of International Cancer Conference, September 23-25, 2019, London, UK, Title: Introducing Sorush Cancer Treatment Protocol (SCTP).

141

[52] IIS-ISCR Conference 2019, to be held in Dan Panorama, Tel Aviv Israel on 23- 25 September 2019. Abstract Title is: Introducing Sorush Cancer Treatment Protocol, Abstract Submission Number is: 460, Oral Presentation.

[53] PSOH Annual Scientific Meeting, October 4, 2019, Annual Meeting at the George J. Magovern, MD Conference Center, Allegheny General Hospital, 320 East North Avenue, Pittsburgh, PA., Abstract: Introducing Sorush Cancer Treatment Protocol.

[54] THE RELATION BETWEEN THE QUANTUM ENTANGLEMENT IN THEORETICAL PHYSICS AS A NEW INSIGHT INTO THE CANCER BIOLOGY, Authors: Sorush Niknamian1; Control Number: A-10930, Biophysical Society Conferences, Molecular Biophysics of Membranes, which is being held, June 7–12, 2020, at the Granlibakken in Tahoe, California, USA. Description: The meeting, focused on the topic of membrane biophysics, will bring together scientists with a diverse range of perspectives, approaches, and disciplines, including (but not limited to) physiology, engineering, cell biology, chemistry, and physics. The program seeks to catalyze cross-fertilization that spurs frontier research advances, bringing together scientists working in different areas of membrane biology, including those using computational methods and those using experimental methods, those focusing on the membrane lipids and those focusing on the membrane proteins, those studying model membranes and those studying biological membranes. The attendees, particularly students and junior researchers, will be provided with a positive and informal environment for interaction with the leaders in the field to stimulate the exchange of ideas and foster collaborations among them. Biophysical Society, 5515 Security Lane, Suite 1110, Rockville, Maryland 20852, P: 240-290-5600 F: 240-290-5555 W: www.biophysics.org E: [email protected]/

[55] Designing a MODEL to Investigate the Role of the Factors Formulation Public Policies in the Implementation of the Administrative System Health Policy, Session Selection: Licensing, Credentialing and Career Planning: AIChE's Role, Preferred Presentation Format: Oral Preferred, Abstract ID: 584531, 2020 AIChE Spring Meeting & 16th Global Congress on Process Safety (GCPS) on March 29 – April 2 in Houston, TX.

142

[56] The Role of Human Microbiome in the Cause and Prevention of Cancer, Session Selection: Keynote Speaker, Abstract ID: 584552, 2nd International Conference on Microbiome Engineering (ICME 2019) – taking place December 2- 4, 2019, in Boston, Ma, keynote speakers Christopher Voigt (Massachusetts Institute of Technology), Wenyuan Shi (Forsyth Institute) and Wendy Garrett (Harvard School of Public Health) as well as other experts in this field. Conference Chairs: Rachel Haurwitz, Caribou Biosciences, Inc. and Ophelia Venturelli, University of Wisconsin-Madison.

[57] Introducing Sorush Cancer Treatment Protocol, 2020 ASCO-SITC Clinical Immuno-Oncology Symposium. The Symposium combines ASCO’s application- driven educational approach with SITC’s global immunotherapy network. February 6-8, 2020 | Rosen Shingle Creek | Orlando, FL | #ImmunoOnc20.

[58] Keynote Speaker at 8th World Conference and Expo on Nanoscience and Nanotechnology, Theme: Latest Innovations in Nanotechnology for the Next Generation, Date: February 17-18, 2020 Venue: Philadelphia, USA. URL: https://scientificfederation.com/nanoscience-conferences-2020/speakers.php.

[59] Keynote Speaker at the 3rd International Biotechnology Congress (IBC-2019), Singapore on October 25-27, 2019, Abstract: Explanation of how do individuals with multiple sclerosis cope with social isolation... in the Track 602: Pharmaceutical/Medical Biotechnology. URL: http://www.bitcongress.com/ibc2019/programlayout.asp, http://www.bitcongress.com/ibc2019/.

[60] Keynote Speaker at 2nd international Conference on Medical Science 2019, Denver Colorado, URL: https://biomedconferences.org/biomedical- sciences/organizing-committee.php. November 01 – 02, 2019.

[61] Keynote Speaker at International Conference on Medical Pathology, February 17-19, 2020 | Houston, TX, Doubletree by Hilton, Houston Intercontinental Airport, ABOUT MED PATH-2020: MedPath-2020 hosts an important gathering and foster connections that will spur the innovations in Anatomical, Clinical and Molecular

143

Pathology. It is a three-day event with an assemblage of inspirational keynote addresses, theoretical presentations, interactive panels and valuable real-world case studies from across the academia and industry spectrum of Pathology & Allied areas. It paves ideal layout for Pathologists, Scientists, Molecular Biologists, Geneticists, Physicians, Researchers, Professors and Business People to meet and share advances that offers diagnostic, prognostic and predictive information essential for best patient care. The key lectures will sketch vistas from higher up in the basic research discoveries, linking pathology with its firm science roots, About Organizer: United Scientific Group takes the honor to invite you to the First International Conference on Medical Pathology which will be held during February 17 - 19, 2020 at Houston, TX. Our aim is to provide you with a scientific panorama on all major fields of expertise in Pathology.

[62] Keynote Speaker at 7th International Conference on Stem Cell Engineering 2019, From Organoids to Synthetic Embryo: Tools, Technologies, and Novel Applications, December 11-13, 2019, Hotel Barcelona Center, Barcelona, Spain, presented by the Society for Biological Engineering (SBE), this conference will bring together leaders and trainees from cutting edge fields of stem cell engineering to develop the next-generation of stem cell technologies. Title: Introducing Sorush Cancer Treatment Protocol, ID: 587222.

[63] Keynote Speaker at 5th World Congress on Public Health and Health Care Management, April 16-17, 2020 in Miami, USA, Official Portal: https://scientificfederation.com/public-health-2020/index.php,

[64] Control Number: A-10958, Title: THE ROLE OF HUMAN MICROBIOME IN THE CAUSE AND PREVENTION OF CANCER, Biophysical Society Thematic Meeting on Physical and Quantitative Approaches to Overcome Antibiotic Resistance. This meeting will be held at Karolinska Institute in Stockholm, Sweden, August 30–September 2, 2020. The Organizing Committee, Peter Kasson, University of Virginia, USA, Joanna Slusky, University of Kansas, USA, Georgios Sotiriou, Karolinska Institute, Sweden, Biophysical Society, 5515 Security Lane, Suite 1110, Rockville, Maryland 20852, P: 240-290-5600 F: 240-290-5555 W: www.biophysics.org E: [email protected].

144

[65] Oral Presenter at 2020 Annual Scientific Meeting | 4 - 6 June, Hilton Warsaw Hotel & Convention Centre | Warsaw, Poland. Sponsor: International Society for Minimally Invasive Cardiothoracic Surgery.

[66] Oral Presenter at the Seventh International Mammalian Synthetic Biology Workshop (mSBW 7.0), taking place at Dynamic Earth in Edinburgh, Scotland on May 21-22, 2020. Abstract ID: 590498, Sponsor: AIChE®, 120 Wall St, 23rd Fl, New York, NY 10005, © 2019 AIChE 3484_18 • 11.19 EM1. Invited by: Dejuanah Collymore, Engineering Associate, Society for Biological Engineering, [email protected].

[67] Keynote Speaker at the World Summit on Diabetes and Metabolism, March 23- 24, 2020 at Toronto, Canada, the conference will cover a wide range of research fields in Diabetes Mellitus, Endocrinology, Obesity, Diabetes Diet and Nutrition, Metabolic and Diabetic Syndromes, Diabetes Drugs and Developments, Diabetes Treatment and Management, etc. Diabetes Metabolism 2020 will be the world best platform for all the Eminent Scientific Professionals, Professors, Directors, Young Scientists, Students, Industrial Delegates and Research Organizations to share their research and experience in this meeting. conference website: https://www.meetingsint.com/conferences/diabetesmetabolism/.

[68] Keynote Speaker at 2nd World Congress on Cardiology and Cardiovascular Diseases (WCCD-2020) during September 21-22, 2020 at Paris, France. conference website: https://www.phronesisonline.com/cardiology-congress/.

[69] Winner of NSF grant (registration only) to attend FEW Nexus 2019, 2019 Food- Energy-Water Nexus Conference | NYIT, New York, NY | Dec. 5-6, 2019, Grant Code: code FEW1900, AIChE Technical Entities, 120 Wall St. 23rd Fl. New York, NY 10005. URL: https://www.aiche.org/ifs/conferences/food-energy-water- nexus/2019.

[70] Oral Presenter at the Seventh International Mammalian Synthetic Biology Workshop (mSBW 7.0), taking place at Dynamic Earth in Edinburgh, Scotland on May 21-22, 2020. Abstract ID: 590739, Detail: We are pleased to announce the Seventh International Mammalian Synthetic Biology Workshop (mSBW 7.0), to be held in Edinburgh, UK on the week of May 21-22, 2020. The mSBW series has grown exponentially in recent years to become a signature worldwide event. This

145 event brings pioneers of synthetic biology together with experts from other relevant fields to highlight and inspire cutting-edge synthetic biology research, emphasizing both basic and applied science. The workshop format will provide a forum for exposition of the latest developments in the field and discussions of how experts from related fields can benefit from and contribute to mammalian synthetic biology. Plenary Speaker: Megan Levings, University of British Columbia, Confirmed Speakers: Diego Di Bernardo, Telethon Institute of Genetics and Medicine, Barbara Di Ventura, University of Freiburg, Karmella Haynes, Emory University, Conference Chair: Susan Rosser, University of Edinburgh, Organizing Committee: Leo Bleris, UT Dallas, Yvonne Chen, UCLA, Tara Deans, University of Utah, Ahmad (Mo) Khalil, Boston University, Samira Kiani, Arizona State University, Joshua Leonard, Northwestern University, Leonardo Morsut, University of Southern California, Laura Segatori, Rice University, Velia Siciliano, Italian Institute of Technology, Ron Weiss, Massachusetts Institute of Technology, Wilson Wong, Boston University. Title: Cancer Incidence in Wild Animals and the Rejection of Peto’S Paradox Theory. Conference Website: http://mammalian-synbio.org/2020.

[71] Organizing Committee Member of the International Conference on Pharmacy and Pharma Network held on August 25-27, 2020 in Germany/Munich. Details: ICPPN Germany 2020 welcomes all participants throughout the world to attend the International Conference on Pharmacy and Pharma Network held on August 25-27, 2020 in Germany. The Conference deals with the theme on "Recent Innovations and Advances in Pharmacy and Pharma Networks" and it has a branch of Scientific Sessions concerned with the departments of Pharmacology, Pharmacognosy, Toxicology, Pharmaceutical Sciences, Clinical Pharmacy, Biopharmaceutics and which included with subdivisions they are Hospital Pharmacy, Industrial Pharmacy, Pharmaceutical Biotechnology, Medicinal Chemistry, Pharmaceutical Nanotechnology, Pharmaceutical Microbiology. Pharma Conference 2020 is a chance to extend and exhibit your ideas and explore the new innovations with experts from everywhere throughout the globe. The Conference serves researchers from academia and industry and intended to be of interest to a broad audience of Pharmaceutical, Medical and Health professionals, Worldwide pharmacists, Professors, researchers, they will present their novel research and provide an insight to the current research and future expansions in pharmacy and pharma network.

146

[72] Organizing Committee Member for the 4th World Congress on Biotechnology and Healthcare which has been scheduled for the month of September 28 - 29, 2020 San Diego, USA. Invited by: Brenda Marshal, Program Facilitator | BioHe2020, CPG Scientific Events | USA. Website: http://www.biohealthconference.org/. Scope of the conference: The idiopathic goal of the conference is to promote research and developmental activities in Biotechnology and Healthcare and to encourage scientific information interchange between researchers, developers, students, and practitioners working around the World. This will also provide you an opportunity to share knowledge and channels for extending businesses between industry and academia.

[73] Introducing the Sorush Cancer Treatment Protocol (SCTP), Oral Presentation, BEIS-2020, Biomedical Engineering Conference, About BEIS 2020: Keeping updated on the latest trends in Biomedical Engineering and related areas United Scientific Group-A non-profit organization hosting 2nd Biomedical Engineering and Instrumentation Summit during July 20-22, 2020 in Boston, Massachusetts, United States. This Bioengineering conference is organizing with a view to promote awareness and enhance research aiming in developing solutions for the challenges encountered. After the successful edition of BEIS 2019 during June 3-5, 2019, San Francisco, CA the team came up with the new theme to fill the gap between knowledge and innovation. Predictable with our subject, we have organized entire keynotes from leading academic researchers and industrial. A broad array of scientific sessions will cover various subjects in research and development in bioengineering, medical device technology innovation R&D, innovation and business entrepreneurship, and biomedical training. BEIS-2020 program planned to provide three days of productive discussion on biomedical engineering education, biomaterial, and tissue engineering, health monitoring devices, image processing, sensor technology, and wearable health devices, radiography, novel drug delivery system, etc. These are the key topics that are going to be addressed at the conference. Big data networking, research, and application in biomedical health care also going to discuss at the conference. BEIS-2020 concludes with a special session “Medical Technology Innovation and Invention” on the Industry focus concentrating on innovations in the field of Biomedical Engineering and Instrument devices and networking with the plenary speakers and investors. USG-United Scientific Group, A Non-Profit Organization, an expert-driven initiative led by the editor’s association

147 and the advisory board which includes academicians, researchers, and industry leaders across various fields of research. USG provides broad range of services in the fields of science and technology including publishing, conducting world class scientific events, and holding highly interactive and proficient world forums. For more information, please visit: http://unitedscientificgroup.com/editors- association.php. USG United Scientific Group, A non-profit organization, 8105, Suite 112, Rasor Blvd, Plano, TX 75024, USA, Phone: +1 408 426 4832/33, Toll Free: +1-844-395-4102, Email: [email protected]. Website: https://biomedical.unitedscientificgroup.org/about-BEIS-2020.

[74] Invited Speaker at International Conference and Expo on Applied Science, Engineering and Technology, June 15-16, 2020 in Montreal, Canada, Website: https://www.olcinternational.com/applied-science-2020/, URL: https://www.olcinternational.com/applied-science-2020/committee.php, About Conference: Research in the field of engineering not only presents highly original ideas and advanced technology but also focuses on practical applications of appropriate technology in different fields. Using engineering as a means to customize innovations that have been tested and formalized by science and applying them for different industries help in accommodating new technologies and in addressing local and global challenges on any given field of research. To contribute to ongoing research and present novel research results in all the aspects of applied science, engineering and technology, OLC International is organizing International Conference and Expo on Applied Science, Engineering and Technology and invites you to join in the mission to find great approaches to make a lasting difference in the world of Engineering and Science. The conference will be held from June 15-16, 2020 in Montreal, Canada with the theme "Latest Scientific Advances and Contemporary Challenges in Applied Science" The conference seeks to contribute to presenting novel research results in all aspects of Engineering Technology and Applied Sciences while bringing together leading scientists, researchers, students, professionals from the industry, academia, and government to discourse on research and development in applied sciences and engineering technology to exchange and share their experiences about different aspects of these fields. This event provides the opportunity for the attendees to join hands with the global scholarly community in concerned fields and get connected with influential peers who can be potential mentors in your field. In addition to prompt keynote lectures and plenary talks

148 focusing on the latest research findings, it also offers various academic and learning activities including poster and video presentations, workshops, exhibition and brain- storming discussions in the field. It will be a perfect platform for students to present their unique research work and express innovative thoughts on a global platform and gain informative insights from eminent scholars in your field. For members of scientific associations, policymakers, and industry leaders, this will be the right platform to develop new network opportunities for the advancement of science and humanity.

[75] Organizing Committee Member, Keynote Speaker and position as the chair/co- chair at International Conference on Pharmaceutics and Drug Delivery Systems, September 24-26, 2020 at Rome, Italy, ICPD 2020 would lay a platform for the interaction between experts around the world and aims in accelerating scientific discoveries. The main theme of the conference is “Futuristic Scope of Pharmaceutics and Drug Delivery Systems”, Conference Website: https://irisscientificgroup.com/conferences/pharmaceutics-and-drug-delivery- systems/. Invited by: Anna Mary - Conference Manager (ICPD 2020) - Dallas, TX, 75208 USA, E-mail: [email protected], Office: 1 (214) 736-3454.

[76] Speaker at 4th Edition of Global Conference on Pharmaceutics and Novel Drug Delivery Systems (PHARMA 2020) scheduled during April 27-29, 2020 at Dubai, UAE. Pharma 2020 4th Edition of Global Conference on Pharmaceutics and Novel Drug Delivery Systems (PHARMA 2020) scheduled during April 27-29, 2020 welcomes speakers, students, delegates and young researchers to Dubai, UAE. PHARMA 2020 is designed to focus on next generation advancements in pharmaceutics and drug delivery systems. This includes interactive keynote lectures, oral and poster sessions and panel discussions on the topics such as drug delivery, Bio pharmaceutics, pharmaceutical innovations with respect to recent innovations and achievements in the specific field of the subject. Pharma 2020 brings together pharmaceutical scientists and engineers from industry, academia, and regulatory agencies along with different pharma business delegates to discuss recent developments and future trends in the field of pharmaceutical product and process development. Upcoming Pharma Conferences, Pharma Conferences 2020, Pharma 2020, Pharmaceutical Conferences, Pharmaceutical Conferences 2020, Drug Delivery Conferences. URL: https://magnusconferences.com/pharmaceutical- sciences/.

149

[77] Organizing Committee at World Congress on Public Health (WCPH-2020), May 21-22, 2020, Berlin, Germany, website: https://conferenceera.com/publichealth-conference/, World Congress on Public Health (WCPH-2020) is an International Conference organized by Conference Era on May 21-22, 2020,at Berlin, Germany. WCPH-2020invitesand unites researchers, scholar’s, students, academicians, research organizations, and making the congress a perfect platform to share most happening scientific advancements, progressive research in Public Health over the globe. WCPH-2020 allows multiple opportunities for scientific networking and knowledge sharing interaction. As well as the active poster discussion sessions, panel discussions for speakers and participants to engage beyond discussing the data, into envisioning a future that integrates rapidly evolving procedures in Public Health.WCPH-2020 will be a communicating environment to share deliberate current challenges and ways to move the field forward. The conference will foster the exchange of ideas and spur multidisciplinary collaborations. Venue: World Congress on Public Health, May 21-22, 2020, Berlin, Germany. Berlin is the capital and largest city of Germany by both area and population.Berlin straddles the banks of the River Spree, which flows into the River Havel (a tributary of the River Elbe) in the western borough of Spandau. Among the city's main topographical features are the many lakes in the western and southeastern boroughs formed by the Spree, Havel, and Dahme rivers (the largest of which is Lake Müggelsee). Due to its location in the European Plain, Berlin is influenced by a temperate seasonal climate. About one-third of the city's area is composed of forests, parks, gardens, rivers, canals and lakes. The city lies in the Central German dialect area, the Berlin dialect being a variant of the Lusatian-New Marchian dialects. Berlin is a world city of culture, politics, media and science. Berlin serves as a continental hub for air and rail traffic and has a highly complex public transportation network. The metropolis is a popular tourist destination. Significant industries also include IT, pharmaceuticals, biomedical engineering, clean tech, biotechnology, construction and electronics. Berlin is home to world-renowned universities, orchestras, museums, and entertainment venues, and is host to many sporting events.Its Zoological Garden is the most visited zoo in Europe and one of the most popular worldwide.

[78] Organizing Committee Member of the 2nd World Congress On Cardiology and Cardiovascular Diseases, Theme: Emerging Procedures and Transpiring research in

150

Cardiology and Cardiovascular Diseases, 21-22 September 2020, Paris, France, URL: https://www.phronesisonline.com/cardiology-congress/, WCCD-2020 has a great scholarly Scientific Program with 2 days of methodical sessions. This program will feature new research findings, chances to learn from world famous connoisseurs and discussions with contemporaries WCCD-2020 is a unique platform to bring together worldwide distinguished academicians in the field of Cardiology, cardiovascular & cardiac researchers, public health & business professionals, scientists, industry researchers and scholars to exchange about growing research and technologies. Expert faculties will discuss the relevant progress in Cardio research and will explore the latest trends to reduce the effects of cardiovascular risk factors. WCCD-2020 Conference provide a worldwide stage for trading most recent developments in the field of Cardiology and cardiovascular and offering opportunities to listen the presentations conveyed by eminent experts from everywhere throughout the globe. Participating at WCCD-2020 give an approach to meet, cooperate with, and make contacts with different specialists in your claim to frame region.

[79] Keynote Speaker at 28th International Conference on ancer Research and Pharmacology, July 01-02, 2020, Paris, France, About Conference. Organizing committee of Cancer Researh 2020 is glad to invite all the participants across the globe to attend 28th International Conference on Cancer Research and Pharmacology” scheduled between July 01-02, 2020 in Paris, France which will mark the gathering of many renowned Oncologists, Pharmacologists, Healthcare Professionals, Researchers, Academicians, Students and Business Delegates. The meeting for this year will revolve around the theme “Conquering Cancer with the Modern progression” Cancer Research 2020 is an extraordinary event designed for International medical health professionals, Pharmacologists and oncologists to facilitate the dissemination and application of research findings related to Cancer. The Cancer Research Conference invites participants from all leading universities, clinical research institutions, and diagnostic companies to share their research experiences on all aspects of this rapidly expanding field and thereby, providing a showcase of the latest techniques. Cancer Research 2020 provides an opportunistic environment and vibrant podium through these auspicious events to amplify these steps and meet the highest demand ever, by reflexive and cerebrative connections. Pulsus has been progressively organizing scientific conferences across the globe,

151 rendezvous which consist of various streams of scientific study to improve and accelerate discovery for a better tomorrow. The non-profit firm plans for organizing an average of 100 international conferences per year which is supported by 100+ open access journals and 10,000 Editorial Board Members. The number of reader views of the website has clocked 7.5 million and still counting. Lately, around more than 1000 scientific associations of various fields from all over the world have shown interest in association with PULSUS to promote their research work. PULSUS conferences offer exciting features like international symposia, B2B meetings, trade shows, exhibitions, and international workshops to build global networking and meaningful academic research and industry alliances. PULSUS initiated the 'Young Scientist Awards' to the enterprising young science researchers and scholars across the globe. Cancer Research 2020 provides an excellent opportunity to share views, exchange knowledge and establish research collaborations & networking. The main aim of this conference is to provide Informative Sessions on Cancer and Pharmacology Research: Challenges and Achievements. Cancer Research 2020 is a unique oncology conference forum to bring together worldwide distinguished academics in the field of public health professionals, academic scientists, industry researchers, scholars to exchange about the state of the art research and technologies. Why to attend? Cancer Research 2020 will enlighten the public with recent advances in Cancer diagnosis, Cancer therapy and Pharmacology around the world and to sharpen the related ideas about Cancer Research. Moreover, Cancer Research 2020 provides you a great networking with peers. World-renowned speakers, the most recent techniques, and the newest updates in cancer research fields are the trademark of this conference. Cancer conferences, symposiums, and Workshops provide a dedicated forum for the advancement, execution, and exchange of information about Oncology and Cancer. Cancer Research 2020 is a hallmark in the era of cancer conferences with its eminent speakers and notable organizing committee members. Who should attend? Oncologists, Pharmacologists, Pharma Practitioners, Radiologists, Chemotherapists, Physicians, Academicians, Academic scientists, Industry professionals, Diagnostic laboratory professionals, Undergraduate & Postgraduate students, researchers, business professionals, Postdoctoral fellows and Trainees, Cancer Diagnostics Associations and Societies, Scientific Sessions: Session 1 : Cancer Cell Biology and Genetics, Cancer is caused when cells within the body accumulate genetic mutations and start to grow in an uncontrolled manner. Understanding how cancer develops

152 and progresses, including how gene mutations drive the growth and spread of cancer cells, and how tumours interact with their surrounding environment, is vital for the discovery of new targeted cancer treatments. Cancer Biology aids us in understanding why the cells divide in abnormal manner, when and what are the conceivable consequences of this. This also helps us in Prevention and Curing of the Oncogenesis. Study of the behaviour of these Cancer Cells involves many approaches. Most of the times Cancer Biology and Genetics is studied taking animal models into consideration. Many of the Ground-breaking innovations in Cancer Studies are brought after understanding the behaviour of these Cancer Cells. Related Conferences: Oncology Conferences | Cancer Conferences | Cancer Research Conferences | Biomarkers Conferences | Pharmacology Conferences | Cancer Summit | Oncology Summit. International Conferences on Clinical Oncology and Molecular Diagnostics Dublin, Ireland; 3rd World Congress on Advanced Cancer Science & Therapy October 15-16, 2019 Osaka, Japan; World Congress On Cancer Science And Therapy August 13-14, 2019 Chicago, USA; EACR25: 25th Biennal Congress of the European Association for Cancer Research, Netherlands; 29th Euro- Global Summit on Cancer Therapy & Radiation Oncology Rome, Italy; Experts Meet On Cancer Therapy Melbourne, Australia; 4th Annual Conference on Gynecologic Oncology and Reproductive Disorders Atlanta, Georgia, USA; 4th Annual Conference on Preventive Oncology 2019 Atlanta, Georgia, USA; International Conference on Biomarkers and Cancer Targets 2019 Dubai, UAE; World Cancer Summit 2019 2019 Bangkok, Thailand; 14th Global Biomarkers Summit 2019 | Oslo, Norway; Euro Oncology Summit October 18-19, 2019 | Amsterdam, Netherlands; 9th Euro Breast Cancer Summit October 18-19, 2019 | Amsterdam, Netherlands; Annual Congress on Cancer and Stem Cell Research October 17-18, 2019 New York, USA; 22nd World Conference on Liquid Biopsy & Biomarkers. Cancer and Oncology Associations: Acoustic Neuroma Association, USA; American Association for Cancer Research, USA; American Brain Tumor Association, USA; American Cancer Society, USA; American Childhood Cancer Organization, USA; American Society for Radiation Oncology, USA; American Society of Clinical Oncology, USA; Association of Community Cancer Centers, USA; Cancer and Leukemia Group B, USA; Childhood Brain Tumor Foundation, USA; Children's Neuroblastoma Cancer Foundation, USA; Children's Tumor Foundation, USA; Foundation for Women's Cancer, USA; Lung Cancer Foundation of America, USA; American Childhood Cancer Organization, USA; National

153

Cancer Registrars Association, USA; National Children's Leukemia Foundation, USA; Ocular Melanoma Foundation, USA; Oral Cancer Foundation, USA; Prevent Cancer Foundation, USA; Society for Immunotherapy of Cancer, USA. Session 2: Organ Specific Cancer. Cancer is one of the foremost reasons of death all over the globe. Organ Specific Cancers are cancers named based on the location of cancer in the body organ. There are more than 200 different types of cancer diagnosed. Among them, Lung cancer, breast cancer is the most common cancer diagnosed in 2015. Its occurrence is showing a growing trend in various parts of the earth and has been a significant public health problem in spite of advances in the understanding of the molecular and cellular events that underlie. The ongoing research is discovering new carcinogens, clearing up how they cause cancer, providing insight into ways to prevent and treat. Related Conferences: Oncologist Summit | Pharmacology Summit | Cancer Events | Oncology Events | Pharmacology Events | Oncology Congress. International Conference on Molecular Markers and Cancer Therapeutics October 8-9, 2019 Dubai, UAE; Cancer Genomics Conference: New Era for Cancer Prevention October 08-09, 2019 Dubai, UAE; International Conference on Cancer Diagnosis & Treatment August 2-3 2019 Oslo, Norway; 2nd International Conference on Cancer Biology, Therapeutics and Drug Delivery October 03-04, 2019 Los Angeles, California, USA; 12th World Congress on Biomarkers & Clinical Research October 03-04, 2019 Los Angeles, California, USA; 3rd World Conference on Breast and Cervical Cancer September 27-28, 2019 Abu Dhabi, UAE; 3rd Cancer Diagnostics & Treatment Conference November 29-December 01, 2019 Dublin, Ireland; International Conference on Oncogenesis and Oncologic Emergency Medicine September 17-18, 2019 San Diego, California, USA; 28th International Conference on Cancer Research and Anticancer Therapies September 17-18, 2019 San Diego, California, USA; 4th International Congress on Epigenetics & Chromatin September 03-05, 2019 London, UK; International Conference on Cancer Research and Diagnostics August 15-16, 2019 Singapore; 28th Euro Congress on Cancer Science & Therapy August 09-10, 2019 Madrid, Spain; 8th World Conference on Women’s Health and Breast Cancer August 09-10, 2019 Abu Dhabi, UAE, Cancer and Oncology Associations: Radiation Therapy OncologyGroup,USA; Middle-Eastern Association for Cancer Research, Canada; Acoustic Neuroma Association of Canada, Canada; European Association for Cancer Research, UK; European Breast Cancer Coalition, Italy; European Cancer Organisation, Belgium; European Musculo-Skeletal Oncology Society, Italy;

154

European Society of Surgical Oncology, Belgium; European Society of Paediatric Oncology, Belgium; Association of Population-based Cancer Registries in Germany, Germany; Children's Cancer Association, Spain; Asia-Oceana Research Organization on Genital Infection and Neoplasia, India; Asian Society for Neuro- Oncology, Japan; Asian Society of Gynecologic Oncology, Korea; Australasian Lung Cancer Trials Group, Australia; Cancer Therapeutics Research Group, Singapore; Asian Fund for Cancer Research, China; Indian cancer Society, India. Session 3: Radiation Oncology. Radiation oncology is a medical speciality that includes the measured use of radiation to treat cancer either for cure, or to reduce pain and other symptoms produced by cancer. Radiation therapy also called as radiotherapy is the term used to describe the actual treatment delivered by the radiation oncology team. Radiation Oncology includes all parts of research that impacts on the treatment of disease utilizing radiation. Radiation can be given as a healing methodology, either alone or in mix with medical procedure as well as chemotherapy. Related Conferences: Cancer Congress | Pharmacology Congress | Biomarkers Congress | Singapore Events | Singapore Conferences | Global Conferences | Translational Biology Conferences. 15th Asia Pacific Oncologists Annual Meeting September 5-6, 2019 Tokyo, Japan; Molecular Cancer Biomarkers2019; 14th Global Biomarkers Summit August 02-03, 2019 | Oslo, Norway; 29th Euro-Global Summit on Cancer Therapy & Radiation Oncology July 23-25, 2019 Rome, Italy; Experts Meet On Cancer Therapy 2019 July 23-24, 2019 Melbourne, Australia; Cancer Science and Targeted Therapies, October 29-30, 2019 San Francisco, California, USA; 4th Annual Conference on Gynecologic Oncology and Reproductive Disorders, July 18-19, 2019, USA; 4th Annual Conference on Preventive Oncology, July 18-19, 2019, USA; 28th International Conference on Cancer Research and Anticancer Therapies, September 17-18, 2019, USA; International Conference on Oncogenesis and Oncologic Emergency Medicine, September 17-18, 2019, USA; World Cancer Conference, October 11-13, 2019 Zurich, Switzerland; Cancer and Oncology Associations: Cancer Patients Aid Association, India; Cancer Aid Society, India; Indian Association for Cancer Research, India; Indian Medical Association, India; Help Age India, India; Acoustic Neuroma Association of Australia, Australia; Australasian Association of Cancer Registries, Australia; Australasian Lung Cancer Trials Group, Australia; Australian and New Zealand Children's Haematology/Oncology Group, Australia; Australian Capital Territory Cancer Registry, Australia; Australian Cervical Cancer

155

Foundation, Australia; Australian Familial Pancreatic Cancer Cohort, Australia; Australian Prostate Cancer Research, Australia; Bangladesh Cancer Society, Bangladesh; Middle East Cancer Consortium, Israel; SON Foundation, India; Middle East and Mediterranean Association of Gynecologic Oncologist, Turkey; Leukaemia Cancer Society, UK; The British association for Cancer Research, UK; United Kingdom and Ireland Association of Cancer Registries, UK; International Children's Care, UK; Association of Cancer Physicians, UK; Children with Cancer, UK. Session 4: Neuro-Oncology: The Neuro oncology is denounced to various malevolent disorders. Central Nervous System shelters its mechanism, Metastatic pestilence, Cancers, Neurons and Sensory Receptors, Ramification, Neurodegenerative disease, Neurological Disorders and Imaging agents to CNS neurofibroma. Cancer blowouts to the Nervous System by direct assault or compression from nonstop tissues relates to the proximity of the Nervous System to added structures. Related Conferences: Oncology Conferences | Cancer Conferences | Cancer Research Conferences | Biomarkers Conferences | Pharmacology Conferences | Cancer Summit | Oncology Summit. International Conference on Oncology Research & Cancer Stem Cells, 10 May 2019, Germany; Euro-Global Summit on Cancer Therapy & Radiation Oncology, July 23-25, 2019, Italy; Euro Congress on Cancer Science & Therapy, August 09-10, 2019, Spain; Global Summit on Oncology & Cancer, March 12-14, 2019, Singapore; Global Annual Oncologists Meeting, May 24-25, 2019, Japan; World Haematology and Medical Oncology Conference, May 28-30, 2019, Japan; Global Meeting on Oncology and Radiology, June 1-2, 2019, Japan World Cancer Summit 2019, July 02-03, 2019, Thailand; International Conference on Cancer Genetics and Epigenetics, July 18-19, 2019, Australia; Experts Meet on Cancer Therapy 2019, July 23-24, 2019, Australia; Asia Pacific Oncologists Annual Meeting, September 5-6, 2019, Japan; International Conference on Biomarkers and Cancer Targets, July 16-17, 2019, Dubai; Cancer and Oncology Associations:Acoustic Neuroma Association, USA; American Association for Cancer Research, USA; American Brain Tumor Association, USA; American Cancer Society, USA; American Childhood Cancer Organization, USA; American Society for Radiation Oncology, USA; American Society of Clinical Oncology, USA; Association of Community Cancer Centers, USA; Cancer and Leukemia Group B, USA; Childhood Brain Tumor Foundation, USA; Children's Neuroblastoma Cancer Foundation, USA; Children's Tumor Foundation, USA; Foundation for Women's Cancer, USA; Lung

156

Cancer Foundation of America, USA; American Childhood Cancer Organization, USA; National Cancer Registrars Association, USA; National Children's Leukemia Foundation, USA; Ocular Melanoma Foundation, USA; Oral Cancer Foundation, USA; Prevent Cancer Foundation, USA; Society for Immunotherapy of Cancer, USA. Session 5: Cancer Immunotherapy: Immunotherapy improves the immune system’s capability to identify, target, and abolish cancer cells wherever they are in the body, making it a possible universal answer to cancer. Cancer immunotherapy is an effective treatment for patients with certain sorts of cancers that are resilient to previous treatment with chemotherapy and radiation has also been permitted as a first line of treatment in numerous cancers. It may be given unaccompanied or in mixture with other cancer treatments. Cancer immunotherapies can be characterized as active, passive or hybrid. The immune retort including the acknowledgement of cancer-specific antigens, forms the basis of targeted therapy (such as vaccines and antibody therapies) and tumour marker-based diagnostic tests. Related Conferences: Oncologist Summit | Pharmacology Summit | Cancer Events | Oncology Events | Pharmacology Events | Oncology Congress. International Conferences on Clinical Oncology and Molecular Diagnostics Dublin, Ireland; 3rd World Congresson Advanced Cancer Science & Therapy October 15-16, 2019 Osaka, Japan; World Congress On Cancer ScienceAnd Therapy August 13-14, 2019 Chicago, USA; EACR25: 25th Biennal Congress of the European Association for Cancer Research, Netherlands; 29th Euro-Global Summit on Cancer Therapy & Radiation Oncology Rome, Italy; Experts Meet On Cancer Therapy Melbourne, Australia; 4th Annual Conference on Gynecologic Oncology and Reproductive Disorders Atlanta, Georgia, USA; 4th Annual Conference on Preventive Oncology 2019 Atlanta, Georgia, USA; International Conference on Biomarkers and Cancer Targets 2019 Dubai, UAE; World Cancer Summit 2019 2019 Bangkok, Thailand; 14th Global Biomarkers Summit 2019 | Oslo, Norway; Euro Oncology Summit October 18-19, 2019 | Amsterdam, Netherlands; 9th Euro Breast Cancer Summit October 18-19, 2019 | Amsterdam, Netherlands; Annual Congress on Cancer and Stem Cell Research October 17-18, 2019 New York, USA; 22nd World Conference on Liquid Biopsy & Biomarkers

Cancer and Oncology Associations: Radiation Therapy Oncology Group, USA; Middle-Eastern Association for Cancer Research (MEACR) , Canada; Acoustic Neuroma Association of Canada, Canada; European Association for Cancer

157

Research, UK; European Breast Cancer Coalition, Italy; European Cancer Organisation, Belgium; European Musculo-Skeletal Oncology Society, Italy; European Society of Surgical Oncology, Belgium; European Society of Paediatric Oncology, Belgium; Association of Population-based Cancer Registries in Germany, Germany; Children's Cancer Association, Spain; Asia-Oceana Research Organization on Genital Infection and Neoplasia, India; Asian Society for Neuro- Oncology, Japan; Asian Society of Gynecologic Oncology, Korea; Australasian Lung Cancer Trials Group, Australia; Cancer Therapeutics Research Group, Singapore; Asian Fund for Cancer Research, China; Indian cancer Society, India. Session 6 : Innovation and Clinical Trials, Cancer being one of the deadliest diseases in the world many have made it as priority to find complete cure for this. The same reason has made much advancement to be evolved in recent years. Cancer research has fetched enhancements in bioinformatics for emerging better drug development tools, Radiology to carry healthier diagnosis tools, Surgery to bring improved choices to achieve minimal invasive methods. Related Conferences: Cancer Congress | Pharmacology Congress | Biomarkers Congress | Singapore Events | Singapore Conferences | Global Conferences | Translational Biology Conferences, International Conference on Molecular Markers and Cancer Therapeutics October 8-9, 2019 Dubai, UAE; Cancer Genomics Conference: New Era for Cancer Prevention October 08-09, 2019 Dubai, UAE; International Conference on Cancer Diagnosis & Treatment August 2-3 2019 Oslo, Norway; 2nd International Conference on Cancer Biology, Therapeutics and Drug Delivery October 03-04, 2019 Los Angeles, California, USA; 12th World Congress on Biomarkers & Clinical Research October 03-04, 2019 Los Angeles, California, USA; 3rd World Conference on Breast and Cervical Cancer September 27-28, 2019 Abu Dhabi, UAE; 3rd Cancer Diagnostics & Treatment Conference November 29-December 01, 2019 Dublin, Ireland; International Conference on Oncogenesis and Oncologic Emergency Medicine September 17-18, 2019 San Diego, California, USA; 28th International Conference on Cancer Research and Anticancer Therapies September 17-18, 2019 San Diego, California, USA; 4th International Congress on Epigenetics & Chromatin September 03-05, 2019 London, UK; International Conference on Cancer Research and Diagnostics August 15-16, 2019 Singapore; 28th Euro Congress on Cancer Science & Therapy August 09-10, 2019 Madrid, Spain; 8th World Conference on Women’s Health and Breast Cancer August 09-10, 2019 Abu Dhabi, UAE. Cancer and Oncology Associations: Cancer Patients Aid Association,

158

India; Cancer Aid Society, India; Indian Association for Cancer Research, India; Indian Medical Association, India; Help Age India, India; Acoustic Neuroma Association of Australia, Australia; Australasian Association of Cancer Registries, Australia; Australasian Lung Cancer Trials Group, Australia; Australian and New Zealand Children's Haematology/Oncology Group, Australia; Australian Capital Territory Cancer Registry, Australia; Australian Cervical Cancer Foundation, Australia; Australian Familial Pancreatic Cancer Cohort, Australia; Australian Prostate Cancer Research, Australia; Bangladesh Cancer Society, Bangladesh; Middle East Cancer Consortium, Israel; SON Foundation, India; Middle East and Mediterranean Association of Gynecologic Oncologist, Turkey; Leukaemia Cancer Society, UK; The British association for Cancer Research, UK; United Kingdom and Ireland Association of Cancer Registries, UK; International Children's Care, UK; Association of Cancer Physicians, UK; Children with Cancer, UK. Session 7 : Cancer Imaging and Early Detection, Cancer imaging has become a vital part in the early detection, diagnosis and treatment of cancer. Sometime medical imaging is the first step in stopping the spread of cancer through early detection and in many cases makes it probable to cure or abolish the cancer altogether. Imaging forms a vital part of cancer clinical protocols and is able to furnish morphological, structural, metabolic and functional information. It is used to screen, diagnose and stage cancer, guide cancer treatments, determine the efficacy of cancer therapy and monitor cancer recurrence. Integration of oncology medical imaging with other clinical tools, such as in vitro tissue analysis, biomarker tests, and cancer screening, improves decision making. Early detection through screening based on imaging is the key contributor to a reduction in the number of deaths caused by certain types of cancers. Related Conferences: Oncology Conferences | Cancer Conferences | Cancer Research Conferences | Biomarkers Conferences | Pharmacology Conferences | Cancer Summit | Oncology Summit. 15th Asia Pacific Oncologists Annual Meeting September 5-6, 2019 Tokyo, Japan; Molecular Cancer Biomarkers2019; 14th Global Biomarkers Summit August 02-03, 2019 | Oslo, Norway; 29th Euro-Global Summit on Cancer Therapy & Radiation Oncology July 23-25, 2019 Rome, Italy; Experts Meet On Cancer Therapy 2019 July 23-24, 2019 Melbourne, Australia; Cancer Science and Targeted Therapies, October 29-30, 2019 San Francisco, California, USA; 4th Annual Conference on Gynecologic Oncology and Reproductive Disorders, July 18-19, 2019, USA; 4th Annual Conference on Preventive Oncology, July 18-19, 2019, USA; 28th International Conference on Cancer Research and

159

Anticancer Therapies, September 17-18, 2019, USA; International Conference on Oncogenesis and Oncologic Emergency Medicine, September 17-18, 2019, USA; World Cancer Conference, October 11-13, 2019 Zurich, Switzerland; Cancer and Oncology Associations:Acoustic Neuroma Association, USA; American Association for Cancer Research, USA; American Brain Tumor Association, USA; American Cancer Society, USA; American Childhood Cancer Organization, USA; American Society for Radiation Oncology, USA; American Society of Clinical Oncology, USA; Association of Community Cancer Centers, USA; Cancer and Leukemia Group B, USA; Childhood Brain Tumor Foundation, USA; Children's Neuroblastoma Cancer Foundation, USA; Children's Tumor Foundation, USA; Foundation for Women's Cancer, USA; Lung Cancer Foundation of America, USA; American Childhood Cancer Organization, USA; National Cancer Registrars Association, USA; National Children's Leukemia Foundation, USA; Ocular Melanoma Foundation, USA; Oral Cancer Foundation, USA; Prevent Cancer Foundation, USA; Society for Immunotherapy of Cancer, USA. Session 8: Cancer Screening and Diagnosis. Cancer is the mail reason for deaths across the globe. The remedy for cancer is still a matter of research. However, there are few curing techniques available only if the person is diagnosed at the early growth stages. Cancer diagnosis becomes a very vital part of an individual’s survival. Since the cancer cells exhibit properties of a normal cells till it reaches malignant stages, it becomes difficult to diagnose. However, few symptoms can act like the signals for the cancer growth. Once these symptoms are encountered one will have to undergo diagnosis techniques like Biopsy, Radiography etc. Through these methods’ practitioner will be able to predict the stage of the cancer and survivability of the patients. Related Conferences: Oncologist Summit | Pharmacology Summit | Cancer Events | Oncology Events | Pharmacology Events | Oncology Congress International Conference on Oncology Research & Cancer Stem Cells, 10 May 2019, Germany; Euro-Global Summit on Cancer Therapy & Radiation Oncology, July 23-25, 2019, Italy; Euro Congress on Cancer Science & Therapy, August 09-10, 2019, Spain; Global Summit on Oncology & Cancer, March 12-14, 2019, Singapore; Global Annual Oncologists Meeting, May 24-25, 2019, Japan; World Haematology and Medical Oncology Conference, May 28-30, 2019, Japan; Global Meeting on Oncology and Radiology, June 1-2, 2019, Japan World Cancer Summit 2019, July 02-03, 2019, Thailand; International Conference on Cancer Genetics and Epigenetics, July 18-19, 2019, Australia; Experts Meet on Cancer Therapy 2019,

160

July 23-24, 2019, Australia; Asia Pacific Oncologists Annual Meeting, September 5-6, 2019, Japan; International Conference on Biomarkers and Cancer Targets, July 16-17, 2019, Dubai; Cancer and Oncology Associations: Radiation Therapy Oncology Group, USA; Middle-Eastern Association for Cancer Research (MEACR) , Canada; Acoustic Neuroma Association of Canada, Canada; European Association for Cancer Research, UK; European Breast Cancer Coalition, Italy; European Cancer Organisation, Belgium; European Musculo-Skeletal Oncology Society, Italy; European Society of Surgical Oncology, Belgium; European Society of Paediatric Oncology, Belgium; Association of Population-based Cancer Registries in Germany, Germany; Children's Cancer Association, Spain; Asia-Oceana Research Organization on Genital Infection and Neoplasia, India; Asian Society for Neuro-Oncology, Japan; Asian Society of Gynecologic Oncology, Korea; Australasian Lung Cancer Trials Group, Australia; Cancer Therapeutics Research Group, Singapore; Asian Fund for Cancer Research, China; Indian cancer Society, India, Session 9: Biology of Pediatrics and Young Adult Cancer About 70,000 young people (ages 15 to 39) are diagnosed with cancer each year in the accounting for about 5 percent of cancer diagnoses. This is 6 times the number of cancers diagnosed in children ages 0 to 14. Young adults are more likely than either younger children or older adults to be detected with certain cancers, such as testicular cancer, Hodgkin lymphoma, and sarcomas. However, the frequency of specific cancer types varies according to age. Leukemia, lymphoma, testicular cancer, and thyroid cancer are the most common cancers among 15- to 24-year-olds. Among 25- to 39-year-olds breast cancer and melanoma are the most common. Adolescent and young adult (AYA) cancer patients have not attained the same improvements in overall survival that either younger children or older adults have. One possible reason for this disparity may be that the AYA cancers exhibit unique biological characteristics resulting in differences in clinical and treatment resistance behaviors. Related Conferences: Cancer Congress | Pharmacology Congress | Biomarkers Congress | Singapore Events | Singapore Conferences | Global Conferences | Translational Biology Conferences. International Conferences on Clinical Oncology and Molecular Diagnostics Dublin, Ireland; 3rd World Congresson Advanced Cancer Science & Therapy October 15-16, 2019 Osaka, Japan; World Congress On Cancer ScienceAnd Therapy August 13-14, 2019 Chicago, USA; EACR25: 25th Biennal Congress of the European Association for Cancer Research, Netherlands; 29th Euro- Global Summit on Cancer Therapy & Radiation Oncology Rome, Italy; Experts

161

Meet On Cancer Therapy Melbourne, Australia; 4th Annual Conference on Gynecologic Oncology and Reproductive Disorders Atlanta, Georgia, USA; 4th Annual Conference on Preventive Oncology 2019 Atlanta, Georgia, USA; International Conference on Biomarkers and Cancer Targets 2019 Dubai, UAE; World Cancer Summit 2019 2019 Bangkok, Thailand; 14th Global Biomarkers Summit 2019 | Oslo, Norway; Euro Oncology Summit October 18-19, 2019 | Amsterdam, Netherlands; 9th Euro Breast Cancer Summit October 18-19, 2019 | Amsterdam, Netherlands; Annual Congress on Cancer and Stem Cell Research October 17-18, 2019 New York, USA; 22nd World Conference on Liquid Biopsy & Biomarkers. Cancer and Oncology Associations: Cancer Patients Aid Association, India; Cancer Aid Society, India; Indian Association for Cancer Research, India; Indian Medical Association, India; Help Age India, India; Acoustic Neuroma Association of Australia, Australia; Australasian Association of Cancer Registries, Australia; Australasian Lung Cancer Trials Group, Australia; Australian and New Zealand Children's Haematology/Oncology Group, Australia; Australian Capital Territory Cancer Registry, Australia; Australian Cervical Cancer Foundation, Australia; Australian Familial Pancreatic Cancer Cohort, Australia; Australian Prostate Cancer Research, Australia; Bangladesh Cancer Society, Bangladesh; Middle East Cancer Consortium, Israel; SON Foundation, India; Middle East and Mediterranean Association of Gynecologic Oncologist, Turkey; Leukaemia Cancer Society, UK; The British association for Cancer Research, UK; United Kingdom and Ireland Association of Cancer Registries, UK; International Children's Care, UK; Association of Cancer Physicians, UK; Children with Cancer, UK. Session 10: Radiology and Imaging Technologies. Radiology is a division of medicine that uses imaging technology to diagnose and treat disease.Radiology is divided into different areas, such as diagnostic radiology and interventional radiology. Diagnostic radiology helps the health care professionals to see structures inside your body. Doctors that specialize in the reading of these images are called diagnostic radiologists. Interventional radiologists use imaging such as CT, MRI, ultrasound and fluoroscopy to help guide procedures. The imaging is helpful to the doctor when inserting catheters, wires, and other small instruments and tools into body. This typically allows for smaller incisions that is cuts on body. Doctors can use this technology to diagnose or to treat conditions in almost any part of the body instead of needing to directly look inside of your body through a scope or with open surgery. Interventional radiologists often are involved in treating cancers or tumors,

162 blockages in the arteries and veins, fibroids in the uterus, back pain, liver problems, and kidney problems. Related Conferences: Oncology Conferences | Cancer Conferences | Cancer Research Conferences | Biomarkers Conferences | Pharmacology Conferences | Cancer Summit | Oncology Summit. International Conference on Molecular Markers and Cancer Therapeutics October 8-9, 2019 Dubai, UAE; Cancer Genomics Conference: New Era for Cancer Prevention October 08-09, 2019 Dubai, UAE; International Conference on Cancer Diagnosis & Treatment August 2-3 2019 Oslo, Norway; 2nd International Conference on Cancer Biology, Therapeutics and Drug Delivery October 03-04, 2019 Los Angeles, California, USA; 12th World Congress on Biomarkers & Clinical Research October 03-04, 2019 Los Angeles, California, USA; 3rd World Conference on Breast and Cervical Cancer September 27-28, 2019 Abu Dhabi, UAE; 3rd Cancer Diagnostics & Treatment Conference November 29-December 01, 2019 Dublin, Ireland; International Conference on Oncogenesis and Oncologic Emergency Medicine September 17-18, 2019 San Diego, California, USA; 28th International Conference on Cancer Research and Anticancer Therapies September 17-18, 2019 San Diego, California, USA; 4th International Congress on Epigenetics & Chromatin September 03-05, 2019 London, UK; International Conference on Cancer Research and Diagnostics August 15-16, 2019 Singapore; 28th Euro Congress on Cancer Science & Therapy August 09-10, 2019 Madrid, Spain; 8th World Conference on Women’s Health and Breast Cancer August 09-10, 2019 Abu Dhabi, UAE. Cancer and Oncology Associations: Acoustic Neuroma Association, USA; American Association for Cancer Research, USA; American Brain Tumor Association, USA; American Cancer Society, USA; American Childhood Cancer Organization, USA; American Society for Radiation Oncology, USA; American Society of Clinical Oncology, USA; Association of Community Cancer Centers, USA; Cancer and Leukemia Group B, USA; Childhood Brain Tumor Foundation, USA; Children's Neuroblastoma Cancer Foundation, USA; Children's Tumor Foundation, USA; Foundation for Women's Cancer, USA; Lung Cancer Foundation of America, USA; American Childhood Cancer Organization, USA; National Cancer Registrars Association, USA; National Children's Leukemia Foundation, USA; Ocular Melanoma Foundation, USA; Oral Cancer Foundation, USA; Prevent Cancer Foundation, USA; Society for Immunotherapy of Cancer, USA, Session 11 : DNA Damage, Mutation and Cancer, DNA is the source of genetic information in each living cell, its integrity and stability are essential to life. However, DNA is not inert

163 rather, it is a chemical entity subject to assault from the environment and in resulting damage will lead to mutation and possibly disease. Perhaps the best-known example of the link between environmental-induced DNA damage and disease is skin cancer, which can be caused by excessive exposure to UV radiation. Beyond environmental agent’s DNA is also subject to oxidative damage from by-products like free radicals. It is also estimated that an individual cell can suffer up to one million DNA changes per day. In accumulation to genetic insults caused by the environment the very process of DNA replication during cell division is inclined to error.Mutations in an organism's DNA which is a part of life. Genetic code is exposed to a variability of insults that threaten its integrity. But a rigorous system of checks and balances is in place over the DNA repair machinery. The errors that slip over the cracks may sometimes be related with disease, but they are also a source of variation that is acted upon by longer-term processes, such as evolution and natural selection. Related Conferences: Oncologist Summit | Pharmacology Summit | Cancer Events | Oncology Events | Pharmacology Events | Oncology Congress. 15th Asia Pacific Oncologists Annual Meeting September 5-6, 2019 Tokyo, Japan; Molecular Cancer Biomarkers2019; 14th Global Biomarkers Summit August 02-03, 2019 | Oslo, Norway; 29th Euro-Global Summit on Cancer Therapy & Radiation Oncology July 23-25, 2019 Rome, Italy; Experts Meet On Cancer Therapy 2019 July 23-24, 2019 Melbourne, Australia; Cancer Science and Targeted Therapies, October 29-30, 2019 San Francisco, California, USA; 4th Annual Conference on Gynecologic Oncology and Reproductive Disorders, July 18-19, 2019, USA; 4th Annual Conference on Preventive Oncology, July 18-19, 2019, USA; 28th International Conference on Cancer Research and Anticancer Therapies, September 17-18, 2019, USA; International Conference on Oncogenesis and Oncologic Emergency Medicine, September 17-18, 2019, USA; World Cancer Conference, October 11-13, 2019 Zurich, Switzerland; Cancer and Oncology Associations: Radiation Therapy Oncology Group, USA; Middle-Eastern Association for Cancer Research (MEACR) , Canada; Acoustic Neuroma Association of Canada, Canada; European Association for Cancer Research, UK; European Breast Cancer Coalition, Italy; European Cancer Organisation, Belgium; European Musculo-Skeletal Oncology Society, Italy; European Society of Surgical Oncology, Belgium; European Society of Paediatric Oncology, Belgium; Association of Population-based Cancer Registries in Germany, Germany; Children's Cancer Association, Spain; Asia-Oceana Research Organization on Genital Infection and Neoplasia, India; Asian Society for

164

Neuro-Oncology, Japan; Asian Society of Gynecologic Oncology, Korea; Australasian Lung Cancer Trials Group, Australia; Cancer Therapeutics Research Group, Singapore; Asian Fund for Cancer Research, China; Indian cancer Society, India. Session 12 : Cancer Nanotechnology, Cancer nanotechnology offers numerous possible aids to cancer therapy, detection and diagnosis. The profits start by way of the fundamental properties of nanotechnology and the biological challenges of which it can aid to overcome. Nanotechnology in Cancer is working to guarantee that nanotechnologies for cancer applications are established responsibly. There is zero inherently risky about being nanosized. Related Conferences: Cancer Congress | Pharmacology Congress | Biomarkers Congress | Singapore Events | Singapore Conferences | Global Conferences | Translational Biology Conferences International Conference on Oncology Research & Cancer Stem Cells, 10 May 2019, Germany; Euro-Global Summit on Cancer Therapy & Radiation Oncology, July 23-25, 2019, Italy; Euro Congress on Cancer Science & Therapy, August 09-10, 2019, Spain; Global Summit on Oncology & Cancer, March 12-14, 2019, Singapore; Global Annual Oncologists Meeting, May 24-25, 2019, Japan; World Haematology and Medical Oncology Conference, May 28-30, 2019, Japan; Global Meeting on Oncology and Radiology, June 1-2, 2019, Japan World Cancer Summit 2019, July 02-03, 2019, Thailand; International Conference on Cancer Genetics and Epigenetics, July 18-19, 2019, Australia; Experts Meet on Cancer Therapy 2019, July 23-24, 2019, Australia; Asia Pacific Oncologists Annual Meeting, September 5-6, 2019, Japan; International Conference on Biomarkers and Cancer Targets, July 16-17, 2019, Dubai; Session 13: Cancer Epidemiology. The epidemiology of cancer is the investigation of the variables influencing growth, as an approach to construe conceivable patterns and causes. The investigation of growth the study of disease transmission utilizes epidemiological strategies to discover the reason for tumour and to recognize and create enhanced medicines. This region of study must fight with issues of lead time inclination and length time predisposition. Lead time predisposition is the idea that early analysis may falsely expand the survival measurements of a tumour, without extremely enhancing the regular history of the illness. Length inclination is the idea that slower developing, more sluggish tumour will probably be analysed by screening tests, however changes in diagnosing more instances of lethargic malignancy may not convert into healthier patient results after the implementation of screening programs. A related concern is over diagnosis, the propensity of screening tests to analyse disease that may not

165 really affect the patient's life span. Related Conferences: Oncology Conferences | Cancer Conferences | Cancer Research Conferences | Biomarkers Conferences | Pharmacology Conferences | Cancer Summit | Oncology Summit International Conferences on Clinical Oncology and Molecular Diagnostics Dublin, Ireland; 3rd World Congresson Advanced Cancer Science & Therapy October 15-16, 2019 Osaka, Japan; World Congress On Cancer ScienceAnd Therapy August 13-14, 2019 Chicago, USA; EACR25: 25th Biennal Congress of the European Association for Cancer Research, Netherlands; 29th Euro-Global Summit on Cancer Therapy & Radiation Oncology Rome, Italy; Experts Meet On Cancer Therapy Melbourne, Australia; 4th Annual Conference on Gynecologic Oncology and Reproductive Disorders Atlanta, Georgia, USA; 4th Annual Conference on Preventive Oncology 2019 Atlanta, Georgia, USA; International Conference on Biomarkers and Cancer Targets 2019 Dubai, UAE; World Cancer Summit 2019 2019 Bangkok, Thailand; 14th Global Biomarkers Summit 2019 | Oslo, Norway; Euro Oncology Summit October 18-19, 2019 | Amsterdam, Netherlands; 9th Euro Breast Cancer Summit October 18-19, 2019 | Amsterdam, Netherlands; Annual Congress on Cancer and Stem Cell Research October 17-18, 2019 New York, USA; 22nd World Conference on Liquid Biopsy & Biomarkers

Cancer and Oncology Associations: Cancer Patients Aid Association, India; Cancer Aid Society, India; Indian Association for Cancer Research, India; Indian Medical Association, India; Help Age India, India; Acoustic Neuroma Association of Australia, Australia; Australasian Association of Cancer Registries, Australia; Australasian Lung Cancer Trials Group, Australia; Australian and New Zealand Children's Haematology/Oncology Group, Australia; Australian Capital Territory Cancer Registry, Australia; Australian Cervical Cancer Foundation, Australia; Australian Familial Pancreatic Cancer Cohort, Australia; Australian Prostate Cancer Research, Australia; Bangladesh Cancer Society, Bangladesh; Middle East Cancer Consortium, Israel; SON Foundation, India; Middle East and Mediterranean Association of Gynecologic Oncologist, Turkey; Leukaemia Cancer Society, UK; The British association for Cancer Research, UK; United Kingdom and Ireland Association of Cancer Registries, UK; International Children's Care, UK; Association of Cancer Physicians, UK; Children with Cancer, UK. Session 14 : Oncology Nursing Care: Today’s Oncology is different compare to early days of cancer treatment which provides more treatment options for better pain control and

166 reduced treatment side effects. Oncology nurses work in a multi-disciplinary team, in a variety of settings, from the inpatient ward, to the bone marrow transplant unit, through to the community. Oncology nurses frequently serve as your first line of communication and help coordinate the many aspects of your care all over cancer treatment. The science is dynamic and continually evolving, with many new therapies on the horizon. Oncology nurses have significant roles to play all along the cancer care continuum. The Specialized Oncology Nurse is one who has a combination of expanded education focused on cancer care and experience, The Specialized Oncology Nurse might acquire specialty education through a variety of ways; for example, enrolment in an undergraduate nursing program, completion of an Oncology Certificate Program, distance specialty education (such as offered in Adult and Paediatric Oncology Nursing) or registration in and completion of the certification exam. Related Conferences: Oncologist Summit | Pharmacology Summit | Cancer Events | Oncology Events | Pharmacology Events | Oncology Congress: International Conference on Molecular Markers and Cancer Therapeutics October 8-9, 2019 Dubai, UAE; Cancer Genomics Conference: New Era for Cancer Prevention October 08-09, 2019 Dubai, UAE; International Conference on Cancer Diagnosis & Treatment August 2-3 2019 Oslo, Norway; 2nd International Conference on Cancer Biology, Therapeutics and Drug Delivery October 03-04, 2019 Los Angeles, California, USA; 12th World Congress on Biomarkers & Clinical Research October 03-04, 2019 Los Angeles, California, USA; 3rd World Conference on Breast and Cervical Cancer September 27-28, 2019 Abu Dhabi, UAE; 3rd Cancer Diagnostics & Treatment Conference November 29-December 01, 2019 Dublin, Ireland; International Conference on Oncogenesis and Oncologic Emergency Medicine September 17-18, 2019 San Diego, California, USA; 28th International Conference on Cancer Research and Anticancer Therapies September 17-18, 2019 San Diego, California, USA; 4th International Congress on Epigenetics & Chromatin September 03-05, 2019 London, UK; International Conference on Cancer Research and Diagnostics August 15-16, 2019 Singapore; 28th Euro Congress on Cancer Science & Therapy August 09-10, 2019 Madrid, Spain; 8th World Conference on Women’s Health and Breast Cancer August 09-10, 2019 Abu Dhabi, UAE: Cancer and Oncology Associations: Acoustic Neuroma Association, USA; American Association for Cancer Research, USA; American Brain Tumor Association, USA; American Cancer Society, USA; American Childhood Cancer Organization, USA; American Society for Radiation Oncology, USA; American

167

Society of Clinical Oncology, USA; Association of Community Cancer Centers, USA; Cancer and Leukemia Group B, USA; Childhood Brain Tumor Foundation, USA; Children's Neuroblastoma Cancer Foundation, USA; Children's Tumor Foundation, USA; Foundation for Women's Cancer, USA; Lung Cancer Foundation of America, USA; American Childhood Cancer Organization, USA; National Cancer Registrars Association, USA; National Children's Leukemia Foundation, USA; Ocular Melanoma Foundation, USA; Oral Cancer Foundation, USA; Prevent Cancer Foundation, USA; Society for Immunotherapy of Cancer, USA. Session 15: Cancer Nanomedicine: The emergence of nanomedicine as an innovative and promising alternative technology shows many advantages over conventional cancer therapies and provides new opportunities for early detection, improved treatment, and diagnosis of cancer. Cancer nanomedicines has the capability of delivering chemotherapeutic agents while providing lower systemic toxicity and it is paramount to consider the cancer complexity and dynamics for bridging the translational bench- to-bedside gap. It is very important to conduct suitable investigations for exploiting the tumour microenvironment and achieving a more comprehensive understanding of the fundamental biological processes in cancer and their roles in modulating nanoparticle–protein interactions, blood circulation, and tumour penetration. Related Conferences: Cancer Congress | Pharmacology Congress | Biomarkers Congress | Singapore Events | Singapore Conferences | Global Conferences | Translational Biology Conferences: 15th Asia Pacific Oncologists Annual Meeting September 5-6, 2019 Tokyo, Japan; Molecular Cancer Biomarkers2019; 14th Global Biomarkers Summit August 02-03, 2019 | Oslo, Norway; 29th Euro-Global Summit on Cancer Therapy & Radiation Oncology July 23-25, 2019 Rome, Italy; Experts Meet On Cancer Therapy 2019 July 23-24, 2019 Melbourne, Australia; Cancer Science and Targeted Therapies, October 29-30, 2019 San Francisco, California, USA; 4th Annual Conference on Gynecologic Oncology and Reproductive Disorders, July 18-19, 2019, USA; 4th Annual Conference on Preventive Oncology, July 18-19, 2019, USA; 28th International Conference on Cancer Research and Anticancer Therapies, September 17-18, 2019, USA; International Conference on Oncogenesis and Oncologic Emergency Medicine, September 17-18, 2019, USA; World Cancer Conference, October 11-13, 2019 Zurich, Switzerland. Cancer and Oncology Associations: Radiation Therapy Oncology Group, USA; Middle-Eastern Association for Cancer Research (MEACR) , Canada; Acoustic Neuroma Association of Canada, Canada; European Association for Cancer Research, UK;

168

European Breast Cancer Coalition, Italy; European Cancer Organisation, Belgium; European Musculo-Skeletal Oncology Society, Italy; European Society of Surgical Oncology, Belgium; European Society of Paediatric Oncology, Belgium; Association of Population-based Cancer Registries in Germany, Germany; Children's Cancer Association, Spain; Asia-Oceana Research Organization on Genital Infection and Neoplasia, India; Asian Society for Neuro-Oncology, Japan; Asian Society of Gynecologic Oncology, Korea; Australasian Lung Cancer Trials Group, Australia; Cancer Therapeutics Research Group, Singapore; Asian Fund for Cancer Research, China; Indian cancer Society, India, Session 16: Cancer Prevention Vaccines, Cancer Vaccine helps in treating existing Cancer or stops its expansion. Vaccines that treat existing Cancer is known as therapeutic Cancer Vaccines. Some of the Vaccines are autologous prepared from samples taken from the patient and are specific to that patient. Some researchers claim that cancerous cells usually arise and are destroyed by the immune system and that Tumors form when the immune system fails to destroy them. Cancer vaccines stimulate the ability of the immune system to protect the body against the infectious agents that may cause disease. Cancer vaccine are also called as biological response modifiers. Cancer vaccine are of two types: Preventive vaccine and treatment vaccine. The Preventive vaccine is used to stop the growth of the Cancer cell while the treatment vaccine is used to treat the existing cancer by natural immune system to fight against the cancer. Related Conferences: Oncology Conferences | Cancer Conferences | Cancer Research Conferences | Biomarkers Conferences | Pharmacology Conferences | Cancer Summit | Oncology Summit International Conference on Oncology Research & Cancer Stem Cells, 10 May 2019, Germany; Euro-Global Summit on Cancer Therapy & Radiation Oncology, July 23-25, 2019, Italy; Euro Congress on Cancer Science & Therapy, August 09-10, 2019, Spain; Global Summit on Oncology & Cancer, March 12-14, 2019, Singapore; Global Annual Oncologists Meeting, May 24-25, 2019, Japan; World Haematology and Medical Oncology Conference, May 28-30, 2019, Japan; Global Meeting on Oncology and Radiology, June 1-2, 2019, Japan World Cancer Summit 2019, July 02-03, 2019, Thailand; International Conference on Cancer Genetics and Epigenetics, July 18-19, 2019, Australia; Experts Meet on Cancer Therapy 2019, July 23-24, 2019, Australia; Asia Pacific Oncologists Annual Meeting, September 5-6, 2019, Japan; International Conference on Biomarkers and Cancer Targets, July 16-17, 2019, Duba Cancer and Oncology Associations: Cancer Patients Aid Association, India; Cancer Aid Society,

169

India; Indian Association for Cancer Research, India; Indian Medical Association, India; Help Age India, India; Acoustic Neuroma Association of Australia, Australia; Australasian Association of Cancer Registries, Australia; Australasian Lung Cancer Trials Group, Australia; Australian and New Zealand Children's Haematology/Oncology Group, Australia; Australian Capital Territory Cancer Registry, Australia; Australian Cervical Cancer Foundation, Australia; Australian Familial Pancreatic Cancer Cohort, Australia; Australian Prostate Cancer Research, Australia; Bangladesh Cancer Society, Bangladesh; Middle East Cancer Consortium, Israel; SON Foundation, India; Middle East and Mediterranean Association of Gynecologic Oncologist, Turkey; Leukaemia Cancer Society, UK; The British association for Cancer Research, UK; United Kingdom and Ireland Association of Cancer Registries, UK; International Children's Care, UK; Association of Cancer Physicians, UK; Children with Cancer, UK. Session 17: Pharmacology Pharmacology is the study of action of drugs. This subject deals with how these drug molecules enter the body, interact with the body, Affect the host system, Affect the foreign bodies, pathogens, its dynamics and how it is removed out from the body. This involves many other topics such as- Pharmacokinetics, Pharmacodynamics, Pharmacognosy, Pharmacoeconomics, Pharmacogenomics. Related Conferenc [es:Oncologist Summit | Pharmacology Summit | Cancer Events | Oncology Events | Pharmacology Events | Oncology Congress International Conferences on Clinical Oncology and Diagnostics Dublin, Ireland; 3rd World Congresson Advanced Cancer Science & Therapy October 15-16, 2019 Osaka, Japan; World Congress On Cancer ScienceAnd Therapy August 13-14, 2019 Chicago, USA; EACR25: 25th Biennal Congress of the European Association for Cancer Research, Netherlands; 29th Euro-Global Summit on Cancer Therapy & Radiation Oncology Rome, Italy; Experts Meet On Cancer Therapy Melbourne, Australia; 4th Annual Conference on Gynecologic Oncology and Reproductive Disorders Atlanta, Georgia, USA; 4th Annual Conference on Preventive Oncology 2019 Atlanta, Georgia, USA; International Conference on Biomarkers and Cancer Targets 2019 Dubai, UAE; World Cancer Summit 2019 2019 Bangkok, Thailand; 14th Global Biomarkers Summit 2019 | Oslo, Norway; Euro Oncology Summit October 18-19, 2019 | Amsterdam, Netherlands; 9th Euro Breast Cancer Summit October 18-19, 2019 | Amsterdam, Netherlands; Annual Congress on Cancer and Stem Cell Research October 17-18, 2019 New York, USA; 22nd World Conference on Liquid Biopsy & Biomarkers/ zancer and Oncology Associations: Acoustic

170

Neuroma Association, USA; American Association for Cancer Research, USA; American Brain Tumor Association, USA; American Cancer Society, USA; American Childhood Cancer Organization, USA; American Society for Radiation Oncology, USA; American Society of Clinical Oncology, USA; Association of Community Cancer Centers, USA; Cancer and Leukemia Group B, USA; Childhood Brain Tumor Foundation, USA; Children's Neuroblastoma Cancer Foundation, USA; Children's Tumor Foundation, USA; Foundation for Women's Cancer, USA; Lung Cancer Foundation of America, USA; American Childhood Cancer Organization, USA; National Cancer Registrars Association, USA; National Children's Leukemia Foundation, USA; Ocular Melanoma Foundation, USA; Oral Cancer Foundation, USA; Prevent Cancer Foundation, USA; Society for Immunotherapy of Cancer, USA.Session 18: Pharmacogenomics It is very well- known fact that one size doesn’t fit all. The genetic makeup of everyone is different, and the way drugs react to those genes keep on changing from individual to individuals. Frequently this change in action evidences to be lethal in many individuals. Worldwide many hospitalizations and death occur due to the adverse effect of the drugs. In the recent days it has been in practice to develop the drugs specific to the genetic makeup of the patient to yield better results. This is proven to be a promising field of Pharmacy. Related Conferences: Cancer Congress | Pharmacology Congress | Biomarkers Congress | Singapore Events | Singapore Conferences | Global Conferences | Translational Biology Conferences. International Conference on Molecular Markers and Cancer Therapeutics October 8-9, 2019 Dubai, UAE; Cancer Genomics Conference: New Era for Cancer Prevention October 08-09, 2019 Dubai, UAE; International Conference on Cancer Diagnosis & Treatment August 2-3 2019 Oslo, Norway; 2nd International Conference on Cancer Biology, Therapeutics and Drug Delivery October 03-04, 2019 Los Angeles, California, USA; 12th World Congress on Biomarkers & Clinical Research October 03-04, 2019 Los Angeles, California, USA; 3rd World Conference on Breast and Cervical Cancer September 27-28, 2019 Abu Dhabi, UAE; 3rd Cancer Diagnostics & Treatment Conference November 29-December 01, 2019 Dublin, Ireland; International Conference on Oncogenesis and Oncologic Emergency Medicine September 17-18, 2019 San Diego, California, USA; 28th International Conference on Cancer Research and Anticancer Therapies September 17-18, 2019 San Diego, California, USA; 4th International Congress on Epigenetics & Chromatin September 03-05, 2019 London, UK; International Conference on

171

Cancer Research and Diagnostics August 15-16, 2019 Singapore; 28th Euro Congress on Cancer Science & Therapy August 09-10, 2019 Madrid, Spain; 8th World Conference on Women’s Health and Breast Cancer August 09-10, 2019 Abu Dhabi, UAE. xancer and Oncology Associations: Radiation Therapy Oncology Group, USA; Middle-Eastern Association for Cancer Research (MEACR) , Canada; Acoustic Neuroma Association of Canada, Canada; European Association for Cancer Research, UK; European Breast Cancer Coalition, Italy; European Cancer Organisation, Belgium; European Musculo-Skeletal Oncology Society, Italy; European Society of Surgical Oncology, Belgium; European Society of Paediatric Oncology, Belgium; Association of Population-based Cancer Registries in Germany, Germany; Children's Cancer Association, Spain; Asia-Oceana Research Organization on Genital Infection and Neoplasia, India; Asian Society for Neuro- Oncology, Japan; Asian Society of Gynecologic Oncology, Korea; Australasian Lung Cancer Trials Group, Australia; Cancer Therapeutics Research Group, Singapore; Asian Fund for Cancer Research, China; Indian cancer Society, India. Session 19 : Ethnopharmacology Ethnopharmacology is about association of the usual medication rehearsed by different ethnic gatherings and particularly by indigenous people groups. Ethnomedicine is now and then used as an equivalent word for conventional medication. Ethnomedical investigate about interdisciplinary in its investigation of customary prescriptions. It applies the strategies for ethnobotany and restorative human sciences. Over and over the prescription customs it contemplates are protected just by oral convention.Valid ethnomedical contemplates constitute either anthropological research or medication disclosure examine. Anthropological investigations examine the social observation and setting of a customary drug. The motivation behind medication disclosure investigate is to recognize and build up an attractive pharmaceutical item. Related Conferences:: Oncology Conferences | Cancer Conferences | Cancer Research Conferences | Biomarkers Conferences | Pharmacology Conferences | Cancer Summit | Oncology Summit 15th Asia Pacific Oncologists Annual Meeting September 5-6, 2019 Tokyo, Japan; Molecular Cancer Biomarkers2019; 14th Global Biomarkers Summit August 02-03, 2019 | Oslo, Norway; 29th Euro-Global Summit on Cancer Therapy & Radiation Oncology July 23-25, 2019 Rome, Italy; Experts Meet On Cancer Therapy 2019 July 23-24, 2019 Melbourne, Australia; Cancer Science and Targeted Therapies, October 29-30, 2019 San Francisco, California, USA; 4th Annual Conference on Gynecologic Oncology and Reproductive Disorders, July 18-19,

172

2019, USA; 4th Annual Conference on Preventive Oncology, July 18-19, 2019, USA; 28th International Conference on Cancer Research and Anticancer Therapies, September 17-18, 2019, USA; International Conference on Oncogenesis and Oncologic Emergency Medicine, September 17-18, 2019, USA; World Cancer Conference, October 11-13, 2019 Zurich, Switzerland; Cancer and Oncology Associations: Cancer Patients Aid Association, India; Cancer Aid Society, India; Indian Association for Cancer Research, India; Indian Medical Association, India; Help Age India, India; Acoustic Neuroma Association of Australia, Australia; Australasian Association of Cancer Registries, Australia; Australasian Lung Cancer Trials Group, Australia; Australian and New Zealand Children's Haematology/Oncology Group, Australia; Australian Capital Territory Cancer Registry, Australia; Australian Cervical Cancer Foundation, Australia; Australian Familial Pancreatic Cancer Cohort, Australia; Australian Prostate Cancer Research, Australia; Bangladesh Cancer Society, Bangladesh; Middle East Cancer Consortium, Israel; SON Foundation, India; Middle East and Mediterranean Association of Gynecologic Oncologist, Turkey; Leukaemia Cancer Society, UK; The British association for Cancer Research, UK; United Kingdom and Ireland Association of Cancer Registries, UK; International Children's Care, UK; Association of Cancer Physicians, UK; Children with Cancer, UK, Session 20: Advances in Pharmacological Research Advances in pharmacological research uses Nanoscale drug delivery systems with liposomes and nanoparticles which is a rising technologies for the rational delivery of chemotherapeutic drugs in the treatment for various disorders. Nanoparticles can present probable dangers both medically and environmentally. Pharmaceutical industry is clearly filled by the research conducted with prescription drugs, vaccines and OTC drugs which are produced based on findings from the study of life sciences. Clinical trials are conducted to ensure that products being developed are tested on how well they work on individuals affected by the diseases or conditions they are created to treat. Related Conferences: Oncologist Summit | Pharmacology Summit | Cancer Events | Oncology Events | Pharmacology Events | Oncology Congress, International Conference on Oncology Research & Cancer Stem Cells, 10 May 2019, Germany; Euro-Global Summit on Cancer Therapy & Radiation Oncology, July 23-25, 2019, Italy; Euro Congress on Cancer Science & Therapy, August 09-10, 2019, Spain; Global Summit on Oncology & Cancer, March 12-14, 2019, Singapore; Global Annual Oncologists Meeting, May 24-25, 2019, Japan; World Haematology and Medical Oncology

173

Conference, May 28-30, 2019, Japan; Global Meeting on Oncology and Radiology, June 1-2, 2019, Japan World Cancer Summit 2019, July 02-03, 2019, Thailand; International Conference on Cancer Genetics and Epigenetics, July 18-19, 2019, Australia; Experts Meet on Cancer Therapy 2019, July 23-24, 2019, Australia; Asia Pacific Oncologists Annual Meeting, September 5-6, 2019, Japan; International Conference on Biomarkers and Cancer Targets, July 16-17, 2019, Dubai; Session 21: Pediatrics Pharmacology Pediatrics pharmacology is an associate–reviewed, multi-disciplinary that is concerned to promoting the safe and effective use of medications in infants and children. Pediatrics Pharmacology focuses on the importance to understand in that pediatrics dosage form and drug interaction and how they can affect the children physiology. It is with better understanding of Pharmacology knows the right dosage and dosage forms of drugs. Further research in pharmacology deals with recognizing and responding to drug interactions and its side effects. And, its mechanism of action and its therapeutic index to treat accordingly. More intensive study with the interaction between pediatrics drug and its therapeutic effect helps to identify the properties of ideal pediatrics drugs. Related Conferences: Cancer Congress | Pharmacology Congress | Biomarkers Congress | Singapore Events | Singapore Conferences | Global Conferences | Translational Biology ConferencesInternational Conferences on Clinical Oncology and Molecular Diagnostics Dublin, Ireland; 3rd World Congresson Advanced Cancer Science & Therapy October 15-16, 2019 Osaka, Japan; World Congress On Cancer ScienceAnd Therapy August 13-14, 2019 Chicago, USA; EACR25: 25th Biennal Congress of the European Association for Cancer Research, Netherlands; 29th Euro- Global Summit on Cancer Therapy & Radiation Oncology Rome, Italy; Experts Meet On Cancer Therapy Melbourne, Australia; 4th Annual Conference on Gynecologic Oncology and Reproductive Disorders Atlanta, Georgia, USA; 4th Annual Conference on Preventive Oncology 2019 Atlanta, Georgia, USA; International Conference on Biomarkers and Cancer Targets 2019 Dubai, UAE; World Cancer Summit 2019 2019 Bangkok, Thailand; 14th Global Biomarkers Summit 2019 | Oslo, Norway; Euro Oncology Summit October 18-19, 2019 | Amsterdam, Netherlands; 9th Euro Breast Cancer Summit October 18-19, 2019 | Amsterdam, Netherlands; Annual Congress on Cancer and Stem Cell Research October 17-18, 2019 New York, USA; 22nd World Conference on Liquid Biopsy & Biomarkers, Cancer and Oncology Associations: Acoustic Neuroma Association, USA; American Association for Cancer Research, USA; American Brain Tumor

174

Association, USA; American Cancer Society, USA; American Childhood Cancer Organization, USA; American Society for Radiation Oncology, USA; American Society of Clinical Oncology, USA; Association of Community Cancer Centers, USA; Cancer and Leukemia Group B, USA; Childhood Brain Tumor Foundation, USA; Children's Neuroblastoma Cancer Foundation, USA; Children's Tumor Foundation, USA; Foundation for Women's Cancer, USA; Lung Cancer Foundation of America, USA; American Childhood Cancer Organization, USA; National Cancer Registrars Association, USA; National Children's Leukemia Foundation, USA; Ocular Melanoma Foundation, USA; Oral Cancer Foundation, USA; Prevent Cancer Foundation, USA; Society for Immunotherapy of Cancer, USA. Session 22 : Pharmacognosy Pharmacognosy in the simple terms this is the study of Drugs of natural Origin. This field of science take into consideration how a chemical, physical or a biological compound which are derived from the Nature acts in an individual’s body. The way it enters the body, interact with the host and foreign body are taken into consideration. Though this branch of science has been in practice since a long- time people are turning toward this in the recent days after learning how good and safe, they are compared to the Industrial Pharmaceutics. Related Conferences: Oncology Conferences | Cancer Conferences | Cancer Research Conferences | Biomarkers Conferences | Pharmacology Conferences | Cancer Summit | Oncology Summit International Conference on Molecular Markers and Cancer Therapeutics October 8-9, 2019 Dubai, UAE; Cancer Genomics Conference: New Era for Cancer Prevention October 08-09, 2019 Dubai, UAE; International Conference on Cancer Diagnosis & Treatment August 2-3 2019 Oslo, Norway; 2nd International Conference on Cancer Biology, Therapeutics and Drug Delivery October 03-04, 2019 Los Angeles, California, USA; 12th World Congress on Biomarkers & Clinical Research October 03-04, 2019 Los Angeles, California, USA; 3rd World Conference on Breast and Cervical Cancer September 27-28, 2019 Abu Dhabi, UAE; 3rd Cancer Diagnostics & Treatment Conference November 29-December 01, 2019 Dublin, Ireland; International Conference on Oncogenesis and Oncologic Emergency Medicine September 17-18, 2019 San Diego, California, USA; 28th International Conference on Cancer Research and Anticancer Therapies September 17-18, 2019 San Diego, California, USA; 4th International Congress on Epigenetics & Chromatin September 03-05, 2019 London, UK; International Conference on Cancer Research and Diagnostics August 15-16, 2019 Singapore; 28th Euro Congress on Cancer Science & Therapy August 09-10, 2019 Madrid, Spain; 8th

175

World Conference on Women’s Health and Breast Cancer August 09-10, 2019 Abu Dhabi, UAE: Cancer and Oncology Associations: Radiation Therapy Oncology Group, USA; Middle-Eastern Association for Cancer Research (MEACR) , Canada; Acoustic Neuroma Association of Canada, Canada; European Association for Cancer Research, UK; European Breast Cancer Coalition, Italy; European Cancer Organisation, Belgium; European Musculo-Skeletal Oncology Society, Italy; European Society of Surgical Oncology, Belgium; European Society of Paediatric Oncology, Belgium; Association of Population-based Cancer Registries in Germany, Germany; Children's Cancer Association, Spain; Asia-Oceana Research Organization on Genital Infection and Neoplasia, India; Asian Society for Neuro- Oncology, Japan; Asian Society of Gynecologic Oncology, Korea; Australasian Lung Cancer Trials Group, Australia; Cancer Therapeutics Research Group, Singapore; Asian Fund for Cancer Research, China; Indian cancer Society, India. Session 23: Drug screening and Discovery Reverse pharmacology includes drug screening deals with reverse pharmacology and forward pharmacology are two approaches to drug discovery. Drug discovery targets the process through which potential new medicines are identified. The worldwide market for drug discovery technologies reached nearly $39.5 billion and $46.5 billion in 2013 and 2014, respectively. This market is expected to grow at a compound annual growth rate (CAGR) of 11.3% to nearly $79.5 billion for the period 2014-2019.Related Conferences: Oncologist Summit | Pharmacology Summit | Cancer Events | Oncology Events | Pharmacology Events | Oncology Congress 15th Asia Pacific Oncologists Annual Meeting September 5-6, 2019 Tokyo, Japan; Molecular Cancer Biomarkers2019; 14th Global Biomarkers Summit August 02-03, 2019 | Oslo, Norway; 29th Euro-Global Summit on Cancer Therapy & Radiation Oncology July 23-25, 2019 Rome, Italy; Experts Meet On Cancer Therapy 2019 July 23-24, 2019 Melbourne, Australia; Cancer Science and Targeted Therapies, October 29-30, 2019 San Francisco, California, USA; 4th Annual Conference on Gynecologic Oncology and Reproductive Disorders, July 18-19, 2019, USA; 4th Annual Conference on Preventive Oncology, July 18-19, 2019, USA; 28th International Conference on Cancer Research and Anticancer Therapies, September 17-18, 2019, USA; International Conference on Oncogenesis and Oncologic Emergency Medicine, September 17-18, 2019, USA; World Cancer Conference, October 11-13, 2019 Zurich, Switzerland, Cancer and Oncology Associations: Cancer Patients Aid Association, India; Cancer Aid Society, India; Indian Association for Cancer

176

Research, India; Indian Medical Association, India; Help Age India, India; Acoustic Neuroma Association of Australia, Australia; Australasian Association of Cancer Registries, Australia; Australasian Lung Cancer Trials Group, Australia; Australian and New Zealand Children's Haematology/Oncology Group, Australia; Australian Capital Territory Cancer Registry, Australia; Australian Cervical Cancer Foundation, Australia; Australian Familial Pancreatic Cancer Cohort, Australia; Australian Prostate Cancer Research, Australia; Bangladesh Cancer Society, Bangladesh; Middle East Cancer Consortium, Israel; SON Foundation, India; Middle East and Mediterranean Association of Gynecologic Oncologist, Turkey; Leukaemia Cancer Society, UK; The British association for Cancer Research, UK; United Kingdom and Ireland Association of Cancer Registries, UK; International Children's Care, UK; Association of Cancer Physicians, UK; Children with Cancer, UK, Session 24: Medical Toxicology, Medical toxicology is a division of science and drug worried about the investigation of the antagonistic responses of chemicals on living life forms. It additionally thinks about the hurtful impacts of substance, natural and physical specialists in organic frameworks that builds up the degree of harm in living creatures. The bond among dosage and its consequences for the bare living being is of high criticalness in toxicology. Variables that influence compound poisonous quality incorporate the measurements the course of presentation, the species, age, sex and condition. Toxicologic inspection assumes urgent part in the cutting-edge examinations. Essential standards of a few orders like natural chemistry, systematic science, pharmacodynamics, the study of disease transmission, pathology, and physiology are connected in such sort of investigation. Related Conferences: Cancer Congress | Pharmacology Congress | Biomarkers Congress | Singapore Events | Singapore Conferences | Global Conferences | Translational Biology Conferences International Conference on Oncology Research & Cancer Stem Cells, 10 May 2019, Germany; Euro-Global Summit on Cancer Therapy & Radiation Oncology, July 23-25, 2019, Italy; Euro Congress on Cancer Science & Therapy, August 09-10, 2019, Spain; Global Summit on Oncology & Cancer, March 12-14, 2019, Singapore; Global Annual Oncologists Meeting, May 24-25, 2019, Japan; World Haematology and Medical Oncology Conference, May 28-30, 2019, Japan; Global Meeting on Oncology and Radiology, June 1-2, 2019, Japan World Cancer Summit 2019, July 02-03, 2019, Thailand; International Conference on Cancer Genetics and Epigenetics, July 18-19, 2019, Australia; Experts Meet on Cancer Therapy 2019, July 23-24, 2019, Australia; Asia Pacific

177

Oncologists Annual Meeting, September 5-6, 2019, Japan; International Conference on Biomarkers and Cancer Targets, July 16-17, 2019, Dubai Cancer and Oncology Associations: Acoustic Neuroma Association, USA; American Association for Cancer Research, USA; American Brain Tumor Association, USA; American Cancer Society, USA; American Childhood Cancer Organization, USA; American Society for Radiation Oncology, USA; American Society of Clinical Oncology, USA; Association of Community Cancer Centers, USA; Cancer and Leukemia Group B, USA; Childhood Brain Tumor Foundation, USA; Children's Neuroblastoma Cancer Foundation, USA; Children's Tumor Foundation, USA; Foundation for Women's Cancer, USA; Lung Cancer Foundation of America, USA; American Childhood Cancer Organization, USA; National Cancer Registrars Association, USA; National Children's Leukemia Foundation, USA; Ocular Melanoma Foundation, USA; Oral Cancer Foundation, USA; Prevent Cancer Foundation, USA; Society for Immunotherapy of Cancer, USA, Session 25: Therapeutic Innovation in Pharmacology, Related Conferences: Oncology Conferences | Cancer Conferences | Cancer Research Conferences | Biomarkers Conferences | Pharmacology Conferences | Cancer Summit | Oncology Summit, International Conferences on Clinical Oncology and Molecular Diagnostics Dublin, Ireland; 3rd World Congresson Advanced Cancer Science & Therapy October 15- 16, 2019 Osaka, Japan; World Congress On Cancer ScienceAnd Therapy August 13-14, 2019 Chicago, USA; EACR25: 25th Biennal Congress of the European Association for Cancer Research, Netherlands; 29th Euro-Global Summit on Cancer Therapy & Radiation Oncology Rome, Italy; Experts Meet On Cancer Therapy Melbourne, Australia; 4th Annual Conference on Gynecologic Oncology and Reproductive Disorders Atlanta, Georgia, USA; 4th Annual Conference on Preventive Oncology 2019 Atlanta, Georgia, USA; International Conference on Biomarkers and Cancer Targets 2019 Dubai, UAE; World Cancer Summit 2019 2019 Bangkok, Thailand; 14th Global Biomarkers Summit 2019 | Oslo, Norway; Euro Oncology Summit October 18-19, 2019 | Amsterdam, Netherlands; 9th Euro Breast Cancer Summit October 18-19, 2019 | Amsterdam, Netherlands; Annual Congress on Cancer and Stem Cell Research October 17-18, 2019 New York, USA; 22nd World Conference on Liquid Biopsy & Biomarkers, Cancer and Oncology Associations: Radiation Therapy Oncology Group, USA; Middle-Eastern Association for Cancer Research (MEACR) , Canada; Acoustic Neuroma Association of Canada, Canada; European Association for Cancer Research, UK;

178

European Breast Cancer Coalition, Italy; European Cancer Organisation, Belgium; European Musculo-Skeletal Oncology Society, Italy; European Society of Surgical Oncology, Belgium; European Society of Paediatric Oncology, Belgium; Association of Population-based Cancer Registries in Germany, Germany; Children's Cancer Association, Spain; Asia-Oceana Research Organization on Genital Infection and Neoplasia, India; Asian Society for Neuro-Oncology, Japan; Asian Society of Gynecologic Oncology, Korea; Australasian Lung Cancer Trials Group, Australia; Cancer Therapeutics Research Group, Singapore; Asian Fund for Cancer Research, China; Indian cancer Society, India, Session 26: Clinical Research and Drug Legislation, Related Conferences: Oncologist Summit | Pharmacology Summit | Cancer Events | Oncology Events | Pharmacology Events | Oncology Congress, International Conference on Molecular Markers and Cancer Therapeutics October 8-9, 2019 Dubai, UAE; Cancer Genomics Conference: New Era for Cancer Prevention October 08-09, 2019 Dubai, UAE; International Conference on Cancer Diagnosis & Treatment August 2-3 2019 Oslo, Norway; 2nd International Conference on Cancer Biology, Therapeutics and Drug Delivery October 03-04, 2019 Los Angeles, California, USA; 12th World Congress on Biomarkers & Clinical Research October 03-04, 2019 Los Angeles, California, USA; 3rd World Conference on Breast and Cervical Cancer September 27-28, 2019 Abu Dhabi, UAE; 3rd Cancer Diagnostics & Treatment Conference November 29-December 01, 2019 Dublin, Ireland; International Conference on Oncogenesis and Oncologic Emergency Medicine September 17-18, 2019 San Diego, California, USA; 28th International Conference on Cancer Research and Anticancer Therapies September 17-18, 2019 San Diego, California, USA; 4th International Congress on Epigenetics & Chromatin September 03-05, 2019 London, UK; International Conference on Cancer Research and Diagnostics August 15-16, 2019 Singapore; 28th Euro Congress on Cancer Science & Therapy August 09-10, 2019 Madrid, Spain; 8th World Conference on Women’s Health and Breast Cancer August 09-10, 2019 Abu Dhabi, UAE, Cancer and Oncology Associations: Cancer Patients Aid Association, India; Cancer Aid Society, India; Indian Association for Cancer Research, India; Indian Medical Association, India; Help Age India, India; Acoustic Neuroma Association of Australia, Australia; Australasian Association of Cancer Registries, Australia; Australasian Lung Cancer Trials Group, Australia; Australian and New Zealand Children's Haematology/Oncology Group, Australia; Australian Capital Territory Cancer Registry, Australia; Australian Cervical Cancer Foundation,

179

Australia; Australian Familial Pancreatic Cancer Cohort, Australia; Australian Prostate Cancer Research, Australia; Bangladesh Cancer Society, Bangladesh; Middle East Cancer Consortium, Israel; SON Foundation, India; Middle East and Mediterranean Association of Gynecologic Oncologist, Turkey; Leukaemia Cancer Society, UK; The British association for Cancer Research, UK; United Kingdom and Ireland Association of Cancer Registries, UK; International Children's Care, UK; Association of Cancer Physicians, UK; Children with Cancer, UK, Market Analysis, Cancer is the second leading cause of death worldwide. It’s crucial to remember that cancer is not one disease – it’s more than 200 cancer diseases involved. All different, unique diseases, which require different approaches for treatment. The most common types of cancer being lung cancer causing 1.4 million deaths per year, stomach cancer causing 740,000 deaths, liver cancer causing 700,000 deaths, colorectal cancer causing 610,000 and breast cancer causing 460,000 deaths. This proves invasive cancer to be the leading cause of death in the present century .Treatments that work for some cancers don’t work for others and sometimes those treatments simply stop working. Only worldwide research will enhance our understanding of cancer and help us find and develop better, more effective treatments. And only a global search for answers will help us get to grips with this disease. . The conference will provide with an exceptional opportunity for the delegates from Universities and Institutes to interact with the world class Scientists and Industry Professionals working in the field of cancer (or) oncology. Children and middle age group individuals are highly prone to cancers like Leukemia (34%), brain tumors (23%) and lymphomas (12%). These are the most occurring types of cancer in middle aged individuals also. Breast cancer prevalent in women ranks second as a cause of cancer death in women Cancer reports by Health Organizations in the recent years As per reports of 2012, cancer is the leading cause of mortality worldwide with its chances of being increased by 70% in the next two years. In 2012, an estimated 14.1 million new cases of cancer occurred worldwide out of which nearly 8.2 million people died. Alcohol drinking causes an estimated 6% of cancer deaths worldwide, (2012) and it is most prevalent in Europe and America. Use of tobacco is the most important risk factor for cancer, causing 22% of cancer deaths Cancer accounted for 8.8 million deaths in 2015. The recent advancements in the cancer treatments & cancer care are accelerating. A cluster of innovative treatments, often combined with other new or existing medicines, and frequently associated with biomarkers, are emerging from the research and development pipeline. Over the past

180 five years, 70 new oncology treatments have been launched and are being used to treat over 20 different tumour types. The global cancer biomarker market size was valued at USD 10.3 billion in the year 2016 and is estimated to reach a value of USD 33.7 billion by 2025, growing with CAGR of 14.3 %. Growing prevalence of malignancies coupled with increasing focus on development of targeted therapies is a major factor affirming growth of this market. Global cancer drugs market accounted for $78,238.9 million in 2015. The cancer drugs market is driven by the growing prevalence of various types of cancer, increasing demand of biological and targeted drug therapies, continuous patent expiry of key cancer drugs and the rising impact of biosimilars. Global Oncology/Cancer Drugs Market is expected to garner $111.9 billion by 2020, registering a CAGR of 7.1% during the forecast period 2014 to 2020. Recent progress in biological therapies has widened the scale of therapeutic targets for treatment of cancer with the identification of tumour cell specific genes. The global cancer diagnostics market is segmented based on technology, application, and region. This report studies the global cancer diagnostics market for the forecast period of 2015 to 2020. This market is expected to reach $13.1 Billion by 2020 from $7.1 Billion in 2015 and is poised to grow at a CAGR of 12.9% during the forecast period.

[80] Organizing Committee Member of International Conference on Pharmacy and Pharma Networks, August 25-27, 2020, Germany, ICPPN Germany 2020 welcomes all participants throughout the world to attend the International Conference on Pharmacy and Pharma Network held on August 25-27, 2020 in Germany. The Conference deals with the theme on "Recent Innovations and Advances in Pharmacy and Pharma Networks" and it has a branch of Scientific Sessions concerned with the departments of Pharmacology, Pharmacognosy, Toxicology, Pharmaceutical Sciences, Clinical Pharmacy, Biopharmaceutics and which included with subdivisions they are Hospital Pharmacy, Industrial Pharmacy, Pharmaceutical Biotechnology, Medicinal Chemistry, Pharmaceutical Nanotechnology, Pharmaceutical Microbiology.

[81] Program Committee Member of Global Conference on Biotechnology and Bioinformatics, June 18-19, 2020 Boston, USA. (GCBB-2020), URL: https://moraft.com/biotechnology-and-bioinformatics-2020, About GCBB -2020:

181

MORAFT welcomes you to attend the Global Conference on Biotechnology and Bioinformatics. GCBB -2020 is scheduled on June18-19, 2020 in Boston, USA. This conference specifically designed to bring subject matter professionals together to exchange and discuss current research findings in the field globally. Moraft is an international scientific conference-organizing group involved in promoting global current research through high profile conferences. We enable like-minded people to connect for sharing information, ideas, and opportunities for networking by providing the attendees platform to participate, enrich and discover innovation and future research. Well-known speakers all over the globe are invited to present their latest research updates and share findings, able to discuss the new techniques, procedures involved. Participants can have breakout sessions to have in-depth discussions, B2B meetings poster symposia, video presentations and workshops.

[82] Honorary Keynote Speaker and Organizing Committee Member of World Congress on Genetics and Molecular Biology, Theme: Modernization and Discoveries in the field of Genetics will lead to better future. 12-Apr-2021 - 13-Apr- 2021 Prague, Czech Republic. The World Congress on Genetics and Molecular Biology will be held from April 12-13, 2021 in Prague, Czech Republic. The Conference provides a unique platform for eminent biologists, biochemists, molecular biologists, bio-technologists, students, researchers in the field, educators, scientists and industry experts to come together on a single stage and provide answers for the upcoming challenges in the respective areas of Genetics and Molecular Biology. Current challenges, achievements in the field and possible suggestions for new technological advances will be discussed by the participants. Keynote presentations by eminent researchers in the field, poster presentations, research results and suggestions for developing new scientific equipment will be discussed at the event paving a new way of opportunities for professionals in the field. Molecular biology is the study of biology at molecular level and it overlaps with the areas of chemistry, biology, biochemistry and genetics and is concerned with the understanding of the various systems of a cell. The conference further seeks to understand how molecules which make up cells play a key role in determining the behavior of things. The event will cover a broad range of challenges related to molecular and cell biology including proteomics, functional genomics, biomedicine, bio-informatics, molecular virology, immunology and enzymology. The gather will discuss on various scientific sessions and tracks related to the field of

182 genetics and molecular biology including, but not limited to, genomics, diabetes and obesity, clinical genetics, cancer genetics, cytogenetics, genetic disorders, neuro developmental disorders, anthropology, drug discovery, transplantation, pharmacogenetics, bio-informatics in human genetics, evolutionary and population genetics, molecular genetics, immunogenetics, genetic testing, and DNA sequencing. The conference provides a platform for students and researchers in the field to participate in brain storming sessions related to the subject and gain insights with discussions aimed around the subject by professionals in the field including scientists, researchers, professors and academic professionals. Associations and societies related to molecular biology, industry leaders and medical device manufacturing personnel will be able to foster new partnerships and collaborations that will help in enhancing their goals. URL: https://www.axiomaticconferences.com/conferences/genetics-and-molecular- biology.

[83] Honorary Speaker at 4th Edition of Global Conference on Pharmaceutics and Drug Delivery Systems (PDDS 2020) scheduled during June 15-17, 2020 at Rome, Italy. Website: https://pharmaceuticsconference.com/, Invited by: Luciana Jones, Conference Manager | PDDS 2020, Office +1 (702) 988-2320, Toll Free: 1800–883- 8082 (USA & Canada), WhatsApp: +1 434 381 1007, Email: [email protected], 1033 Sterling Rd, Unit 104, Herndon, VA 20170, USA. About the Conference: Magnus Group with great pride and honour announcing its "4th Edition of Global conference on Pharmaceutics and Drug Delivery Systems" (PDDS 2020), which is going to be held in Rome, Italy During June 15-17, 2020. PDDS 2020 serve as a podium for the interaction between experts in the areas of pharmaceutics, drug delivery, Nano medicine, biotechnology, and nanotechnology around the world and aims in sharing some unique research and translational studies on various advances in the related fields. The conference opens the doors for many researchers in academia, clinicians, and industry representatives working in these exciting areas. It is expected to bring together both reputable scientists in advanced stages of their career and young researches from many related disciplines. The conference expects many new ideas to emerge at the interfaces between disciplines aiming to solve the most important problems relating to the health and wellbeing of the humanity.

183

[84] Honorary Keynote Speaker at The 4th International Biotechnology Congress (IBC-2020), Time: Nov. 9-11, 2020, Place: Dubai, UAE. IBC-2020 is a dedicated event where you will have the opportunity to learn about new developments in the field of Biotechnology, Gene and Life Sciences, and share aspects of your own work by submitting a poster or oral presentation. With the participation of outstanding international experts, we hope productive discussions would stimulate new creative ideas to translate new discoveries into better practice and application. IBC-2020 continues to expand with magnificent scientific and social programs to maximize your network in a free communication meeting environment. We create a great platform to researches, scientists, academicians and industry experts to share experiences, discuss research findings and acquire the desired knowledge for practical exercise. URL: https://www.bitcongress.com/ibc2020.

[85] Organizing Committee Member of Global Conference on Biotechnology and Bioinformatics, June 18-19, 2020 Boston, USA, Global Conference on Biotechnology and Bioinformatics- GCBB-2020, About GCBB -2020: MORAFT welcomes you to attend the Global Conference on Biotechnology and Bioinformatics. GCBB -2020 is scheduled on June18-19, 2020 in Boston, USA. This conference specifically designed to bring subject matter professionals together to exchange and discuss current research findings in the field globally. Moraft is an international scientific conference-organizing group involved in promoting global current research through high profile conferences. We enable like-minded people to connect for sharing information, ideas, and opportunities for networking by providing the attendees platform to participate, enrich and discover innovation and future research. Well-known speakers all over the globe are invited to present their latest research updates and share findings, able to discuss the new techniques, procedures involved. Participants can have breakout sessions to have in-depth discussions, B2B meetings poster symposia, video presentations and workshops.

URL: https://www.moraft.com/biotechnology-and-bioinformatics-2020/program- committee.

[86] Honorary Organizing Committee Member and Keynote Speaker at 2nd European Congress on Cancer Science & Oncology during September 28-29, 2020 in Novotel Zurich - Messe, Switzerland. For More Information: https://www.coalesceresearchgroup.com/conferences/oncology, 2nd European

184

Congress on Cancer Science & Oncology is going to be held during September 28- 29, 2020 at Zurich, Switzerland. Oncology congress is an initiative to unite the diverse researchers and business communities working in the field of cancer under one roof to understand the underlying cancer procedures, current treatments which can be amended to increase effectiveness, precision, survivability and quality of life in cancer patients. It is not a single disease to combat. Hence, there is a need for inter-disciplinary search globally: on how cancers develop, how to detect cancers at an early stage, how to design new anti-cancer therapies with greater efficiency, how to evaluate cancer risk and how to prevent cancer from arising. Our conference includes plenary lectures, keynote lectures and short courses by eminent personalities from around the world. Contributed papers includes, we also have oral presentations, poster presentations, video presentations and E-posters. This International Cancer Conference will help participants to learn the fundamentals of cancer science and to develop new skills necessary to envision and design cutting- edge cancer research projects that can contribute to high impact cancer research and cancer care. About Us: Conferences are not just about discussion, but to connect people with people, people with ideas, and people with opportunities. The key motto of Coalesce Research Group is to unite the Energy of Like-Minded Individuals to mold the future of research which will shape the future of the world. Coalesce Research Group is the key to unlock the doors of innovation. Hence, Coalesce Research Group will be a unique platform to sharpen your skill to achieve your goals. Diverse and innovative. Our Mission: • To provide best platform for learning, • To promote a culture where the professionals will show the path to novices, • Networking Opportunities to cultivate mutual communications.

[87] Plenary Speaker at Valencia, Spain for the “2nd International Congress on Cancer Research and Therapy” during June 16-18, 2020. website at: https://www.impactcancer2020.com/. About the Conference: The 2nd International Conference on Cancer research and Therapy is scheduled for June 18-19 2020, Valencia, Spain. Impact Cancer 2020 invites all the participants from all over the world which includes prompt Keynote talks, Oral talks, Poster presentations, Sponsor Ships and Exhibitions. The aim of this conference is " Inspiring Innovations and Advanced Practice in Cancer Care ". Impact Cancer 2020 is comprised of many interactive scientific sessions as well as various diagnostic and therapeutic advancements in cancer. It is an initiative to unite the diverse research and business

185 communities working in this field under a one roof to explore every single aspect of oncology. Importance & Scope: Impact Cancer 2020 will be the best platform for all the oncologists, hematologist's, research scholars, students who are working in this field to exchange their knowledge related to Oncology Research. This international event is an effort to understand the underlying biological procedures which are amended to increase effectiveness, precision, survivability and quality of life. Impact Cancer 2020 is the premier event that brings together international experts, Training Institutes, Manufacturing Medical Devices Companies, Business Entrepreneurs, Medical Colleges, Researchers, Academicians, Physicians, Post Docs, Students, Pharmacy Industries, Academic scientists, Industry professionals, Diagnostic laboratory professionals and decision makers across the globe to exchange their knowledge, experience and research innovations to build Cancer Research scientists to reduce the global burden of cancer.

[88] Organizing Committee Member at Valencia, Spain for the “2nd International Congress on Cancer Research and Therapy” during June 16-18, 2020. website at: https://www.impactcancer2020.com. About the Conference: The 2nd International Conference on Cancer research and Therapy is scheduled for June 18-19 2020, Valencia, Spain. Impact Cancer 2020 invites all the participants from all over the world which includes prompt Keynote talks, Oral talks, Poster presentations, Sponsor Ships and Exhibitions. The aim of this conference is " Inspiring Innovations and Advanced Practice in Cancer Care ". Impact Cancer 2020 is comprised of many interactive scientific sessions as well as various diagnostic and therapeutic advancements in cancer. It is an initiative to unite the diverse research and business communities working in this field under a one roof to explore every single aspect of oncology. Importance & Scope: Impact Cancer 2020 will be the best platform for all the oncologists, hematologist's, research scholars, students who are working in this field to exchange their knowledge related to Oncology Research. This international event is an effort to understand the underlying biological procedures which are amended to increase effectiveness, precision, survivability and quality of life. Impact Cancer 2020 is the premier event that brings together international experts, Training Institutes, Manufacturing Medical Devices Companies, Business Entrepreneurs, Medical Colleges, Researchers, Academicians, Physicians, Post Docs, Students, Pharmacy Industries, Academic scientists, Industry professionals, Diagnostic laboratory professionals and decision makers across the globe to exchange their

186 knowledge, experience and research innovations to build Cancer Research scientists to reduce the global burden of cancer. Attendees will include: Academicians, Oncologists, Radiologists, Chemotherapists, scientists, clinicians, researchers, world Doctors, Health practitioners, Pharmaceutical organizations, Clinical Research organizations. Associations and Societies sponsoring the meeting and looking for collaborative partners. hospitals sharing their novel researches in the arena of Nursing (exhibiting). Policy and decision makers with disciplines in the field of Radiation Therapy and chemotherapy, nursing stakeholders including academic researchers and entrepreneurs, industry policy makers. IMPACT conferences attract participants representing more than 53 countries around the world. IMPACT Executive Program: If you are a young scientist who is interested in dementia care and wishes to exchange ideas with industry experts, the IMPACT EXECUTIVE PROGRAM may well be the event for you. It is a 2 days’ event held in parallel to the conference, tailored around Stem cell and its advances. This program provides a unique opportunity to meet like-minded individuals and share the insights of the world's foremost specialists in Oncology innovators. Attendees will include: Academicians, Oncologists, Radiologists, Chemotherapists, scientists, clinicians, researchers, world Doctors, Health practitioners, Pharmaceutical organizations, Clinical Research organizations. Associations and Societies sponsoring the meeting and looking for collaborative partners. hospitals sharing their novel researches in the arena of Nursing (exhibiting). Policy and decision makers with disciplines in the field of Radiation Therapy and chemotherapy, nursing stakeholders including academic researchers and entrepreneurs, industry policy makers. IMPACT conferences attract participants representing more than 53 countries around the world. IMPACT Executive Program: If you are a young scientist who is interested in dementia care and wishes to exchange ideas with industry experts, the IMPACT EXECUTIVE PROGRAM may well be the event for you. It is a 2 days’ event held in parallel to the conference, tailored around Stem cell and its advances. This program provides a unique opportunity to meet like-minded individuals and share the insights of the world's foremost specialists in Oncology innovators.

[89] honorable Session Chair/Speaker at Valencia, Spain for the “2nd International Congress on Cancer Research and Therapy” during June 16-18, 2020. website at: https://www.impactcancer2020.com/. About the Conference: The 2nd International

187

Conference on Cancer research and Therapy is scheduled for June 18-19 2020, Valencia, Spain. Impact Cancer 2020 invites all the participants from all over the world which includes prompt Keynote talks, Oral talks, Poster presentations, Sponsor Ships and Exhibitions. The aim of this conference is " Inspiring Innovations and Advanced Practice in Cancer Care ". Impact Cancer 2020 is comprised of many interactive scientific sessions as well as various diagnostic and therapeutic advancements in cancer. It is an initiative to unite the diverse research and business communities working in this field under a one roof to explore every single aspect of oncology. Importance & Scope: Impact Cancer 2020 will be the best platform for all the oncologists, hematologist's, research scholars, students who are working in this field to exchange their knowledge related to Oncology Research. This international event is an effort to understand the underlying biological procedures which are amended to increase effectiveness, precision, survivability and quality of life. Impact Cancer 2020 is the premier event that brings together international experts, Training Institutes, Manufacturing Medical Devices Companies, Business Entrepreneurs, Medical Colleges, Researchers, Academicians, Physicians, Post Docs, Students, Pharmacy Industries, Academic scientists, Industry professionals, Diagnostic laboratory professionals and decision makers across the globe to exchange their knowledge, experience and research innovations to build Cancer Research scientists to reduce the global burden of cancer. Attendees will include: Academicians, Oncologists, Radiologists, Chemotherapists, scientists, clinicians, researchers, world Doctors, Health practitioners, Pharmaceutical organizations, Clinical Research organizations. Associations and Societies sponsoring the meeting and looking for collaborative partners. hospitals sharing their novel researches in the arena of Nursing (exhibiting). Policy and decision makers with disciplines in the field of Radiation Therapy and chemotherapy, nursing stakeholders including academic researchers and entrepreneurs, industry policy makers. IMPACT conferences attract participants representing more than 53 countries around the world. IMPACT Executive Program: If you are a young scientist who is interested in dementia care and wishes to exchange ideas with industry experts, the IMPACT EXECUTIVE PROGRAM may well be the event for you. It is a 2 days’ event held in parallel to the conference, tailored around Stem cell and its advances. This program provides a unique opportunity to meet like-minded individuals and share the insights of the world's foremost specialists in Oncology innovators.

188

[90] Fuzzy Logic Controller for Parallel Plug-In Hybrid Vehicle, Panel Registration, 3rdInternational Conference on Industrial Engineering and Operation Research, 3rd International IE Conference on New Challenges in Industrial Engineering, Operations Research and Management in Istanbul, on February 11th, 2020. Canadian Institute for Knowledge Development (CIKD) is an international, multidisciplinary research, publishing, consulting and training non-profit institute which is one of the most expert institutions of its kind. It is committed to organizing and developing educational events and conferences in different fields. It also encourages who wish to participate in academic conferences, and publish in peer-reviewed journals. CIKD also has in-depth activities related to publishing academics journals and proceedings. This institute also develops quality business and finance research. In this filed the institute aims to provide educators, business leaders, and public- sector decision-makers with applied and in-depth research in the fields of business trends in general and economy, finance, information technology and marketing and in particular. The research which is being conducted by CIKD specialists results in some certain outcomes which are very helpful for business leaders, state and local government agencies, public and private researchers, industrial organizations and chambers of commerce. This institute also holds series of courses with the highest academic and applied qualification available, especially in the fields of business, economy, finance, marketing, research methods and information technology. We plan to provide solutions in our training programs which will allow learners the opportunity to learn how to solve the real -world problems and achieve new skills. Mission: Our mission is to expand, deepen and spread knowledge, understanding and expertise in different fields of science. We are committed to facilitate the required conditions for new knowledge dissemination, promote brilliant ideas, and provide high quality services to expand relationship between the researchers, technicians, businessmen, and entrepreneurs. Canadian Institute for Knowledge Development aims: To identify new areas of study and research which is needed for development, To offer the opportunity to create and expand network with other professionals and generate ideas to keep experts on a leading position in the competitive world, To create a conductive environment for knowledge and experience sharing, To offer efficient solutions for sharing scientific and experimental findings in various fields, To conduct world class research and to offer holistic and realistic consultancy services, To work effectively with universities, institutions and organizations, in order to conduct outstanding research and

189 trainings; To provide comprehensive, holistic, high-quality and evidence-based trainings which nourishes strengths of learners in a diverse and inspiring environment.

[91] Honorary Keynote Speaker at 2nd International Conference on Clinical & Pharmaceutical Microbiology, 22-24, September 2020, Theme: Fostering the Advances in Clinical Microbiology and Pharmaceutical Science, Paris, France, Magnus Corpus has come into being with the mission to promote conference, events, seminars, and open discussions based on different fields of science and technologies globally. This conference discusses how best the benefits and fruits be carried over to every human being across nations and make the world a better place to live in. After a warm and glorious completion of Microbiology 2019, it takes immense pleasure in honouring you back to cherish your moments In 2nd International Conference on Clinical and Pharmaceutical Microbiology which is to be slated in September 22nd -24th, 2020 at Paris, France. We welcome all the participants across the globe with the theme Fostering the Advances in Clinical Microbiology and Pharmaceutical Science to widen your scientific research in the field. Our conference provides you with the platform to witness the lead gathering of presidents, vice presidents, head of the departments, scientists, researchers, faculties, business entrepreneurs, delegates, industrialists, students and young researchers across the world. It fabricates the best opportunity to propose your research in the form of keynote presentations, poster presentations, oral talks and exhibitions and to explore information with current potential and eminent scientists. Microbiology 2020 also adheres the industrialists and academicians in the field of Microbiology, pharmaceutics, Molecular Biology, Pathology, Infectious Diseases, Immunology and more to transverse your brainstorm and impression. The major focus of this congress is to enhance and support the research work and to exchange the ideas and methodologies among eminent speakers and researchers. We are very much excited to gather you all in one place to attend Microbiology 2020 in the heartbeat city of Paris. Explore the evidence to make the difference!

[92] Honorary Keynote Speaker at World Congress on Infectious Diseases, Holiday Inn Rome Aurelia Via Aurelia, Km 8.400, 00165 Rome, Italy, Contact Info: Phone : 1 (702) 988 2320, Toll Free: 1800–883-8082, WhatsApp: +1 804-876-0431, Email: [email protected], June 22-24, 2020 | Rome, Italy, Magnus Group takes the pleasure to announce “World Congress on Infectious Diseases”

190

(WCID 2020) during June 22-24, 2020 at Rome, Italy. Infectious Disease conference will provide all the attendees, the opportunity to network with experts, present their research findings to an international audience and notify the latest scientific developments from world’s eminent speakers and contribute to various discussions that will shape future health policies and a proper patient care all around the world. The Conference will have a mix of lectures of keynote addresses, panel discussions, case discussions, current reports of scientific progress featured in oral abstracts and posters. The chosen topics will be of great benefit to practicing clinicians and academicians in the field of infectious diseases, medicine, microbiology, epidemiology, public health, critical care, pulmonology, pharmacology, pathology, pharmacy, nursing, and clinical research. This conference offers an opportunity for faculty, postgraduates, fellows, residents, and undergraduates to present their work, learn and network with the experts. Major Speech: Discovering new insights for a disease free life. URL: https://infectious-diseases-conferences.magnusgroup.org/.

[93] Honorary Keynote Speaker at Functional and Healthy Foods for Longevity: Bioactive Compounds and Biomarkers in Age-Related Diseases, 28th International Conference of FFC - 16th International Symposium of ASFFBC, August 28-29, 2020, San Diego Convention Center, San Diego, CA, USA. About the Functional Food Center: The Functional Food Center (FFC) is the leading organization in the world for evaluating functional food products and educating public in Functional Food Science. The primary goal of the FFC is to educate physicians, health professionals, researchers, scientists, students, and the public on the health benefits of functional foods and food bioactive compounds to increase their knowledge in this specific field of science. For these reasons, FFC organizes annual international conferences, publishes textbooks and research articles, as well as writes informative newsletters promoting these events and accomplishments. Since 1998, FFC has hosted 27 international conferences around the globe, upheld an open-access journal for more than 7 years, published more than 30 books including 7 textbooks on functional food science and establishing the Academic Society of Functional Foods and Bioactive Compounds (ASFFBC) with more than 3,000 scientists. URL: https://www.functionalfoodscenter.net/.

[94] Fourteenth International Conference on Computational Structures Technology & Eleventh International Conference on Engineering Computational Technology 2020, 8-10 September 2020 | Palma, Mallorca, Spain Submission ID: 90,

191

Conference: CST 2020, Title: Investigation on the effect of cold drawing process on mechanical properties and structure of seamless steel (Ck60) tube, Copyright © 2018 Elsevier B.V., Powered by Oxford Abstracts. This is the fourteenth conference in the Computational Structures Technology (CST) series that commenced in 1991. The conference is concerned with the application of the latest computational technology to structural mechanics and engineering. Computational technology encompasses both the latest hardware and software developments as well as algorithmic and theoretical techniques. The conference is also concerned with both theoretical, mathematical and scientific developments as well as applications of established technology to new domains. The word 'structures' is interpreted in its widest sense. The conference runs concurrently with the Eleventh International Conference on Engineering Computational Technology (ECT). Participants may attend sessions from either conference. The CST2020 Conference will be opened jointly with the ECT2020 Conference with a lecture presented by Professor Klaus- Jürgen Bathe of Massachusetts Institute of Technology, USA. History: This is the fourteenth conference in the Computational Structures Technology series that commenced in 1991. Previous events have been organized by Civil Comp Press. Previous venues for the conference have included: Edinburgh, Prague, Leuven, Lisbon, Gran Canaria, Athens, Valencia, Dubrovnik, Naples and in 2018, Sitges near Barcelona. URL: http://www.cstconference.com/.

[95] Keynote Speaker at International Conference on Material Science” which is going to be held during April 20-21, 2020 at Paris, France. https://materialscience.averconferences.com/.

[96] Keynote Speaker (Speech: EFFECT OF WIND-STRUCTURE INTERACTION ON LONGITUDINAL RESPONSE OF TALL BUILDINGS) at International Conference on Material Science, Paris, France on April 20-21, 2020. The conference will focus on “Future Enhancement and Innovative Approaches in Materials Science”. URL: https://materialscience.averconferences.com/. “International Conference on Material Science” which is going to be held in Paris, France on April 20-21, 2020. The conference will focus on “Future Enhancement and Innovative Approaches in Materials Science” We promise you an exciting and informative scientific program that will be both broad and varied, encompassing prompt Keynote Presentations, Breakout Sessions, Workshops, Symposiums, Oral talks, delegates, Poster Presentations, and Exhibitions by world-renowned experts.

192

The program will feature with a 21 variety of topics, enabling you to tailor the program specifically to your own interests and clinical practice. Professors, Researchers around the globe will showcase their research work and will light up the way wherein Men, Women, and Children of all demographics can be Enhancement and Innovative Approaches in Materials sciences. We look forward to meeting you all in Paris in April 2020 for one of the best scientific gatherings in the region. Invited by Naveen | Program Director, ICMS 2020. Email: [email protected].

[97] Keynote Speaker at 4th Edition of International Cancer Conference” during September 14-15, 2020 at Paris, France., https://magnusconferences.com/cancer- oncology/. Campanile Roissy-En-France Hotel, Roissy Park Activity Area - Allee Des Vergers 95700 Roissy In France, Magnus Group welcomes participants from different parts of the world to join “4th Edition of International Cancer Conference” scheduled during September 14-15, 2020 at Paris, France. It includes interesting Keynote presentations, Oral presentations, Poster presentations, Workshops and Exhibitions where you get a chance to interact and learn. This is going to be one of the most remarkable events of the year. Our Theme: Cancer Free World - Possible or Not celebrates our achievements and examines current and future challenges and celebrates the diversity of our health care system. ICC 2020 goal is to bring together bright minds to gives talk that are ideas-focused, and on a wide range of scientific sessions, to faster learning inspiration. It will provide an international platform to share expertise, foster collaborations, discover new clinical information, stay updated with recent trends and advances in the field of cancer and oncology. Upcoming Cancer Conferences: Cancer Conferences 2020 | International Cancer Conference | Cancer Conference 2020 | Oncology Conferences. Email: [email protected]. Phone: 1 (702) 988-2320.

[98] Honorary Keynote Speaker at on September 03-04, 2020 in Madrid, Spain, Neuroscience and Neurology are allied fields of study and treatment. Neuroscience deals with the study of the physiology, structure, function, diseases and genetics related to central nervous system. The focus of neurology is on the diagnosis and treatment of disorders and diseases of the central, peripheral and autonomic nervous systems. These fields are advancing rapidly and today neuroscientists and neurologists around the world work alongside industry to advance and develop new diagnostic and treatment methodologies involving cutting edge laboratory tests and

193 state of the art imaging technologies. NeuroTalks brings together scientists, academics, physicians, entrepreneurs, and specialists from industry to share the same stage as they discuss topics ranging from neuro-immunology and oxidative stress, to neuro-informatics and the latest Alzheimer’s disease evidence. Where better to spend an exciting time exchanging and learning new knowledge? Madrid is a lively, friendly, cosmopolitan city – a place where business and the latest trends in food and fashion meet and blend with ease. It’s a city that promises an enjoyable and rich experience with its artistic heritage, modern transport network, quality accommodation options, excellent cuisine, and vibrant and safe night life. Welcome to NeuroTalks. URL: https://www.theneurotalks.com/.

[99] Keynote Speaker at 4th Edition of Global Conference on Pharmaceutics and Novel Drug Delivery Systems, June 15-17, 2020 | Rome, Italy, Conference Venue: Holiday Inn Rome Aurelia, Via Aurelia Km 8.400, 00165, Rome, Italy. Contact Info: Phone: 1 (702) 988 2320, Toll Free: 1800–883-8082, WhatsApp: +1 434 381 1007, Email: [email protected]. PDDS 2020: Magnus Group with great pride and honour announcing its "4th Edition of Global conference on Pharmaceutics and Drug Delivery Systems" (PDDS 2020), which is going to be held in Rome, Italy During June 15-17, 2020. PDDS 2020 serve as a podium for the interaction between experts in the areas of pharmaceutics, drug delivery, nanomedicine, biotechnology, and nanotechnology around the world and aims in sharing some unique research and translational studies on various advances in the related fields. The conference opens the doors for many researchers in academia, clinicians, and industry representatives working in these exciting areas. It is expected to bring together both reputable scientists in advanced stages of their career and young researches from many related disciplines. The conference expects many new ideas to emerge at the interfaces between disciplines aiming to solve the most important problems relating to the health and wellbeing of the humanity. URL: https://pharmaceuticsconference.com/.

[98] Honorary Keynote Speaker at 3rd International Conference and Exhibition on Pharmaceutical Nanotechnology and Nanomedicine " scheduled on February 24-25, 2020 at Rome, Italy. Invited by: Richard Gilbert | Program manager, 47 Churchfield Road, W3 6AY,London, Email : [email protected], What’s App at: +441639288009.

194

[99] Organizing Committee Member of 5th Global Conference on Pediatrics and Neonatology, December 17-18, 2020 | Istanbul, Turkey. The 5th Global Conference on Pediatrics and Neonatology will be held from December 17-18, 2020 in Istanbul, Turkey. Organized by Scientific Federation, the conference will open new doors for the global scientific and research community to focus on future advancements in these fields. The conference is organized around the theme and will witness specialists around the globe taking interest in novel strategies and techniques used in practice today in pediatrics and neonatology. Several inspiring and educating academic sessions, workshops, plenary talks, keynote speeches, oral and poster presentations, technical workshops and social gathering will all add to the future advancements in neonatology and pediatrics and discuss more about the course of research in these subjects. The aim of the conference is to propagate knowledge about life sciences and medical sciences and create new information about the procedures and apparatuses used in general. The scientific sessions and tracks form major part of the conference that will enable participants to share their latest research results and to involve in peer-to-peer discussions with students in related fields from all over the world. The gathering will set the stage for pediatricians, medical care specialist, early-career researchers, healthcare practitioners, pediatric surgeons, and professionals from industry and academia to share their experiences and exchange perspectives to unfold new knowledge in pediatrics and kids’ health for the advantage of communities and also for advancements in business. Numerous programs including comprehensive lectures, workshops on session topics, poster displays, exhibition and other social events will make this meeting more educating, energizing and engaging. We hope this conference will provide a wonderful forum to refresh your knowledge base and explore innovations in pediatrics and neonatology and will be a stimulating occasion both socially and scientifically. URL: https://www.scientificfederation.com/pediatrics-neonatology-event/.

[100] Plenary Speaker at Scholars International Conference on Advanced Materials and Nanotechnology, THEME: "Current and Emerging Trends in Materials Research and Nanotechnology". 01-02 Jun 2020, Orlando, FL. About Conference: Scholars Conferences is proud to announce the Scholars International Conference on Advanced Materials and Nanotechnology, which is to be held during March 23- 24, 2020 and Orlando, Florida, USA. On this great gathering, Organizing Committee invites participants from all over the globe to take part in this annual conference with

195 the theme “Current and Emerging Trends in the Field of Materials Science and Nanotechnology”. Advanced Materials 2020 aims at sharing new ideas and new technologies amongst the professionals, industrialists and students from research areas of Advanced Materials and Nanotechnology to share their recent innovations and applications and indulge in interactive discussions and technical sessions at the event. The Conference will also have a space for companies and/or institutions to present their services, products, innovations and research results. Advanced Materials and Nanotechnology involves the tracks like Advanced Materials and Functional Devices, Engineering Materials, Composite Materials, Magnetism & Multiferroism, Optical materials and plasmonics, Energy and Harvesting Materials, Nanotechnology-Basics to applications, Nanopore science, Nanomedicine, Bio Nanotechnologies, Carbon nanostructures and graphene, Spintronics, Nanoparticle synthesis and applications. About Organization: Welcome to Scholars International, a leading organization where the search ends for the diversified International Meetings and Conferences. With the accountability of service, uniqueness, and dependability, we seek to provide a highly enthusiastic ambiance for exploring and unveiling the Research, Business and Edu-tech oriented skills to our global attendees. Endorsed with various scientific societies and medical accreditation council, Scholars International Organizes International Conferences & Expo’s in USA, Europe & Asia Pacific zone, critically covering and valuing every prospect and avenues in the fields of Life Sciences, Pharmaceutical Sciences, Healthcare, and Engineering. With the acknowledgement of all the original and contemporary works and discussions in the associated streams like Medical, Clinical, Nursing, Nanomedicines, Drug Delivery Oncology, Dentistry, Neuroscience, Pediatrics, Pathology, Microbiology, Chemistry, Physics, Environmental Sciences, Materials Sciences and many more, Scholars International entertains and encourages the Global research fraternity with its variant and dynamic features, and providing them the most professional and conventional decorum. URL: https://scholarsconferences.com/advancedmaterials/about-conference.

[101] Honorary Speaker at SciTech Central Pharma 2020. Pharmacology & Drug Development Congress. Palms Hotel, Mauritius, April 27-28, 2020. Pharmacology Conferences 2020 and Drug Development Congress 2020 is an annual event scheduled during April 27-28, 2020 at Mauritius, hosting researchers, scientists, students, workshop & symposium organizers, industrialists, companies, exhibitors,

196 sponsors, media partners, oral & poster presenters from all over the world. It is an International Platform to promote ideas and exchange knowledge on various topics in the field of Pharmacology, Toxicology, Drug Development and innovations. URL: https://www.scitcentralconferences.com/details/pharmacology-drug- development-congress.

[101] Keynote Speaker about Explanation of how do individuals with multiple sclerosis cope with social isolation, The 4th International Biotechnology Congress (IBC-2020), Time: Nov. 9-11, 2020, Place: Dubai, UAE. IBC-2020 is a dedicated event where you will have the opportunity to learn about new developments in the field of Biotechnology, Gene and Life Sciences, and share aspects of your own work by submitting a poster or oral presentation. With the participation of outstanding international experts, we hope productive discussions would stimulate new creative ideas to translate new discoveries into better practice and application. IBC-2020 continues to expand with magnificent scientific and social programs to maximize your network in a free communication meeting environment. We create a great platform to researches, scientists, academicians and industry experts to share experiences, discuss research findings and acquire the desired knowledge for practical exercise. Invited by: Ms. Sophie Yu, Organizing Committee of IBC-2020, Tel: 0086-411-84799606, Fax: 0086-411-84799629, Email: [email protected], https://www.bitcongress.com/ibc2020.

197 knowledge and their research outcomes and help the modern world to get the maximum utilization of knowledge. WHAT WE DO: SciTech Central Conferences invites participants for the events related to various fields across the world to get their research work showcased at an International platform. The SciTech Central Conferences is making its mark in the world of researchers and analyst, inventors and inventions, science and education, business and economics, health and medicine and many more by providing details of related events, seminars and conferences. The concept of these events is basically to exchange knowledge and share the research experience on a stage where scientists & researchers from different parts of the world gather to aware the society regarding the recent advancements & breakthroughs in the field of science and technology. SciTech Central Conferences’ uniqueness is manifested in its technological flexibility and the implementation of innovative technologies. WHY SCITECH: Lead by young and innovative team, the company has a winning combination of people with vast experience in the field of research and development. The result is a path-breaking knowledge that provides participants, the most organized and easy ways to learn and explore. More than that, the attendees in the conferences and events will acquire knowledge that will potentially improve the benefits of their participation in the event, or making business connections. Our conferences include an abstract collection and conference plan building system, coordination of meeting calendars between participants, a conference application for management optimization, pre-registration via registration forms & landing pages and maximizing conference guests' benefits.

[103] Honorary Keynote Speaker at 3rd International Conference on Physical and Theoretical Chemistry, May 18-19, 2020 Budapest, Hungary. About Conference: Physical Chemistry 2020 Conference Series is now proud to announce the “3rd International Conference on Physical and Theoretical Chemistry” during May 18- 19, 2020 Budapest, Hungary. Organizing Committee was inviting the participants from all over the globe to take part in this annual conference with the theme “changing the World by Exploring the Emerging Trends in Physical and Theoretical Chemistry”. Physical Chemistry 2020 aims at sharing new technologies and new ideas amongst the students, professionals and industrialists from research areas of Physical chemistry, thermochemistry, surface science, geochemistry, astrochemistry to share their recent changes and applications in various fields and indulge in interactive discussions and technical sessions at the event. The Conference was also

198 providing a space for institutions and/or companies to present their research results, services, products and their innovations. Theme: "Changing the World by Exploring the Emerging Trends in Physical and Theoretical Chemistry" - Physical Chemistry 2020. Website: https://physicalchemistry.alliedacademies.com/.

[104] Organizing Committee Member at 3rd International Conference on Physical and Theoretical Chemistry, May 18-19, 2020 Budapest, Hungary. About Conference: Physical Chemistry 2020 Conference Series is now proud to announce the “3rd International Conference on Physical and Theoretical Chemistry” during May 18-19, 2020 Budapest, Hungary. Organizing Committee was inviting the participants from all over the globe to take part in this annual conference with the theme “changing the World by Exploring the Emerging Trends in Physical and Theoretical Chemistry”. Physical Chemistry 2020 aims at sharing new technologies and new ideas amongst the students, professionals and industrialists from research areas of Physical chemistry, thermochemistry, surface science, geochemistry, astrochemistry to share their recent changes and applications in various fields and indulge in interactive discussions and technical sessions at the event. The Conference was also providing a space for institutions and/or companies to present their research results, services, products and their innovations. Theme: "Changing the World by Exploring the Emerging Trends in Physical and Theoretical Chemistry" - Physical Chemistry 2020. Website: https://physicalchemistry.alliedacademies.com/.

[105] Comparison of classical and ultrasound-assisted extraction methods on antioxidant activities of pharmaceutically active compounds from Valeriana officinalis, 2nd International Conference on Traditional Medicine and Nutrition being held at Paris, France in the month of September from 22-24, 2020. Website: https://cellscience.magnuscorpus.com/organizing-committee.

[106] Webinar, Topic: Gen2Gen Innovation Showcase, Description: Come hear Encore.org's five new Gen2Gen Innovation Fellows / Early Childhood share their big ideas (in fast-pitch style) for leveraging the talents of older adults to improve the care and education of children 0-5. You’ll also have the chance to hear from Encore.org CEO Marc Freedman, ask questions, and connect with fellows afterwards. Time: Feb 12, 2020 11:00 AM in Pacific Time (US and Canada),

199

Webinar ID: 432-086-869. Honorary Invited by: Janet Oh, Director of Innovation Fellowships, Encore.org.

[107] Organizing Committee Member of 2nd International Conference on Traditional Medicine and Nutrition, 22-24, September 2020, Theme: Contemporary Advancements and research in Traditional Medicine and Nutrition, https://traditionalmedicine.magnuscorpus.com/organizing-committee. Hotel Name: Hyatt Regency Paris - Charles de Gaulle, Address: 351 Av. Du Bois De La Pie Cs 42048 Paris, Nord 2 Cedex, 95912 Roissy-en-France, France.

[108] Keynote Speaker at conference “Hematology World Forum” being held in Bucharest, Romania from December 04-05, 2020. https://www.continuumforums.com/hematology-2020/, About Conference: Hematology World Forum is anticipated to be the most comprehensive event bringing together top minds in this field for an invaluable educational experience. Scheduled to be held in Bucharest, Romania during December 04-05, 2020, the forum will provide an invaluable educational experience and will highlight updates in the hottest topics in hematology. The theme of the conference is “Renewing Enthusiasm to respond to the Complex Needs of People” and will encompass various aspects of hematology research. The conference will serve as a global platform for researchers, scientists, students, clinicians, healthcare professionals, industry experts, policy makers, members of scientific institutions and academic professionals with an active interest in hematology research. The meeting is also a great place to introduce new participants to the field of hematology and to highlight new and innovative tools and approaches. This two-day event will provide a global platform for all the participants for the exchange of ideas and facilitates formation of new work groups which work towards providing better outcomes for the communities worldwide. It will include several keynote presentations, oral talks, poster presentations, oral presentations, discussions, exhibition, technical workshops, breakout sessions and other social events that promote networking opportunities among the participants. The organizing committee has further assembled an outstanding group of speakers who will provide both established and budding researchers with a unique platform to interact with professionals and build collaborations with established industries to create an exciting and interdisciplinary exchange among the participants from different verticals to learn from each other and foster new collaborations for the betterment of societies across the world. We

200 hope this exciting forum will deliberate and discuss all the facets of hematology and facilitates information exchange for the advance of research in this field.

[109] Keynote Speaker at Global Congress on Infectious Diseases and Clinical Microbiology, June 25-26, 2020 in Toronto, Canada. Infectious-Diseases-2020 anticipates more than 300 participants around the globe with thought provoking plenary sessions, keynote lectures, Oral Presentations and Poster Presentations. The attending delegates incorporate Editorial Board Members of related International Journals. This is a magnificent opportunity for the delegates from Universities and Institutes to interact with the world class Scientists. This will bring together world leaders in their respective fields in the fascinating environment of Toronto, Canada. Infectious-Diseases-2020 Conference is to explore on Current Issues of Innovative Approach and Novel Technologies in Prevention and Control of Infectious Diseases. The aim of the Infectious-Diseases-2020 is to promote quality research and real- world impact in an atmosphere of true international cooperation between scientists by bringing together again the world class researchers, International Communities and Industrial heads to discuss the latest developments and innovations in the fields of clinical microbiology with colleagues from different countries and other parts of Canada. Conference: Objectives: To ease opportunities for networking, collaboration and exchange of ideas with internationally renowned leaders in infectious diseases and clinical microbiology. To identify research and practice based innovations in optimizing Infectious diseases research and development. To debate gaps and priorities for sustainable development in optimizing Infectious Diseases and Clinical Microbiology research and development. To discuss and debate the challenges and opportunities in the new era of optimizing Infectious Diseases and Clinical Microbiology research and development reforms. To identify opportunities for evidence-based practice in optimizing Infectious Diseases and Clinical Microbiology research and development. Conference Website: http://scientificfederation.biz/infectious-diseases-2020/. Speakers URL: https://www.scientificfederation.com/infectious-diseases- 2020/speakers.php.

[110] Keynote Speaker at International Conference on Structural Biology and Mass Spectrometry, Theme: A Distinctive Outlook in Structural Biology Research, June 22-23, 2020. Hotel Mercure Roma West, Viale Eroi di Cefalonia, 301, 00128 Roma RM, Italy, Coalesce Research Group cordially invites you to attend the prestigious

201 event International Conference on Structural Biology and Mass Spectrometry during June 22-23, 2020 at Rome, Italy. The main theme of the conference is "A Distinctive Outlook in Structural Biology Research". Structural Biology 2020 scheduled for two-day event will be a global platform for sharing information and ability from both scientific and industrial group. The meeting goes for uniting the academicians, scientists, instructors, business pioneers, investors and young researchers to a global stage where they can showcase their novel research and contributions in the field of structural biology and its allied research. Abstract Submissions and Registrations are going on for this upcoming conference Structural Biology 2020.

[112] Invited Speaker at 3rd International Conference on Materials Research and Nanotechnology conference during June 22-24, 2020 in Osaka, Japan; with the theme Materials Science-Nanotechnology: Cutting edge of Scientific discovery. ICMRN-2020 Meeting serves as an international arena for the assessment and dissemination of current and emerging Materials Science and Nanotechnology research. At this ICMRN meeting, researchers from all scientific fields, backgrounds and employment sectors—from students to eminent scientists— converge at this event to exchange technical information, engage in broader impact programming, network with friends and colleagues, and contribute to the advancement of materials Science and Nanotechnology. ICMRN-2020 will present recent breakthroughs, high-impact scientific and technological advances in Materials Science and Nanotechnology. It delivers unlimited opportunities for making business deals, product enhancements, cutting edge solutions for improving and elevating research profiles. ICMRN-2020 provides an unique platform for all the leading professionals and will feature a plenary session, Keynote session, parallel topical sessions, and poster session, Mark your calendar today and plan to attend. We bring the globally immense information from Materials Science, Graphene and Nanotechnology fields under one roof with diversified Knowledge oriented scientific sessions which widen professional contact and create new opportunities in the ocean of knowledge. Come and be a part of this meeting....We are looking forward to seeing you at ICMRN-2020 in Osaka, Japan. https://phronesisonline.com/materials-research-conference/.

[113] Event Details at a Glance: Date: Thursday, February 20, Time: 5:30-7:30 p.m. Location: IDENTIV, 1525 Wilson Blvd., Suite 225, Arlington, VA 22209, COMPLIMENTARY SECURITY INDUSTRY NETWORKING, SIAThere! is a

202 complimentary security industry networking event. SIA is coming to you with a series of free networking events known as SIAThere! You're invited – whether you are a SIA member, a company that wants to learn more, or a security practitioner that would like to network. As a series of industry-wide FREE networking gatherings, SIAThere! events bring a mix of the security industry: SIA member companies, manufacturers and solution providers, integrators, installing companies, consultants, IT and physical security managers. https://www.securityindustry.org/upcoming-events/sia-there/siathere-washington- dc-feb-20/.

[114] Speaker/Delegate at revered 3rd European Pathology Congress scheduled on July 20-21, 2020, Paris, France. https://www.meetingsint.com/conferences/europathology. Theme: To Spotlight the Innovations in Pathology, About Euro Pathology 2020. 3rd European Pathology Congress will be held during July 20-21, 2020 in Paris, France. The main theme of the Conference is " To Spotlight the Innovations in Pathology " which covers a wide range of critically important sessions. Euro Pathology 2020 will be a creative and strengthening International gathering representing the course of pathology in the 21st century in a protected yet energizing condition that offers an extensive variety of preoccupations to members of all foundations. This meeting gives a splendid chance to talk about the most recent advancements latest developments within the field. Euro Pathology 2020 will concentrate on the most recent and exciting innovations in every aspect of research offering an interesting opportunity for pathologists across the globe to meet, arrange, and discuss new logical advancements. On behalf of the Organizing and Advisory Committees we take great pleasure in welcoming pathologists, scientists, researchers, professors, research scholars, students and experts of application fields to attend 3rd European Pathology.

[115] Honorable Speaker at 13th World Congress on Nursing and Health Care” scheduled from March 16-17, 2020 at Berlin, Germany The Conference deliberations will be on the following themes: “Explore the New Horizon in Nursing and Health Care”. Note: On conformation as a speaker to the Nursing and Health Care 2020 we are happy to provide free stay of 2 nights in the Berlin, Germany during the congress (T&C Apply). About Nursing Healthcare 2020: We are overwhelmed to welcome you to participate in “13th World Congress on Nursing and Health Care” held during March 16-17th, 2020 in Berlin, Germany with a theme

203

“Exploring the New Horizon in Nursing and Health Care”. We take an extraordinary joy welcoming nursing understudies, specialists, staff, senior members, doctors, medicinal services experts for taking an interest in the "Nursing-Healthcare-2020" forthcoming for sharing thoughts, investigate the problems and build their answers through the workshops, oral and publication introductions. It is a global stage for uniting people of various fields of nursing like cardiovascular, pediatric and crisis nursing and specialists to work together on issues influencing nursing and social insurance examine about the advancement in the nursing field and to share their encounters by the eminent scientists through the world. This conference provides delegates the chance of meeting and interacting with the nurses starting from students, deans, professors and alternative nursing college from around the world. Attend the foremost necessary sessions regarding the problems effecting medical aid related to Nursing and Health care.

[116] Honorable Delegate/Speaker at International Conference on "Tissue Engineering and Regenerative Medicine" which will be held in September 18-19, 2020 in Paris, France carries with the theme “Advancement in Tissue Engineering and Regenerative Medicine”. URL: https://magnusconferences.com/tissue- engineering/. Office: +1 (702) 988-2320, Toll Free: 1800–883-8082 (USA & Canada), What’s App: +1(804) 876-043, Email: tissue- [email protected], Twitter: @TERMC2020, ------1033 Sterling Rd, Unit 104, Herndon, VA 20170, USA. About TERMC 2020: We are pleased to announce the International Conference on Tissue Engineering and Regenerative Medicine on September 18-19, 2020 at Paris, France. The TERMC 2020 is a two- day conference bringing together the entire cell and tissue engineering community from major European city and other countries. Covering a wide range of scientific topics from regenerative research and tissue engineering methods, this program will feature expert-led panels, exclusive networking opportunities following with the dedicated presentations focusing on the emerging field of Regenerative Medicine. TERMC 2020 aims to bring together the leading academic scientists, researchers and clinicians and physical therapists to exchange and share their experiences and research results on all aspects of Regenerative Therapies and Tissue Engineering approaches. The main agenda is designed to create a platform for bridging these areas of expertise in a setting that fosters conversations, interaction, cross-discipline pollination and networking.

204

[117] Honorable Organizing Committee Member of Global Public Health Management sector is projected to reach a market value of US$ 86.3 billion by 2024 with a compound annual growth rate of 25%. Increasing demand for efficient patient care systems, disease management programs, adoption of healthcare information technology and the need to opt for cost-effective treatment options are some of the primary factors affecting the growth. Further research in public health and healthcare management examines possible initiatives to improve healthcare infrastructure. To facilitate discussions on a wide range of topics related to improving Public Health, OLC International is organizing its 3rd International Conference and Exhibition on Public Health and Health Care Management – OLCPHHM-2020 – which will be held from November 09-10, 2020 in Vienna, Austria. The event invites all public health professionals, students, policy makers, health care specialists, health care workers, health economists, eminent researchers, scientists, social workers and other related professionals to share their work and experience with others to move public health research into policy and practice. It includes several keynote lectures by eminent speakers, plenary speeches, workshops, discussions, exhibits, and video and poster presentations showcasing new learning about public health industry. This highly exciting and challenging conference intends to be a forum and networking place for professionals from academic and industry backgrounds to network with each other and share their achievements and strategies to enhance their career and business goals for better outcomes in Public Health research. We hope OLCPHHM- 2020 will help attendees in gaining new knowledge and skills in their research areas by providing unlimited resources and opportunities. We look forward to welcoming you at OLCPHHM-2020 in Vienna, Austria.

[118] Honorable Delegate/Speaker at “16th International Conference on Nursing Education and Practice”, scheduled on March 16-17, 2020 in Berlin, Germany. This conference will examine research development both locally and internationally. On conformation as a speaker/Delegate to the Nursing Education 2020 we are happy to provide you the registration price only for 299 Euros (T&C Apply), https://www.meetingsint.com/conferences/nursing-education, Invited by: Hannah Florentia, Program Manager, Nursing Education 2020, [email protected]. Hannah Florentia, Program Manager, Nursing Education 2020, [email protected]. About Nursing Education 2020: Meetings International extends its welcome to “16th International

205

Conference on Nursing Education and Practice” scheduled on March 16-17, 2020, Berlin, Germany with a theme of “Innovative ideas and Approaches in Nursing Education”. This global meeting will provide a distinctive forum to meet eminent personalities and experience inspiring talks in the field of Nursing and there will be a great affiliation of healthcare scientists, professors, nurse practitioners, health care researchers, nurse associations, registered nurses, doctors, and faculty of nursing during exciting round table discussions, question-answer sessions and unique poster presentations which will help in modernization and advancement of nursing education and Practice. Nursing Education 2020 Conference offers a number of unique opportunities to enrich your career. You can learn new approaches to clinical practice, fine-tune your skills, work with state-of-the-art technology and learn from professionals at the forefront of medical advance everyone who seeks to improve their institution's nursing program and learn about advanced technical skill is invited to register. We promise that attendees return to their hospitals energized to improve their nursing practice and equipped with proven methods to do so. This conference advances the specialty practice of nursing professional development for the enhancement of healthcare outcomes. Meetings International Nursing Education 2020 Conference will offer you an unmatched attendee experience. Join us in Berlin to learn about innovative educational strategies you can apply in your work setting and connect with a network of nurse educators representing academics, staff development, and continuing education.

[119] Organizing Committee Member and Honorable Speaker at “Annual Summit on Infectious Disease & Healthcare” scheduled on May 22-23, 2020 at Paris, France. About Infectious Disease 2020: Annual Summit on Infectious Disease & Healthcare is the main gathering where you can find out about Infectious Diseases from an assortment of points of view, both research-based and clinical. We will examine the freshest remedial methods and analytic devices just as the most exceptional research on hereditary, etiology, indicative, clinical viewpoints and novel treatments of Infectious sicknesses. Worldwide Infections Conferences furnishes an opportunity to work together with industry peers and find learning and assets that can be utilized to accomplish your own and authoritative objectives. It is a stage for, (Doctors, researchers, understudies, modern and Pharma experts) to uncover their examination work, to Share their insight in Infectious sicknesses. It is a chance to communicate with individuals over the globe concentrated on finding out about Infectious.

206

Incredibly famous speakers, the latest treatments and the most recent updates in Infectious are signs of this meeting. URL: https://www.meetingsint.com/conferences/infectiousdisease, Infectious Disease Conference 2020, 28 MAXWELL ROAD, #03-05 RED DOT | TRAFFIC, SINGAPORE (069120), CONTACT: Contact + 6531654890/ + 441974510006.

[120] Keynote Speaker at 3rd Global Summit on Metabolomics and Enzymology, Theme: Recent Trends and Future Challenges in Metabolomics, Metabolomics- 2020 which will be held in Las Vegas, USA from July 13-14, 2020. The theme of the conference is “Recent Trends and Future Challenges in Metabolomics” which focuses on advancements and strategies for better research outcomes. http://scientificfederation.com/metabolomics-2020.

[121] Plenary Speaker at World Congress on Materials science and Nanotechnology (WCMN 2020) to be held at Barcelona, Spain on March 23-24, 2020, Coalesce Research Group, 33 Market Point Dr, Greenville, SC 29607, USA, Phone: +1-718- 543-9362, WhatsApp: +1-315-902-2237, Email: [email protected]. The World Congress on Materials Science will look in to the solutions but not problems. This event will explore the examples and case studies in the field of Materials Science and Nanotechnology. This annual event has been specifically designed to facilitate cross-stakeholder dialogue about providing unified solutions, innovations related to Materials Science and Nanotechnology. This event will gather over 150+ global influencers, Keynote Speakers, private sector CEOs, academia, and healthcare professionals from around the world, why to Attend? To transmit current issues and advances of your latest research. For Thought provoking speeches by Scientists, Professors, Ph.D.'s and Young Researchers. For Exhibition of your Devices, tools, Applications, and Services. For Network development with Academic and Business Professionals, Venue: Hotel SB BCN Events Ronda de Can Rabadà, 22-24, 08860 Castelldefels, Barcelona, Spain. Contact Us: Coalesce Research Group, 33 Market Point Dr, Greenville, SC 29607, USA, [email protected], +1-718-543- 9362, +1-315-902-2237, +1-585-228-6799.

[122] Speaker/Delegate at Global Conference on Complementary, Traditional medicine & Medicinal Herbs” during May 11-13, 2020 in Tokyo, Japan. Moving ahead into the new era Scient Global Conferences would like to extend the arms and

207 heartily welcomes you to the Global Conference on Complementary, Traditional medicine & Medicinal Herbs which is set to hit the calendar on May 11-13, 2020 at Tokyo, Japan. The conference theme is “Green Pharmacy - Sharing a new vision to improvise global health” GCCTMH-2020 plans to provide a platform for all the researchers to share their cup of knowledge & research findings to support the need to discover and learn the efficacy and safety of herbal, traditional and alternative medicine in keeping the population healthy. The conference aims to assemble all the researchers who are involved in diverse disciplines of Traditional Medicine, Complementary Medicine, Alternative Medicine, Traditional Chinese Medicine, Unani Medicine, Acupuncture and more. URL: https://scientonline.org/traditionalmedicine-conferences/index.php.

[23] Keynote Speaker at 11TH WORLD CONFERENCE AND EXPO ON NANOSCIENCE AND NANOTECHNOLOGY, February 18-19, 2021 | Osaka, Japan, About Conference: Following the overwhelming success of our earlier conferences in the series, Scientific Federation is pleased to announce the 11th World Conference and Expo on Nanoscience and Nanotechnology which will be held during February 18-19, 2021 in Osaka, Japan. The theme of the conference is “Recent Advances, Current Issues and Future Applications in Nanoscience and Nanotechnology”. The conference invites nanotechnology researchers, scientists, nanotechnology investors, policy makers, industry experts and members of professional bodies to share their perspectives about the newest interdisciplinary approaches in nanoscience and nanotechnology. It offers wonderful opportunities to all participants to enhance their knowledge and to create new contacts by providing valuable networking time to meet eminent researchers in the field. The congress will emphasize recent works and discoveries involving young researchers who will have the opportunity to gain a compact overview of the field and build new networks by easily getting in touch with celebrated scientists and key opinion leaders in nanoscience and nanotechnology. This international conference seeks to bring together researchers interested in nanoscience and nanotechnology and will offer an opportunity to be inspired by keynote speakers who exemplify excellence in the fields of nanoscience and nanotechnology. And will showcase the latest research at the multidisciplinary frontier of nanostructured materials and devices. It features several plenary talks, keynote lectures, academic discussions, peer-to-peer interactions, invited talks by leading scientists from internationally renowned

208 institutions, and oral poster presentations. It will present the latest research at the multidisciplinary frontier of nanostructured materials and devices and covers several inspiring topics including Nano engineering, molecular nanotechnology, industrial nanotechnology, Nano photonics and optics, advanced nanomaterials, Nano electronic devices and nanomedicine, Nano drug delivery systems and biopharmaceuticals among many others. The conference remains the world’s premier meeting place for eminent scientists, researchers, students, policy makers and professionals from industry and academia to share their perspectives and showcase technological innovations for overall industry excellence. URL: https://www.scientificfederation.com/nanoscience-nanotechnology/.

Scientific Society/Association Membership:

[1] MRSB Member of Royal Society of Biology (RSB) – (Membership Number: P0126512)

[2] Weston A. Price Honorary and Gifted Membership by Mrs. Sally Fallon Morell the President of WAPF.

[3] Member of American Association for Cancer Research (AACR) – Membership ID: 373521

[4] Member of International Society of Infectious Diseases (ISID)

[5] Member of American Institute of Chemical and Biological Engineers. (AIche) – (Membership Number: 9901787645)

[6] Member of International Society for Environmental Information Sciences

(ISEIS)

[7] Member of Royal Biochemical Society, London, Charles Darwin House, (Membership Number: 01077285)

[8] Member of American Association for Advancements of Science (AAAS) - (Membership ID: 41563701)

[9] Member of European Association for Cancer Research (EACR)

209

[10] Active Member of the Society of Federal Health Professionals, and United States Military Medicine (AMSUS) - (Federal Member ID: 98581)

[11] Member of the Risk Management Society (RIMS) – (Membership ID: 002050722I)

[12] Registered Member of the Royal Society of Medicine (RSM), United Kingdom.

[13] AIChE International Student Member

[14] Food, Pharmaceutical, & Bioengineering Division

[15] Member of Forest Bio-products Division

[14] Member of Institute for Sustainability

[15] Member of International Metabolic Engineering Society (IMES)

[16] Member of International Society for Water Solutions (ISWS)

[17] SBE Member

[18] Member of the Royal Statistical Society of England (RSS)

[19] Member of American Society of Clinical Oncology (ASCO),

Membership ID: 701681.

[20] Active Member of International Chemical Biology Society (ICBS).

[21] Member of the Massachusetts Medical Society (MMS).

[22] Member of the European Society of Medical Oncology (ESMO) – Membership Number: 531212

[23] MRSB Member of the Royal Society of Biology, Great Britain. 2018.

[24] Full Member of Pennsylvania Society of Oncology and Hematology (PSOH), Subscription period: 1 year, on: January 1st, Member ID: 47218647

[25] Fellow member of Texas Society for Clinical Oncology, USA, Subscription period: 1 year, on: January 1st.

210

[26] Fellow Member of Northern New England Clinical Oncology Society, Subscription period: 1 year, on: January 1st, Member ID: 47218716.

[27] Member of Florida Society for Clinical Oncology (FLASCO) – 2018 to 2019.

[28] member of American Cancer Society (ACS), American Cancer Society, Inc., 250 Williams Street, Atlanta, GA 30303, Phone: 1.800.227.2345 – Member since 2018 till Present.

[29] Member of Pennsylvania Society of Oncology and Hematology, 777 East Park Drive, PO Box 8820, Harrisburg, PA 17105-8820, (717) 558-7750 phone (717) 558-7841 fax. - Member ID: 47218647, Member since 15 Aug 2018.

[30] Member of Madison County Medical Society, Madison County Medical Society, 3330 L&N Dr. SW, Suite 1, Huntsville, AL 35801, 2018. Phone: 256.881.7321 - Fax: 256.881.7424 - www.madisoncountydoctors.org

[31] Registered Member of Institute of Natural Science and Advanced Technology.

[32] Member of American Physical Society (APS), membership id: 61286398.

[33] Active Member of EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY (ESMO) – Membership ID: 562045

[34] Member of Society for Neuro-Oncology (SN) - Society for Neuro-Oncology, PO Box 273296, Houston, TX 77277-3296. Member ID: 747606

[35] Member of American Institute of Physics, Scitation account number: 000001319438

[36] Member of Society for Free Radical Research Europe (SFRR Europe), Membership ID: 63610

[37] Member of International Chemical Biology Society (ICBS), Membership: Regular Membership, Membership Expiration: 8/27/2019.

[38] Active Member of Society for Free Radical Research – Europe (SFRR), Member ID: 2015.

211

[39] Member of the Society for Science-Based Medicine, A Society for a community of like-minded individuals, both in and out of health care, who support Science- Based Medicine.

[40] Member of MEDSCAPE COMMUNITY, Medscape, LLC, 395 Hudson Street, 3rd Floor, New York, NY 10014.

[41] Member of British Society of Animal Science (BSAS), Member ID: 920190115, 2019-Present.

[42] Full-Time Member of American Red Cross - National Capital Area, Membership Number: 17249835, Website: https://www.redcross.org/

[43] Fellow member of New England Clinical Oncology Society (NNECOS), Member ID: 49612286, Northern New England Clinical Oncology Society, P.O. Box 643, Sandown, NH 03873-0643, Telephone: (603) 887-1948, [email protected].

[44] Active Member of National Comprehensive Cancer Network (NCCN).

[45] Active Member of International Society for Evolution, Medicine, and Public Health (ISEMPH), Member since: 23 Jan 2019 till Present, User ID: 49299558.

[46] A/C Type: MU Alumni member of Maynooth University, National University of Itrland Maymouth.

[47] Active Member of Cancer Society, Maynooth University, Cancer Society, Society Constitution.

[48] Active Member of American Federal Health Professionals Smart Brief Community.

[49] Active Member of Microbiology Society, Membership No: C023338, Website: https://microbiologysociety.org,

[50] Registered Member of the Society for Scientific Exploration (SSE), Open Access peer-reviewed research on consciousness, physics, energy, healing. 2019 – Present. Website: https://www.scientificexploration.org/

[51] Active member of Cancer Action Network, American Cancer Society, Grassroots Campaigns. Senior Director: Korinne Moore Berenson.

212

[52] Active Member of Union for International Cancer Control (UICC), 2019- Present.

[53] Member of World Public Health Nutrition Association (WPHNA). Membership ID: 50228104.

[54] Active Member of American College of Physicians (ACP) - ACP ID: 03860312.

[55] Active Member of the Global Organization for Stress. Related Emails: Dr Judy Esmond and her team at [email protected].

[56] Active Member of Teaching & Education Research Association (TERA), Unique ID: 1387

[57] Active Member of About Marriott Bonvoy (Marriott Plaza) Hotel, Member Number: 877525712. Web link: https://www.marriott.com/

[58] Active Member of US Chapter Army & Air Force ACP, United States Army Forces. ACP ID: 03860312.

[59] Certified Volunteer at 2019 International Conference on Frontiers of Neural Networks, ICFNN 2019, DATE: 26 July, 2019 - 28 July, 2019 VENUE: Rome, Italy.

[60] Certified and Active Member of ICFNN 2019 Technical committee, INTERNATIONAL ACADEMY OF SCIENCE AND ENGINEERING FOR DEVELOPMENT, Hong Kong, South Korea.

[61] Active and Certified Member of Healthcare & Biological Sciences Research Association (HBSRA), Eurasia Research Academy, Membership Category: Life- Time, Membership ID: HBSRA-M19399. Website: www.eurasiaresearch.org.

[62] Ambassador of Lung Cancer Community, Lung Cancer Registry, USA.

[63] Active Member of American Academy of Family Physicians (AAFP), Member ID: 9359081.

[64] Active Member of Helicsgroup Scientific Networks, Membership Web link: https://helicsgroup.net/index.php/user/member_details/1595/35, Website: https://helicsgroup.net/home/conferences/

213

[65] Individual Member of ACA (American Camp Association), Membership ID: 9130661.

[66] Member of High Scope Organization. Website: https://highscope.org/

[67] Active Member of University and College Union (UCU), Membership Number: 325479, UCU | University and College Union, Carlow Street, London NW1 7LH, Telephone: 020 7756 2500.

[68] Active Member of IMRTC-USA (International Management Research and Technology Consortium Research) as Advisor, Referee, Professor at IMRTC-USA (International Management Research and Technology Consortium Panel. Website: imrtc.org/default.asp/, Member ID: IndApp_RT_647855, Chapter ID: NA3355647, Country: United States.

[69] Active Member of Chinese American Medical Society, Member ID: 51505205, Website: https://camsociety.org/

[70] Certified Member of Institute For Supply Management (ISM), Member Number: 000000661351, Website: https://www.instituteforsupplymanagement.org.

[71] Certified Member of American Planning Association (APA), Membership ID: 368144, Primary Chapter: VA, Membership Expires: 09/30/2019, Website: https://www.planning.org/

[72] Professional Member of Association of North America Higher Education International (ANAHEI), Sorush Niknamian, Department: Military Medicine, College Liberty University Professor of Oncology, Cell and Molecular Biology, Department of Military Medicine, Liberty University, Research Areas Oncology, Biomedicine, Military Medicine, Molecular Biology, Biological Sciences, Cellular Biology, Country United States, Type Professor, Sorush Niknamian, Department Military Medicine, College Military Medicine, University American Military University, Research Areas Military Medicine, Country United States, Type Professor, Website: https://anahei.org/members-directory/

[73] Member of AMA (American Medical Association) & JAMA (Journal of American Medical Association) Network community.

214

[74] Senior Doctor (MD) Member of World Medical Association (WMA), Medical ID: 5c7b154b01602, Website: https://www.wma.net/

[75] Professional Member of BGDO (Belgian Group of Digestive Oncology), BGDO account number BE63 3400 2014 3908 - Bic = BBRUBEBB. 2019

[76] Fellow Member of MDCSCO ( Maryland/DC Society of Clinical Oncology), Web link: http://my.memberclicks.com/msco,

[77] Affiliate Member of TROG Cancer Research, Ph.: +61 2 4014 3911, Fax: +61 2 4014 3902, Copyright © 2015 TROG, all rights reserved. Our mailing address is: Trans-Tasman Radiation Oncology Group Limited, TROG Cancer Research, PO Box 88, Waratah NSW 2298 Australia, Website: https://www.trog.com.au/

[78] Active International Member of European Association of Urology, EAU membership: EAU-113339, Website: https://myeau.uroweb.org/myeau/login

[79] Active Member of NGAUS (The National Guard Association of the United States), [email protected], Member Number: 4401556, Rank: Major Dr.

[80] Member of AACC, AACC Account Number: 307032. https://www.aacc.org/

[81] Service Member of Modern Military Association of America (MMAA).

[82] Member of European Based Community of Engaged Management Scholars. Web Link: https://www.xcdsystem.com/euram/member/member_home.cfm/

[83] Honorary Member of APAO (Association of Physician Assistants in Oncology). Website: https://apao.memberclicks.net/

[84] Fellow Member of Illinois Medical Oncology Society, Expiration Date: 12/31/2019, Join Date: 07/27/2019, Member Type: Fellow, Group: Fellow, Member Status: Active, Member Number: 960, Full Name: Dr. Sorush Niknamian, Contact Name: Sorush Niknamian, Organization: Liberty University, Web Link: https://imos.memberclicks.net/index.php?option=com_content&view=article&id= 14&Itemid=1, Brief Summary: Illinois Medical Oncology Society (IMOS): Formed on July 29, 1989, the Illinois Medical Oncology Society (IMOS) represents the common interests of a majority of the oncologists treating cancer in Illinois. As the oncology society in Illinois, we strive to provide our members with innovative

215 resources to help them stay ahead of the shifting healthcare landscape and challenges that directly impact the high-quality care their patients deserve.

[85] Member of American Association for Clinical Chemistry, Account: 307032, URL: www.aacc.org.

[84] Certified Member of Military Officers Association of America (Member Number: 05670401, Rank: Major).

[85] Certified Member of Emirates Diabetes Society (EDS), Member Number: 351, Membership End Date: 2020-08-26, www.emiratesdiabetessociety.com.

[86] Certified Member of European Association of Urology (EAU), Membership ID: EAU-113339, Web Link: https://uroweb.org/

[87] certified member of Texas Section of the American Physical Society. URL: http://www.phys.ttu.edu/TSF19/index.html/

[88] Senior Member of Asia Society of Researchers (ASR), Senior Membership Number: R219091901, ASR Website: http://www.asr.org/

[89] Certified Member of American Psychiatric Association (APA), APA ID: 1402085, Member Class: MS, APA, URL: https://www.psychiatry.org/home/, APA Membership Department, 800 Maine Avenue S.W. Ste 900, Washington, DC 20024, 888-357-7924 x3567 or 202-559-3567, [email protected].

[90] Certified Member of Impact Coaching Academy, URL: https://impactcoaching.academy/member-login/

[91] Certified Member of World Society of Emergency Surgery (WSES), https://www.wses.org.uk/

[92] Certified Member of Oncology Nursing Society (ONS), 125 Enterprise Drive, Pittsburgh, PA 15275-1214, [email protected] (email), 412-859-6100 (phone), 412- 859-6162 (fax). Member ID: 751023. https://www.ons.org/

[93] Certified Member of International Association of Outsourcing Professionals (IAOP), https://www.iaop.org/, Membership Confirmation Number: IAOP-77327.

[94] Active Member of Society of Physics Students (SPS),

216

[95] Certified Member of Society of Hematologic Oncology (SOHO), URL: https://www.sohoonline.org/site_signin.cfm/. The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders. SOHO represents physicians and other health care professionals from all corners of the world. The SOHO global network supports and is supported by members from more than 100 countries, who are leading the vital efforts to further treatments for those afflicted by these diseases.

[96] Certified Member of IEEE EMBS (IEEE Engineering in Medicine and Biology Society Member), Member Number: 96256112, https://www.ieee.org/

[97] Associate Member of International Association of Innovation Professionals (IAOIP), Associate Member ID: 60060293, Personalized URL: https://iaoipmember.org/member/CANCERTREATMET, Website: https://iaoipmember.org,

[98] Certified Member of UCU (University and College Union), Membership Number: 325479, https://cpd.web.ucu.org.uk/.

[99] Active Member of APHA (American Public Health Association), Membership ID: 10081556, Website: www.apha.org/. Description: APHA champions the health of all people and all communities. We are the only organization that combines a nearly 150-year perspective, a broad-based member community and the ability to influence policy to improve the public's health. The American Public Health Association is a Washington, D.C.-based professional organization for public health professionals in the United States. Founded in 1872 by a group of physicians, including Dr. Stephen Smith and Dr. Henry Hartshorne, APHA has more than 25,000 members worldwide. Founder: Stephen Smith, Founded: 1872, Headquarters location: Washington, D.C., United States, Motto: "For science. For action. For health.".

[100] Active Member of Biophysical Society URL: https://www.biophysics.org/. Member ID:

217

[101] Certified Member of European Society of Cardiology (ESC), Membership ID: 993224, URL: https://www.escardio.org/

[102] Resident Member of American College of Radiation Oncology (ACRO), URL: https://www.acro.org/

[103] Certified Student Member (STU), ID: 1383387, Texas Medical Association, 401 West 15th Street, Austin TX 78701, (800) 880-1300 | (512) 370-1300. Website: https://www.texmed.org/

[104] Associate Member of Institute of Consultants/Southern Africa, Membership number: A00405, Referral Link: http://www.iocsa.org/Register/A00405, The Institute of Consultants Southern Africa (IOCSA) was formed to represent all professionals who consult to, advise or counsel clients in business, government, SOE’s, NGO’s and society in general. These professionals can provide services on a permanent, interim or freelance basis. Purpose: The purpose of the Institute is to create a flourishing, competitive consulting marketplace in which business solutions are delivered ethically for the benefit of all key stakeholders, namely the Consultant, the Client and Society. Code of Conduct: All members of the Institute are required and agree, as a condition of membership, to adhere to a Code of Conduct.

[105] Certified Member of International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS), 500 Cummings Center, Suite 4400, Beverly, MA 01915, Tel: +1 978-927-8330 Fax: +1 978-524-0461, Membership ID: F4A348B5- CD54-43BF-B706-DEB0B0A65B5F.

[106] Regular Member of European Association of Preventive Cardiology, Membership number (ESC ID): 993224, Website: https://www.escardio.org/Sub- specialty-communities/European-Association-of-Preventive-Cardiology-(EAPC)/. EAPC is a community of more than 6700 members - Over 70 experts in epidemiology, exercise, rehabilitation and sports cardiology give their time to support the Association and its community, including the EAPC Board, EAPC Sections and EAPC Committees.

[107] Graduate Student Member of Society for Industrial and Applied Mathematics - 15 Months, 10/01/2019 to 12/31/2020, SIAG on Mathematics of Planet Earth,

218

10/01/2019 to 12/31/2020, SIAG on Algebraic Geometry Membership - 15 Months, 10/01/2019 to 12/31/2020. Start Date 10/01/2019 Paid Thru Date 12/31/2020 Member Type Graduate Student Members - 15 Months, Member Number: 020893157. Website: https://www.siam.org/. Society for Industrial and Applied Mathematics, 3600 Market Street, 6th Floor, Philadelphia, PA 19104 USA, phone (toll free USA/Canada) 800-447-SIAM, phone +1-215-382-9800, fax +1-215-386- 7999, [email protected], www.siam.org.

[108] Fellow Member of HEALTHCARE AND BIOLOGICAL SCIENCES RESEARCH ASSOCIATION (HBSRA).

[109] Member of SIAM (Society for Industrial and Applied Mathematics), 3600 Market Street, 6th Floor, Philadelphia, PA 19104-2688 USA, Phone(s): +1-215-382- 9800, toll-free 800-447-SIAM (US and Canada), Fax: +1-215-386-7999, [email protected], www.siam.org. For more than 50 years, SIAM books have been a leading source of knowledge for the world’s applied mathematics and computational science communities. SIAM’s line-up of stellar, prize-winning authors and titles that address both timely and fundamental topics have made SIAM books indispensable to researchers, faculty, and students around the world. The collection includes more than 450 searchable titles for institutions to offer to their users electronically. SIAM’s Proceedings bring you peer-reviewed original research from conferences covering discrete algorithms, data mining, and control. Recent Proceedings are easily accessed electronically and are available from as far back as 2001 through the current year.

[110] Fellow Member of Institute of Mathematical Statistics (IMS), Founded: 1935, ID: 32896, President: Regina Liu [email protected], The Institute of Mathematical Statistics is an international professional and scholarly society devoted to the development, dissemination, and application of statistics and probability. The Institute currently has about 4,000 members in all parts of the world. Beginning in 2005, the institute started offering joint membership with the Bernoulli Society for Mathematical Statistics and Probability as well as with the International Statistical Institute. The Institute was founded in 1935 with Harry C. Carver and Henry L. Rietz as its two most important supporters.

219

[111] Resident Member of the American Academy of Emergency Medicine Resident and Student Association (AAEM/RSA). Who We Are: We are an accessible, collaborative organization that fosters innovation, education and advocacy for residents and students in emergency medicine. We provide resources and opportunities that educate, inspire and inform emergency medicine residents and students. Website: https://www.aaemrsa.org/, Membership ID: 85737.

[112] Executive Editor of Scientific Research & Community (SRC), URL: http://www.onlinescientificresearch.com/members.php. Scientific Research and Community is Independent Open Access Publishers and encourages all the academic disciplines to publish their research globally. Scientific Research and Community finds the people from worldwide as community for publishing research in the arena of science and Technology. It is a Platform for all the Scientific researchers and Young researchers to promote their research values through this organization. Scientific Research and Community is an Independent and Non Profitable Organization encourages people from Medical, Clinical, Health care, Engineering, Life sciences, Pharmacy research backgrounds. Scientific Research & Community is team with well qualified people as community and advisory board members who discovers new research and development for this organization. Scientific Research and Community aims to publish original research work that contributes significantly to enhance the scientific knowledge in Medical Sciences Clinical Research, Health Care, Engineering and Technology, Pharmacy, Life sciences, Environmental Sciences. Scientific Research and Community focus on Clinical Research, Epidemiology, Oncology, Biomedicine, Dentistry, Medical Education, Physiotherapy, Pulmonology, Nephrology, Gynecology, Dermatology, Dermatoepidemiology, Otorhinolaryngology, Ophthalmology, Sexology, Osteology, Kinesiology, Neuroscience, Hematology, Psychology, Pediatrics, Angiology/Vascular Medicine, Critical care Medicine, Cardiology, Endocrinology, Gastroenterology, Infectious Diseases and Vaccinology, Hepatology, Geriatric Medicine, Bariatrics, Pharmacy and Nursing, Pharmacognosy and Phytochemistry, Radiobiology, Pharmacology, Toxicology, Clinical immunology, Clinical and Hospital Pharmacy, Cell Biology, Genomics and Proteomics, Pharmacogenomics, Bioinformatics and Biotechnology, Earth & Environmental sciences, Pharmaceutical research, Engineering and Technology.

220

[113] Certified Member of Academy of Communication in Healthcare (ACH), About the Academy: We, the leadership of the ACH (Academy of Communication in Healthcare) and EACH: International Association for Communication in Healthcare, support the free movement of information and of all interested participants across international boundaries to improve our knowledge and practice in communication and healthcare. We are experts in the field of healthcare communication. We recognize the value of diversity and relationship to both individual and public health. We believe strongly in open borders that allow researchers, educators, patients, clinicians, and students to meet for a free exchange of ideas in order to support collaboration with professionals from all countries. We particularly wish to welcome and support scholars and practitioners in communities that are challenged by war, poverty, and inadequate infrastructure. Website: https://www.achonline.org/.

[114] Active Member of American Academy of Pas (AAPA), AAPA ID: 110-704- 206, Website: https://www.aapa.org/, About AAPA: Founded in 1968, the American Academy of PAs is the national professional society for PAs. It represents a profession of more than 131,000 PAs across all medical and surgical specialties in all 50 states, the District of Columbia, U.S. territories, and the uniformed services. AAPA advocates and educates on behalf of the profession and the patients PAs serve. We work to ensure the professional growth, personal excellence and recognition of PAs. We also enhance their ability to improve the quality, accessibility and cost-effectiveness of patient-centered healthcare. Address: 2318 Mill Rd., Ste. 1300, Alexandria, VA 22314.

[115] Resident/Post Doc Student Member of the American Academy of Emergency Medicine Resident and Student Association (AAEM/RSA), ID: 85737, Critical Care and Emergency Ultrasound Sections, Virginia Chapter Division. URL: https://www.aaemrsa.org/,

[116] Member of Learning & Performance Institute, Awarded by: Michael Strawbridge FLPI, Head of Global Content, Networks & Member Services, Learning and Performance Institute, p: +44 (0)2476 496215 m: 07584 992885 w: www.thelpi.org. Rank: MLPI.

221

[116] Professional/Fellow Member of Institute for Engineering Research and Publication (IFERP), Institute For Engineering Research and Publication (IFERP) is one of the world's largest Non-profitable professional associations operating under Technoarete Research And Development Association (TRADA) meant for research and development in the field of Engineering, Science & Technology. IFERP is a paramount body which has brought technical revolution and sustainable development in the field of Engineering, science and technology. IFERP is a forum where innovations & research interest could be supported and developed prioritizing our mutual interest. Our forums & Associates constitutes of Professional leaders, Universities, Organizations & Associations connecting each other with a mission to work as wizards of science for defending the earth. URL: https://www.iferp.in/, Fellowship ID: PMIR02714698.

[117] Col. Sorush Niknamian, PE, Member ID: 300720849, Post Doc Student of National Society of Professional Engineers (NSPE), Membership Expiration Date: 08/31/2021, In 1934, a group of professional engineers met in New York City to establish an organization dedicated to the non-technical concerns of licensed professional engineers. The National Society of Professional Engineers stands today as the only national organization committed to addressing the professional concerns of licensed PEs across all disciplines. NSPE was established in 1934 to realize a simple but vital goal: create an inclusive, nontechnical organization dedicated to the interests of licensed professional engineers, regardless of practice area, that would protect engineers (and the public) from unqualified practitioners, build public recognition for the profession, and stand against unethical practices and inadequate compensation. Much has changed since then, but NSPE’s fundamental commitment to this vision, articulated at its founding, remains unchanged. The NSPE Strategic Plan—including our Vision, Mission, Values, and Goals—is developed by the NSPE Board of Directors in collaboration with NSPE’s representative House of Delegates. It is not a static document. Rather, it is a commitment to ongoing, open, and transparent strategic planning and execution. Our Vision: A world where the public can be confident that engineering decisions affecting their lives are made by qualified and ethically accountable professionals. Our Mission: To foster licensed professional engineers in service to society. URL: https://www.nspe.org/. NSPE Headquarters: 1420 King Street, Alexandria, VA, 22314-2794, Tel.: 888-285-NSPE

222

(6773), Fax: (703) 684-2821, Hours: 8:30 AM - 5 PM (EST), Monday through Friday.

[118] Member of PEs in Construction Community, community.nspe.org. Member ID: 300720849.

[119] Member of PEs in Higher Education Community, community.nspe.org. Member ID: 300720849.

[118] Fellow Member of International City/County Management Association, About ICMA: International City/County Management Association is the leading organization of local government professionals dedicated to creating and sustaining thriving communities throughout the world. Member Number: 1012999.

[119] Certified/Resident Member of the American Academy of Emergency Medicine Resident and Student Association (AAEM/RSA), Member ID: 85737, Member type: Student/Resident, Member since: 12/20/2019, Membership expires: 06/30/2020.

[120] Member of American Society of Clinical Oncology Act Network. https://asco.quorum.us/action_center/.

[121] Member of NVA's Talent Network (NVA Professional Talent Community) , https://nva.avature.net/talentcommunity/, NVA is a community of individual hospitals and resorts with their own unique story and culture. By joining our Talent Network, you will see and hear stories about what makes each hospital and resort unique and learn how NVA supports them.

[122] Member of TCEA Community, https://tcea.mobilize.io/users/sign_in.

[234] Grad Student Member of American Institute of Chemical Engineers, Status: Grace. Paid Thru Date: 12/31/2019, Member Type: Grad Student Member, Member Number: 009903222217. Industry: Biotechnology & Bioprocessing, Job Function: Research & Development.

[235] Student Dr. Member of American Osteopathic Association (AOA), 142 E. Ontario St. Chicago, IL 60611-2864, AOA ID 438843, AOA membership is active through May 31, 2021. Website: https://osteopathic.org/.

223

[236] Certified Member of EADO (European Association of Dermato Oncology, membership number/personal identification is: EAD000909. EADO (European Association of Dermato-Oncology) is an independent non-profit organization dedicated to promote, coordinate and improve clinical and laboratory research activities in the field of skin cancer including primary and secondary prevention, early detection, clinical diagnosis and clinical and experimental research. The EADO has a European and international membership of dermatologists, oncologists and clinical as well as basic research scientists interested in the field of Dermato Oncology. The EADO provides leadership by formulating and disseminating quality standards and guide-lines for diagnosis and treatment of skin cancer. The EADO provides direction, coordination and organizations of clinical, therapeutically and experimental trials in the area of skin cancer. The EADO supports and organizes meetings dedicated to the presentation of new research findings, exchange of information and education for its members in the field of Dermato-Oncology. The EADO offers coordination and support of projects of the respective national skin cancer groups. Website: https://www.eado.org/.

[237] Post Doc Student Member of Academy of Communication in Healthcare ACH, 201 E. Main Street, Suite 1405 Lexington, KY 40507 Phone: 859-514-9211 Fax: 859-514-9207. Website: https://www.achonline.org/. Mission Statement: ACH is the professional home for all those who are committed to improving communication and relationships in healthcare. ACH accomplishes this through: Welcoming researchers, educators, clinicians, patients, patient advocates, and all members of the healthcare team. Providing opportunities for collaboration, support and personal and professional development. Identifying strengths, resources and needs of patients, their family members and healthcare professionals, both as unique individuals and in relationship to one another. Developing skills that integrate biological, psychological and social domains. Applying existing scholarship from multiple disciplines and developing new knowledge through research. Promoting collaborative relationships between clinicians and patients, teachers and learners, and all members of the health care team. Incorporating core values of respect, empathy and genuineness in human relationships and the importance of self- awareness in all activities. Vision Statement: A health care system where all patients, healthcare professionals, trainees and researchers feel valued, are treated equitably with respect, compassion, understanding, and are actively engaged in healthcare

224 processes and decisions. Basic Beliefs We Share as an Organization ACH believes that the healing human relationship among healthcare professionals, patients and their families is a critical aspect of healthcare. We believe that highly performing interpersonal and inter-professional delivery systems are necessary to achieve the greatest benefit from our biotechnical services. ACH believes in the highest quality, most fully accessible and cost-effective health care for all. ACH believes that relationship skills, communication skills, and teaching skills are learnable and teachable. ACH believes that improved relationships and communication enhance team and patient satisfaction, reduce errors and grievances, improve efficacy, efficiency and safety, and enhance health outcomes, as documented in the peer- reviewed literature. ACH believes that organizational investment in the continuous quality improvement of relationships and communication rewards the organization in many dimensions. ACH believes in learner-centered methods of teaching and coaching, facilitating discovery of learning needs and preferred learning styles. ACH leaders and teachers live the relationship-centered human values we teach, with each other in the organization and in our interactions with patients, family members, colleagues on the health care team, clients, and interested others; we strive to remain curious about and respectful of all forms of diversity that our individual experiences bring to our relationships. ACH is committed to evidence-based practice in healthcare and teaching, grounded in highest quality research that continually informs our work. ACH is committed to promoting diversity in its membership and leadership, including but not limited to diversity in profession, seniority, interests, gender, race/ethnicity, and sexual orientation. It believes that such diversity is critical to attaining the best research, scholarship, teaching, health care and other strategic goals of the Academy. Accordingly, ACH believes it essential to assertively recruit under-represented minorities into our organization. ACH is committed to assisting in the training of under-represented minority healthcare professionals and to reducing healthcare disparities. ACH is committed to human relationships grounded in integrity, congruence, transparency, empathy and unconditional positive regard. As a non-profit human service organization, ACH adheres to a clear mission and assures that resources are used on mission-centered activities. [Our basic beliefs were developed by participants at the 2009 Winter Course and edited by the Executive Committee. The mission, vision, and beliefs were updated by the Board in February 2014 and October 2015.]

225

[238] Certified Member (Post Doc Student) of American College of Obstetricians and Gynecologists (ACOG), Membership Period: 01/06/2020 - 06/30/202, Founded in 1951, the American College of Obstetricians and Gynecologists is the specialty's premier professional membership organization dedicated to the improvement of women’s health. With more than 58,000 members, the College is a 501(c)(6) organization and its activities include producing the College's practice guidelines and other educational material. Fellows of ACOG are board certified ob-gyns whose professional activities are devoted to the practice of obstetrics and/or gynecology, who possess unrestricted licenses to practice medicine, and have attained high ethical and professional standing. Fellows of ACOG can be recognized by the designation of FACOG (Fellow, American College of Obstetricians and Gynecologists) after the physician’s name. ACOG ID: 001278959I.

[238] Member of MCAA | Mechanical Contractors Association of America, https://www.mcaa.org/, 1385 Piccard Dr, Rockville, MD 20850, The Mechanical Contractors Association of America (MCAA) serves the unique needs of approximately 2,600 firms involved in heating, air conditioning, refrigeration, plumbing, piping, and mechanical service. We do this by providing our members with high-quality educational materials and programs to help them attain the highest level of managerial and technical expertise. MCAA includes the Mechanical Service Contractors of America, the Plumbing Contractors of America, the Manufacturer/Supplier Council, the Mechanical Contracting Education and Research Foundation and the National Certified Pipe Welding Bureau. Mechanical Contractors Association of America, 1385 Piccard Drive, Rockville, MD 20850, 301 869 5800, [email protected].

[239] Certified Member of the Woodrow Wilson National Fellowship Foundation, Our Mission: The Woodrow Wilson National Fellowship Foundation identifies and develops leaders and institutions to meet the nation’s critical challenges. The History of the Woodrow Wilson National Fellowship Foundation: In 1945, as it became clear that the G.I. Bill would soon bring unprecedented numbers of students onto college campuses around the United States, Princeton University professor Whitney Oates worried that promising scholars who had left the academy to fight in World War II would not return to pursue advanced degrees and become college teachers. He and Princeton’s graduate dean, Sir Hugh Taylor, persuaded Miss Isabelle Kemp, a private donor, to support the first of a group of graduate fellowships that would

226 attract veterans back to academic careers. Soon leaders nationwide realized the urgent need for a new generation of outstanding college and university professors. In 1949, the Carnegie Corporation granted Princeton $100,000 to extend its fellowship program nationwide. Now called the Woodrow Wilson Fellowship Program—in honor of Princeton’s best-known leader and academic innovator—the effort remained small until 1957. In that year the Ford Foundation granted $24.5 million to support 1,000 fellowships each year for five years, and the program became a new independent nonprofit, the Woodrow Wilson National Fellowship Foundation. Over the subsequent decade and a half, the Foundation selected and supported more than 15,000 Woodrow Wilson Fellows. These Fellows became intellectual leaders not only within the academy, but also in government, the corporate world, and the nonprofit sector. Today, they include 14 Nobel Laureates, 38 MacArthur Fellows, 20 Pulitzer Prize winners, and hundreds of other distinguished individuals—as well as everyday classroom heroes. As new educational opportunities opened to women and people of color in the late 1960s and early 1970s, the Woodrow Wilson Foundation broadened its commitment to opportunities in higher education for the best students from all walks of life. New programs of the era included the Martin Luther King Fellowships, which prepared African-American veterans for public service careers, the Woodrow Wilson Women’s Studies Dissertation Fellowship, the first and still the only national program supporting young scholars in gender studies. Even as the Foundation continued to draw outstanding young scholars into higher education and public service, it also recognized that the nation had growing needs in elementary and secondary education. Programs of the 1980s and 1990s, like the Leadership Program for Teachers and Teachers as Scholars, created bridges between K–12 teachers and university faculty, seeking to reinvigorate teachers’ intellectual interests and offering them new understandings to use in the classroom. In recent years, the Woodrow Wilson Foundation has continued to cultivate talented emerging leaders for both the academy and public service, administering programs like the Thomas R. Pickering Foreign Affairs Fellowships, the Charlotte W. Newcombe Doctoral Dissertation Fellowships, and the Mellon-Mays Undergraduate Fellows (MMUF) Dissertation Grants and Travel/Research Grants. Various other Foundation initiatives have sought not only to prepare leaders but to transform institutions, addressing the need for change in American doctoral education (the Humanities at Work, the Responsive Ph.D.) and in school-university partnerships that promote the transition to college

227

(Early College High Schools). Continuity and change: the best minds for the nation’s most important challenges Today, Woodrow Wilson seeks to build upon its legacy of excellence, maintaining its historic commitments and attacking one of the nation’s most urgent contemporary challenges: the pervasive achievement gap between Americans, by race and income. Using the prestige of its historic fellowships as well as harnessing new resources, the Foundation has created the Woodrow Wilson Teaching Fellowships to both recruit exceptionally able individuals to careers in high school teaching and create new models for preparing such promising teachers to teach in low-income communities and high-need schools. As the Foundation’s current signature program, the Woodrow Wilson Teaching Fellowships bring full circle the Foundation’s work in creating access to educational excellence for some of the nation’s most talented young people—and thereby serving urgent national needs. https://woodrow.org/.

[240] Member and Activist in ASCO Action Network, Web Link: https://asco.quorum.us/action_center/.

[241] Certified Member of American Society for Laser Medicine and Surgery (ASLMS), About ASLMS: The American Society for Laser Medicine and Surgery, Inc. (ASLMS) was founded in 1980 and is the world's largest professional organization dedicated to promoting research, education and high standards of clinical care in the field of medical laser and energy-based applications. ASLMS provides a forum for the exchange of scientific information and participates in communicating the latest developments in laser and energy-based research to investigators, regulatory agencies, and the public. 2100 Stewart Avenue, Suite 240, Wausau, WI • Phone: (715) 845-9283 / (877) 258-6028•Fax: (715) 848-2493 •E- mail: [email protected], Website: https://www.aslms.org/about-aslms. Membership ID is 130646.

[242] Resident Member of American College of Radiation Oncology (ACRO), ID: 50536, American College of Radiation Oncology, 2001 6th Ave., Suite 2700, Seattle, WA 98121, Phone: (206) 956-3642 Email: [email protected]. Member Since 11/5/2019, Expires: 12/31/2022. About ACRO: The College is managed by a volunteer Board of Chancellors elected by the membership and guided by the By- laws. The Board consists of 11 elected Chancellors made up of the Chair, the President (Chair Elect), the Vice-President (President Elect), the Secretary-

228

Treasurer, the three (3) Chairs of select ACRO Standing Committees (Governmental & Economic Affairs Committee, Standards Committee, and Membership Committee), and four (4) At-large members of the Board. The Board meets twice each year, at the Annual Meeting and at a mid-year meeting in October. The Executive Committee meets monthly by telephone conference call. Elections are held annually prior to the College’s Annual Meeting. Each chancellor serves a 4- year term but not more than two consecutive terms. The chief executive officer of the College is the President of the College who automatically ascends to the position of Chairman. Programming is by committees whose members are appointed by the Board of Chancellors. The Board of Chancellors adheres to guidelines of tenure for committee personnel to ensure periodic rotation. The Board of Chancellors, through a contract with an association management company (WSMA Association Management Services), is supported by an Executive Director who, with other assigned staff members, is responsible for all functions related to management direction, administrative services, membership administration, publications, conference management, financial management, continuing medical education, and committee support. The strength of the College lies in the careful appointment of committees for the varied assignments and in the broad participation of members in the educational activities.

[243] Active Member of American Society for Transplantation and Cellular Therapy (ASTCT), User ID: 7420 | Group: In Training Member Group, Who We Are: The American Society for Transplantation and Cellular Therapy is an international professional membership association of more than 2,200 physicians, investigators and other health care professionals from more than 45 countries. Our mission is dedicated to improving the application and success of bone and marrow transplantation and related cellular therapies. We strive to be the leading organization promoting research, education and clinical practice in the field. Bylaws Preferred Future, 2019-2021 Strategic Plan. What We Do: ASTCT promotes: Education, Scholarly publications, including the renowned journal Biology of Blood and Marrow Transplantation, Clinical standards, Research, Patient access to care, Recruitment of professionals to the field, Identification and support for the work of young investigators, Adoption of government policies and regulations helpful to advancing quality patient care. We help our members: Advance their skills and expertise in the field, stay on top of the latest developments through our various

229 publications, solicit expert counsel from their peers on challenging cases, Find jobs and identify training opportunities, Find highly qualified job candidates for their centers or organizations, Network with — and learn from — the ASTCT community at meetings and events, Get actively engaged through committees, special interest groups and the Corporate Council. What We Value: ASTCT holds in highest regard: Comprehensive development and advancement of the field of blood and marrow transplantation, Excellence in clinical care and treatment outcomes through standards for blood and marrow transplantation, Innovative research to advance the science and clinical applications of other cellular therapies, Rapid dissemination of basic and clinical BMT research findings within the medical field and to the general public. URL: https://www.astct.org/higherlogic/s/l/li/in/.

[274] Associate Member of International Association of Innovation Professionals – Chapters: Virginia, Associate Member ID: 60060293, Personalized URL: https://iaoipmember.org/member/CANCERTREATMET. ABOUT: A professional membership organization, the International Association of Innovation Professionals (IAOIP) is the world’s only innovation certification body, providing members with the knowledge, skills, and opportunities to deliver real change in their industry or field. The IBoK (Innovation Body of Knowledge) is developed and maintained by members through a transparent and democratic process that assures everyone the opportunity to contribute. The IAOIP is a US 501(c), non-for-profit and its chapters are equivalent not-for-profits in their respective countries. IAOIP CERTIFICATION: The International Association of Innovation Professionals (IAOIP) acts as an expert third party to certify individuals as knowledgeable professionals in the science of innovation. As a non-profit organization, IAOIP’s goals are to grow the formal recognition of a profession, enrich the knowledge and practice of the science of innovation, and to support career development for professional innovators throughout world. Website: https://iaoipmember.org/.

[275] Active and Honorable Member of Cystic Fibrosis Foundation teamMATE and CF community. About: Community Voice is the entry point to learn about opportunities for people with cystic fibrosis and their family members to get involved in national CF Foundation initiatives. Members are directly impacting programs and initiatives for the CF community by sharing their experiences and insights with the CF Foundation, other organizations, and researchers working with the CF community. Through this partnership, members of Community Voice are

230 helping to shape the Infections Research Initiative, inform the development of CF clinical care guidelines, give feedback on CF research projects, and much more. Website: https://www.cff.org/Get-Involved/Connect/Community-Voice/. What Is Community Voice? Community Voice is composed of more than 900 members, including people with cystic fibrosis and their families. Members are directly impacting programs and initiatives for the CF community by sharing their experiences and insights with the Cystic Fibrosis Foundation and other organizations and researchers working in CF. We can't be successful without the input of the CF community, and Community Voice is the avenue for getting that input. Because each person's experience is unique, it's critical to hear from as many people as possible. Whether filling out a survey or participating in a focus group or committee, Community Voice members are helping to shape efforts for the entire CF community.

[276] Affiliate Event organizer of Biophysical Society. Biophysical Society | 5515 Security Lane, Suite 1110, Rockville, MD 20852 | P: 240-290-5600 | F: 240-290- 5555, [email protected], www.biophysics.org.

[277] Registered Member of National Association of Boards of Pharmacy®(NABP®), NABP e-Profile ID: 1485867. The National Association of Boards of Pharmacy is an international association which assists member boards and jurisdictions in administrating its pharmacist license transfer and pharmacist competence assessment programs for the purpose of ensuring public health. The NABP membership is composed of 54 active members and 12 associate members. Active member boards include all 50 United States, the District of Columbia, Guam, Puerto Rico, and the Virgin Islands. Associate member boards are Australia, Bahamas, and 10 Canadian provinces. NABP supports its member boards of pharmacy by offering: Examinations that assess pharmacists’ competency to practice pharmacy. These examinations include the North American Pharmacist Licensure Examination (NAPLEX) and the Multistate Pharmacy Jurisprudence Examination (MPJE). License transfer program that alleviates the administrative burden on boards by verifying pharmacists’ applications for license transfer, Accreditation programs that create uniform standards and perform inspections to supplement board staff and alleviate financial burden. Many other services that provide pertinent resources to assist the boards of pharmacy as they work to protect the public health each day. The NABP originated in the United States in 1904. In

231

1999, the NABP developed the Verified Internet Pharmacy Practice Sites (VIPPS) program to accredit online pharmacies. In 2004, the NABP developed the Verified- Accredited Wholesale Distributors (VAWD) program to accredit Wholesale Distributors and to help protect the public from the threat of counterfeit drugs. In 2011, the NABP implemented a data exchange that allows authorized pharmacists, law enforcement agents, and regulatory boards to access patient-specific controlled substance prescription information. Known as NABP PMP InterConnect®, the platform provides a single page summary of patient's drug seeking activities across state lines. As of 2018, authorized users in 42 states have accessed data using the system in order to prevent drug abuse and drug diversion. https://my.pharmacyprofiles.com/profile.

[278] Fellow Member of the Medical Society of the State of New York (MSSNY) The Medical Society of the State of New York (MSSNY) is an organization of approximately 30,000 licensed physicians, medical residents, and medical students in New York State. Members participate in both the state society and in their local county medical societies. MSSNY is a non-profit organization committed to representing the medical profession as a whole and advocating health related rights, responsibilities and issues. MSSNY strives to promote and maintain high standards in medical education and in the practice of medicine in an effort to ensure that quality medical care is available to the public. MSSNY offers to physician’s various educational courses that are accredited by the ACCME. URL: https://cme.mssny.org/home. MEMBER ID: 3009762.

Editorial Board and Reviewer

[1] Guest Editor – Nature Medicine Journal - Impact factor: 32.621 (2017) - ISSN: 1078-8956 (print); 1546-170X (web) - ISO 4: Nat. Med - Discipline: Medicine - LCCN: 95660642 - OCLC number: 471508019. 2018-2019.

[2] Peer Review corps - Journal of Global Oncology.

[3] Peer Review Corps – Journal of Clinical Oncology (JCO) - Impact Factor: 26.303 - ISSN: 0732-183X (print); 1527-7755 (web) - Open access: Delayed, after 1 year - ISO 4: J. Clin. Oncol - The Journal of Clinical Oncology is a peer-reviewed medical

232 journal published 3 times a month by the American Society of Clinical Oncology. It covers research on all aspects of clinical oncology. Journal Website: http://ascopubs.org/journal/jco

[4] Peer Review Corps - JCO Clinical Cancer Informatics – Journal Website: http://ascopubs.org/journal/cci

[5] Peer Review Corps - JCO Precision Oncology – Journal Website: http://ascopubs.org/journal/po

[6] Peer Review Corps - Journal of Oncology Practice - Discipline: Oncology - OCLC number: 77640911.

[7] peer reviewer of Dove Medical Press - Adolescent Health, Medicine and Therapeutics Journal - ISSN: 1179-318X - Editor-in-Chief: Professor Alastair Sutcliffe, Journal Website: https://www.dovepress.com/adolescent-health- medicine-and-therapeutics-journal.

[8] Peer Reviewer of Dove Medical Press - Biologics: Targets and Therapy Journal - Biologics: Targets and Therapy is a peer-reviewed medical journal covering research on the clinical application of biologic agents in the management of pathologies where a molecular target can be identified., OCLC number: 754942526, Publisher: Dove Medical Press - ISSN: 1177-5491, Editor-in-Chief: Dr Doris Mangiaracina Benbrook, Journal Website: https://www.dovepress.com/biologics- targets-and-therapy-journal

[9] Peer Reviewer of Dove Medical Press - Cancer Management and Research - Cancer Management and Research is a peer-reviewed medical journal covering research on cancer. It is published by Dove Medical Press., Impact factor: 3.702, Discipline: Oncology, Editor: Kenan Onel, OCLC number: 422989826, ISO 4: Cancer Manag. Res, ISSN: 1179-1322, Editor-in-Chief: Kenan Onel, MD.

[10] Peer Reviewer of Dove Medical Press - International Journal of General Medicine - The International Journal of General Medicine is a peer-reviewed medical journal covering general and internal medicine. It was established in 2008 and is published by Dove Medical Press. - Discipline: Medicine - Editor: Scott Fraser - LCCN: 2009263358 - OCLC number: 502421378 - ISSN: 1178-7074 - Editor-in- Chief: Professor Scott Fraser - This journal is a member of and subscribes to the

233 principles of the Committee on Publication Ethics (COPE). - Indexed online: Emerging Sources Citation Index (ESCI), from 2016, PubMed and PubMed Central (Int J Gen Med), Embase, from 2009 (Correct as at December 8, 2016), Scopus, from 2009 (Correct as at December 8, 2016), Directory of Open Access Journals (DOAJ), OAIster - The Open Access Initiative. Journal Website: https://www.dovepress.com/international-journal-of-general-medicine-journal.

[11] Professional Reviewer at National Institute for Health Research (NIHR) , United Kingdom, https://www.nihr.ac.uk/,

[12] Editor of the Publishing Research Group, American Society of Clinical Oncology, 2318 Mill Road, Suite 800, Alexandria, VA 22314, Phones: 888-282- 2552, 703-299-0158, Licensed by asco.org • cancer.net • conquer.org • cancerlinq.org

[13] Editorial Board and member of Global Oncology Interest Group, American Society of Clinical Oncology. USA.

[14] Member of Technology Research Group, American Society of Clinical Oncology. USA.

[15] Member of Cancer Informatics Group, ASCO, USA.

[15] Member of US Government Bookstore. https://bookstore.gpo.gov/, GPO

[16] Active member of British Association for Cancer Research (BACR)

[17] Active Member of Researcher Academy, Elsevier.

[18] Editorial Board Member, Global Access Publishers, Global Journal of Neurology. Global Journal of Neurology is a multidisciplinary peer-reviewed, Open Access journal. The emphasis of our journal is to provide significant contribution in advancing knowledge on research of brain, behaviour and environment, utilizing multiple levels of analysis. These include behavioral, electrophysiological, pharmacological, cellular, genetic, molecular, and neural-network model approaches. Our journal is an important platform for Clinical neurology, neuroimmune interactions and behavior, Neurophysiology, Neuropsychology, Neuropharmacology, Neuro-oncology, Degenerative neurology, Behavioral neurology, Brain neurology, Neurological brain disorders, Experimental neurology,

234

Surgical neurology, Neurological rehabilitation, Traumatic brain injury, and novel findings in neural development, regeneration, Transplantation, conceptual approaches to improve regeneration and rehabilitation along with study on central, peripheral and autonomic nervous systems and many other interesting research topics in the field of Neurology. The journal publishes original research, review articles, case reports, short communications, mini review, letter to editor, conference proceedings, opinion articles, editorials etc., Review processing is performed by the editorial board member’s experts in this field; at least two independent reviewer’s approvals followed by editor is required for the acceptance of any citable manuscript. Website: http://globalaccesspub.com/editorboard/global_journal_of_neurology_editorial_bo ard.

[19] Editorial Board Member of EC Nutrition/Ecronicon Journal. EC Nutrition (ECNU) is a multidisciplinary, peer-reviewed scientific journal that covers topics relevant to nutrition and diet and also palatability of foods and their applications. The journal aims to focus on the advancements in the field of nutrition, dietetics and food sciences. EC Nutrition journal is an amazing platform to present advances in nutritional research including clinical nutrition and various technological advancements. The vision of the journal is to enhance the human well-being for a healthy society. The field of nutrition includes the study of nutrients, biomarkers for assessing the influence of dietary components on human health status. The journal explores all the aspects of nutrition some of which include energy metabolism and its regulation, proteins, lipids, carbohydrates, amino acids, vitamins, minerals, nutritional microbiology, comparative nutrition, culinology, sports nutrition, nutritional toxicology, public health nutrition and all the relevant topics of nutritional science. Website: https://www.ecronicon.com/nutrition.php.

[20] Editorial Board Member of EC Medical and Clinical Case Reports Journal, Ecronicon, URL: https://www.ecronicon.com/ECCMC_editorial_panel.php, EC Clinical & Medical Case Reports (ECCMC) is a multidisciplinary journal whose main motto is to enhance the comprehensive knowledge on new cases that are emerging in medical & clinical field, ultimately focusing on exclusive detailed report on symptoms, diagnosis, therapy’s and preventions of the unknown newly evolved cases. ECCMC aids as a growing depot for all these unique cases covering all accepts of health. This Journal is an online, peer reviewed journal devoted to the publication

235 of unique case reports and intended to pay attention in the elaboration of clinical & medical knowledge. Hence, we cordially invite doctors, health care professionals & researchers to participate, read & share the placed case reports.

[21] Editorial Board of EC Pulmonology and Respiratory Medicine (ECPRM) Journal, Ecronicon, URL: https://www.ecronicon.com/ECPRM-EB.php, The respiratory system is vital to the whole functioning of the body. Pulmonology deals with all the diseases related to respiratory tract. Pulmonology is synonymous with pneumology, respirology and respiratory medicine. Today, both clinical and basic research of the respiratory system ranging from the anatomy of respiratory epithelium to the most effective treatment of pulmonary hypertension has become most essential. Scientific research is also taking place to look for causes and possible treatment in diseases such as pulmonary tuberculosis and lung cancer. Advancements in the field of Pulmonary Research play a major role in building a safe and healthy society. ECPRM accepts articles on all the topics related to Lung such as Pulmonology, Respiratory Medicine, Thoracic Surgery, Lung Diseases, Chronic Obstructive Pulmonary Disease, Acute Lung Injury, Acute Respiratory Distress Syndrome, Tuberculosis, Pulmonary Hypertension, Pulmonary Embolism, Pulmonary Edema, Pulmonary Function Tests, Respiratory Care, Respiratory Therapy, Pulmonary Alveolar Proteinosis, Pulmonary Angiography, Pulmonary Aspergillosis, Pulmonary Cancer, Pulmonary Circulation, Pulmonary Thromboembolism, Pulmonary Critical Care, Pulmonary Dysplasia, Pulmonary Oedema, Pulmonary Effusion, Pulmonary Eosinophilia, Pulmonary Fibrosis, Pulmonary Hypoplasia, Pulmonary Interstitial Fibrosis, Pulmonary Lymphoma, Pulmonary Neoplasm, Pulmonary Rehabilitation, Pulmonary Vasculitis, Pulmonary Arterial Hypertension, Pulmonary Parenchyma, Paediatric Pneumology, Occupational Medicine, Intensive Care, Sleep Medicine, etc.

[22] Editorial Board of EC Diabetes and Metabolic Research, Ecronicon Journal, EC Diabetes and Metabolic Research (ECDMR) is an internationally peer reviewed journal that desires to publish articles on all aspects of Diabetes and Metabolism, diagnosis, management and prevention of Diabetic and Metabolic disorders. The journal aims to publish clinical and experimental work on all the topics related to Diabetes and Metabolism. The main motto of ECDMR is to bring latest developments and current research in Diabetes and Metabolism into light by

236 publishing quality and original articles. We deal with all aspects of Diabetic and Metabolic disorders and therapeutic interventions.

[23] Peer-review member of MDPI Nutrients (journal), Discipline: Food science, nutrition, Language: English, Publication history: 2009-present, Publisher: MDPI, Frequency: Monthly, Open access: Yes, Impact factor (2016): 3.550, ISO 4, Nutrients, Indexing: CODEN, NUTRHU, ISSN: 2072-6643, OCLC no. 608471106

[24] Peer-Review member of MDPI Medicina Journal. Published since 1920, MEDICINA is a peer reviewed bi-monthly scientific journal of the Lithuanian University of Health Sciences, Lithuanian Medical Association, Vilnius University, Rīga Stradiņš University, the University of Latvia, and the University of Tartu. The journal serves as a platform for exchange of knowledge by publishing original research articles, reviews, and case reports that will contribute to the current knowledge and encourage future research including, but not limited to, the following subjects: Cardiology and Cardiovascular Medicine, Neurology (clinical), Ophthalmology, Orthopedics and Sports Medicine, Surgery, Cancer Research, Pharmaceutical Science and Pharmacology, Hematology, Oncology, ndocrinology, Diabetes and Metabolism, Public Health, Environmental and Occupational Health, The journal’s main focus is on reviews as well as clinical and experimental investigations. The journal aims to advance knowledge related to problems in medicine in developing countries as well as developed economies, to disseminate research on global health, and to promote and foster prevention and treatment of diseases worldwide. MEDICINA publications cater to clinicians, diagnosticians and researchers, and serve as a forum to discuss the current status of health-related matters and their impact on a global and local scale. ISSN 1010-660X.

[25] Peer-Review Member of MDPI Foods Journal, Foods (ISSN 2304-8158) is an international, peer-reviewed scientific open access journal which provides an advanced forum for studies related to all aspects of food research. It publishes reviews, regular research papers and short communications. Our aim is to encourage scientists, researchers, and other food professionals to publish their experimental and theoretical results in as much detail as possible alongside sharing their knowledge with as many readers as possible. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced.

237

[26] Peer-Review Member of Biomedicines Journal MDPI, Biomedicines (ISSN 2227-9059; CODEN: BIOMID) is an international, scientific, peer-reviewed, open access journal on biomedicines published quarterly online by MDPI.

[27] Peer-Review Member of Biology — Open Access Journal MDPI. Biology (ISSN 2079-7737; CODEN: BBSIBX) is an international peer-reviewed open access journal of biological sciences published quarterly online by MDPI. High visibility: citations available in PubMed, full-text archived in PubMed Central. Covered by BIOSIS Previews, Zoological Record and Scopus, Cite Score 2017 (Scopus): 3.56, which equals rank 12/177 (Q1) in the category 'General agricultural and Biological Sciences.

[28] Peer-Review Corp of Beverages — Open Access Journal, MDPI, Beverages (ISSN 2306-5710; CODEN: BEVEBN) is an international peer-reviewed open access journal on beverage research and development published online quarterly by MDPI, free for readers, free publication for well-prepared manuscripts submitted in 2018, High visibility: Indexed in Chemical Abstracts / SciFinder® and Food Science and Technology Abstracts (FSTA).

[29] Peer- Review Corp of Pathogens — Open Access Journal, MDPI, High visibility: Indexed in the Science Citation Index Expanded (SCIE) - Web of Science, BIOSIS Previews and Scopus. Citations available in PubMed, full-text archived in PubMed Central, Cite Score 2017 (Scopus): 3.52, which equals rank 40/266 (Q1) in the 'Infectious Diseases' category, 9/39 (Q1) in 'General Immunology and Microbiology' and 21/109 (Q1) in 'Microbiology (medical).

[30]. Active Member of Oxford Academic, https://academic.oup.com/journals.

[31] Active Member of International Society for Evolution, Medicine, and Public Health (ISEMPH), Member since: 23 Jan 2019, User ID: 49299558.

[32] Nominee of Assistant Editor, Wiley, ID: 35268, Job Function: Editorial

[33] Nominee of Editorial Board – Neuroscience, Wiley, ID: 35163, Job Function: Editorial

[34] Member of AIChE Publication Committee. Elected by Arthur Baulch Managing Editor, Journals, AIChE

238

[35] Member of Science Council, ID: (A-0009479), he Science Council is a UK organisation that was established by Royal Charter in 2003. The principal activity of The Science Council is the promotion of the advancement and dissemination of knowledge of and education in science pure and applied, for the public benefit.

[36] Editorial Board Member of European Journal of Cancer Research & Clinical Oncology, Web link: https://ejcrco.edwiserinternational.com/editorial-board- members.php. About European Journal of Cancer Research & Clinical Oncology: Edwiser International Journal, European Journal of Cancer Research & Clinical Oncology publishes cutting-edge and ground-breaking articles within the fields of experimental and clinical oncology. The journal has vast scope and cover the topics of tumor biology, carcinogenesis - etiology, mechanisms; molecular biology; recent developments in tumor therapy; general diagnosis; laboratory diagnosis; diagnostic and experimental pathology; oncologic surgery; and epidemiology. The journal accepts high quality original Research articles, Review articles, Short communications, Case reports, Editorials, Video articles, Conference proceedings, Abstracts, Image articles etc.

[37] Editorial Board of EC Endocrinology and Metabolic Research, Publisher: ECronicon Open Access, Frequency: Monthly, Language: English, Format: Online, Review: Double Blinded Peer Review, Description: ECEMR accepts articles on all the topics related to Endocrinology and Metabolism such as Lipid disorders, Cardiovascular and Metabolic Risk, Obesity, Metabolic Disorders, Interdisciplinary Practices in Endocrinology, Aging Research, Traditional Medicine, Diabetes Metabolic Syndrome and Obesity, Diabetes and Metabolic Syndrome, Metabolic Syndrome and Obesity Therapy, Diabetes Metabolic Memory, Type 1 and Type 2 Diabetes Metabolic Syndrome, Pharmacology of diabetic metabolic disorders, Pharmacotherapy of Diabetic Metabolic Disorders, Clinical Studies on Diabetic Metabolic Disorders, Diabetes Metabolic Disorders Views, Complications in diabetes Metabolic Disorders, Genetic Studies in Diabetes Metabolic Disorders, Metabolic Syndrome and Cardiovascular Risk, Metabolic Disorders and Cardiovascular Risk, Metabolic and Cardiovascular Risk, Oxidative Stress Markers in Diabetes Metabolic Disorders, Heterogeneity in diabetic Metabolic Disorders, Melatonin Role in Metabolic Disorders, Apoptosis in Diabetic Metabolic Disorders, HIV in Diabetic Metabolic Disorders, Smoking in Diabetes, Matrix Metalloproteinases in Diabetes, Liver Enzymes in Diabetes, Anthropometric Studies

239 in Diabetic Metabolic Disorders, Depression in Metabolic Disorders, Insulin Therapy in Metabolic Disorders, Diabetes and Hyperglycemia, Pre-Diabetes, Insulin Resistance, Diabetes & Abdominal Fat, Hyper/High Fasting Blood Glucose, Diabetes & High Carbohydrate Diet, Diagnosis of Diabetics, Pathogenesis of Diabetics, Clinical Management of Diabetics, Diabetic Retinopathy, Neuropathy and Nephropathy, Peripheral Vascular Disease and Coronary Heart Disease, Gastrointestinal Disorders, Renal Failure and Impotence, Hypertension and Hyperlipidemia, Coronary Heart Disease, Diabetic Nephropathy, Diabetic Neuropathy, Gastrointestinal Disorders, Glomerular Filtration Rate, Hypertension and Hyperlipidemia, Impaired Glucose Tolerance, Insulin Resistance, Islet Transplantation, Non Insulin Dependent Diabetes Mellitus, Renal Failure and Impotence, Amino Acids and Proteins, Anabolism, Carbohydrates, Catabolism, Coenzymes, Detection and Prevention of Hypoglycemia, Diabetes Classification, Aging Research, Diabetic Emergencies, Endocrinopathies, Osteoporosis, Epidemiology, Metabolic Disorders, Exocrine Pancreatic Defects, Genetic Defects in Insulin Processing or Insulin Action, Genetic Defects of β-cell Function, Nucleotides, Pathophysiology, Xenobiotics and Redox Metabolism, Menstruation abnormalities, Thyroid problems, Parathyroid problems, Pituitary adenomas, Neuro- endocrine tumours, Acne, Acromegaly, Addison's Disease, Androgen Deficiency in Men, Breast Cancer and Oestrogen, Congenital Adrenal Hyperplasia, Cushing's Syndrome, Dwarfism, Growth Hormone, Headache and Hormones, Hormones - Cortisol and Corticosteroids, Menopause, Obesity and Hormones, Pancreas, Pituitary tumour, Reproductive system, Thyroid – Hyperthyroidism, Thyroid – Hypothyroidism, Thyroid Gland, Adrenal Insufficiency and Addison's Disease, Cushing's Syndrome, Cystic Fibrosis, Graves' Disease, Growth Hormone, Hashimoto's Disease, Hyperthyroidism, Hypothyroidism, Multiple Endocrine Neoplasia Type 1, Polycystic Ovary Syndrome (PCOS), Pregnancy and Thyroid Disease, Primary Hyperparathyroidism, Prolactinoma, Turner Syndrome, etc. Editorial Panel: https://www.ecronicon.com/ECEMR-EB.php, Journal Website: https://www.ecronicon.com/ECEMR.php.

[36] Editorial Board Member of EC Microbiology, ECRONICON Open Access, EC Microbiology (ECMI) is a multidisciplinary and internationally peer-reviewed journal that covers significant advancements in the field of microbiology encompassing bacteria, viruses, archaea and all the other microbes. The journal is

240 also concerned with publishing articles on the most outstanding worldwide research in the spectrum of microbiology. The journal also covers various themes of microbiology including biochemical, molecular genetics, physiological and also physical investigations into microbial cells and their interactions with their environments, including their eukaryotic hosts. The journal also focuses on medical microbiology, immunology, ecology and systematic, including description of novel taxa. The journal covers all aspects of microbial cells that include prokaryotes, eukaryotes and various viruses, along with the fields of general, medical and applied microbiology and virology. The journal aims to provide cutting-edge information on exciting trends emerging in the light of advances in molecular and clinical microbiology. Web link: https://www.ecronicon.com/microbiology-editorial- panel.php.

[37] Editorial Board Member of European Journal of Cancer Research & Clinical Oncology, Edwiser International Publishing Group, https://ejcrco.edwiserinternational.com/editorial-board-members.php.

[38] Reviewer of American Association for Science and Technology (AASCIT), World Journal of Biochemistry and Molecular Biology, The American Association for Science and Technology (AASCIT) is a not-for- profit association of scientists from all over the world dedicated to advancing the knowledge of science and technology and its related disciplines, fostering the interchange of ideas and information among investigators.Weblink: http://www.aascit.org/journal/reviewer?journalId=832

[39] Editorial Board Role| Journal of Health Policy and Management, Pulsus Journals, Pulsus Group is a publisher of scientific, technical, and medical literature. It was formed in 1984, primarily to publish peer-reviewed medical journals. As of 2016, Pulsus published 49 hybrid and full open-access journals, 15 of which had been adopted as the official publications of the related medical societies. Pulsus Group also conducts conferences in association with scientific societies. OMICS Publishing Group, an open access publisher widely regarded as predatory, purchased Pulsus in 2016, causing controversy and putting the future of the journals into question. The company has been placed on Jeffrey Beall's list of "Potential, possible, or probable" predatory open-access publishers.

241

[40] Editorial Board of International Medicine (Int Med), ISSN: 2667-7008, International Medicine (Int Med) is an open access fully refereed international medical journal without any submission and publication fees. All costs are sponsored by the Editorial Board. The journal is based on independent and unbiased double- blinded peer-reviewed principles. Only unpublished papers that are not under review for publication elsewhere can be submitted. International Medicine does not accept multiple submission and duplicate submission. The authors are responsible for the scientific content of the material to be published. International Medicine reserves the right to request any research materials on which the paper is based. International Medicine publishes interesting original research conducted in all fields of medicine, interesting case reports and clinical images, reviews, editorials, letters, comments and letters to the Editor including reports on publication and research ethics. International Medicine encourages and enables academicians, researchers, specialists and primary care physicians of all countries to publish their valuable research in all branches of medicine. The primary aim of the journal is to publish original articles with high scientific and ethical quality and serve as a good example of medical publications in the World. The journal is printed four times a year, in March, June, September and December. The language of the journal is English. The Editorial Board of International Medicine adheres to the principles of the Committee on Publication Ethics (COPE), the World Association of Medical Editors (WAME) and International Council of Medical Journal Editors (ICMJE). Website: https://www.theinternationalmedicine.com/, Editorial Board Web link: https://www.theinternationalmedicine.com/pages/editorialboard.php.

[41] Peer Reviewer at Journal of Diagnostics MDPI. Diagnostics (ISSN 2075-4418; CODEN: DIAGC9) is an international peer-reviewed open access journal on medical diagnosis published quarterly online by MDPI. High visibility: Indexed in the Science Citation Index Expanded (SCIE - Web of Science), EMBASE (Elsevier) and Chemical Abstracts (CAS). Citations available in PubMed, full-text archived in PubMed Central. To be added in Scopus from Vol. 9 (2019). Rapid publication: manuscripts are peer-reviewed and a first decision provided to authors approximately 19.7 days after submission; acceptance to publication is undertaken in 4.3 days (median values for papers published in this journal in the second half of 2018). Recognition of reviewers: reviewers who provide timely, thorough peer- review reports receive vouchers entitling them to a discount on the APC of their next

242 publication in any MDPI journal, in appreciation of the work done. Diagnostics (ISSN 2075-4418) is an international scholarly open access journal on medical diagnostics. It publishes original research articles, reviews, short communications, case reports and interesting images. There is no restriction on the length of the papers. Our aim is to encourage scientists to publish their experimental and theoretical research in as much detail as possible. Full experimental and/or methodological details must be provided for research articles. Scope: radiology, nuclear medicine medical imaging, endoscopy, pathology, biopsy, molecular diagnostics, medical screening, biomarkers, diagnostic, icrobiology and infectious disease, point-of-care testing and devices, microfluidic & lab-on-a-chip technologies, biosensors and biochips in diagnostics, mobile health, clinical decision support systems, machine learning and artificial intelligence in diagnostics.

[42] Lead Guest Editor of American Journal of Traffic and Transportation Engineering, ISSN Print: 2578-8582, Online:2578-8604), http://www.ajtte.org.

[43] Reviewer at Physical Review Journals ( https://journals.aps.org) :

I. Physical Review Letters: Physical Review Letters (PRL) is the premier APS journal for current research, providing rapid publication of short reports of important fundamental research in all fields of physics. PRL provides its diverse readership with weekly coverage of major advances in physics and cross-disciplinary developments. II. Physical Review X: Physical Review X (PRX) is an online-only, fully open access, peer-reviewed journal that aims to publish, as timely as possible, exceptional original research papers from all areas of pure, applied, and interdisciplinary physics. III. Reviews of Modern Physics: Reviews of Modern Physics (RMP) brings the broad fundamental physics literature in established topical areas together and places it within the context of current trends in research and applications. Its in-depth review articles and shorter Colloquia serve students, engineers, and physics researchers in a range of fields. IV. Physical Review A: covering atomic, molecular, and optical physics and quantum information

243

V. Physical Review A (PRA) provides a dependable resource of worldwide developments in the rapidly evolving area of atomic, molecular, and optical physics, as well as quantum information. VI. Physical Review B: covering condensed matter and materials physics VII. Physical Review B (PRB) is the largest and most comprehensive international journal specializing in condensed matter and materials physics phenomena. VIII. Physical Review C: covering nuclear physics IX. Physical Review C (PRC) publishes leading research in all areas of experimental and theoretical nuclear physics. X. Physical Review D: covering particles, fields, gravitation, and cosmology XI. Physical Review D (PRD) publishes leading research in elementary particle physics, field theory, gravitation, and cosmology. XII. Physical Review E: covering statistical, nonlinear, biological, and soft matter physics, Physical Review E (PRE), broad and interdisciplinary in scope, focuses on collective phenomena of many-body systems, with statistical physics and nonlinear dynamics as the central themes of the journal. XIII. Physical Review Research: The latest fully open access title in the Physical Review family of journals, PR Research is a peer-reviewed, international, multidisciplinary journal covering all research topics of interest to the physics community. XIV. Physical Review Accelerators and Beams: Physical Review Accelerators and Beams (PRAB) is a peer-reviewed, online-only, open access journal funded by contributions from national and international laboratories and other partners. It covers the full range of accelerator science and technology. XV. Physical Review Applied: Physical Review Applied (PRApplied) is an online- only journal dedicated to publishing the highest quality research across all aspects of experimental and theoretical applications of physics, including their interactions with other sciences, engineering, and industry. XVI. Physical Review Fluids: Physical Review Fluids (PRFluids) is an online-only journal dedicated to publishing innovative research that will significantly advance the fundamental understanding of fluids. XVII. Physical Review Materials: Physical Review Materials (PRMaterials) is a broad-scope international journal for the multidisciplinary community engaged in research on materials.

244

XVIII. Physical Review Physics Education Research: Physical Review Physics Education Research (PRPER) is a peer-reviewed, online-only, open access journal covering the full range of experimental and theoretical research on the teaching and learning of physics. XIX. Physics: Physics provides daily online-only news and commentary about a selection of papers from the APS journal collection. The website is aimed at the reader who wants to keep up with highlights of physics research with explanations that don’t rely on jargon and technical detail.

[44] Editorial Board of General Internal Medicine and Care, Description: General Internal Medicine is a medical specialty that deals with prevention, diagnosis, and treatment of diseases in children as well as adults. General Internal Medicine and Care is an open access peer reviewed journal initiated by Science Text Publishers which aims to provide cutting-edge findings in the field of medicine and allow researchers and practitioners to excel their knowledge in the advancements that have taken place recently and ongoing developments that are being taken place in basic and translational medical sciences. This aim of this journal is to provide an extensive coverage on all aspects related to general internal medicine along with the measures to be taken in care of the patients for achieving better results. This journal will bring in the contributions and opinions from researchers of various fields in medicine under a single open access platform. This is a wide scoped journal that consider articles in the areas of Cardiology, Critical care medicine, Endocrinology, Gastroenterology, Geriatric medicine, Hematology/Oncology, Infectious diseases, Immunology, Nuclear medicine, Nephrology, Pulmonology, Rheumatology etc. Website: http://sciencetxt.org/

[45] Editorial Board Member of General Medicine and Clinical Practice. ISSN Online: 2639-4162, Journal DOI: 10.31579/2639-4162/JGMCP/, Website: https://www.auctoresonline.org/journals/general-medicine-and-clinical-practice. Description: Journal of General medicine and Clinical Practice (JGMCP) predominantly encourages submission of manuscripts related to General Health, Primary care, Epidemiology, Diagnosis, Pathogenesis, Adolescent medicine, Preventive Medicine, Diabetes mellitus, Metabolic syndrome, Immunology infectious diseases, Critical Care Medicine, General Surgery, General Medicine

245

Doctor, Systemic Diseases, Clinical Medicine, Treatment and diagnosis, Clinical Practices, Clinical practitioners, Clinical trials, Translational Science, Genetics, Immunology, Anatomy and physiological studies, Clinical aspects types of the treatment for early detection and diagnosis. Journal of General medicine and Clinical Practice is a Peer-Reviewed, Open Access Journal that aims to publish Scholarly Articles describing clinical examinations, investigative studies and practices related to etiology, diagnosis, treatment and prevention of General medicine and Clinical Practice. Address and Contact Information: AUCTORES PUBLISHING LLC, 16192 Coastal Highway, Lewes, DE 19958, USA, Phone: +1-(302)-601-7170, E- mail: [email protected]. Editorial Board Website: https://www.auctoresonline.org/journals/general-medicine-and-clinical- practice/editorial-board.

[46] Contributor and Board Member of Weston A Price Foundation Journal (WAPF), Website: https://www.westonaprice.org/. Description Website: https://en.wikipedia.org/wiki/Weston_A._Price_Foundation.

[47] Certified Reviewer of Bioscience Reports, Portland press, Portland Press Ltd registered in England and Wales No. 2453983, Registered Office: 5th Floor, 90 High Holborn, London WC1V 6LJ, 5th Floor, 90 High Holborn, London WC1V 6LJ. Website: http://www.bioscirep.org/, General Information: Bioscience Reports provides a home for sound scientific research in all areas of cell biology and molecular life sciences. Since 2012, Bioscience Reports has been fully Open Access and publishes all papers under the liberal CC BY licence, giving the life science community quality research to share and discuss. Bioscience Reports adheres to the Budapest Open Access Initiative (BOAI) definition of open access: that users have the right to read, download, copy, distribute, print, search, or link to the full texts of open access articles published in the Journal. Authors will retain copyright and assign Portland Press an exclusive Licence to Publish. For Open Access articles published in Bioscience Reports, the Licence to Publish assigned to the publisher by authors will reference the Creative Commons CC BY 4.0 licence, to guide use and re-use terms for authors and readers. Print ISSN: 0144-8463, nline ISSN: 1573-4935, Frequency: Continuous publication, Submission information: No submission or page charges, No charges for colour figures, Fully Open Access, so Article Publication Charges are due on acceptance; Online submission site: bioscirep.msubmit.net, VAT registration number GB 523 2392 69.

246

[48] Editorial Board of EC Clinical and Experimental Anatomy. EC Clinical & Experimental Anatomy (ECCEA) is a professionally edited internationally reviewed journal that gives a research platform to the scholars, researchers, doctors and other professionals to spread practical and theoretical knowledge in the form of research, reviews, commentaries, letters, communications, book reviews, etc., with the universal readers. ECCEA is contented to publish the research outputs in the various fields of anatomy emphasizing on the base line data for the clinical and experimental areas ultimately leading to the high standards of the paper.

[49] Editorial Board of International Journal of Biochemistry, Biophysics & Molecular Biology, Science Publishing Group, USA, http://www.sciencepublishinggroup.com.

[50] Reviewer at WPHN Congress 2020, The Congress will be held at the Brisbane Convention & Exhibition Centre from Tuesday 31 March to Thursday 2 April 2020. Each reviewer will be responsible for blind reviewing up to 20 abstracts and each abstract will have 3 reviewers. Review criteria and information on how to review the abstracts will be provided once the call for reviewers closes on Sunday 21 July 2019. All reviewing is done electronically via a website portal and instructions will be provided to enable you to view, score and comment on the abstracts and recommend the best presentation type. Reviews will start from Tuesday 23 July 2019 and are asked to be completed by no later than Sunday 4 August 2019, 11:59pm AEST. If you are able to review abstracts, please complete the online registration below. Abstract reviewer registrations will close on Sunday 21 of July 2019, unless capacity is reached sooner. Your support would be very well appreciated, as it would help us to have a diverse range of expertise, maintain research quality and relevance; and to ensure novel knowledge is shared in our next Congress. If you have any questions on the review process, please email the PHAA Events Team at [email protected]. Website: https://mail.google.com/mail/u/0/h/1rgvwths339id/?&th=16bff2951f87ce46&v=c WPHNA Congress, Brisbane Australia.

[51] Honorary Editor of American Journal of Biomedical and Science Research (Supported by National Autonomous University of Mexico), the purpose of the American Journal of Biomedical Science and Research is to publish scientific and technical research papers, to bring attention to the importance of technology in the

247 field of human sciences. Ever advancing technology plays a vital role in several emergency medical and clinical scenarios, and is thus the the key focus of this journal; biomedical research. Bringing together content that is rich and enables information sharing between like-minded readers who crave for quality content on biomedical research. The wide scope of this journal is to aid the growth of scientific information about better healthcare. With this aim in mind, AJBSR has set out to become a great tool for professors, academicians, researchers and students of the relevant disciplines to gather all their scientific knowledge and also gain more insights from the research of other writers in the form of an original research article, review article, case reports, short communication, e-books, video articles, etc. This multidisciplinary, open access publisher is a global platform for the to share their scientific excellence. Our aim and scope of work is governed by the AJBSR members, which consist of authors, editorial committee members, advisory board, reviewers board and technical support teams. We trust in mutual sharing of scientific know-how between individuals and groups of research centers and hope to give them an opportunity to learn, grow and create advanced cures and discoveries. We want to be the catalysts for information transformation and an international gateway of online content. American Journal of Biomedical Science & Research is an Open access online Journal dedicated in advancing the latest scientific knowledge of science, medicine, technology and its related disciplines. Contact info Biomed Grid LLC, 725 W Duarte Rd, suite #1675, Arcadia, CA 91007, USA. +1 949 447-5577, [email protected]

[52] Editorial Board of Budapest International Research in Exact Sciences (BirEx) Journal, Exact Sciences, ISSN: 2655-7835 (Print) ||| ISSN : 2655-7827 (Online), Budapest International Research in Exact Sciences (BirEx-Journal) is a peer reviewed journal published in January, April, July, October welcome research paper in Medical Science, Agriculture Science, Biological Science, Engineering Science and other related areas and it is published in both online and printed version.

[53] Lead Guest Editor of Cancer Research Journal, (http://www.sciencepublishinggroup.com/specialissue/specialissueinfo?journalid= 158&specialissueid=158011/ Introduction: Oncology and Molecular Biology Research (OMBR) is an internationally peer-reviewed journal that aspires to publish eminent quality papers in all the arenas of cancer and Molecular Biology related fields. The special issue main focus is on the novel concepts, new methodologies,

248 advanced regimens, novel therapeutic agents and also alternative approaches for early detection and intervention of cancer. Aims and Scope: Cancer Molecular Biology, Cellular Biology, Military Medicine (Oncology), Cancer Biology, Oncology.

[54] Editorial Board Member of Journal of Internal and Emergency Medicine, ISSN: 2638-1621, Personal Web Link: https://madridge.org/editorial_board_member/Sorush-Nik-Namian, (Brief Summary: MADRIDGE is one of the trusted and pioneer journal publishers across the world which esteems an ‘Open Access’ platform for traversing of scientific information over an extensive arena of therapeutic sciences. With a collection of 47 peer-reviewed top-notch journals contrived by MADRIDGE, it aims for the development and headway of scientific discernments, ideologies or formative notions prevailing in the core of the scientific fraternity. With an emergent and active 'Open Access' methodology, MADRIDGE does commit to dissemination of scholastic insightful data with online access availed in a split of a second after distribution. This specificity encourages beeline scholars to present their absolute works, be receptive of the responses they receive and also effectively paves a channel to communicate with authors, editors, review specialists, and other experts from their respective fields. MADRIDGE maintains copyright for their works and also entails full credit to the authors or the contributors associated with the same. Our team of experts working at MADRIDGE ensure a quality proof of all your valuable works and provide value to excellence in terms of delivering it on a timely basis globally!!! The essential spotlight is on the use of innovative techniques and excellent outcome-based modus operandi for publishing journals spanning a wide range of health and other therapeutic fields of science to let flourish the definitive, methodical, ultra-precise thoughts and ideas. MADRIDGE endeavors to consolidate the readership of all the most foremost players in the arena (researchers, college and school professors, students, research specialists, members and clients of educational libraries) by dint of its peer-viewed journals and let them enjoy the benefits of visibility and ease to access of critical, present information and also the support that winds up inside the research community itself. Publications at MADRIDGE enable authors to be perceived for their responsibility in their specific field and beyond, with an easy to go scrutinize process of learning. MADRIDGE likewise takes pride over presenting, publishing or disseminating scientific information digitally, in print

249 or in other forms (with request!) and at the most minimal and insignificant costs! We publish journals with a view to serve various purposes which incorporates aspects not just constrained to peer review, broad distribution, branding and authority, portability and creation of an archive of a body of literature!

[55] Certified Reviewer of Bioscience Reports, Biomedical Society, Portland Press, Website: http://www.bioscirep.org/, ioscience Reports provides a home for sound scientific research in all areas of cell biology and molecular life sciences. Since 2012, Bioscience Reports has been fully Open Access and publishes all papers under the liberal CC BY licence, giving the life science community quality research to share and discuss. Bioscience Reports adheres to the Budapest Open Access Initiative (BOAI) definition of open access: that users have the right to read, download, copy, distribute, print, search, or link to the full texts of open access articles published in the Journal. Authors will retain copyright and assign Portland Press an exclusive License to Publish. For Open Access articles published in Bioscience Reports, the License to Publish assigned to the publisher by authors will reference the Creative Commons CC BY 4.0 license, to guide use and re-use terms for authors and readers. Print ISSN: 0144-8463, Online ISSN: 1573-4935, Impact Factor of 4.654. Frequency: Continuous publication.

[56] Peer Reviewer of Archives of Civil and Mechanical Engineering, Editor-in- chief: Zbigniew Gronostajski, ISSN: 1644-9665. (Archives of Civil and Mechanical Engineering (ACME) publishes both theoretical and experimental original research articles which explore or exploit new ideas and techniques in three main areas: structural engineering, mechanics of materials and materials science. The aim of the journal is to advance science related to structural engineering focusing on structures, machines and mechanical systems. The journal also promotes advancement in the area of mechanics of materials, by publishing most recent findings in elasticity, plasticity, rheology, fatigue and fracture mechanics. The third area the journal is concentrating on is materials science, with emphasis on metals, composites, etc., their structures and properties as well as methods of evaluation. In addition to research papers, the Editorial Board welcomes state-of-the-art reviews on specialized topics. All such articles have to be sent to the Editor-in-Chief before submission for pre-submission review process. Only articles approved by the Editor- in-Chief in pre-submission process can be submitted to the journal for further processing. Approval in pre-submission stage doesn't guarantee acceptance for

250 publication as all papers are subject to a regular referee procedure. ACME does not accept manuscripts containing: • Simulation with no experimental verification and/or which gives no new insight into the process. • The analysis of material properties or product performance without reference to the processing which caused them or their application. Archives of Civil and Mechanical Engineering (ACME) is an official journal of Wrocław University of Technology. CiteScore: 3.47 ℹ, Impact Factor: 2.846 ℹ, 5-Year Impact Factor: 2.805 ℹ, Source Normalized Impact per Paper (SNIP): 2.064 ℹ, SCImago Journal Rank (SJR): 0.846 ℹ. Website: https://www.journals.elsevier.com/archives-of-civil-and-mechanical-engineering/

[57] Assistant Editor, Disney Publishing Worldwide, Employee ID: 692588BR. Formerly: The Disney Publishing Group (1992 - 1998), Buena Vista Publishing (1998 - 1999), Type: Subsidiary, Industry: Publishing, Founded: 1991; 28 years ago, Founder: Michael Lynton, Headquarters: Glendale, California[1], Number of locations: 2 creative centers (2009), Area served: Worldwide, Key people: Andrew Sugerman (EVP) Jeff Sellinger (SVP, Learning) Jeanne Mosure Raj Murari (SVPs, Group Publishers) Lyle Underkoffler (VP, Digital), Parent: Disney Parks, Experiences and Products, (The Walt Disney Company), Divisions: Core Publishing, Digital Publishing, Subsidiaries: Disney Book Group, LLC, Disney Learning, Disney Magazine Publishing, Inc.

[58] Executive Director - Digital Research (OTV), ID: 666246BR, Disney Publishing Worldwide, (The Walt Disney Company).

[59] Editorial Board Member of International Journal of Biochemistry, Biophysics & Molecular Biology, Science Publishing Group, Science Publishing Group is an independent international publisher of 200+ open access, online, peer-reviewed journals covering a wide range of academic disciplines. With an editorial team comprising some of the world's leading researchers, Science Publishing Group communicates scientific discoveries to over 175 countries. There are also a series of special issues and conference papers in the related fields like journals. Besides these services, SciencePG has over 60 high-quality published and upcoming books covering different fields of Science, Technology and Medicine etc, most of which are also open access. Science Publishing Group is dedicated to advancing technological innovation and excellence for the benefit of humanity. Science Publishing Group and its members inspire a global community through its

251 publications, conferences and professional and educational activities. We ensure that scientists and researchers get the recognition and rewards that they deserve and the opportunity to play a significant role in the global scientific community. ISSN Print: 2575-5889, Frequency: Semiyearly, ISSN Online: 2575-5862, Web Link: http://www.sciencepublishinggroup.com/journal/editorialboard?journalid=246

[60] Editorial Board Member of Advances in Diagnostics and Laboratory Medicine, Url: http://medoa.uk/ADLM/editorial-board, Advances in Diagnostics and Laboratory Medicine is an inclusive, rational journal. This journal enunciates cutting-edge research trends characterized by clinical laboratory techniques, scientific methodologies and world class equipment to diagnose, evaluate and monitor diseases. The ADLM journal adjures submission of scholarly articles from all disciplines related to Diagnostics and Laboratory Medicine essentially Biochemistry (clinical chemistry, immunoassay, luminescence techniques in chemical and biochemical analysis), Hematology, Histopathology, Transfusion medicine, Clinical microbiology dealing with bacteriologic, parasitic, sepsis, spirochetal, ycoplasmal, chlamydial, rickettsial, fungal infections and Advanced diagnostics like 3D imaging, mammography, radiology services and comprehensive interventional procedures. The journal aims at bolstering the research knowledge base in the discipline with advanced screening methods to detect and identify diseases and to reinforce the designing of better scientific medical tools for cost effective laboratory tests and productive test outcomes, devise solutions to address public health challenges through contributed systematized and coordinated clinical research works. Discussions of the journal includes but not limited to following topics: Clinical diagnostics, Microbiology, Blood culture, Antibiotic susceptibility testing, Molecular Diagnostics, Hematology, Blood Transfusion, Microbiology, Immunology, Histopathology, Bowel Cancer Screening, Cytopathology, Phlebotomy, Pathology Systems, Full Blood Count, Erythrocyte Sedimentation Rate, Haemoglobinopathy Screen, Immunohistochemistry, Frozen sections, Macrosectioning for complex lesions, Lymph node recovery by lipid extraction, Immunofluorescence, Cervical cytology, Post vasectomy + fertility testing, Non gynaecological cytology tests, Thrombopenia screening, Haemochromatosis (HFE) genotyping, Plasma EGFR analysis, Hematocrit, Protein electrophoresis, Western blot, Liver function tests, Polymerase chain reaction (DNA), Northern blot (RNA), Sexually transmitted diseases, Saliva Tests, Microemulsion, Self-powered,

252

[61] Editorial Board of General Medicine and Clinical Practice Journal, ISSN: 2639-4162, Journal DOI: 10.31579/2639-4162/2018, Journal of General medicine and Clinical Practice (JGMCP) predominantly encourages submission of manuscripts related to General Health, Primary care, Epidemiology, Diagnosis, Pathogenesis, Adolescent medicine, Preventive Medicine, Diabetes mellitus, Metabolic syndrome, Immunology infectious diseases, Critical Care Medicine, General Surgery, General Medicine Doctor, Systemic Diseases, Clinical Medicine, Treatment and diagnosis, Clinical Practices, Clinical practitioners, Clinical trials, Translational Science, Genetics, Immunology, Anatomy and physiological studies, Clinical aspects types of the treatment for early detection and diagnosis. Journal of General medicine and Clinical Practice is a Peer-Reviewed, Open Access Journal that aims to publish Scholarly Articles describing clinical examinations, investigative studies and practices related to etiology, diagnosis, treatment and prevention of General medicine and Clinical Practice. All the articles submitted to JGMCP subject to rigorous double-blind peer review process under the guidance of an international editorial board consisting of a distinguished team of General medicine and Clinical Practice researchers and reviewers, URL: https://www.auctoresonline.org/journals/general-medicine-and-clinical-practice.

[62] Editor-In-Chief for the Journal of Multidisciplinary Research and Reviews, Journal of Multidisciplinary Research and Reviews is an international, peer reviewed, open access, scientific and scholarly journal which publishes Research papers, Review papers, Mini reviews, Case reports, Case studies, Short communications, Letters, Editorials, Books, Thesis, Dissertation works, etc., from all the aspects of Agricultural Science, Biological Science, Business, Chemical Science, Education Science, Engineering and Technology, Humanities, Life Science, Physical Science, Marine Science, Social science. After publishing, articles are freely available through online without any restrictions or any other subscriptions to researchers and readers worldwide. Area – Multidisciplinary, Frequency – Biannual, Language – English, Review Process – Double Blinded, Publication Timeline: 21 Days peer review process, Available online by 45 days from the date

253 of submission. URL: https://www.innovationinfo.org/journal-of-multidisciplinary- research-and-reviews/aboutjournal/

[63] Editor In Chief of Britain International of Exact Sciences Journal (BIoEx – Journal), ISSN: 2686-1208 (online) | 2686-1216 (print) | Britain International of Exact Sciences Journal is a peer-reviewed journal published in January, May and September by BIAR Publisher. BIoEx Journal welcomes research paper in mathematics, physics, chemistry, biology, engineering, medical sciences, agricultural sciences and other related fields which is published in both online and printed versions. URL: http://biarjournal.com/index.php/bioex/

[64] Board Member of Current Research in Oncology, https://kosmospublishers.com/board-members-oncology-research-and-therapy/, Kosmos Publishers, Current research in Oncology is an online open access scientific journal which publishes peer reviewed articles from all the subjects of Cancer research and topics related to Oncology essentially for all those with an active interest in the treatment of cancer. Focus: Oncology Research and Therapy deals with diagnosis, treatment of cancerous tumours of different types. It mainly focuses on the progress of clinical and basic research for cancer which promotes to understand the causes and their cure with best possible advancements. This journal works to accelerate the advanced clinical research for cancer patients and its prevention towards it by publishing original research articles, review articles, case reports, brief reports, communications, image articles, commentaries, etc. Mostly diagnosis techniques like Biopsy, Endoscopy, X-rays, MRI, CT scan, Blood tests can be followed to determine malignancy are realms of high interest for the journal publications. There is tremendous ongoing research on the treatment of different categories of cancer like chemotherapy, radiotherapy and surgery, where our journal plays a vital role in focusing the improvements in treatment and cancer detection thereby enhances the quality of life. All published articles are permanently archived and available at Kosmos Publishers website in HTML and PDF formats.

[65] Editorial Board of SunKrist Public Health and Research Journal, URL: http://publichealth.sunkristpublishing.com/editorial-board-members.php, SunKrist Public Health and Research Journal (SPHRJ) is an international, peer reviewed,

254 scholarly open access journal that welcomes to publish articles covering all Public Health related fields which include the Communicable Diseases, Community health, Mental Health Education, Community Drug Abuse and Alcoholism, Behavioral health, Adolescent health. The journal accepts and welcomes you to submit Research, Review, Mini Review, Case Reports, Clinical Images, Clinical Videos, Perspectives, Editorials, Commentary articles. SunKrist Public Health and Research Journal aims to encourage and provide a platform for Public Health specialists, scientists, doctors, professors, physicians and health care professionals to find and innovate the newly advanced procedures, clinical observations, clinical investigations, new diagnostic and surgical techniques, treatment methods, instrument updates, the latest drug findings, results of clinical trials, research findings, clinical studies, clinical and medical case reports in Public Health. SunKrist Public Health and Research Journal follows double blind peer review process through editorial management system to maintain quality for all the submitted manuscripts. By maintaining quality, we will bring the finest manuscripts for readers, once the article is online readers can access the article immediately without any barriers.

[66] Editorial Board of International Journal of Bio-Medical Informatics and e- Health (IJBMIeH), URL: http://www.warse.org/IJBMIeH/editorialBoard/, Aims and Scope: International Journal of Bio-Medical Informatics and e-Health (IJBMIeH) ISSN 2321 – 9017 is the open-access journal, porviding a platform for publishing high quality research articles.. It is a peer-reviewed International online journal that publishes technical papers describing recent research and development work in all aspects of Bioinformatics, Medical Informatics and Health Informatics. IJBMIeH provides an international forum for presentation of original papers and reviews on the latest developments in all aspects of Bioinformatics, Medical Informatics, Medical knowledge-based systems and Health Informatics. IJBMIeH is an international online journal published 6 issues (January , March, May, July, September, November) per year to promote the scientific research in the latest and state of art topics in Bioinformatics, Medical Informatics and Health Informatics. It is an international online journal intended for scientists, academia, engineers, practitioners, research scholars and students. IJBMIeH seeks to provide the latest research and the best practices in the field of bioinformatics, medical informatics

255 and health informatics. This journal provides technologies, applications and experiences in Bioinformatics, Medical Informatics and Health Informatics and also provides guidance to the professionals who will use this journal to inform their practices. IJBMIeH stands as a platform to bring out the research talent and the works of scientists, academia, engineers, practitioners, research scholars and students. IJBMIeH has a primary aim to publish research being conducted and carried out in the field of Bioinformatics, Medical Informatics and Health Informatics. The journal also invites clearly written reviews, short communications and notes dealing with numerous disciplines covered by the fields. We also accept extended version of papers which are previously published in conferences and/or journals. All the submitted articles should report original, unpublished research arcitles, experimental or theoretical and it will undergo the double blind review process. Articles submitted to the journal shjould meet these criteria and must not be under consideration for publication elsewhere. Manuscripts submitted should follow the style of the journal and are subject to both review and editing. All the papers selected for publication are also available freely as full-text in on-line.

[67] Certified Reviewer of Current Microbiology, Editor-in-Chief: Erko Stackebrandt, ISSN: 0343-8651 (print version), ISSN: 1432-0991 (electronic version), Journal no. 284, Current Microbiology is a well-established journal that publishes articles in all aspects of microbial cells and the interactions between the microorganisms, their hosts and the environment. Current Microbiology publishes original research articles, short communications, reviews and letters to the editor, spanning the following areas: physiology, biochemistry, genetics, genomics, biotechnology, ecology, evolution, morphology, taxonomy, diagnostic methods, medical and clinical microbiology and immunology as applied to microorganisms. URL: https://www.springer.com/life+sciences/microbiology/journal/284/

[68] Certified Peer Review Corp of Medicine Journal. Medicine® (1922 – Present) is a fully open access publication, providing authors with a distinctive new service offering continuous publication of original research across a broad spectrum of medical scientific disciplines and sub-specialties. Medicine® covers the latest research and clinical developments in medicine and health sciences. As reported in the 2018 ISI Journal Citation Reports Medicine's Impact Factor is a 1.870. Medicine® is indexed in: Medicus, MEDLINE, PubMed, PubMed Central, Directory of Open Access Journals (DOAJ), Web of Science, ISI Journal Citation

256

Reports, Ovid®. ISSN: 0025-7974 (print), 1536-5964 (web), LCCN: 32003850, OCLC no. 807498951, Publisher: Wolters Kluwer, Frequency: Bimonthly, Impact Factor:1.804 (2016), URL: https://journals.lww.com/md- journal/pages/default.aspx.

[69] Organizing Committee Member at 2nd International Conference on Neurology and Neurosurgery held during May 04-05, 2020 at Miami, USA. Madridge Conferences invites all the participants from all over the world to attend 2nd International Conference on Neurology and Neurosurgery during May 4-5, 2020 at Orlando, USA. The annual Neurology conference provide opportunity for direct communication between the Young Researchers and highly affiliated personalities in medical field whether they are working in the similar field and also provides an opportunity to explore the innovative ideas of the other communities, companies and associations. The First International Conference on Neurology has gathering of neuron research experts from 18 different countries all over the world. Neurology- 2020 conference brings Research Institutions, Neurosurgeons, Neuron specialists, Physicians, Neuroscientists, Psychiatrist, Health Care Personnel, CEO's, Presidents of Industries, Business Delegates, Young Researchers and talented Student populations under a solitary gable catalyzing information exchange for the advancement of research in the field of Neurology from around the world in addition to contributed papers both oral and poster presentations. We look forward to welcoming participants from all over the world to the sparkling country of USA and are highly optimistic of making this event a cherishable experience for our participants and collaborator. URL: https://neurology.madridge.com/

[70] Presidential Editorial Board of International Journal of Nursing and Health Care, International Journal of Nursing and Health Care is an online-only, broad based, peer reviewed open access journal with a global focus on scientific research in all related areas of Clinical Cytology and Pathology. The main objective of the journal is to serve a forum for scientists, researchers, physicians, Surgeons and other health professionals to find current advances in the areas of Clinical Cytology and Pathology. International Journal of Nursing and Health Care, an Open Access peer reviewed Journal welcomes varied article types such as Original Articles, Research Articles, Review Articles, Short Reports, Case Reports, Perspectives (Editorials). URL: http://www.scitechz.com/nursing/eb.php.

257

[71] Presidential Editorial Board of Open Access Journal of Mycology & Mycological Sciences (OAJMMS), Medwin Publishers. Description: Mycology & Mycological Sciences is an open access journal. Mycology is the branch of biology that deals with the study of fungi. OAJMMS includes the research of their genetic and biochemical properties, and their use in medicine and food along with their hazards. (OAJMMS) publishes original articles, also welcomes reviews and several other types of papers on fungal physiology and biochemistry, ecology, pathology, development and morphology, systematic, cell biology and ultra structure, genetics, molecular biology, evolution, applied aspects, and new techniques. Authors are encouraged to share their thoughts and significant research through this platform. Journal Website: https://medwinpublishers.com/OAJMMS/index.php.

[72] Honorary Editorial Board Member of Journal of Applied Psychiatry, Applied Psychiatry covers research, theory, experimental aspects and the application of psychological principles to address recognized disorders, diagnosis, treatment, social policy, and cross-cultural and legal issues. The journal also focuses on understanding brain and behavior especially emphasizes on pre-clinical and clinical research, including studies at the cellular, molecular, integrative, clinical, advanced imaging and psychopharmacology levels. It publishes reviews on current and controversial issues, innovations in assessment, epidemiology, diagnosis and treatment, clinical issues in behavior sciences, commentaries addressing mental disorders, case management articles, methodologies, original investigations, pathophysiology of neuropsychiatric disorders. Website: http://www.sciaeon.org/applied-psychiatry/home, Editorial Board URL: http://www.sciaeon.org/applied-psychiatry/editorial-board/, 160 City Road, London, EC1V 2NX, United Kingdom.

[73] Editorial Board Member of Journal of Cancer Science & Treatment (ISSN: 2641-7472) is open access, peer-reviewed journals founded by Min Li. The Journal provides a forum for researchers, physicians, and other health professionals to publish high-quality original research on the latest advances of cancer. Journal of Cancer Science & Treatment (ISSN: 2641-7472) aims to improve the lives of those affected by cancer by facilitating the free and open exchange of knowledge in the areas like cell and tumor biology, animal models, carcinogenesis, etiology, Recent

258 developments in tumor therapy, Diagnostic and experimental pathology, cellular signalling and molecular biology, epidemiology, cancer stem cells, cancer- associated pathways, cancer therapies, and other cancer-related research. Journal of Cancer Science & Treatment (ISSN: 2641-7472) accepts submissions in the field of cancer and biomedical sciences across the globe in the form of Research Articles, Review Articles, Mini-review, Case Reports, Opinion, Letters to the Editor and Editorials, Rapid and Short Communications and Commentary. The Journal follows the policy of quick and quality peer review process of 21 days under the guidance of Editors & Editor-in-Chief to ensure the highest standards of selection and review. URL: http://www.scitcentral.com/journals.php?journal=25/

[74] Presidential Editorial Board of International Journal of Clinical Nursing & Care, website: https://www.omspinternational.com, Personal Editorial Board Member URL: https://omspinternational.com/Omsp_controller/editorial_board/17. Description: Nursing is a worldwide companion evaluated academic diary distributes amazing original copies on creative research covering all parts of Nursing and Medicinal services. The extent of points shrouded in the diary incorporates General Well-being Nursing, Propelled Work on Nursing, Family Nursing, Basic Consideration Nursing including Medical procedure, Pediatrics, Prescription, Maternity care and Obstetrical Nursing, Mishap, Crisis, Cardiovascular, Renal, Neurosciences, Hematology, and so forth. Diary of Nursing and Human services acknowledges Unique Exploration Articles, Survey Articles, Case Reports, Smaller than normal Audits, Fast Correspondence, Sentiments and Publications on every single related part of nursing and social insurance. Office Locations: 535, Bronze Drive Lexington, South Carolina 29072, United States. Email: [email protected], Copyright © OMSP International All Rights Reserved. 2019.

[75] Presidential Editorial Board of Journal of Cancer Science & Treatment (ISSN: 2641-7472). Editorial Board URL and Web Link: http://www.scitcentral.com/editorboardDetails.php?id=2047&journal=25, Description: Journal of Cancer Science & Treatment(ISSN: 2641-7472) is open access, peer-reviewed journals founded by Min Li. The Journal provides a forum for researchers, physicians, and other health professionals to publish high-quality original research on the latest advances of cancer. Journal of Cancer Science & Treatment (ISSN: 2641-7472) aims to improve the lives of those affected by cancer

259 by facilitating the free and open exchange of knowledge in the areas like cell and tumor biology, animal models, carcinogenesis, etiology, Recent developments in tumor therapy, Diagnostic and experimental pathology, cellular signaling and molecular biology, epidemiology, cancer stem cells, cancer-associated pathways, cancer therapies, and other cancer-related research. Journal of Cancer Science & Treatment (ISSN: 2641-7472) accepts submissions in the field of cancer and biomedical sciences across the globe in the form of Research Articles, Review Articles, Mini-review, Case Reports, Opinion, Letters to the Editor and Editorials, Rapid and Short Communications and Commentary. The Journal follows the policy of quick and quality peer review process of 21 days under the guidance of Editors & Editor-in-Chief to ensure the highest standards of selection and review. Journal Web Link: http://www.scitcentral.com/journals.php?journal=25/, Address and Telephone: SciTech Central Inc.340 S Lemon Ave # 2725, Walnut, CA 91789, United States, Tel: +1- 909-245-1470, Toll Free: +1-888-880-9144, Email: [email protected], [email protected].

[76] Editorial Board of Cancer Research and Cellular Therapeutics: Open Access, Journal Impact Factor: 1.05, ISSN Online: 2640-1053, Journal DOI: https://doi.org/10.31579/jcrct/26401053/, PubMed Indexed, Aims and Scope: Journal of Cancer Research and Cellular Therapeutics (JCRCT) predominantly encourages submission of manuscripts related to Cancer, Oncological interventions, but not limited to the genetics of cancer, Medical Oncology, Surgical Oncology, Cancer Etiology and Epidemiology, Cancer Prevention methods, Chemotherapy, Early Detection and Diagnosis, Radiology, therapeutics of the drugs, Oncology diagnostic tools, cytology and pathology, Clinical aspects types of the treatment for early detection and diagnosis. Journal of Cancer Research and Cellular Therapeutics is a Peer-Reviewed, Open Access Journal that aims to publish Scholarly Articles describing clinical examinations, investigative studies and practices related to etiology, diagnosis, treatment and prevention of Cancer Disease. All the articles submitted to JCRCT subject to rigorous double-blind peer review process under the guidance of an international editorial board consisting of a distinguished team of cancer researchers and reviewers. Website: https://www.auctoresonline.org/journals/cancer-research-and-cellular-

260 therapeutics/, URL: https://www.auctoresonline.org/journals/cancer-research-and- cellular-therapeutics/editorial-board/, Auctores Publishing LLC.

[77] Editorial Board Member of Enliven: Biosimilars and Bioavailability, Editorial URL: http://www.enlivenarchive.org/biosimilars-and- bioavailability/index.php?content=editorial_board#, About Eliven Archive: Enliven Archive is an international publisher for Open access and peer reviewed journals with a wide range of journals in multiple disciplines with broad scope. As Enliven aims to be the world’s leading provider of open access, we will serve free access journals to all scientists, researchers, scholars, students and academicians. Enliven is an exclusively open access model which supports all Open access statements without any controversies and will maintain all the required standards to support Open access with complete dedication. Enliven Archive supports all the statements of COPE (http://publicationethics.org/), OASPA (http://oaspa.org/), BOAI (http://www.budapestopenaccessinitiative.org/list_signatures?indorg=all&keyword =Enliven+Archive) and many more open access policies to ensure that we have transparent flow in journal management. All the articles submitted to Enliven journals will be passed for peer review. Article acceptance will be completely under the guidance of editorial board members and received review comments. Editorial board members will assign the reviewers and all reviews will be done under the guidance of editorial board members. Each and every article which will be published online in Enliven will undergo two review comments and article processing will be proceeded only based on the comments received from the reviewers. Reviewers of Enliven will have no conflict of interest with the authors. Enliven rely on single blind review process. All the reviewers assigned will be from the same field and also of high cadre to the author to have a smooth review process. Review comments will be passed to authors without letting them know the reviewer details. Manuscripts will be considered for further procedure after revision only if the author resubmits the article by fulfilling the review comments. We pass the article for multiple revisions until we get the quality output with the reviewer comments. We also rely on repeated review process upon the guidance of editorial board members. Enliven Archive is an open access scientific publisher started with the aim of dissemination of science and research worldwide and available freely for readers without any cost. Our multidisciplinary open access journals will fulfill the aim. We follow the ethical policies and standards for publishing the research worldwide. We maintain the rapid

261 publication process and accepted articles will publish online within 7-10 days. We follow the quality review process and process the articles as per the open access standard peer review rules and regulations. We protect the author copyrights for the article with Creative Commons Attribution License. We provide the benefits to author with rapid publication process, high quality review process, copyrights with creative commons and dissemination of the work worldwide. We are available to aspirant readers by disseminating updated research with open access and cost free access. We publish original research, news, reviews, case reports, conference proceedings in all areas of Science and Technology. Enliven Archive is a strong aspirant to spread the science knowledge to every human for better world.

[78] Executive Editor and Board Member - Journal of Cancer Research Reviews & Reports, Journal Website: http://www.onlinescientificresearch.com/index.php, Members URL: http://www.onlinescientificresearch.com/members.php, Scientific Research and Community is Independent Open Access Publishers and encourages all the academic disciplines to publish their research globally. Scientific Research and Community finds the people from worldwide as community for publishing research in the arena of science and Technology. It is a Platform for all the Scientific researchers and Young researchers to promote their research values through this organization. Scientific Research and Community is an Independent and Non Profitable Organization encourages people from Medical, Clinical, Health care, Engineering, Life sciences, Pharmacy research backgrounds. Scientific Research & Community is team with well qualified people as community and advisory board members who discovers new research and development for this organization. Test Scientific Research and Community aims to publish original research work that contributes significantly to enhance the scientific knowledge in Medical Sciences Clinical Research, Health Care, Engineering and Technology, Pharmacy, Life sciences, Environmental Sciences. Scientific Research and Community focus on Clinical Research, Epidemiology, Oncology, Biomedicine, Dentistry, Medical Education, Physiotherapy, Pulmonology, Nephrology, Gynaecology, Dermatology, Dermatoepidemiology, Otorhinolaryngology, Ophthalmology, Sexology, Osteology, Kinesiology, Neuroscience, Haematology, Psychology, Paediatrics, Angiology/Vascular Medicine, Critical care Medicine, Cardiology, Endocrinology, Gastroenterology, Infectious Diseases and Vaccinology, Hepatology, Geriatric Medicine, Bariatrics, Pharmacy and Nursing, Pharmacognosy and Phytochemistry,

262

Radiobiology, Pharmacology, Toxicology, Clinical immunology, Clinical and Hospital Pharmacy, Cell Biology, Genomics and Proteomics, Pharmacogenomics, Bioinformatics and Biotechnology, Earth & Environmental sciences, Pharmaceutical research, Engineering and Technology.

[79] Editorial Board Member of Whites Science Journal – A Scientific Erudition, URL: https://www.whitesscience.com/journal/ijimhs-international-journal-of- innovative-medicine-and-health-science/editorial-board-ijimhs/, Address: Editorial Office, 27, Cunningham Way Leavesden, Watford, UK, WD25 7NG.

[80] Organizing Committee of OCM for EPIGENETICS Series Conferences, Epigenetics and Chromosome, June 24-25, 2020 Zurich, Switzerland, Theme: Exceeding the Vision in the Field of Epigenetics and Molecular Biology, URL: https://epigenetics.europeannualconferences.com/organizing-committee.php/, Conferenceseries LLC Ltd and its subsidiaries including iMedPub Ltd and Conference Series Organise 3000+ Conferences across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members. Conferenceseries LLC Ltd is an amalgamation of Open Access Publications and worldwide international science conferences and events. Established in the year 2007 with the sole aim of making the information on Sciences and technology "Open Access", Conferenceseries LLC Ltd publishes scholarly journals in all aspects of Science, Engineering, Management and Technology journals. Conferenceseries LLC Ltd has been instrumental in taking the knowledge on Science & technology to the doorsteps of ordinary men and women. Research Scholars, Students, Libraries, Educational Institutions, Research centers and the industry are main stakeholders that benefitted greatly from this knowledge dissemination. Conferenceseries LLC Ltd also organizes 3000+ International conferences across the globe, where knowledge transfer takes place through debates, round table discussions, poster presentations, workshops, symposia and exhibitions.

[80] Senior Editor at the Journal of Cancer Research and Cellular Therapeutics (JCRCT), Web link: https://www.auctoresonline.org/journals/cancer-research-and- cellular-therapeutics/editorial-board/, AUCTORES PUBLISHING LLC, 16192

263

Coastal Highway, Lewes , DE 19958, USA, Phone : +1-(302)-313-1778, Email : [email protected], About AUCTORES: Auctores is an emerging international open access publisher aimed at development and rapid dissemination of scientific knowledge to the global community without any restrictions. Auctores encompasses journals on discipline of science, technology and engineering, publishes the work in a manner that represents the highest standards and integrity. We run the operation in accordance with (COPE) guidelines which is universally acceptable. We are steadfast to safeguard the highest standards of publication ethics and take all probable actions contrary to publication misconduct, as stated in the Code of Conduct and for resolving the case suspected malpractice in publication ethics we follow COPE Flowcharts. We encourage the academics all over the globe of various fields to get connected with Auctores and publicize their findings. We follow rigorous standard peer review process and accept papers from all parts of the globe and there is no demographic, racial, and socioeconomic barriers. Auctores facilitate the dissemination of research discoveries to the global community without restriction. Thus, all articles published in Auctores journals are freely available online. Another slogan behind the establishment of Auctores is to act as a connecting link among researchers, academia, industry and policy makers. We planned a display place to emphasize quality innovative work and to encourage move towards to serve the scientific community with 30 worldwide open access, peer reviewed journals via the academics who focus on science, technology and engineering discipline through the work they publish with us. Auctores encompasses the time and quality consequently drives us on the way to the achievement and development of our ideas; broadening in our excellence services to guide our associates and figure out our commitment. Our opinion is welcoming Novelties and a vision to authorize the existing researchers to enlighten the scientific world, expanding its support in guiding the academics and researchers in all parts of the globe.Auctores is ardent supporter to The Budapest Open Access Initiative (BOAI). In accordance with the (BOAI): All articles published by Auctores journals are under the terms of Creative Commons Attribution License. This permits anyone read, download, copy, share, print or use them for any other legalized determination, without asking permission from the publisher or the author, the original work and source is appropriately cited.

[81] Editorial Board Member of EC Emergency Medicine and Critical Care, ECRONICON, EC Emergency Medicine and Critical Care (ECEC) is an

264 internationally peer reviewed journal that desires to publish articles on all aspects of Emergency Medicine and Critical Care. The journal aims to publish clinical and experimental work on all the topics related to Emergency Medicine and Critical Care. The main motto of ECEC is to bring latest developments and current research in Emergency Medicine and Critical Care into light by publishing quality and original articles. We deal with all aspects of Emergency Medicine and Critical Care, diseases and therapeutic interventions. Journal Website: https://www.ecronicon.com/ECEC.php, Editorial Panel URL: https://www.ecronicon.com/ECEC-EB.php/.

[83] Editorial Board Member of Acta Scientific Cancer Biology, Acta Scientific Cancer Biology (ASCB) aims to promote communication among clinical researchers worldwide. The journal aims to publish original work in all the areas of cancer biology and clinical oncology. The journal focus on the novel concepts, new methodologies, advanced regimens, novel therapeutic agents and alternative approaches for early detection and intervention of cancer. Acta Scientific Cancer Biology journal works with a determination to show an open window of the progress in oncological sciences. The journal warmly welcomes your reliable articles for publication at [email protected], [email protected], Aim and scope: As cancer, has become a major, serious and a complex problem, it is very essential to put a huge effort to understand and control it, that is possible with the help of original and innovative research findings that helps to disseminate knowledge regarding the etiology of cancer and improvements can be made in its treatment that facilitates the survival of patients. Acta Scientific Cancer Biology (ASCB) is a platform to bring into light the major advances in cancer research and oncology. The research areas covered by the journal include, but are not restricted to the following fields: Molecular and cellular mechanisms of cancer, Mechanisms for the sensitivity and the resistance to cancer therapies and development of better cancer therapies, Cancer genetics, Cancer cytology, Cancer pathology, Gynecologic cancer, Ovarian cancer, Clinical aspects of cancer, Liver cancer, Lung cancer, Cancer endocrinology, Genitourinary cancer, Colorectal cancer, Bone cancer, Prostate cancer, Benign tumours, Cancer chemotherapy, Pediatric oncology, Cancer prevention, Recent developments in tumor therapy, Radiation oncology, Apoptosis, Oncogenes, Angiogenesis, Metastasis, Cancer image and interventional diagnosis and therapy, Tumor markers, Chemotherapy, Radiotherapy and biotherapy,

265

Veterinary and Comparative oncology, Clinical trials in oncology, Cancer nanotechnology, Carcinoma, Sarcoma, Myeloma, Leukemia, Lymphoma, Osteosarcoma or Osteogenic sarcoma, Chondrosarcoma, Leiomyosarcoma, Rhabdomyosarcoma, Mesothelial sarcoma or mesothelioma, Fibrosarcoma, Angiosarcoma or Haemangioendothelioma, Liposarcoma, Glioma or Astrocytoma, Myxosarcoma, Mesenchymous or Mixed mesodermal tumor. All the topics relevant to cancer are accepted by International Journal of Cancer Biology and Clinical Oncology that aims to provide information on original cancer research.

[84] Editorial Board Member of Physical Medicine and Rehabilitation Research, Online ISSN: 2398-3353, Journal Impact Factor: 1.93*, Martin Grabois (Editor-in- Chief) - Baylor College of Medicine, USA, Journal Website: https://www.oatext.com/Physical-Medicine-and-Rehabilitation-Research- PMRR.php#About_Journal, About Journal: Rehabilitation journal is a scientific journal for practitioners and rehabilitation researches in different medical and surgical specialties and rehabilitation disciplines. The main objective of Rehabilitation journal is to advance education and effect the specialty of physical medicine and rehabilitation through the timely delivery of clinically relevant and evidence-based research and review information. Topics incorporate acute and chronic musculoskeletal disorders and pain, geriatric rehabilitation, brain injury rehabilitation, sports medicine/ortho rehabilitation, neuromuscular medicine, spine medicine, musculoskeletal medicine, rehabilitation of impairments associated with disabilities in adults and children. Rehabilitation journal provides a wide range of inmate and patient clinical administration that works to upgrade the standard of life and foster independence for patients living with each kind of inabilities. All physiatrists square measure prepared and include a put down disciplinary way with a decent type of human care professionals supply seamless, patient targeted care. Rehabilitation journal incorporates specific techniques like exercise therapy, balance, postural, gait and manual manipulation joints, co-ordination re-training. Physiotherapists can include physical therapy modalities including ultrasound, needle therapy and electrotherapy. Physiotherapists are specialists in diagnosing and treating the injuries. Physical medicine and rehabilitation or physiatry are a part of prescription used to restore, upgrade functional ability and enhance personal satisfaction to those with physical disabilities or impairments. Rehabilitation journal incorporates all the vital aptitudes to diagnose and treat musculoskeletal injuries in

266 the physically dynamic individual. Rehabilitation is the way of restoring and regaining physical strength and function. Rehabilitation journal incorporates different treatments to enable an individual to restore function after illness or injury. Rehabilitation journal portrays healthcare dedicated to enhancing, keeping up or restoring physical strength, mobility and cognition with maximum results. Normally, rehabilitation enables individuals to increase more independence after disease, surgery or injury. Rehabilitation journal will include articles that are contemporary and vital to both research and clinical practice. Rehabilitation journal publishes original research, clinical studies, editorials, review papers, commentaries, letters to editor, expert opinion and perspective papers, statistical themes, images, emerging issues, ethical/legal topics and book reviews. Copyright is retained by the authors and articles can be freely used and distributed by others. Articles are distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published by Rehabilitation journal, is properly cited *2018 Official Journal Impact Factor is the ratio of the number of citations achieved in the year 2018 based on Google Search and Google Scholar Citations to the total number of articles published in the last two years i.e. in 2016 and 2017. Impact factor measures the quality of the Journal. If ‘X’ is the total number of articles published in 2016 and 2017, and ‘Y’ is the number of times these articles were cited in indexed journals during 2018 then, impact factor = Y/X. Editorial URL: https://www.oatext.com/Physical-Medicine- and-Rehabilitation-Research-PMRR.php#Editorial_Board/.

[85] Editorial Board Member of Acta Scientific Cancer Biology Journal. Acta Scientific Cancer Biology (ASCB) aims to promote communication among clinical researchers worldwide. The journal aims to publish original work in all the areas of cancer biology and clinical oncology. The journal focus on the novel concepts, new methodologies, advanced regimens, novel therapeutic agents and alternative approaches for early detection and intervention of cancer. Acta Scientific Cancer Biology journal works with a determination to show an open window of the progress in oncological sciences. URL: https://actascientific.com/ASCB-EB.php#popup1/.

[86] Editorial Board Member of EC Emergency Medicine and Critical Care, EC Emergency Medicine and Critical Care (ECEC) is an internationally peer reviewed journal that desires to publish articles on all aspects of Emergency Medicine and

267

Critical Care. The journal aims to publish clinical and experimental work on all the topics related to Emergency Medicine and Critical Care. The main motto of ECEC is to bring latest developments and current research in Emergency Medicine and Critical Care into light by publishing quality and original articles. We deal with all aspects of Emergency Medicine and Critical Care, diseases and therapeutic interventions. Emergency medicine is a medical specialty involving care for undifferentiated, unscheduled patients with acute illnesses or injuries that require immediate medical attention. While not usually providing long-term or continuing care, emergency physicians undertake acute investigations and interventions to resuscitate and stabilize patients. Emergency medicine is now recognized as an essential public service. Intensive care medicine or critical care medicine is a branch of medicine concerned with the diagnosis and management of life-threatening conditions requiring sophisticated organ support and invasive monitoring. Patients requiring intensive care may require support for instability, airway, more commonly referred to now as multiple organ dysfunction syndrome. Intensive care is usually only offered to those whose condition is potentially reversible and who have a good chance of surviving with intensive care support. Advancements in the field of Emergency Medicine and Critical Care play a major role in building a safe and healthy society. ECEC accepts articles on all the topics related to Emergency Medicine and Critical Care such as Environmental Health, Community Health, Behavioral Health, Health Economics, Public Policy, Insurance Medicine, Occupational Health and other important subfields along with Prevention and Treatment of Disease, Illness, Injury, and Other Physical and Mental Impairments Promoting Healthy Behaviors, Palliative Medicine, Critical Care Medicine- Intensive Care, Medical Toxicology, Wilderness Medicine, Pediatric Emergency Medicine, Sports Medicine, Hyperbaric Medicine, Trauma, National Health Issues, Health Education, Behavior & Improvement, Health Protection, Public Health Ethics, Social Determinants of Health, Impact of Health Policies, Public Health Practice Models, Health Problems and their Solutions, Public Health Policy and Practice, Population Based studies, Diet and Nutrition, Infection and Public Health Health Care Analysis-Biostatics, Intensive and Critical care, Trauma and Surgical Intensive Care, Pediatric Intensive Care, Acute and Emergency Medicine, Perioperative medicine, Resuscitation, Infection control, Organ Dysfunction, Accidental Injuries, Acute Cardiology, Neurological Emergency, Acute Respiratory Failure, Acute Pain Management, Critical Care, Injury Prevention, Resuscitation,

268

Surgical Emergency, Acute Infection, Toxicology, Hematology/ Oncology, ECG Patterns, Pediatric Emergency, Emergency Medicine, Medical Chemistry, Patient Safety, Critical Patients, Ballistics and Firearm Wounds, Traumatic Injuries, Emergency Medicinal Technologies, etc. URL: https://www.ecronicon.com/ECEC- EB.php.

[87] Honorary Editorial Board Member of Advances in Medical & clinical Sciences- Research Journal, Advances in Medical & clinical Sciences-Research is an Open Access journal that is committed to publish seminal work in the field of medical sciences. This journal aims to publish innovative scientific content as research articles, case reports, review articles, short communications, commentaries to name a few. The journal deals with all branches of Biology and Medicine including Anatomy, Biochemistry, Anesthesia, Cancer research, Dentistry, Internal Medicine, Physiology, Pathology, Community Medicine, Ophthalmology, Pharmacology, General Surgery, Geriatric Medicine, Pediatrics, Orthopedics, Obstetrics and Gynecology, Radiology, Dermatology and Venereal diseases, Pulmonary Medicine, Infectious Diseases, Cardiology, Diabetes, Neurology, Endocrinology, Nephrology and Medical education. The journal accepts articles from Medical Education, Pharmacy, and Nursing and from the thrust areas such as Free radical biology, Medical Genetics, Biotechnology and Medical Statistics. Journal Website: http://worldsciencepub.com/Advances-in-Medical&clinical-Sciences- Research.html, Editorial Board URL: http://worldsciencepub.com/Editorial-Board- Advances-in-Medical&clinical-Sciences-Research.html, Copyright © 2019 world science Publishers All Rights Reserved. Address: [email protected], #4299, Express Avenue lane, Sarasota, Florida. USA. TOPICS: Anatomy & Physiology, Anesthesiology, Basic and Clinical Immunology, Bio-Chemistry, Bioinformatics, Bio-Technological Research, Cardiology, Community medicine and Public health, Dermatology, Emergency Medicine, Endocrinology, Gastroenterology, Genetic and Genomic Medicine, Gerontology, Hematology, Immunology, Nephrology, Neurology, Oncology, Ophthalmology, Orthopedic, Otolaryngology, Pediatrics, Urology, Vascular Medicine etc…

[88] Editorial Board Member of Surgery Journal, Journal of Surgery: Current Trends and Innovations (ISSN 2578-7284), Journal Website: http://www.heraldopenaccess.us/journals/Surgery-Current-Trends-&- Innovations/index.php/. Editorial Board URL:

269 http://www.heraldopenaccess.us/journals/Surgery-Current-Trends-&- Innovations/editorial-board.php/, About the Journal: Journal of Surgery: Current Trends and Innovations (ISSN 2578-7284) is an international open access peer- reviewed journal focusing on minimally invasive surgical techniques, new instruments such as laparoscopes and endoscopes, and new technologies. The journal aims to prepare surgeons to think and work in "the operating room of the future" through learning new techniques, understanding and adapting to new technologies, maintaining surgical competencies, and applying surgical outcomes data to their practices. Journal of Surgery: Current Trends & Innovations is a scholarly surgery journal, which publishes articles on general surgery research topics, current problems in surgery, surgical reviews, surgery research papers, surgery case reports etc. This HSOA surgery journal is indexed in Google Scholar, DOI and J-Gate. Readers can access and download the articles freely, which eventually increases the impact factor. As a clinical discipline, surgery relies on a tradition of research and attracting the brightest young minds. Innovation in surgery to date has been impressive, but inconsistently supported. Hence this journal is like a breath of fresh air catering various articles on new techniques and innovations under one platform to understand innovation in surgery, discover, translate, and commercialize advances to address major clinical problems, and to support the future of our profession consistently and rationally. Journal of Surgery: Current Trends & Innovations covers different aspects of General Surgery; Cardiothoracic Surgery; Vascular Surgery; Otorhinolaryngology Surgery; Plastic Surgery; Paediatric Surgery; Colorectal Surgery; Transplant Surgery; Surgical Oncology; Trauma Surgery; Endocrine Surgery; Breast Surgery; Skin Surgery; Transplant Surgery; Oral and Maxillofacial Surgery; Dental Surgery; Orthopaedic Surgery; Neurosurgery; Ophthalmology; Podiatric Surgery; Urology; Laparoscopic Surgery; Laser Surgery; Liver Resection Surgery; Neonatal Surgery; Vitreoretinal Surgery; Gynecologic Surgery; Minimally Invasive Surgery; Gastrointestinal Surgery; Reconstructive Surgery; Bariatric Surgery; Surgical Robotic Systems; Surgery Innovations. Aim and Scope: The future of surgical research lies, in part, in computer and visual technology. This journal aims in throwing light on current trends and latest innovations in surgery. HERALD MISSION: Herald Scholarly Open Access is a leading, internationally publishing house in the fields of Sciences. Our mission is to provide an access to knowledge globally. We provide high-quality articles to the scientific community and we strive for your research improvement and

270 distinguishment throughout the world. CONTACT INFO: Herald Scholarly Open Access, 2561 Cornelia Rd, #205, Herndon, VA 20171, USA. Tel: +1 202-499-9679, Email: [email protected].

[89] Editorial Board Member of World Journal of Physical Medicine and Rehabilitation (ISSN: 2688-9382), World Journal of Physical Medicine and Rehabilitation (ISSN: 2688-9382) is an international, peer reviewed, open access journal publishes high quality manuscripts in all related aspects of physical medicine, rehabilitation, physical impairments, disability, biomedical engineering, neuroscience, neurorehabilitation, physical therapy, sports medicine, orthopaedics and more. URL: http://www.medtextpublications.com/world-journal-of-physical- medicine-and-rehabilitation-editorial-board.php.

[90] Honorary Peer Reviewer Corp of Archives of Civil and Mechanical Engineering, https://www.springer.com/journal/43452, Electronic ISSN: 1644- 9665, © Wroclaw University of Science and Technology, © 2019 Springer Nature Switzerland AG. Part of Springer Nature. Editor-in-Chief: Zbigniew Gronostajski, Archives of Civil and Mechanical Engineering publishes both theoretical and experimental original research articles which explore or exploit new ideas and techniques in three main areas: structural engineering, mechanics of materials and materials science. The aim of the journal is to advance science related to structural engineering focusing on structures, machines and mechanical systems. The journal also promotes advancement in the area of mechanics of materials, by publishing most recent findings in elasticity, plasticity, rheology, fatigue and fracture mechanics. The third area the journal is concentrating on is materials science, with emphasis on metals, composites, etc., their structures and properties as well as methods of evaluation. In addition to research papers, the Editorial Board welcomes state-of-the-art reviews on specialized topics. All such articles have to be sent to the Editor-in-Chief before submission for pre-submission review process. Only articles approved by the Editor-in-Chief in pre-submission process can be submitted to the journal for further processing. Approval in pre-submission stage doesn't guarantee acceptance for publication as all papers are subject to a regular referee procedure. ACME does not accept manuscripts containing: • Simulation with no experimental verification and/or which gives no new insight into the process. • The analysis of

271 material properties or product performance without reference to the processing which caused them or their application. Archives of Civil and Mechanical Engineering is an official journal of Wrocław University of Technology.

[91] Editorial Board of Frontiers in Medical Case Reports, Frontiers in Medical Case Reports is a lively and informative journal covering international issues relevant to medical and clinical sciences worldwide. The Frontiers in Medical Case Reports is an international standard open access peer-reviewed journal which provides a source for publishing original communications, case reports and case series in all areas of medical and clinical sciences. The journal is the platform for medical and clinical sciences periodical publishing high-quality, peer-reviewed articles. Frontiers in Medical Case Reports Mission…. The purpose of the journal is to enhance the field by offering new basic and clinical research with highlighting on knowledge that will motivation the way medical treatments are practiced. Frontiers in Medical Case Reports provides a high-profile forum to promote major advances in Medical and Clinical Research. Main focuses of interest include: systemic anticancer therapy, top-level guidelines, and new fields currently emerging as key components of personalized medicine, such as molecular pathology, bioinformatics, modern statistics, and biotechnologies. Radiotherapy, surgery and pediatrics manuscripts can be considered if they display a clear interaction with one of the fields above or are paradigm-shifting. Frontiers in Medical Case Reports features latest publication of the recent advances in the diagnosis, management, and treatment of all types of diseases. Every Medical practitioner/young scientist interested in the recent advances in medical and clinical practices needs access to the information in this valuable journal. Frontiers in Medical Case Reports will…. Bring together scientists of various backgrounds who are engaged in investigations relevant to Medical and Clinical Research, and To facilitate communication among these scientists and promote education in Medical Sciences. URL: https://www.jmedicalcasereports.org/editorial_board.php.

[92] Associate Editor and Editorial Board Member of The Applied Medical Research Journal, E-ISSN 2149-2018, URL: http://www.ejmamr.com/index.php, The "Applied Medical Research" is a peer-reviewed publication, aims to publish all the latest and outstanding research articles, reviews and letters in all areas of medical sciences from molecules to organ systems. The journal aims to provide the most complete and reliable source of information on current developments in the field.

272

Both experimental and clinical research and studies are welcome. By this way, one of the main aims of the journal is to supply original information from bench to bedside. Thus, submitted manuscripts should provide a significant advance to the field supported by evident data.

[93] Executive Editor of Scientific Research & Community (SRC), URL: http://www.onlinescientificresearch.com/members.php. Scientific Research and Community is Independent Open Access Publishers and encourages all the academic disciplines to publish their research globally. Scientific Research and Community finds the people from worldwide as community for publishing research in the arena of science and Technology. It is a Platform for all the Scientific researchers and Young researchers to promote their research values through this organization. Scientific Research and Community is an Independent and Non Profitable Organization encourages people from Medical, Clinical, Health care, Engineering, Life sciences, Pharmacy research backgrounds. Scientific Research & Community is team with well qualified people as community and advisory board members who discovers new research and development for this organization. Scientific Research and Community aims to publish original research work that contributes significantly to enhance the scientific knowledge in Medical Sciences Clinical Research, Health Care, Engineering and Technology, Pharmacy, Life sciences, Environmental Sciences. Scientific Research and Community focus on Clinical Research, Epidemiology, Oncology, Biomedicine, Dentistry, Medical Education, Physiotherapy, Pulmonology, Nephrology, Gynecology, Dermatology, Dermatoepidemiology, Otorhinolaryngology, Ophthalmology, Sexology, Osteology, Kinesiology, Neuroscience, Hematology, Psychology, Pediatrics, Angiology/Vascular Medicine, Critical care Medicine, Cardiology, Endocrinology, Gastroenterology, Infectious Diseases and Vaccinology, Hepatology, Geriatric Medicine, Bariatrics, Pharmacy and Nursing, Pharmacognosy and Phytochemistry, Radiobiology, Pharmacology, Toxicology, Clinical immunology, Clinical and Hospital Pharmacy, Cell Biology, Genomics and Proteomics, Pharmacogenomics, Bioinformatics and Biotechnology, Earth & Environmental sciences, Pharmaceutical research, Engineering and Technology.

[94] Program Committee Member of World Congress on Public Health May 21-22, 2020, Berlin, Germany. URL: https://conferenceera.com/public-health- conference/program-committee, World Congress on Public Health (WCPH-2020):

273

World Congress on Public Health (WCPH-2020) is an International Conference organized by Conference Era on May 21-22, 2020, at Berlin, Germany. WCPH- 2020invitesand unites researchers, scholar’s, students, academicians, research organizations, and making the congress a perfect platform to share most happening scientific advancements, progressive research in Public Health over the globe. WCPH-2020 allows multiple opportunities for scientific networking and knowledge sharing interaction. As well as the active poster discussion sessions, panel discussions for speakers and participants to engage beyond discussing the data, into envisioning a future that integrates rapidly evolving procedures in Public Health.WCPH-2020 will be a communicating environment to share deliberate current challenges and ways to move the field forward. The conference will foster the exchange of ideas and spur multidisciplinary collaborations.

[95] Editorial Board Member of Iatrology Archives Journal, Website: http://iatrology.org/journal/, About: Medical research always tends to benefit mankind by implementing the use of current technologies and research to cure a person and providing an ailment free life. Research activity pertaining to Medical sciences is a rapidly evolving area that owes much to the basic biology and claims high importance in understanding and accelerating the research in the associated subjects. The modern medicine discipline is wide enough to accommodate multiple disciplines and sub disciplines with several specialties. This periodical emphasizes to publish articles in all aspect of medical research covering the basic scientific aspects, medicine and associated topics and advanced research which will be contributing to the future of medicine. Aims and Scope: Iatrology Archives is a peer- reviewed, open access journal designed for the wide dissemination of research in the field of medicine to worldwide audience. Medical Research covers the basic, applied and translational research conducted so as to aid and build knowledge in the field of medicine. This journal publishes articles from all areas of medical research of international interests. With an emphasis on conceptual breakthroughs and current trends, its goal is to facilitate towards developing new medicines and improving the application of the medical procedures, thereby improving the quality of life for the Human population. Iatrology Archives has a broad area and is not only confined to surgery, internal medicine, infectious disease, orthopedics, obstetrics and gynecology, oncology, and neurology. But, instead can include articles from the related fields such as studies in clinical areas like immunology, biophysics,

274 translational medicine, personalized medicine, anesthesia, cardiovascular medicine, complementary medicine, dentistry, pathology, pharmacology and therapeutics, dermatology, respiratory medicine, rheumatology, drugs and medicines, nutrition and metabolism, endocrinology, gastroenterology, geriatric medicine, hematology, psychiatry, radiology, pediatrics, urology, epidemiology, ethnic studies. Each article undergoes a peer review process under the aegis of an assigned Editor. To be acceptable for publication, an article should be positively considered by two individual reviewers followed by the Editor’s consent. Authors looking forward to submit important articles containing advanced research output aiding in forwarding the subject are most welcome. The wide scope of the journal will aid in contributing a great measure of scientific information related to the advances in towards better healthcare.

[96] Editorial Board Member of Journal of Clinical Research and Reports, URL: https://www.auctoresonline.org/journals/journal-of-clinical-research-and- reports/editorial-board, About AUCTORES: Auctores is an emerging international open access publisher aimed at development and rapid dissemination of scientific knowledge to the global community without any restrictions. Auctores encompasses journals on discipline of science, technology and engineering, publishes the work in a manner that represents the highest standards and integrity. We run the operation in accordance with (COPE) guidelines which is universally acceptable. We are steadfast to safeguard the highest standards of publication ethics and take all probable actions contrary to publication misconduct, as stated in the Code of Conduct and for resolving the case suspected malpractice in publication ethics we follow COPE Flowcharts. We encourage the academics all over the globe of various fields to get connected with Auctores and publicize their findings. We follow rigorous standard peer review process and accept papers from all parts of the globe and there is no demographic, racial, and socioeconomic barriers. Auctores facilitate the dissemination of research discoveries to the global community without restriction. Thus, all articles published in Auctores journals are freely available online. Another slogan behind the establishment of Auctores is to act as a connecting link among researchers, academia, industry and policy makers. We planned a display place to emphasize quality innovative work and to encourage move towards to serve the scientific community with 30 worldwide open access, peer reviewed journals via the academics who focus on science, technology and engineering discipline through

275 the work they publish with us. Auctores encompasses the time and quality consequently drives us on the way to the achievement and development of our ideas; broadening in our excellence services to guide our associates and figure out our commitment. Our opinion is welcoming Novelties and a vision to authorize the existing researchers to enlighten the scientific world, expanding its support in guiding the academics and researchers in all parts of the globe. Auctores is ardent supporter to The Budapest Open Access Initiative (BOAI). In accordance with the (BOAI): All articles published by Auctores journals are under the terms of Creative Commons Attribution License. This permits anyone read, download, copy, share, print or use them for any other legalized determination, without asking permission from the publisher or the author, the original work and source is appropriately cited.

[97] Peer Reviewer Member of Archives of Civil and Mechanical Engineering, Electronic ISSN: 1644-9665, © Wroclaw University of Science and Technology, © 2019 Springer Nature Switzerland AG. Part of Springer Nature. Editor-in-Chief: Zbigniew Gronostajski, Archives of Civil and Mechanical Engineering publishes both theoretical and experimental original research articles which explore or exploit new ideas and techniques in three main areas: structural engineering, mechanics of materials and materials science. The aim of the journal is to advance science related to structural engineering focusing on structures, machines and mechanical systems. The journal also promotes advancement in the area of mechanics of materials, by publishing most recent findings in elasticity, plasticity, rheology, fatigue and fracture mechanics. The third area the journal is concentrating on is materials science, with emphasis on metals, composites, etc., their structures and properties as well as methods of evaluation. In addition to research papers, the Editorial Board welcomes state-of-the-art reviews on specialized topics. All such articles have to be sent to the Editor-in-Chief before submission for pre-submission review process. Only articles approved by the Editor-in-Chief in pre-submission process can be submitted to the journal for further processing. Approval in pre-submission stage doesn't guarantee acceptance for publication as all papers are subject to a regular referee procedure. ACME does not accept manuscripts containing: • Simulation with no experimental verification and/or which gives no new insight into the process. • The analysis of material properties or product performance without reference to the processing which caused them or their application. Archives of Civil and Mechanical

276

Engineering is an official journal of Wrocław University of Technology. URL: https://www.springer.com/journal/43452.

[98] Honorary and Executive Editorial Board of Archives of Chemical & Pharmaceutical-Research, Archives of Chemical & Pharmaceutical-Research is an open access, peer reviewed journal dedicated to publishing articles in all areas of Pharmaceutical Science. Spanning the entire spectrum of pharma and pharmaceutical sciences, drug discovery, development, evaluation, and regulatory approval. Small drug molecules, biotechnology products including genes, peptides, proteins and vaccines, and genetically engineered cells are an integral part of papers published here. Cardiovascular Pharmacology, Pulmonary, Neosomes, Microspheres, Gastrointestinal and urogenital Pharmacology, Endocrine Pharmacology, Immunopharmacology and Inflammation, Regenerative pharmacology, Translational pharmacology, Neuropharmacology, Pharmaceutics, Pharmacogenomics, Medicinal Chemistry, Pharmacognosy, Pharmacotherapeutics. URL: http://worldsciencepub.com/Archives-of-Chemical-Pharmaceutical- Research.html.

[99] Editorial Board Member of EC Emergency Medicine and Critical Care, URL: https://www.ecronicon.com/ECEC.php, EC Emergency Medicine and Critical Care (ECEC) is an internationally peer reviewed journal that desires to publish articles on all aspects of Emergency Medicine and Critical Care. The journal aims to publish clinical and experimental work on all the topics related to Emergency Medicine and Critical Care. The main motto of ECEC is to bring latest developments and current research in Emergency Medicine and Critical Care into light by publishing quality and original articles. We deal with all aspects of Emergency Medicine and Critical Care, diseases and therapeutic interventions. Aim and scope: Emergency medicine is a medical specialty involving care for undifferentiated, unscheduled patients with acute illnesses or injuries that require immediate medical attention. While not usually providing long-term or continuing care, emergency physicians undertake acute investigations and interventions to resuscitate and stabilize patients. Emergency medicine is now recognized as an essential public service. Intensive care medicine or critical care medicine is a branch of medicine concerned with the diagnosis and management of life-threatening conditions requiring sophisticated organ support and invasive monitoring. Patients requiring intensive care may require support for instability, airway, more commonly referred to now as multiple organ

277 dysfunction syndrome. Intensive care is usually only offered to those whose condition is potentially reversible and who have a good chance of surviving with intensive care support. Advancements in the field of Emergency Medicine and Critical Care play a major role in building a safe and healthy society. ECEC accepts articles on all the topics related to Emergency Medicine and Critical Care such as Environmental Health, Community Health, Behavioral Health, Health Economics, Public Policy, Insurance Medicine, Occupational Health and other important subfields along with Prevention and Treatment of Disease, Illness, Injury, and Other Physical and Mental Impairments Promoting Healthy Behaviors, Palliative Medicine, Critical Care Medicine-Intensive Care, Medical Toxicology, Wilderness Medicine, Pediatric Emergency Medicine, Sports Medicine, Hyperbaric Medicine, Trauma, National Health Issues, Health Education, Behavior & Improvement, Health Protection, Public Health Ethics, Social Determinants of Health, Impact of Health Policies, Public Health Practice Models, Health Problems and their Solutions, Public Health Policy and Practice, Population Based studies, Diet and Nutrition, Infection and Public Health Care Analysis-Biostatics, Intensive and Critical care, Trauma and Surgical Intensive Care, Pediatric Intensive Care, Acute and Emergency Medicine, Perioperative medicine, Resuscitation, Infection control, Organ Dysfunction, Accidental Injuries, Acute Cardiology, Neurological Emergency, Acute Respiratory Failure, Acute Pain Management, Critical Care, Injury Prevention, Resuscitation, Surgical Emergency, Acute Infection, Toxicology, Hematology/ Oncology, ECG Patterns, Pediatric Emergency, Emergency Medicine, Medical Chemistry, Patient Safety, Critical Patients, Ballistics and Firearm Wounds, Traumatic Injuries, Emergency Medicinal Technologies, etc.

[100] Professional/Fellow Member of Institute For Engineering Research and Publication (IFERP), Institute For Engineering Research and Publication (IFERP) is one of the world's largest Non-profitable professional associations operating under Technoarete Research And Development Association (TRADA) meant for research and development in the field of Engineering, Science & Technology. IFERP is a paramount body which has brought technical revolution and sustainable development in the field of Engineering, science and technology. IFERP is a forum where innovations & research interest could be supported and developed prioritizing our mutual interest. Our forums & Associates constitutes of Professional leaders, Universities, Organizations & Associations connecting each other with a mission to

278 work as wizards of science for defending the earth. URL: https://www.iferp.in/, Fellowship ID: PMIR02714698.

[101] Editor in Chief at Britain International of Exact Sciences Journal (BIoEx – Journal), ISSN: 2686-1208 (online) | 2686-1216 (print) |, Britain International of Exact Sciences (BioEx) Journal is a peer-reviewed journal published in January, May and September by Britain International for Academic Research (BIAR) Publisher. BioEx Journal welcome research paper in mathematics, physic, chemistry, biology, engineering, medical, Agriculture and other sciences related areas and it is published in both online and printed versions. Website: http://biarjournal.com/index.php/bioex/index.

[102] Honorary Editorial Board of Journal of Clinical Research and Reports : Open Access, Journal DOI: 10.31579/JCRR/2019, Website: https://www.auctoresonline.org/journals/journal-of-clinical-research-and-reports, About the Journal: Journal of Clinical Research and Reports (JCRR) is an international peer reviewed scholarly journal whose primary aim is to dissemination and development of knowledge on all aspects of clinical trial design, management, legal, ethical and regulatory issues, case record form design, data collection, quality assurance and data auditing methodologies. The journal has a broad coverage for articles are clinical trial methodology, traditional results papers, clinical trial design, conduct, decision analysis, synthesis, history, statistical methods, data management, legal, ethical and regulatory issues, case record form design, data collection, quality assurance, data auditing methodologies, risk-benefit, cost-effectiveness, clinical or policy impact of all types of clinical trials and related medical research methodologies. All the articles submitted to JCRR subject to rigorous double-blind peer review process under the guidance of an international editorial board consisting of a distinguished team of Addiction researchers and reviewers. Call for submissions: Journal of Clinical Research and Reports editor welcomes all types of articles like Research, Case Report, Short Communication, Review, Hypothesis, Method and protocol, Editorials, Perspectives, Letter to the editor from every corner of the globe. All published articles will be assigned DOI provided by CrossRef. Open Access Policy: This journal is an open access journal which provides immediate, worldwide, boundary-free access to the full content of every distributed article without charging readers or their institutions for access. Readers are given the authorization to read, circulate, copy, print, download, search, or link to the full texts

279 of all articles in JCRR. JCRR implements the Creative Commons Attribution License to all works published providing instant and permanent access for free to all types of original works. The license grants copyright to the author concerned and makes the articles available for their dissemination. Anyone can use the articles in any constructive way as long as the credit is given to the author and citation to the original source.

[103] Editorial Committee Member of Open Access Journal of Oncology and Medicine LUPINE PUBLISHERS, ISSN: 2638-5945, Linking ISSN (ISSN-L): 2638-5945, Open Access Journal of Oncology and Medicine (OAJOM) aims to provide effective cancer therapies through the discovery and development of novel therapeutics where we pine to select a pioneering researches and practitioners with their valuable ideas and articles based on medicine (diagnosis and treatment of disease and the maintenance of health) and oncology (treatments of tumors) of common, acute, long term, late effects and its recently developed treatments and welcomes research across all tumor types and their treatments in medical oncology, surgical oncology and radiation oncology. And also on two major divisions of medicine academic medicine and clinical medicine. Some of the branches of medicine are environmental medicine, family medicine, forensic medicine, internal medicine, and physical medicine. It maintains a precise, conscientious fair peer review system. Besides, quality control is engrossed in each step of the publication is in high quality Our editorial team is committed to improving the researcher experience by providing excellent editorial service, fast publication, and high visibility for all papers. Email Us: [email protected] Call Us: +1 (914) 407-6109 57 West 57th Street, 3rd floor, New York - NY 10019, USA. URL: https://lupinepublishers.com/cancer-journal/.

[104] Editorial Board Member of Frontiers in Medical Case Reports, About the journal: Frontiers in Medical Case Reports Online Submission Contact us: [email protected], Frontiers in Medical Case Reports is a lively and informative journal covering international issues relevant to medical and clinical sciences worldwide. The Frontiers in Medical Case Reports is an international standard open access peer-reviewed journal which provides a source for publishing original communications, case reports and case series in all areas of medical and clinical sciences. The journal is the platform for medical and clinical sciences periodical publishing high-quality, peer-reviewed articles. Frontiers in Medical Case

280

Reports Mission…. The purpose of the journal is to enhance the field by offering new basic and clinical research with highlighting on knowledge that will motivation the way medical treatments are practiced. Frontiers in Medical Case Reports provides a high-profile forum to promote major advances in Medical and Clinical Research. Main focuses of interest include: systemic anticancer therapy, top-level guidelines, and new fields currently emerging as key components of personalized medicine, such as molecular pathology, bioinformatics, modern statistics, and biotechnologies. Radiotherapy, surgery and pediatrics manuscripts can be considered if they display a clear interaction with one of the fields above or are paradigm-shifting. Frontiers in Medical Case Reports features latest publication of the recent advances in the diagnosis, management, and treatment of all types of diseases. Every Medical practitioner/young scientist interested in the recent advances in medical and clinical practices needs access to the information in this valuable journal. Frontiers in Medical Case Reports will…. Bring together scientists of various backgrounds who are engaged in investigations relevant to Medical and Clinical Research, and To facilitate communication among these scientists and promote education in Medical Sciences. URL: https://www.jmedicalcasereports.org/editorial_board.php.

[105] Associate Editor of Archives of Nanomedicine: Open Access Journal, Editorial Manager: Jessica Rose, Email: [email protected], [email protected], URL: https://lupinepublishers.com/nano-science-nanotechnology-journal/editorial-committee.php, Archives of Nanomedicine: Open Access Journal (ANOAJ) is a peer reviewed scientific journal meant for professionals and researchers in Nanomedicine and Nanotechnology. This journal publishes high quality original articles, review articles, case reports, short communications, etc. It is an international, peer-reviewed journal presenting significant, novel, interdisciplinary theoretical and experimental results related to nanoscience and nanotechnology in the life sciences. Content includes basic, clinical research addressing diagnosis, treatment, monitoring, prediction, translational and prevention of diseases. This journal covers a wide range of categories such as molecular nanotechnology, Nano sensors, nano particles, Nano drugs, drug delivery, nanomaterials, Nano biotechnology, Nano biopharmaceutics, Nano electronics, nano-devices, nanorobotics etc. The potential scope of nanomedicine is broad, and we expect it to eventually involve all aspects of medicine. Sub-categories include

281 synthesis, bioavailability and biodistribution of nanomedicines; delivery, pharmacodynamics, and pharmacokinetics of nanomedicines; imaging; diagnostics; improved therapeutics; innovative biomaterials; interactions of nanomaterials with cells, tissues, and living organisms; regenerative medicine; public health; toxicology; point of care monitoring; nutrition; Nano medical devices; prosthetics; biomimetics; and bioinformatics. It invites all type of High Quality articles such as Editorial, Research Articles, Short Communications, Opinion Articles, Review Articles, Case Reports. We invite authors to submit original manuscripts in these categories. Lupine Publishers, LLC, 57 West 57th Street, 3rd floor, New York - NY 10019, USA, +1 (914) 407-6109, Fax - +1 (914) 465-7596, [email protected], ISSN: 2637-6660, Linking ISSN (ISSN-L): 2637- 6660.

[106] Certified Volunteer and Member of the ASCO Ed Book expert panel, The STEM International Organization (STEMIO) is a platform for professionals, who contribute meaningfully to STEM research around the world through their scientific investigations and research projects. The United States recognizes the need for investment in STEM education in order for young people to be competitive in the jobs market. In September 2017 President Donald Trump signed a presidential memorandum to expand access to high-quality STEM education for young people. It will put STEM education, particularly computer science, at the forefront of the Department of Education’s priorities. It also aims to devote at least $200 million a year in grant funds towards this area. Our Organization recognizes the importance of encouraging students from an early age to have an appreciation and a growing understanding of science. In an increasingly global society, as an initiative to support the STEM research, we have established this society to create and expand opportunities for all researchers that will enable them to navigate and lead the 21st century. About STEM: The STEM International Organization is a platform for professionals, who contribute meaningfully to STEM research around the world through their scientific, tecnological, engineering and mathematical investigations and research projects. The United States recognizes the need for investment in STEM education in order for young people to be competitive in the jobs market. In September 2017 President Donald Trump signed a presidential memorandum to expand access to high-quality STEM education for young people. It will put STEM education, particularly computer science, at the forefront of the Department of

282

Education’s priorities. It also aims to devote at least $200 million a year in grant funds towards this area. Our Organization recognizes the importance of encouraging Researchers, Scientist and students from an early age to have an appreciation and a growing understanding of STEM. In an increasingly global society, as an initiative to support the STEM research, we have established this organization to create and expand opportunities for all STEM researchers that will enable them to navigate and lead the 21st-century. The STEM Board of directors thrive for-Become a bridge between Educators and students for their research breakthrough investigations. Seek the Sponsors for grants approvals to promote their research through STEM Research Funding. Form a global community of dedicated and passionate STEM professionals for advisory roles. Encourage and research sharing through scientific events worldwide and STEM Expo. Empower the skilled and leading women professionals by Women in STEM. Conduct stem tours for the STEM researchers to explore real- world applications of their research via STEM Tours. Our Mission: Our mission is to promote the research and disseminate and encourage the researchers by channelizing their knowledge through different outreach programs and events. Our Vision: Our Vision stands to broaden the horizons of STEM and become a unique platform for researchers, scientists, physicians where they could get the solution for all their stem-related problems. URL: https://stemio.org/.

[107] Editorial Board Member of Journal of Medical Biomedical And Applied Sciences, JMBAS ISSN (Online): 2349-0748, DOI : 10.15520/jmbas, Published by: Innovative Journal, Website: www.jmbas.in, Journal of Medical Biomedical And Applied Sciences is an international, peer-reviewed journal that welcomes original research articles and reviews on current advances in Medical sciences, preclinical and clinical medicine, and related disciplines. Journal publishes original research article from broad areas like: General & Introductory Medical & Health Sciences, Basic Medical Health Sciences, Addiction, Allergy & Clinical Immunology, Anesthesia & Pain Management, Anatomy, Audiology, Cardiovascular Disease, Cellular & Molecular Medicine, Consumer Health, Dentistry, Dermatology, Emergency Medicine & Trauma etc.

[108] Editorial Board Member of International Journal of Clinical Nursing & Care, URL: https://omspinternational.com/Omsp_controller/category/17, Nursing is a worldwide companion evaluated academic diary distributes amazing original copies on creative research covering all parts of Nursing and Medicinal services. The extent

283 of points shrouded in the diary incorporates General Well being Nursing, Propelled Work on Nursing, Family Nursing, Basic Consideration Nursing including Medical procedure, Pediatrics, Prescription, Maternity care and Obstetrical Nursing, Mishap, Crisis, Cardiovascular, Renal, Neurosciences, Hematology, and so forth. Diary of Nursing and Human services acknowledges Unique Exploration Articles, Survey Articles, Case Reports, Smaller than normal Audits, Fast Correspondence, Sentiments and Publications on every single related part of nursing and social insurance.

[109] Editorial Board Member of Journal of Dentistry: Oral Health & Cosmesis (ISSN: 2473 - 6783), Website: http://www.heraldopenaccess.us/journals/journal-of- dentistry-oral-health-cosmesis, Dentistry: Oral Health & Cosmesis: Journal of Dentistry: Oral Health & Cosmesis (ISSN: 2473 - 6783) is a peer reviewed, open access Journal that facilitates the publication of information through original papers, mini reviews, case reports, short communications, editorials, clinical practice guidelines and papers on novel insights on all aspects of the prevention, diagnosis and management of oral and dental diseases as well as cosmetic dentistry. This oral health journal is an international scholarly journal, which publishes oral health case report, dental research and reviews, oral health facts and dental health articles. Journal is indexed in Google Scholar, DOI and J-Gate. Readers can access and download the articles freely, which eventually increases the impact factor. The broad arena of topics in this journal include Dental Health, Dental Care, Oral Diseases, Advances in dentistry, Root Canal Therapy, Dental Implants, Pediatric Dentistry, Cosmetic Dentistry, Stomatology, Dental Surgery, Dentofacial Orthopedics, Oral and Maxillofacial Surgery, Dental prosthetics, Dental Cavities, Oral Cancer, Tooth Decay, Restorative Dentistry, Aesthetic Dentistry, Dental Medicine, Teeth Whitening. AIMS AND SCOPE: This Journal is devoted to the advancement and dissemination of fundamental knowledge concerning every aspect of oral sciences including oral and maxillofacial pathology, oral and maxillofacial radiology, oral surgery, oral Epidemiology, periodontics, pedodontics, prosthodontics, cariology research, craniofacial biology, dental materials, geriodontics, special care dentistry, endodontics, forensic odontology, oral pathology,oral implantology, restorative dentistry, oral oncology, pharmacology, pulp biology, salivary research, cosmetic dentistry, community dentistry and other fields. It aims to bring important work in the field of oral sciences to a wide international audience.

284

[110] Editorial Board Member of Journal of Medical Case Reports and Reviews, an Open Access Publication ISSN: 2589-8655 | 2589-8647, About the Journal: JMCRR invites original research and review articles not published/submitted for publications anywhere. The journal accepts review articles only if author (s) has included his/her own research work and is an authority in the particular field. Invited or submitted review articles on current medical research developments will also be included. Medical practitioners are encouraged to contribute interesting case reports. The journal publishes special features like and book reviews clinical trials which are registered in the Clinical Trial Registry of India or Clinical trials.gov. We publish innovative original research papers, review articles, case reports and short communications dealing with all the medical specialties like Anatomy, Physiology, Biochemistry, Pharmacology, Pathology, Forensic medicine, Microbiology, Community Medicine, Ophthalmology, Otorhinolaryngology, Internal Medicine, General Surgery, Paediatrics, Obstetrics and Gynecology, Orthopedics, Psychiatry, Radiology, Pulmonary Medicine, Dermatology and Venereal diseases, Infectious Diseases, Anaesthesia, Cardiology, Diabetes, Cancer research, Endocrinology, Urology, Neurosurgery, Geriatric Medicine, Gastroenterology, Neurology, Nephrology, Dentistry and Medical education. About US: We also accept research articles in the field of Medical Research, Free radical biology, Immunology, Infertility, Hematology, Medical Genetics, Laboratory Medicine, Medical Statistics and Biotechnology Welcome to the Journal of Medical Case Reports and Reviews, Rapid publication of original medical and allied research articles, reviews, case reports, preliminary and pilot studies. Symposium proceedings, summaries of presentations or collections of medical data on a specific topic are also welcome, for publication as supplements/special issues. Journal Editorial Board members oversee the peer review process for the journal, including evaluating submissions, selecting reviewers and assessing their comments, and making editorial decisions. Together with Advisory Editorial Board Members they are involved in the development of journal policies and ethics standards and work to promote the Demo Journal mission to provide resources, support and advice for early stage researchers in their journey from writing to publishing their scientific papers while at the same time making free public access to scientific research. URL: http://jmcrr.info/index.php/jmcrr/about/editorialTeam.

285

[111] Organizing Committee Member of 2nd International Congress on Cancer Research and Therapy 2020, 18-19, June 2020 Valencia, Spain, About the Conference: The 2nd International Conference on Cancer research and Therapy is scheduled for June 18-19 2020, Valencia, Spain. Impact Cancer 2020 invites all the participants from all over the world which includes prompt Keynote talks, Oral talks, Poster presentations, Sponsor Ships and Exhibitions. The aim of this conference is " Inspiring Innovations and Advanced Practice in Cancer Care ". Impact Cancer 2020 is comprised of many interactive scientific sessions as well as various diagnostic and therapeutic advancements in cancer. It is an initiative to unite the diverse research and business communities working in this field under a one roof to explore every single aspect of oncology. Importance & Scope: Impact Cancer 2020 will be the best platform for all the oncologists, hematologist's, research scholars, students who are working in this field to exchange their knowledge related to Oncology Research. This international event is an effort to understand the underlying biological procedures which are amended to increase effectiveness, precision, survivability and quality of life. Impact Cancer 2020 is the premier event that brings together international experts, Training Institutes, Manufacturing Medical Devices Companies, Business Entrepreneurs, Medical Colleges, Researchers, Academicians, Physicians, Post Docs, Students, Pharmacy Industries, Academic scientists, Industry professionals, Diagnostic laboratory professionals and decision makers across the globe to exchange their knowledge, experience and research innovations to build Cancer Research scientists to reduce the global burden of cancer. Why To Attend? You do not need to be a member International Conference on Oncology {IMPACT Cancer Research and Therapy 2020} attend the conference. Our conference invite to Leading World Doctors, registered Nurses, Professors, Research fellows and many more from leading universities, companies and medical research institutions, hospitals sharing their novel researches in the arena of Oncology. Attendees will include: Academicians, Oncologists, Radiologists, Chemotherapists, scientists, clinicians, researchers, world Doctors, Health practitioners, Pharmaceutical organizations, Clinical Research organizations. Associations and Societies sponsoring the meeting and looking for collaborative partners. hospitals sharing their novel researches in the arena of Nursing (exhibiting). Policy and decision makers with disciplines in the field of Radiation Therapy and chemotherapy Nursing stakeholders including academic researchers and entrepreneurs, industry policy makers. IMPACT conferences attract participants representing more than 53

286 countries around the world. IMPACT Executive Program: If you are a young scientist who is interested in dementia care and wishes to exchange ideas with industry experts, the IMPACT EXECUTIVE PROGRAM may well be the event for you. It is a 2 days’ event held in parallel to the conference, tailored around Stem cell and its advances. This program provides a unique opportunity to meet like-minded individuals and share the insights of the world's foremost specialists in Oncology innovators. Conference Benefits: International Summit on Cancer conference is comprised of scientific sessions, keynote forums, Exhibitions, workshops, symposia and poster presentations where the most recent developments in Oncology research will be discussed. Website: https://www.impactcancer2020.com/.

[112] Editorial Board Member of Journal of Orthopedic Research and therapeutics SkepticMed Publishers, Journal of Orthopedic Research and therapeutics is an open access, peer-reviewed online journal publishes research articles, review articles, case reports, short communications, letter to editors and short reviews, etc., from the fields related to orthopedics and therapeutics. Aim and Scope: Journal of Orthopedic Research and therapeutics circulates around the corrections of deformities in muscular and non-muscular skeletal system. The aim of the journal is to be the first choice for all the readers around the globe to get benefitted with the research work we publish as papers in and around the topics of orthopedic treatment, in rehabilitation and disability services, and in trauma management. It covers muscles and ligaments, associated structures and the extremities in the skeletal system. URL: http://www.skepticmedpublishers.com/journal-of-orthopedic-research-and- therapeutics/.

[113] Reviewer at International Journal of Infectious Diseases (IJID), CiteScore: 2.89 ℹ, Impact Factor: 3.538 ℹ, 5-Year Impact Factor: 3.041 ℹ, Source Normalized Impact per Paper (SNIP): 1.209 ℹ, SCImago Journal Rank (SJR): 1.456. https://www.journals.elsevier.com/international-journal-of-infectious-diseases/top- articles/. The International Journal of Infectious Diseases (IJID) is published monthly by the International Society for Infectious Diseases. IJID is a peer- reviewed, open access journal and publishes original clinical and laboratory-based research, together with reports of clinical trials, reviews, and some case reports dealing with the epidemiology, clinical diagnosis, treatment, and control of

287 infectious diseases with particular emphasis placed on those diseases that are most common in under-resourced countries.

[114] Technical Committee member for AMS 2020 conference, URL: http://www.apcams.org/comm, Invited by: Betty Y. Chan, On Behalf of Organizing Committee, www.iased.org, http://www.iased.org/bettyother, Flat/rm a 9/f Silvercorp International Tower 707-713 Nathan Road Mongkok, Hong Kong, Email: [email protected]; Tel:+852-30696823. IASEDIsARegisteredNon-Profit International Scientific Research Union of Distinguished Scholars Reg.No.66675552-001-09-16-2. AMS 2020: 2020 2nd Asia-Pacific Conference on Applied Mathematics and Statistics (AMS 2020), When: Feb 17, 2020 - Feb 19, 2020, Sydney, Australia, ●2020 2nd Asia-Pacific Conference on Applied Mathematics and Statistics (AMS 2020)- Ei Compendex & Scopus—Call for papers February 17-19, 2020 ｜ Sydney, Australia｜Website: http://www.apcams.org/, ●Venue: Metro Aspire Hotel Sydney, Sydney, Australia, ●AMS 2020 provides researchers and industry experts with one of the best platforms to meet and discuss groundbreaking research and innovations in the field of Applied Mathematics and Statistics. International invited speakers are invited to present their state-of-the-art work on various aspects, which will highlight important and developing areas. ●Publication and Indexing: All accepted papers will be published in the digital conference proceedings which will be sent to be Indexed by all major citation databases such as Ei Compendex, SCOPUS, Google Scholar, Cambridge Scientific Abstracts (CSA), Inspec, SCImago Journal & Country Rank (SJR), EBSCO, CrossRef, Thomson Reuters (WoS), etc. A selection of papers will be recommended to be published in international journals. ●Keynote Speakers: Prof. Rajkumar Buyya, The University of Melbourne, Australia, Prof. Dr. Priti Kumar Roy, Jadavpur University, India, Prof. Bogdan Gabrys, University of Technology Sydney, Australia, ●Program Preview/ Program at a glance: Feb. 17, 2020: Registration + Icebreaker Reception, Feb. 18, 2020: Opening Ceremony+ KN Speech+ Technical Sessions Feb. 19, 2020: Technical Sessions+ Half day tour/Lab tours.

[114] https://globalhealthcare.pulsusconference.com/organizing-committee.

[115] Editorial Board of Journal of Cancer Science & Treatment (ISSN: 2641-7472), https://www.scitcentral.com/journals.php?journal=25&journal_title=Journal%20of %20Cancer%20Science%20and%20Treatment(ISSN:2641-7472). Journal of

288

Cancer Science & Treatment (ISSN: 2641-7472) is open access, peer-reviewed journals founded by Min Li. The Journal provides a forum for researchers, physicians, and other health professionals to publish high-quality original research on the latest advances of cancer. Journal of Cancer Science & Treatment (ISSN: 2641-7472) aims to improve the lives of those affected by cancer by facilitating the free and open exchange of knowledge in the areas like cell and tumor biology, animal models, carcinogenesis, etiology, Recent developments in tumor therapy, Diagnostic and experimental pathology, cellular signaling and molecular biology, epidemiology, cancer stem cells, cancer-associated pathways, cancer therapies, and other cancer-related research. Journal of Cancer Science & Treatment (ISSN: 2641- 7472) accepts submissions in the field of cancer and biomedical sciences across the globe in the form of Research Articles, Review Articles, Mini-review, Case Reports, Opinion, Letters to the Editor and Editorials, Rapid and Short Communications and Commentary. The Journal follows the policy of quick and quality peer review process of 21 days under the guidance of Editors & Editor-in-Chief to ensure the highest standards of selection and review. Journal of Cancer Science & Treatment (ISSN: 2641-7472) welcomes submissions of manuscripts via Online Submission System or via email to the Editorial Office at [email protected] or [email protected].

[116] Editorial Board Member of International Journal of Diabetes & Metabolic Disorders, Journal DOI: doi.org/10.33140/IJDMD, ISSN: 2475-5451, International Journal of Diabetes & Metabolic Disorders is a peer-reviewed, open access journal that publishes research articles, review articles, as well as clinical studies in all aspects of diabetes research. In addition to general articles on clinical aspects of diabetes mellitus, International Journal of Diabetes & Metabolic Disorders also presents articles on basic research in all areas of diabetes and its related syndromes. This is extremely encouraging for the authors and readers to share important scientific information comprehensively on the relevant topics in the form of original articles, review articles, case reports, short communication, etc. International Journal of Diabetes & Metabolic Disorders publishes articles on all aspects of diabetes including Type 1 Diabetes Mellitus (insulin-dependent diabetes mellitus) or juvenile diabetes, Type 2 Diabetes Mellitus (non-insulin dependent diabetes mellitus), Gestational Diabetes, Endocrinology, Diabetes Therapy, Diabetic Drugs, Genetics of Diabetes, obesity with relation to diabetes, risk factors, associated metabolic

289 disorders etc. Journal Website: https://www.opastonline.com/international-journal- of-diabetes-metabolic-disorders/, Editorial URL: https://www.opastonline.com/editorial-board-ijdmd/, OPAST Group is an open access publishing forum for research and discussions related to contemporary publishing. OPAST Group is a scientific publishing group organized by like-minded researchers, scholars and academia working with prestigious institutions and research organizations across the world. OPAST Group heartily welcomes all the technocrats and authors who had been laying their all in to the area of their interest. It is observed that some researchers or authors have an in depth knowledge in the working field and they work hard for a long time. But they fail to exhibit their work on the world’s platform. OPAST Group publishes their research work globally. In this way the author’s or the researcher’s work reaches to the targeted audience. OPAST Group Journals was initiated with a mission to offer a strong, online journal publishing platform that assists the advancement in research all across the world. The website offers a faster path to the researchers in publishing a high-quality journal. All journal works that attains rigorous ethical and technical standards is published by OPAST Group and is accessible by everyone. The journals that are published on our site are reviewed by leading edge peer. We focus on bringing out the best quality and original research works from scientists, researchers, post graduate students and academia on our online platform. ABOUT US: Opast Publishing Group is an emerging open access journals publisher specializing in all scientific, technical and scholarly disciplines. We operate as an independent publisher with a reputation for quality products and services. Currently, Opast is publishing open access, online, peer-reviewed journals in the areas of science, technology, engineering and medicine. We also serve the global academic communities and contribute to the progress and application of science with our publication. We encourage the promising researchers to submit their valuable manuscripts for publication and also invite reviewers and editors to join editorial team all across the world. Opast is a scientific and medical publishing house committed towards providing a platform to outstanding scientists and researchers to exhibit their findings for the furtherance of science, to provoke debate and promote learning and education. This mission will be carried out through exchanging information, advancing models, setting standards, education, advocacy and the promotion of innovation. Opast has been instrumental in passing the knowledge on Science and technology to the doorsteps of an ordinary people. Opast provides an

290 open access platform for academicians and doctors on the latest scientific procedure, applications, and data interpretation in both clinical and preclinical studies. Opast aim to publish reliable and complete source of information on the current discoveries and developments in the mode of original articles, review articles and case reports, in all areas of the medicine and make them available online without any restrictions. Opast Groups provides a platform for recognition of scholarly works of researchers and dissemination of their innovative ideas worldwide. Students, Libraries, Research Scholars, Research centers and Educational Institutions are main stakeholders that get benefitted greatly from this knowledge dissemination. Our team consists of prominent scientists, physicians, economists and librarians to ensure that our vision of ‘open access’ publishing is feasible and becomes a booming entity which is self- sustaining. We strongly believe that the open access model will spur researches all across the world particularly in developing nations, as researchers gain unrestricted access to quality research articles. We ensure to encourage original and well researched articles for publication and hope to work with our editors, authors and reviewers to create journals, which will be accessible wherever internet is available. Opast Publishing Group is moving ahead with a vision to develop an optimized knowledge sharing platform and an interactive network for researchers around the world through its scientific publications and meetings.

[117] Honorary Editorial Board Member of European Journal for Biomedical Informatics, ISSN: 1801-5603, This journal is one of the official journals of European Federation for Medical Informatics. EFMI Mission and Objectives: To advance international co-operation and dissemination of information in Medical Informatics on a European basis; To promote high standards in the application of medical informatics; To promote research and development in medical informatics; To encourage high standards in education in medical informatics; To function as the autonomous European Regional Council of IMIA, Activities and Governance: All European countries are entitled to be represented in EFMI by a suitable Medical Informatics Society. The term medical informatics is used to include the whole spectrum of Health-/Socialcare Informatics and all disciplines concerned with Health-/Socialcare and Informatics. The organisation operates with a minimum of bureaucratic overhead. Each national society supports the federation by sending and paying for a representative to participate in the decisions of the Federation’s Council, the membership assembly. Apart from the Council, an elected board consisting of

291 nine members governs EFMI.English has been adopted as the official language, although simultaneous translation is often provided for congresses in non-English speaking countries. Membership and Organization: Currently 32 countries have joined the Federation, including Armenia, Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Israel, Italy, Moldova, The Netherlands, Norway, Poland, Portugal, Romania, Russia, Slovenia, Spain, Sweden, Switzerland, Turkey, Ukraine and United Kingdom. All representative societies in countries within the European Region of the WHO are entitled to apply for membership. EFMI is also open for institutional membership. Typical institutions, which become EFMI members, include universities, research organisations, federations, industries and organisations. Currently, 16 organisations have become institutional members of EFMI: 3 universities, 9 industrial companies and 5 not for profit organizations. EFMI has a long tradition in working groups (WG) which are organising and supporting events and projects on a European basis but also worldwide in close co-operation with national and international WGs and institutions. The EFMI council has extended the model of WGs during MIE2011 in Oslo by Project Groups (PG). PGs are established for 3 years. When the concept of the project group proofs to be successful there is an option to become a working group of EFMI. EFMI does not offer personal membership except for the working groups. Congresses and Publications: EFMI organizes two main series of conferences: the Special Topic Conferences (EFMI-STC) and Medical Informatics Europe (EFMI-MIE). In conjunction or independent of the main congress series, working groups in addition organize topic specific workshops, tutorials and seminars. Medical Informatics Europe Conferences (MIE): So far 24 MIE congresses (Medical Informatics Europe) have been organised by the national members and EFMI with up to more than 1000 participants. The concept includes per-reviewed presentations according to the type of paper as oral or poster presentation. Workshops and tutorials prepared or supported by EFMI working groups are an essential part of EFMI MIE conferences. https://efmi.org/.

[118] Editorial Board Member of Current trends in Internal Medicine (ISSN 2638- 003X), Current Trends in Internal Medicine is an online, open access journal covering prevention, diagnosis, and treatment of adult diseases both in academic and community-based practice. The journal owes to create a forum of Physicians

292 specialized in internal medicine for improvising this form of practice and its popularity worldwide. Internists especially skilled in the management of patients ‘treatment who have undifferentiated or multi-system disease processes are highly welcomed to contribute their research experiences to the journal by submitting manuscripts. Internists involved in care for hospitalized, ambulatory patients and playing a leading role in teaching and research are tremendously encouraged to get their exposure at global level by associating with it. Aim and Scope: The main objective of the journal is to maintain and develop science and related research towards internal medicine at an international level. It is important to bring into major field of internal medicine publication, publishing original medical research, both laboratory and clinical, relating to the study and research of human disease from all over the world. Current Trends in Internal Medicine is a scientific, peer-reviewed journal which covers high quality manuscripts which are both relevant and applicable to the broad field of internal medicine. This journal encompasses the study related to medicine and influence patient care. Journal Impact Factor 0.85, URL: https://www.gavinpublishers.com/journals/journals_details/current-trends-in- internal-medicine-ISSN-2638-003X.

[119] Editorial Board Member of Theranostics of Brain, Spine & Neural Disorders (TBSND), ISSN: 2641-8096, URL: https://juniperpublishers.com/tbsnd/.

[120] Reviewer Member of Reviewer Recruitment Module (RRM), Member ID: 131570, Operating Hours. Monday-Friday 8 AM - 6 PM ET, Phone. 1.866.424.2637, Email. HRSA Only: [email protected], All Other Agencies: [email protected]. Website:: https://rrm.grantsolutions.gov/Account/Login?ReturnUrl=%2FHome%2FDashBoa rd.

[121] Editorial Board Member of European Journal for Biomedical Informatics EFMI, URL: https://www.ejbi.org/, EB URL: https://www.ejbi.org/editorial- board.html, Aims and Scope: European Journal for Biomedical Informatics is an online journal publishing submissions in English language, which is devoted towards the progress in biomedical science. The journal welcomes all types of research communications through its rational open access window to maximize the possibilities of global reach for each article. The frequency of issue release is biannual, and strictly supported by peer-review process. The primary aim of the

293 journal is to make all the information’s freely available irrespective of different socio-economic barriers, which further will help in the progress of science. Moreover, the journal intends to showcase all the timely research information on biomedical informatics and its related studies for the effective contribution in the field of biomedical methods and technologies. European Journal for Biomedical Informatics is dealing with a range of topics which is included under the scopes of biomedical informatics. The focus of the journal is on the major aspects of implementation of information science in Medical sciences, which includes Biomedicine, Biometrics, Health informatics, Medical informatics, Clinical informatics, Dental Informatics, Semantics Interoperability, Ontology, Medical devices, Informatics applications in Imaging, Telemedicne/Telehealth, Artificial intelligence in healthcare. Such key topics and associated plenty of sub-topics are the scope of the journal. Certainly, quality and standard are the major issue on which the journal emphasizes most. The research articles of the journal are exceptionally high standard in terms of fact and ethical considerations. The journal put forwards the strict concern for accuracy and authenticity of the communicated article before all nominal need of the journal. Original contribution in terms of research, review, short-communication, case reports, are welcomed from the authors, who are engaged in medical or academic research. The articles selected for publication, must have to go through critical process of peer-review as per journal norms. A well-constructed editorial board is the higher most determining authority for the journal, which is formed by highly experienced subject experts in the field of biomedical informatics. Section editors and guest editors are also engaged there to maintain topic specific proper evaluation of research manuscripts. European Journal for Biomedical Informatics encourages researchers to submit relevant research works within the scope of the journal. To submit manuscripts, authors can use our Online Manuscript Submission System or can send their manuscripts directly to our Editorial Office at [email protected] or [email protected]. Publication Ethics and Publication Malpractice Statement This journal follows the guidelines of the International Committee of Medical Journal Editors (www.icmje.org) and the Committee on Publication Ethics (www.publicationethics.org). *2019 Journal Impact Factor was established by dividing the number of articles published in 2017 and 2018 with the number of times they are cited in 2019 based on Google Scholar Citation Index database. If 'X' is the total number of articles published in 2017 and 2018, and 'Y' is the number of times these articles were cited in indexed journals during 2019 then,

294 impact factor = Y/X. All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal, ISSN: 1801-5603.

[122] Reviewer at Journal of Business Research, Editors-in-Chief: Naveen Donthu, Anders Gustafsson, ISSN: 0148-2963, CiteScore: 5.32 ℹ, Impact Factor: 4.028 ℹ, 5- Year Impact Factor: 4.747 ℹ, Source Normalized Impact per Paper (SNIP): 1.920 ℹ, SCImago Journal Rank (SJR): 1.684, The Journal of Business Research applies theory developed from business research to actual business situations. Recognizing the intricate relationships between the many areas of business activity, JBR examines a wide variety of business decisions, processes and activities within the actual business setting. Theoretical and empirical advances in buyer behavior, finance, organizational theory and behavior, marketing, risk and insurance and international business are evaluated on a regular basis. Published for executives, researchers and scholars alike, the Journal aids the application of empirical research to practical situations and theoretical findings to the reality of the business world. Website: https://www.journals.elsevier.com/journal-of-business-research.

[123] Associate Editorial Board member in Theranostics of Brain, Spine & Neural Disorders (TBSND), https://juniperpublishers.com/tbsnd/editorialboard.php. ISSN: 2641-8096.

[124] Organizing Committee Member of Annual Meeting on Cancer Research (Cancer Conference 2020) during 26 – 27 October, 2020 at Dubai, UAE. Global Episteme Conferences invites all the participants from all over the world to attend “Annual Meeting on Cancer Research” which is going to held in Dubai, UAE scheduled from October 26-27, 2020. The theme will focus on “Future Outlook and Peculiar Trends in Cancer Research”. Aim & Scope: Cancer Conference 2020 is a two-day conference provides a premier interdisciplinary platform for researchers, practitioners and educators to talk about the most latest innovations, trends, and issues as well as challenges encountered and options adopted in the fields of Cancer research. Our goal is to have all the scientists, doctors, professors, researchers, and students under one roof and share their idea provoking thoughts to the global scientific community. Cancer Conference 2020 includes prompt Keynote talks, Oral talks, Poster presentations, Workshops and Exhibitions. Come be a part of our esteemed event. We look forward to see you in Dubai, UAE. Who should attend?

295

Target audience are Doctors, Scientists, Cancer Researchers, Cancer Research Students, Cancer Associations and Societies, Oncologists, Radiologists, Chemotherapists, Pathologists, Hematologists, Immunologists, Professors, Associate Professors, Assistant Professors, Physicians, Healthcare Professionals, Medical Industry Experts, Scholars, Decision Makers, Business Entrepreneurs and other Professionals. Why Should Attend? Cancer Conference 2020 could be an exceptional event that brings along a novel and International mixture of cancer analysis techniques and technology, leading universities and cancer analysis establishments creating the conference an perfect platform to share expertise, foster collaborations across trade and world, and investigate rising technologies across the world. World-renowned speakers, the most recent techniques, tactics, and the newest updates in cancer research are hallmarks of this conference. Market Research Analysis: Worldwide cancer influences more than 10 million human beings each year and this incidence is predicted to expand by 2.4% yearly to reach 14 million per yr by 2020. Cancer is the 2nd most common demise in the industrialized world. According to the UK based Cancer Research Institute, distinctive types of cancer have been responsible for around 9.6 million deaths in the world in the yr. 2018. Cancer is a sickness characterized by way of uncontrolled telephone proliferation. Of the more than one hundred kinds of cancer, lung, breast, and colorectal most cancers account for nearly half of new cases per year in the United States. Lung cancer, which is rather correlated with cigarette smoking, is responsible for more deaths than any other form of cancer. Cigarette smoking and different environmental elements are related with the majority of cancers.

[125] Editorial Board Member of ournal of Rehabilitation Practices and Research, Journal of Rehabilitation Practices and Research is a peer reviewed open access journal dedicated to publish the best quality original, peer-reviewed research and clinical reports in evidence-based and practice-based medical rehabilitation. The aim of the journal is to offer valuable resource for researchers, clinicians, counselors, occupational therapists, physiotherapists, nurses and case managers to improve lives of individuals with disability. Gexin Publication: Gexin Publications is a global Open Access Publisher devoted to publish highest quality journals and provide all research societies a good publishing platform. We work on the open-access model and provide peer-reviewed content with the support of lead researchers and scholars from different countries across the universe and from different academic disciplines.

296

Gexin Publications is based in Odisha India.We follow the best ethical conduct and we strictly follow the Ethical policy and Editor guidelines by: COPE (Committee on Publication Ethics), ICMJE (International Committee of Medical Journal Editors), WAME (World Association of Medical Editors), All the journals follow the creative commons license: Creative Commons Attribution 4.0 International License. Website: https://gexinonline.com/, Journal Website: https://gexinonline.com/journal/journal-of-rehabilitation-practices-and-research, Editorial Board URL: https://gexinonline.com/journal/journal-of-rehabilitation- practices-and-research/editorial-board, Contact Details: Our Location: Plot No. - 156, Basantapedi, Bhubaneswar, Odisha, India, Pin – 752100, Phone: +91 7682 913 291, Email: [email protected]. Website: www.gexinonline.com.

[126] Editorial Board of International Journal of Clinical Nursing & Care, Nursing is a worldwide companion evaluated academic diary distributes amazing original copies on creative research covering all parts of Nursing and Medicinal services. The extent of points shrouded in the diary incorporates General Well-being Nursing, Propelled Work on Nursing, Family Nursing, Basic Consideration Nursing including Medical procedure, Pediatrics, Prescription, Maternity care and Obstetrical Nursing, Mishap, Crisis, Cardiovascular, Renal, Neurosciences, Hematology, and so forth. Diary of Nursing and Human services acknowledges Unique Exploration Articles, Survey Articles, Case Reports, Smaller than normal Audits, Fast Correspondence, Sentiments and Publications on every single related part of nursing and social insurance. Authors are requested to submit their articles at https://omspinternational.com/manuscript, or send as an email to [email protected], Editorial Board URL: https://omspinternational.com/Omsp_controller/editorial_board/17. Office: Locations: 535,Bronze Drive Lexington. South Carolina 29072, United States. [email protected], OMSP INTERNATIONAL: OMSP International publishes Open Access journals that are peer reviewed, widespread, and keeps up its standards and makes an astounding position, in setting up specialists by disseminating quality research that attracts the authors, researchers and experts all around the world. Our goal is advancement of the data in science and its divulgences that drives its way to deal with new manifestations which structures marvellous focal points and for individuals in their lives. OMSP International follows strict policies and expect the same from its readers, authors, editors and reviewers and also

297 maintain the privileges of creators, address their necessities, and cultivate a quick, advantageous, fair-minded, and exhaustive distributing condition, which not just ensures the most elevated quality useful companion survey process, yet in addition gives an assessment framework that includes the whole research network. To satisfy this mission, OMSP International applies the most developed Internet innovations to bring insightful publishing into new generation.

[127] Editorial Board of Journal of Animal Science and Veterinary Medicine, ISSN: 2536-7099, Model: Open Access/Peer Reviewed, DOI: 10.31248/JASVM, Start Year: 2016, Email: [email protected], About JASVM: Journal of Animal Science and Veterinary Medicine (JASVM) (ISSN: 2536-7099) (DOI: 10.31248/JASVM) is an open access, peer-review journal that publishes articles in all areas of Animal Science and Health. The Journal is positioned to provide the most rapid system for reviewing and publishing. The articles published in JASVM will be of tremendous contribution to the field of Veterinary, Medicine and Agriculture. Journal of Animal Science and Veterinary Medicine publishes bimonthly. All published articles are freely accessible and hard copies of the published articles will be made available to the interested authors on request. Scope of JASVM: The subject areas suitable for publication by JASVM include, but are not limited to the following fields: Veterinary science, Animal husbandry, Animal nutrition, Anatomy, Biological science, Animal Pathology, Animal microbiology, Infectious diseases, Animal parasitology, Animal physiology, Animal breeding Animal biotechnology, Animal Genetics, Transgenic animal production, Veterinary medicine, Equine, Animal reproduction, Animal ethology, Animal products technology, Animal management and economics, Poultry farming etc. Website: https://integrityresjournals.org/journal/JASVM.

[128] Editorial Board Member of Current Trends in Gastroenterology and Hepatology (CTGH) (ISSN: 2641-1652), Journal Website: https://lupinepublishers.com/gastroenterology-hepatology-journal/, Current Trends in Gastroenterology and Hepatology is a multi-faceted Open access online journal exclusively allocated to novel work in the fields of Gastroenterology and Hepatology. We thirst for break-through research which is of high standards and contributes to current trends in Gastroenterology and Hepatology. It imparts readers with wide range of themes and provides scientific excellence for researchers. Each article contains reliable research information from eminent experts in their

298 respective fields and subjected to immense peer review. The Journal covers broad spectrum of pivotal themes in Diagnostic, Pathologic, Therapeutic, and Endoscopic advances. It focuses to publish complete and authentic information on the discoveries and present developments in the form of research articles, opinions, case reports, review articles, etc. https://lupinepublishers.com/gastroenterology- hepatology-journal/index.php. Contact Us: Lupine Publishers, LLC. 57 West 57th Street, 3rd floor, New York - NY 10019, USA, +1 (914) 407-6109, Fax - +1 (914) 465-7596, [email protected].

[129] Editorial Board member and Associate Editor of Open Access Journal of Complementary & Alternative Medicine, ISSN: 2644-1217, Impact Factor: 3.637, Journal Website: https://lupinepublishers.com/complementary-alternative- medicine-journal/index.php, Editorial Panel URL: https://lupinepublishers.com/complementary-alternative-medicine- journal/editorial-committee.php, Open Access Journal of Complementary & Alternative Medicine (OAJCAM) is an international peer-reviewed, Open Access journal that seeks to understand the scientific evaluation and integration of complementary and alternative medicine into mainstream medical practice. Journal deals with the original research that directly impacts protocols, patient care therapies and strategies. An important focus is given on subjects related to Standard medical care, Complementary medicine, Alternative medicine, Integrative medicine Ayurveda, Naturopathy, Homeopathy, clinical medicine, clinical events, as well as the related field. Email: [email protected], [email protected], Editorial Manager: Cynthia Paul, Contact: Lupine Publishers, LLC, 57 West 57th Street, 3rd floor, New York - NY 10019, USA, +1 (914) 407-6109, Fax - +1 (914) 465-7596, [email protected].

[130] Editorial Board of Online Journal of Otolaryngology and Rhinology – OJOR, ISSN: 2688-8238, https://irispublishers.com/ojor/, Online Journal of Otolaryngology and Rhinology (OJOR) is an interdisciplinary open access journal focused on publishing high quality articles of otolaryngology with the support of our esteemed editorial team who suggest us in the journal growth. As otolaryngology is a vast subject which helps the researchers and professionals to perform their research work and explore their new methods and techniques to the world. OJOR includes disorders of the ear, nose, throat, base of the skull, head and neck structures and all aspects that falls under the scope of journal. OJOR is a monthly published journal

299 which provides a forum to submit their all types of articles like Editorial, Letter to Editor, Research, Review, Case Report, Short Communication, Perspectives, Mini Review, Clinical Images, Opinion, e-Books, Video articles etc. Contact Details: Iris Publishers, LLC, 315 Montgomery Street, San Francisco, CA 94104, USA, +1- 628-201-9788, Fax - +1-415-962-0669, [email protected].

[131] Editorial Board Member of Medical Research and Clinical Case Reports [ISSN: 2578-3416], About Us: Scientia Ricerca is an Open Access online publishing group which features originally and thought to provoke innovative and scientific excellence pertaining to various interdisciplinary areas. We work with a mission to spread noteworthy ideas and empowers you with endless research information in this fast growing scientific world. Our Estimable editorial & advisory panel members of well-known universities and experts on those subjects, we at Scientia Ricerca strive to become a top notch provider of knowledge and information with a stringent peer review. This ensures our publishing is of superior quality and an efficient platform. Stupendous supervision for quick review and tracking system to trace the article processing for all authors who submitted their precious papers. We aspire to fast track the reviews & processing procedure to compress the time between submission, and acceptance of the manuscript in our prestigious journals. Choosing us for your research work will provide you an opportunity to reach out to the wider community and plays an instrumental role in expanding the reach of research information in the real time, which in turn helps in furthering the research. Get In Touch: Scientia Ricerca, 14160 Red Hill, ve,Tustin, CA 92780,USA. +1 949-783-6980, [email protected], www.scientiaricerca.com, https://www.scientiaricerca.com/mrcr-articles.php. Medical Research and Clinical Case Reports (MRCR) is peer-reviewed, open access journal presenting original research and reports that expands the field of general medical knowledge. Contributions in MRCR grouped into all aspects of biomedical, clinical, and epidemiological that provides timely publication of original research, review articles, case reports and mini review articles etc. Benefits to authors: Medical Research and Clinical Case Reports provide many author benefits, such as free PDFs, A liberal copyright policy, Fast and efficient online submission. Increased visibility of the research work. Special discounts on publications and much more. We heartily welcome to send your valuable manuscript as an email attachment to the Managing Editor at [email protected].

300

[132] Editorial Board Member of Kosmos Publishers, Current Research in Oncology, Current research in Oncology is an online open access scientific journal which publishes peer reviewed articles from all the subjects of Cancer research and topics related to Oncology essentially for all those with an active interest in the treatment of cancer. Focus: Oncology Research and Therapy deals with diagnosis, treatment of cancerous tumours of different types. It mainly focuses on the progress of clinical and basic research for cancer which promotes to understand the causes and their cure with best possible advancements. This journal works to accelerate the advanced clinical research for cancer patients and its prevention towards it by publishing original research articles, review articles, case reports, brief reports, communications, image articles, commentaries, etc. Mostly diagnosis techniques like Biopsy, Endoscopy, X-rays, MRI, CT scan, Blood tests can be followed to determine malignancy are realms of high interest for the journal publications. There is tremendous ongoing research on the treatment of different categories of cancer like chemotherapy, radiotherapy and surgery, where our journal plays a vital role in focusing the improvements in treatment and cancer detection thereby enhances the quality of life. All published articles are permanently archived and available at Kosmos Publishers website in HTML and PDF formats. https://kosmospublishers.com/oncology-research-and-therapy/. Address: Harrison Ave, Harrison, New Jersey-07029, USA. Email: [email protected], [email protected], © 2018 kosmospublishers.com.

[133] Editorial Board Member of Journal of Clinical Review & Case Reports, Journal DOI: doi.org/10.33140/JCRC, https://www.opastonline.com/journal-of- clinical-review-case-reports/. Journal of Clinical Review & Case Reports is a peer reviewed Journal that publishes novel research work conducted as reviews and case reports in the medical field on various types of diseases, covering their respective clinical and diagnosis issues. The Journal also emphasizes to publish reviews in basic, fundamental, critical and state of the art review articles in the field of Medicine and Clinical sciences. We aim to publish high quality original case reports and reviews across all medical disciplines contributing greatly to the advancement of health care. Opast Publishing Group is an emerging open access journals publisher specialising in all scientific, technical and scholarly disciplines. We operate as an independent publisher with a reputation for quality products and services. Currently, Opast is publishing open access, online, peer-reviewed journals in the areas of

301 science, technology, engineering and medicine. We also serve the global academic communities and contribute to the progress and application of science with our publication. We encourage the promising researchers to submit their valuable manuscripts for publication and also invite reviewers and editors to join editorial team all across the world. Opast is a scientific and medical publishing house committed towards providing a platform to outstanding scientists and researchers to exhibit their findings for the furtherance of science, to provoke debate and promote learning and education. This mission will be carried out through exchanging information, advancing models, setting standards, education, advocacy and the promotion of innovation. Opast has been instrumental in passing the knowledge on Science and technology to the doorsteps of an ordinary people. Opast provides an open access platform for academicians and doctors on the latest scientific procedure, applications, and data interpretation in both clinical and preclinical studies. Opast aim to publish reliable and complete source of information on the current discoveries and developments in the mode of original articles, review articles and case reports, in all areas of the medicine and make them available online without any restrictions. Opast Groups provides a platform for recognition of scholarly works of researchers and dissemination of their innovative ideas worldwide. Students, Libraries, Research Scholars, Research centers and Educational Institutions are main stakeholders that get benefitted greatly from this knowledge dissemination. Our team consists of prominent scientists, physicians, economists and librarians to ensure that our vision of ‘open access’ publishing is feasible and becomes a booming entity which is self- sustaining. We strongly believe that the open access model will spur researches all across the world particularly in developing nations, as researchers gain unrestricted access to quality research articles. We ensure to encourage original and well researched articles for publication and hope to work with our editors, authors and reviewers to create journals, which will be accessible wherever internet is available. Opast Publishing Group is moving ahead with a vision to develop an optimized knowledge sharing platform and an interactive network for researchers around the world through its scientific publications and meetings. ISSN: 2573-9565.

[134] Editorial Board Member of International Journal of Clinical Case Reports and Reviews, ISSN 2690-4861, Journal DOI: 10.31579/2690-4861/ijccr, About the Journal: International Journal of Clinical Case Reports and Reviews (IJCCR) is a peer reviewed Journal that publishes novel research work conducted as case reports

302 in the medical field on various types of diseases, covering their respective clinical and diagnosis issues. Our aim is to directly improve global health outcomes and share clinical knowledge using case reports to convey important best practice messages. We welcome case reports, clinical images, and procedural videos from all areas of Medicine, Nursing, Dentistry, Psychology, Medical Ethics, Social Work and Veterinary Science. All the articles submitted to IJCCR subject to rigorous double- blind peer review process under the guidance of an international editorial board consisting of a distinguished team of researchers and reviewers. Open Access Policy: This journal is an open access journal which provides immediate, worldwide, boundary-free access to the full content of every distributed article without charging readers or their institutions for access. Readers are given the authorization to read, circulate, copy, print, download, search, or link to the full texts of all articles in IJCCR. IJCCR implements the Creative Commons Attribution License to all works published providing instant and permanent access for free to all types of original works. The license grants copyright to the author concerned and makes the articles available for their dissemination. Anyone can use the articles in any constructive way as long as the credit is given to the author and citation to the original source. About AUCTORES: Auctores is an emerging international open access publisher aimed at development and rapid dissemination of scientific knowledge to the global community without any restrictions. Auctores encompasses journals on discipline of science, technology and engineering, publishes the work in a manner that represents the highest standards and integrity. We run the operation in accordance with (COPE) guidelines which is universally acceptable. We are steadfast to safeguard the highest standards of publication ethics and take all probable actions contrary to publication misconduct, as stated in the Code of Conduct and for resolving the case suspected malpractice in publication ethics we follow COPE Flowcharts. We encourage the academics all over the globe of various fields to get connected with Auctores and publicize their findings. We follow rigorous standard peer review process and accept papers from all parts of the globe and there is no demographic, racial, and socioeconomic barriers. Auctores facilitate the dissemination of research discoveries to the global community without restriction. Thus, all articles published in Auctores journals are freely available online. Another slogan behind the establishment of Auctores is to act as a connecting link among researchers, academia, industry and policy makers. We planned a display place to emphasize quality innovative work and to encourage move towards to serve the scientific community with 30 worldwide

303 open access, peer reviewed journals via the academics who focus on science, technology and engineering discipline through the work they publish with us. Auctores encompasses the time and quality consequently drives us on the way to the achievement and development of our ideas; broadening in our excellence services to guide our associates and figure out our commitment. Our opinion is welcoming Novelties and a vision to authorize the existing researchers to enlighten the scientific world, expanding its support in guiding the academics and researchers in all parts of the globe. Auctores is ardent supporter to The Budapest Open Access Initiative (BOAI). In accordance with the (BOAI): All articles published by Auctores journals are under the terms of Creative Commons Attribution License. This permits anyone read, download, copy, share, print or use them for any other legalized determination, without asking permission from the publisher or the author, the original work and source is appropriately cited. the articles having National Institutes of Health (NIH), Administration for Community Living (ACL), Agency for Healthcare Research and Quality (AHRQ), Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA) Office of the Assistant Secretary for Preparedness and Response (ASPR), National Aeronautics and Space Administration (NASA), National Institute of Standards and Technology (NIST),U.S. Department of Veterans Affairs (VA) funding will be indexed in PubMed immediately upon acceptance.

[135] Editorial Board Member of Clinical Practice (Therapy), ISSN: 2044-9046, PUBMED NLM ID: 101579384, Journal Website: https://www.scholarscentral.org/submissions/clinical-practice-therapy.html. ISSN: 2044-9038 (Print) 2044-9046 (Electronic), H Index: 8, Scopus SJR 2018: 0.1, Journal Impact Factor: 2.4*, ICV 2016: 75.95, PubMed NLM ID: 101579384, Clinical Practice (Therapy) journal is an open access, peer reviewed scholarly journal that provides an open platform for the worldwide dissemination of original and novel scientific manuscripts based on the various aspects of the adept practical approaches to disease management. The journal prioritizes the publication of manuscripts that can provide useful insights into the real time efficacy and persisting lacunae in the various principles, tools and techniques involved in the diagnosis and treatment of acute and chronic diseases. The journal acts as a bridge between the medical community and the general population by dispersing scientific advancements in medical and clinical research and manuscripts that highlight on

304 how these research advancements can change the currently followed medical procedures. The scope of the journal encompass a broad range of topics including translational science research, genetics, immunology, nutrition, psychosocial research, epidemiology and multidisciplinary team approaches towards imparting quality healthcare services. The journal also welcomes articles written by doctors, physicians and medical giants that present their personal perspectives in treating commonly as well as rarely occurring diseases. The journal invites submission of Phase III clinical trial results as well as outcomes from phase IV/post-marketing studies on novel drugs used in clinical practice. Furthermore, manuscripts describing multiple facets of diabetes research and clinical practice, prevention, technologies and therapy, socio-economic research, complications, new treatments, evidence- based treatment guidelines, unmet clinical needs and therapeutic burden are solicited. Overall, the journal targets promotion of safe and efficacious clinical practices by publishing original data from clinical investigations. You may submit manuscripts online at https://www.scholarscentral.org/submissions/clinical- practice-therapy.html, or as an email attachment to [email protected] or [email protected], Clinical Practice(Therapy) is indexed in the quality indexing sites such as Scopus*, EMBASE/Excerpta Medica, Google Scholar, Publons, CNKI, Open J-Gate to standardized visibility and maintain publication standard. *Published as Therapy (ISSN 1475-0708) until November 2011 (Vol.8, No.6) *2019 Journal Impact Factor was established by dividing the number of articles published in 2017 and 2018 with the number of times they are cited in 2019 based on Google Scholar Citation Index database. If 'X' is the total number of articles published in 2017 and 2018, and 'Y' is the number of times these articles were cited in indexed journals during 2019 then, journal impact factor = Y/X.

[136] Editorial Board Member of Current Trends in Complementary and Alternative Medicine (ISSN: 2641-6905), Current Trends in Complementary and Alternative Medicine (ISSN: 2641-6905) publishes high-quality articles which contribute new theoretical results in all the areas of Alternative Therapies in Health and Medicine, Integrative Medicine, Herbal Medicine, Traditional Medicine and many more. Harrison Ave, New Jersey-07029, USA.

[137] Editorial Board Member of Journal of Dermatology and Clinical Research, ISSN: 2373-9371, Journal of Dermatology and Clinical Research is an open access, peer reviewed academic Journal that deals with skin and its diseases. It widely covers

305 research happening in the field concerned with the problems associated with skin, scalp, hair and nails. This journal provides novel insights upon the Cosmetic dermatology, Dermatopathology, Immunohematology, Mohs surgery, Pediatric dermatology, Tele dermatology and Therapies. As a part JSciMed Central Open Access platform, Journal of Dermatology and Clinical Researchsupports the scientific innovation and advancement in osmetic dermatology, Dermatopathology, Immunodermatology, Mohs surgery, Pediatric dermatology, Teledermatology research community by increasing access to peer reviewed scientific literature. JSciMed Central also brings multiple internationally peer reviewed member journals under one roof thereby encouraging knowledge sharing, collaboration and promotion of interdisciplinary science. The Journal invites variety of article types such as Original Submissions, Reviews, Mini Reviews, Case Reports, Clinical Images, Short Communications, Perspectives and Editorials. URL: https://www.jscimedcentral.com/Dermatology/index.php.

[138] Editorial Board of European Journal for Biomedical Informatics Journal, ISSN: 1801-5603, https://www.ejbi.org/editorial-board.html, General Queries: For subscription requests or cancellations, or reprint requests, please contact us by e- mail at [email protected], Address: EJBI Group SA, Avenue Roger Vandendriessche, 18, 1150 Brussels, Belgium, Phone: +34 911 877 608, Email: [email protected]. Aims and Scope: European Journal for Biomedical Informatics is an online journal publishing submissions in English language, which is devoted towards the progress in biomedical science. The journal welcomes all types of research communications through its rational open access window to maximize the possibilities of global reach for each article. The frequency of issue release is biannual, and strictly supported by peer-review process. The primary aim of the journal is to make all the information freely available irrespective of different socioeconomic barriers, which further will help in the progress of science. Moreover, the journal intends to showcase all the timely research information on biomedical informatics and its related studies for the effective contribution in the field of biomedical methods and technologies. European Journal for Biomedical Informatics is dealing with a range of topics which is included under the scopes of biomedical informatics. The focus of the journal is on the major aspects of implementation of information science in Medical sciences, which includes Biomedicine, Biometrics, Health informatics, Medical informatics, Clinical informatics, Dental Informatics,

306

Semantics Interoperability, Ontology, Medical devices, Informatics applications in Imaging, Telemedicine/Telehealth, Artificial intelligence in healthcare. Such key topics and associated plenty of sub-topics are the scope of the journal. Certainly, quality and standard are the major issue on which the journal emphasizes most. The research articles of the journal are exceptionally high standard in terms of fact and ethical considerations. The journal put forwards the strict concern for accuracy and authenticity of the communicated article before all nominal need of the journal. Original contribution in terms of research, review, short-communication, case reports, are welcomed from the authors, who are engaged in medical or academic research. The articles selected for publication, must have to go through critical process of peer-review as per journal norms. A well-constructed editorial board is the higher most determining authority for the journal, which is formed by highly experienced subject experts in the field of biomedical informatics. Section editors and guest editors are also engaged there to maintain topic specific proper evaluation of research manuscripts. European Journal for Biomedical Informatics encourages researchers to submit relevant research works within the scope of the journal. To submit manuscripts, authors can use our Online Manuscript Submission System or can send their manuscripts directly to our Editorial Office at [email protected] or [email protected]. Publication Ethics and Publication Malpractice Statement This journal follows the guidelines of the International Committee of Medical Journal Editors (www.icmje.org) and the Committee on Publication Ethics (www.publicationethics.org). *2019 Journal Impact Factor was established by dividing the number of articles published in 2017 and 2018 with the number of times they are cited in 2019 based on Google Scholar Citation Index database. If 'X' is the total number of articles published in 2017 and 2018, and 'Y' is the number of times these articles were cited in indexed journals during 2019 then, impact factor = Y/X.

[139] Editorial Board Member of Journal of Addiction & Prevention, ISSN: 2330- 2178, Journal of Addiction & Prevention is an online peer reviewed Open Access journal that encompasses all the habits that leads to addiction, such as tobacco, alcohol, narcotics, illicit drugs and behavioral addictions and focuses on latest and innovative research pertaining to preventive measures. Journal Statistics: Articles Published: 48, Citations: 73, Impact Factor: 2.50, Downloads & Views: 1244, Avens Publishing Group is an international, Open Access publisher of peer-reviewed journals encompassing a broad spectrum of scientific research and technological

307 disciplines. Avens originated with a rigid commitment of serving the scientific and research community by inviting innovations and a vision to encourage the existing scientists, experts and young scientists to enlighten the common society. Avens is a newly started Open Access seeking for the support from individuals, institutes, libraries, universities, funding agencies, and others. Presently we are in our way to serve the scientific community with 46 international Open Access peer-reviewed journals with our aim of Inviting Innovations. Support us In Open Access publishing systems, publishers are paid a fair price for the peer-review, editing, and production services they provide and the complete contents of every journal is made freely available online once the articles are published. We are seeking for creative ways to support and launch of new journals, the investment in new publishing technologies, efforts to increase awareness of, and commitment to Open Access. To support us, please E-mail us your details at [email protected] for information. Avens Publishing Group LLC, 6201 Walter Way, Ellicott City, MD 21043, USA, Tel: +1 (443)-727-7717.

[140] Editorial Board Member of Academic Journal of Pediatrics and Neonatal Health, Academic Journal of Pediatrics and Neonatal Health (AJPNH) is a peer- reviewed journal published by Springfield Publisher. It is and international peer- reviewed journal that provides a tool for publication of elevated quality and fundamental research on all aspects of Pediatrics and Neonatology Health. We welcome manuscripts from all over the world to spread the scientific knowledge in all aspects of Neonatology, Pediatrics and Adolescent Health. JNPA dedicates each issue to a timely and applied topic in Neonatology, Pediatrics, presented by foremost experts in the field. Academic Journal of Pediatrics and Neonatal Health accepts extreme quality submissions presented as an original Research, Review Articles, Case Reports, Mini- Review, Opinions, Letter to Editors, etc., in all aspects of Neonatology, Pediatrics and Adolescent Health. The journal provides readers to access easy information that enhances qualified experience and is appropriate to daily pediatric practice. Springfield publishers is the publisher of the world's most prominent journals and a forerunner in the field of open peer research. Our Journals cover all the major disciplines of medicine, science, engineering, technology, and social sciences through subject specific titles. Springfield publishers is one of the proud members of the open access research publisherswhich provides publishing services for peer-reviewed, online journals in medicine, science, engineering,

308 technology and social sciences on behalf of educational societies and associations with a focus on evolving markets of scientific academia. Address: Springfield Publishers, L LC, 2102 Business Center Drive, Suite 130, Irvine, California 92612, USA, Phone: +1 (909) 844-1022, Email : [email protected]. URL: https://springfieldpublishers.com/journal-of-pediatrics-and-neonatal-health/.

[141] Editorial Board Member of Global Journal of Orthopedics Research – GJOR, Global Journal of Orthopedics Research (GJOR) is an open access journal covering the latest advances in clinical practice and research. It contains original articles addressed to orthopedic surgeons specializing in sports medicine, athletic trainers and physical therapists focusing on the causes and effects of injury or disease resulting from or affected by athletic injury. GJOR provides a forum for papers of the highest quality pertaining to all areas of the biology and pathophysiology of bone, hormones that regulate bone and mineral metabolism and treatment of disorders of bone and mineral metabolism will guide the freshers who starts research recently. It is a monthly published journal which accepts all types of articles like Editorial, Research, Review, Case Report, Short Communication, Perspectives, Mini Review, Clinical Images, Letter to Editor, e-Books, video articles etc. ISSN: 2687-816X, Aim & Scope: The main aim of Iris Publishers is to exploit the scientific information throughout the globe with easily accessible data in most convenient electronic formats. As an Open access publisher we offer a great podium for every researcher to share their knowledge with a wider audience of the scientific community. Here we are providing our services in diversified academic disciplines with a mission to publish innovative research in the fields of science, medicine and technology. Objectives: The main objective of Iris Publishers is to unfold the quality research globally. With world leading expertise and innovation, we bring together the cutting edge technology and data insights to everyone we serve. URL: https://irispublishers.com/gjor/.

[142] Dental Sciences: Current Research, [email protected], About Journal: Dental Sciences: Current Research (DSCR) is a multidisciplinary journal to provide a forum for the demonstration and analysis of original, advanced and incendiary ideas in the field of dental sciences. Dental Sciences: Current Research is an international, open access, peer reviewed, scientific and scholarly journal that publishes all type of manuscripts like research, review, mini reviews, case reports, short communications, letter to editor, editorials, etc. which covers all the aspects of

309

Dental Sciences. This journal covers wide range of topics related to Dental Sciences, Periodontal Diseases, Advanced Implantology, Dental Anesthesia, Dental Hygiene, orthodontics oral and maxillofacial surgery, Forensic odontology, oral medicine, Dental implants, etc. Readers are welcome to share their views & suggestions within the scope of the journal. The journal also covers scientific and experimental studies related to physical condition, ethical and social issues in field of Dentistry. URL: https://springfieldpublishers.com/dentistry-open-access-journals/. Address : Springfield Publishers, LLC, 2102 Business Center, Drive, Suite 130, Irvine, California 92612, USA, Phone: +1 (909) 844-1022, Email: [email protected]. https://springfieldpublishers.com/journals.php.

[143] Editorial Board Member of Global Journal of Reproductive Medicine (GJORM), ISSN: 2575-8594, Global Journal of Reproductive Medicine is an international peer review open access journal that deals with publishing high quality articles related to all branches of Reproductive Medicine & disorders. Journal aims to spread the recent work in fields like Reproductive system, Sexual disorders, Reproductive medicine, Reproductive behavior, Reproductive health, Erectile dysfunction, Sexually transmitted diseases, In vitro fertilization, Sex hormones, Sex- determination, Uterus, Cervical dilation, Adenocarcinomas, Chromosomal abnormalities, Spermatogonia, Abortion, Unisexual Reproduction, Gonadotropin- releasing hormone, Sex organ, Pheromone, Genitalia, Fallopian tube, Mammary gland, Spermatozoa, etc to scientific world. So, we welcome researchers for submission of papers in different formats like original research papers, review articles, Opinions, letter to editors on a breadth of clinical topics in blood & its disorders. NLM ID: 101718866, LCCN: 2017202823, OCoLC: 1009083915. Juniper Publishers INC., 3700 Park View Ln #12B, Irvine, California 92612, United States, Phone: +1-805-200-4030, Fax: 1-855-420-6872, [email protected], www.juniperpublishers.com. Juniper Publishers Vision: “To advance the creation, communication and application of scientific knowledge to benefit society and improve people's lives. The prime mission of juniper publishers is to make continuous efforts in transforming the scientific information from researchers around the world, into easily accessible data by publishing on our website. Our vision is to build an open science platform where everybody has an equal opportunity to seek, share and generate knowledge,

310 empowering researchers and scholars in their daily work." URL: https://juniperpublishers.com/gjorm/index.php.

[144] Editorial Board of Psychology and Behavioral Science International Journal| ISSN: 2474-7688, (Impact Factor: 0.89), PBSIJ science is an Open Access, peer reviewed, multidisciplinary international journal of Juniper publisher. PBSIJ main aim is to publish quality articles related to mind, behavioral changes, mental functions, social behavior, while also exploring the physiological and biological processes that underlie cognitive functions and behaviors around the globe. Juniper publishes intervention strategies that use psychological science to improve the lives of people around the world. The journal promotes the use of psychological science that is contextually informed, culturally inclusive, and dedicated to serving the public interest. PBSIJ welcome authors to submit Research, Review, Mini-Review, Opinion, and Short Communication that explore of the Psychology, Social sciences, Education, and Home science aspects of human behavior. If you have a submission that you believe meets our criteria, we encourage you to consider PBSIJ as an outlet for your academic research. URL: https://juniperpublishers.com/pbsij/.

[145] Editorial Board Member of Journal of Anesthesia and Surgical Reports (JASR), Address: Gavin Publishers, 5911 Oak Ridge Way, Lisle, IL 60532, USA. Phone: +1-630-397-0234, [email protected]. About the Journal: Journal of Anesthesia and Surgical Reports (JASR) is an online open access, peer-reviewed journal publishes all aspects submissions from research, reviews, case reports, case studies, case descriptions, short communication, and letter to editor, short articles, in all areas of anaesthesia and surgical reports. Aim and Scope: This journal aim is to provide a platform for scientists and academicians all over the world to promote, share, and discuss various new issues and developments in the world which covers both clinical and medical aspects of anesthesiology and surgery including pain medicine, anesthesia before and after surgery, resuscitation and intensive care medicine, anesthetic drugs, spinal, epidural and caudal anesthesia, side effects of anesthesia, surgery discusses on current experimental research in all areas of surgery and its related fields like abdominal, cancer, vascular, head and neck, breast, colorectal, and other forms of surgery. As a major aspect of this exertion, with a lot many of physicians and other primary care practitioners to give chances to free trade of ideas and information, serving he aphorism of Public health observation. All published articles are assigned to Digital Object Identifier (DOI) - Crossref. All

311 published articles are permanently archived and available at Gavin Publishers website in HTML and PDF formats.

[146] Current Trends in Clinical & Medical Sciences – CTCMS, ISSN: 2689-4246, About CTCMS: Current Trends in Clinical & Medical Sciences (CTCMS) is a highly interdisciplinary journal that is dedicated to disseminating in-depth information and insights into all areas of current medical and clinical sciences including cardiology, neurology, anaesthesia, gynecology, dentistry, nursing, gastroenterology, ophthalmology, orthopedics, cancer, psychiatry, medical imaging, dermatology, anatomy, genomic medicine, etc. CTCMS welcomes research articles, review articles, case reports, and short communications in all areas of the field making them freely available online without any restrictions to the researchers worldwide. URL: https://irispublishers.com/ctcms/. Contact us at: [email protected], [email protected], [email protected]. Contact Details: Iris Publishers, LLC, 315 Montgomery Street, San Francisco, CA 94104, USA, +1-628-201-9788, Fax - +1- 415-962-0669, [email protected].

[147] Editorial Board Member of Open Access Journal of Surgery (OAJS), ISSN: 2476-1346, URL: https://juniperpublishers.com/oajs/, The Open Access Journal of Surgery (OAJS) is a globally accepted journal that aims to publish innovative scientific developments and high quality information in all kinds of surgical research, education and clinical practice. It aims to support continued developments in surgery through sharing of latest knowledge, ideas and practices across all surgical specialties. The OAJS provides readers with high quality, peer-reviewed and advanced publications in the field of surgery that are relevant to their respective departments. OAJS welcomes original research, review articles, case reports, short communications, mini- reviews, opinions and letter to editors that embody current surgical research, education and clinical practice, as well as technological innovation and discovery of new methods. The journal is available electronically and is open source with the aim making innovations and scientific developments available to scholars and academics in the field of anesthesia and intensive care. The journal employs a rigorous peer review process and employs the ethical standards set forth by ICMJE. Juniper Publishers INC. 3700 Park View Ln #12B, Irvine, California 92612, United States, Phone: +1-805-200-4030, Fax: +1-855-420-6872,

312 [email protected], www.juniperpublishers.com Contact us at: [email protected], [email protected].

[148] Editorial Board Member of COJ Biomedical Science & Research COJBSR, Language of Publication: English, Nature: Online, [email protected], [email protected], [email protected], About Journal: COJ Biomedical Science and Research includes all the molecular aspects and fundamentals of basic medical sciences, with all the prominence on findings of molecular studies including biomedical problems and molecular mechanisms. The purpose of the COJBSR is to publish scientific and technical research papers, to add a limelight to the importance of technology in the field of human sciences. Ever advancing Biomedical technology plays a key role in several emergency medical and clinical scenarios and is thus the vital focus of this biomedical research journal. Bringing together content that is rich and enables information sharing between like- minded readers who crave for quality content on biomedical research. The wide scope of this journal is to aid the growth of scientific information about better healthcare. Edited by our expert Editorial Board, the journal’s open access platform, and fast and thorough peer review attract a large readership worldwide. URL: https://crimsonpublishers.com/cojbsr/.

[149] Editorial Board of JOJ Internal Medicine (JOJIM), URL: https://juniperpublishers.com/jojim/, JOJ Internal Medicine (JOJIM) is an international, peer-reviewed journal designed for internists and emergency physicians. The vision of the journal is to promote improved patient care, research, and education in primary care, general internal medicine, and hospital medicine. JOJ Internal Medicine acknowledge the areas like Clinical Trials, Antibiotic Resistance, Adverse Drug Events Reporting, Menopause, Obesity and Weight Management, Rare Diseases, Palliative Care, Immunization, Substance Abuse and Addiction, Hypertension, Health Diversity, Transplant Hepatology, Interventional cardiology, Adolescent medicine. The Journal publishes original scientific articles, editorials, case reports, short communications and other information relevant to internal medicine and related fields. JOJ Internal Medicine also plays a major role in continuing medical education through review articles relevant to physician education. We welcome both human and experimental animal studies as are new findings on the epidemiology, pathogenesis, diagnosis, and treatment of diseases.

313

[150] Editorial Board Member of Archives in Biomedical Engineering & Biotechnology – ABEB, ISSN: 2687-8100, NLM ID: 101749213, About ABEB: Archives in Biomedical Engineering & Biotechnology (ABEB) is the principal open access journal aimed to publish recent developments in biomedical engineering & biotechnology field. We publish on new concepts in technology/ methodology of relevance to the biological, biomedical, agricultural and environmental sciences as well as it covers the commercial, ethical, aspects of this research also. The journal focuses on biomedical sciences, biotechnology, nanobiotechnology, biothermodynamics, polymer science, biomaterials evaluation and its applications, materials used in biomedical research and its limitations, cellular engineering. We welcome all types of research papers that provide knowledge to readers and research fellows. It is a monthly published journal which accepts all types of articles like Editorial, Research, Review, Case Report, Short Communication, Perspectives, Mini Review, Clinical Image, Letter to Editor, e-Books, Video articles etc. URL: https://irispublishers.com/abeb/. Iris Publishers, LLC, 315 Montgomery Street, San Francisco, CA 94104, USA, +1-628-201-9788, Fax - +1-415-962-0669, [email protected].

[151] Editorial Board Member of Global Journal of Reproductive Medicine (GJORM), NLM ID: 101718866, LCCN: 2017202823, OCoLC: 1009083915, Global Journal of Reproductive Medicine is an international peer review open access journal that deals with publishing high quality articles related to all branches of Reproductive Medicine & disorders. Journal aims to spread the recent work in fields like Reproductive system, Sexual disorders, Reproductive medicine, Reproductive behavior, Reproductive health, Erectile dysfunction, Sexually transmitted diseases, In vitro fertilization, Sex hormones, Sex-determination, Uterus, Cervical dilation, Adenocarcinomas, Chromosomal abnormalities, Spermatogonia, Abortion, Unisexual Reproduction, Gonadotropin-releasing hormone, Sex organ, Pheromone, Genitalia, Fallopian tube, Mammary gland, Spermatozoa, etc to scientific world. So, we welcome researchers for submission of papers in different formats like original research papers, review articles, Opinions, letter to editors on a breadth of clinical topics in blood & its disorders. URL: https://juniperpublishers.com/gjorm/index.php.

[116] Editorial Board Member of Archives of Cancer Science & Treatment, (Fully peer-reviewed, Open access and preferred Journal on cancer research), Archives of

314

Cancer Science & Treatment is an international peer reviewed, open access multidisciplinary journal. The journal aims to publish original research articles and review articles in all areas of cancer research` and effective treatments and most reliable source of information on current trends and developments. It gives information in every aspects of cancer, for example, detection and diagnosis, treatment and novel treatments, causes and biomarkers of malignancy and so on to analysts, academicians, clinicians. All manuscripts published by Journal are made openly available online promptly upon publication, with no subscription charges or boundaries. Manuscripts may be submitted as Original Articles, Rapid and Short Communications, or Reviews, Mini-review, Case Reports, Opinion, Letters to the Editor and Editorials. Archives Of Cancer Science & Treatment manuscripts undergo rigorous peer-review process where each and every manuscript undergoes assessment by the editorial board member first and after that, if appropriate, is looked into by at least three potential reviewers within 2–3 weeks of submission. The time interval between acknowledgment and publication online is 7 days. The scope of the journal includes but not limited to Cancer Diagnosis, Cancer Genetics, Carcinogenesis, Chemotherapy, Epidemiology, Molecular Oncology, Multimodality Treatment and Palliative Care, Pathology, Predictive Markers and Cancer Prevention, Screening and Therapies including Chemotherapy, Surgery, Radiation Therapy, Immunotherapy, Gene Therapy, Tumor Biology, Tumor Immunology, etc. Archives Of Cancer Science & Treatment welcomes direct submissions of manuscripts from authors. You can submit your manuscript to editorial office: [email protected], alternatively to journal: [email protected]. URL: https://www.yumedtext.com/journal/4. Yumed Text is an international, open access publisher of academic journals across various disciplines of science, technology and medicine. Our vision is to build a scientific platform that empowers its readers the freedom to express, to seek, share and generate knowledge which paves a path for researchers in their day to day research work. YumedText will serve as an ideal platform for publishing research work by potential authors, which provides access to a wide range of audience in the scientific community. Yumed Text Publications is an open access publisher where the published articles are freely accessible to all the readers throughout the world without any subscription charges. Authors can retain the copyright of their work by licensing it under Creative Common Attribution License. Articles can be reused or

315 redistributed by the authors without restriction, unless the original work is correctly cited.

[117] Editorial Board Member of Journal of Gynecology and Women’s Health (ISSN: 2474-7602; Impact factor: 2474-7602), URL: https://juniperpublishers.com/jgwh/, JGWH is a peer-reviewed, multidisciplinary, international journal of Juniper group that publishes scientific works within the field of obstetrics, gynecology and women’s health. Gynecology deals with the functions and diseases specific to women and girls, especially those affecting the reproductive system. Obstetrics takes care of the issues related to pregnant females, from the time of conception till childbirth, providing pre-natal care, management of pregnancy, and post-partum care. Women's Health is the primary source of information for meeting the challenges of providing optimal health care for women throughout their lifespan. The Journal delivers cutting-edge advancements in diagnostic procedures, therapeutic protocols for the management of diseases, and innovative research in gender-based biology that impacts patient care and treatment. JGWH publications includes original research articles, opinions, short communications, letter to editors, editorials, reviews etc. on a broad range of subjects related to related to female reproductive system, pregnancy, child birth and other related issues.

Editorial & Reviewer Corps Certificates

[1] Certificate of Completion, 5 Diseases ailing research – and how to cure them, Presented by John Antonakis, 2018, Researcher Academy, Elsevier.

[2] Certificate of Completion, 10 reasons to get – and use – an ORCID ID, Presented by Alice Meadows, 2018, Researcher Academy, Elsevier.

[3] Certificate of Completion, how to become a reviewer and what do editors expect? Presented by Jaap van Harten, 2018, Researcher Academy, Elsevier.

[4] Certificate of Completion. Creating a good research data management plan, Presented by Rob Hooft, 2018, Researcher Academy, Elsevier.

316

[5] Certificate of Completion, Demystifying permissions, Presented by Hop Wechsler, 2018, Researcher Academy, Elsevier.

[6] Certificate of Completion, Discoverability: top tips to get your book out there, Presented by Andrea Topping, 2018, Researcher Academy, Elsevier.

[7] Certificate of Completion, Discover how metrics can boost funding and networking opportunities, Presented by Hans Zijlstra, 2018, Researcher Academy, Elsevier.

[8] Certificate of Excellence, Finding the right journal, 2018, Researcher Academy, Elsevier.

[9] Certificate of Completion, the fundamentals of peer review for the Chemical Sciences, Presented by Shane Snyder, Deirdre Dunne, 2018, Researcher Academy, Elsevier.

[10] Certificate of Excellence, Fundamentals of publishing, 2018, Elsevier.

[11] Certificate of Completion, Funding Hacks for Researchers, Presented by Christian DeFeo, Monik C. Jímenez, Richard Wilder, 2018, Researcher Academy, Elsevier.

[12] Certificate of Completion, how to get your book published, Presented by Nancy Maragioglio, 2018, Researcher Academy, Elsevier.

[13] Certificate of Completion, making academia–industry collaborations work, Presented by David Noble, Robyn Keast, Michael B. Charles, 2018, Researcher Academy, Elsevier.

[14] Certificate of Completion, the nuts & bolts of peer review: a discussion by Biomaterials editors, Presented by Sophie de Koning, Abhay Pandit, Hanry Yu, Marina Soares e Silva, 2018, Researcher Academy, Elsevier.

[15] Certificate of Completion, open science, Presented by Stephane Berghmans, Federica Rosetta, 2018, Researcher Academy, Elsevier.

[16] Certificate of Excellence, Open science, 2018, Elsevier.

317

[17] Certificate of Completion, how reviewers become editors, Presented by Verity J Brown, 2018, Researcher Academy, Elsevier.

[18] Certificate of Completion, Social Media for Researchers, Presented by Christian DeFeo, 2018, Researcher Academy, Elsevier.

[19] Certificate of Completion, Systematic reviews 101, Presented by Naomi Lee, Paul Whaley, 2018, Researcher Academy, Elsevier.

[20] Certificate of Completion, Transparency in peer review, Presented by Richard Morey, Emily Jesper-Mir, Riaz Agha, Catriona Fennell, 2018, Researcher Academy, Elsevier.

[21] Certificate of Completion, How to turn thesis into an article, Presented by Adolfo Cuevas, Cecily L. Betz, 2018, Researcher Academy, Elsevier.

[22] Certificate of Completion, Springer Nature Publisher's Code of Conduct, Progress: Finished successfully, Date of participation: 03-09-2018, 13-12-2017 | Course.

[23] Certificate of Completion, Why you can't afford to ignore publication ethics, Presented by Catriona Fennell, 2018, Researcher Academy, Elsevier.

[24] Certificate of Completion, Diversity in peer review, Presented by Sanjana Balu, Shirin Heidari, 2018, Researcher Academy, Elsevier.

[25] Certificate of Completion, Ethics responsibilities for peer reviewers, Presented by Jaap van Harten, 2018, Researcher Academy, Elsevier.

[26] Certificate of Completion, recognizing peer reviewers: A webinar to celebrate editors and researchers, Presented by Julia Wilson, Luiza Cabeza, Fei Chen, Researcher Academy, Elsevier.

[27] Certificate of Completion, how to respond to reviewers' comments, Presented by Paul Cumine, Researcher Academy, Elsevier.

[28] Certificate of Completion, Open access and navigating the journal landscape, Presented by Els Bosma, Wim Meester, Catriona Fennell, Researcher Academy, Elsevier, 2018.

318

[29] Certificate of Excellence, Open science, Researcher Academy, Elsevier, Saturday 01 September, 2018.

[30] Publons Academy Graduation Certificate, Certified Publons Academy Peer Reviewer. 10th of December 2018.

[31] Certificate of Completion, how to produce highly visible research: Useful tips for researchers, Sunday 16 December, 2018 Presented by Mustapha Belkhouja, Hyungseok (David) Yoon, Researcher Academy, Elsevier.

[32] Certificate of Completion, Conference skills for researchers, Presented by Taraka Dale, Researcher Academy, Elsevier.

[33] Certificate of Completion, Demystifying permissions, Saturday 01 September, 2018, Presented by Hop Wechsler, Researcher Academy, Elsevier.

[34] Certificate of Completion, Discover how metrics can boost funding and networking opportunities, Friday 31 August, 2018, Researcher Academy, Elsevier.

[35] Certificate of Completion, Ethics responsibilities for peer reviewers, Friday 14 September, 2018, Presented by Jaap van Harten, Researcher Academy, Elsevier.

[36] Certificate of Completion, how researchers benefit from citing data, Tuesday 22 January, 2019, Presented by Timothy Clark, Helena Cousijn, Researcher Academy, Elsevier.

[37] Certificate of Completion, how reviewers become editors, Saturday 01 September, 2018, Presented by Verity J Brown, Researcher Academy, Elsevier.

[38] Certificate of Excellence, Social impact, Monday 21 January, 2019, Researcher Academy, Elsevier.

[39] Certificate of Completion, Systematic reviews 101, Saturday 01 September, 2018, Presented by Naomi Lee, Paul Whaley, Researcher Academy, Elsevier.

[40] Certificate of Completion, Tell your research story with Audio Slides, Monday 21 January, 2019 Presented by Lucy Goodchild van Hilten, Researcher Academy, Elsevier.

319

[41] Certificate of Completion, How to turn your thesis into an article, Saturday 01 September, 2018 Presented by Adolfo Cuevas, Cecily L. Betz, Researcher Academy, Elsevier.

[42] Certificate of Completion, why write a book? Tuesday 22 January, 2019 Presented by Stacy Masucci, Researcher Academy, Elsevier.

[43] Certificate of Completion, how to write case reports, Presented by Oliver Kurzai, Adilia Warris, Researcher Academy, Elsevier.

[44] Certificate of Completion, how to turn your thesis into an article, Presented by Adolfo Cuevas, Cecily L. Betz, Researcher Academy, Elsevier.

[45] Certificate of Completion, 5 Diseases ailing research – and how to cure them, Saturday 01 September, 2018 Presented by John Antonakis, Researcher Academy, Elsevier.

[46] Certificate of Completion, Using proper manuscript language, Presented by Anthony Newman, Tuesday 26 March, 2019, Researcher Academy, Elsevier.

[47] Certificate of Completion, How to write a lay summary, on Saturday 13 April, 2019 Presented by Daniel Stammler, Dr. Elaine T. Kiriakopoulos, Researcher Academy, Elsevier.

[48] Certificate of Excellence, Technical writing skills, dedicated by: Suzanne DeBell Managing Director, Education Reference & Continuity Books, Philippe Terheggen Managing Director, Science, Technology & Medical Journals, Researcher Academy, Elsevier

Certificates

[1] Antibiotic Guardian Certificate – Given by Public Health England, Health and Social Care (HSC), Public Health Wales, NHS Scotland. 2017.

[2] Certificate of Ambassadorship in European Association for Cancer Research. 2016 – 2020.

320

[3] Certificate of Continuing Medical Education Credit, Non-Small Cell Lung Cancer MET Molecular Alterations: Molecular Oncology Tumor Boards, ASCO University, March 29, 2017 – March 20, 2020, Certificate Number: 732589c_U61704_A5625_O2_T1.

[4] Certificate of Completion, Patient-Reported Outcomes in Cancer – Capture, ASCO University, American Society of Clinical Oncology, 04/19/2017, Certificate Number: 962148C_U61704_A5622_O2_T4.

[5] Certificate of Continuing Medical Education Credit, Disparities in Cancer Care: Do You Know…? December 11, 2016 – December 11, 2019, ASCO University, American Society of Clinical Oncology, Certificate Number: 872952C_U61704_A3796_O2_T1.

[6] Certificate of Completion, Emergency Medical Service Squad (EMS), Center of Incidence Management and Emergency Medicine of Iran, 2012 – 2014.

[7] Certificate of Recognition, Having Satisfied the Requirement for Membership is now a Certified Epi-Core Member and Is Accorded All the Privileges Pertaining Thereto., 21st of April, 2017.

[8] Certificate of Continuing Medical Education Credit, Disparities in Cancer Care: Take Action! December 11, 2016 - December 11, 2019, Total AMA PRA Category 1 Credit(s) TM Awarded: 1.50, CertificateNumber: 134C_U61704_A3798_O2_T1. ASCO University.

[9] Certificate of Continuing Medical Education Credit, 2016 Annual Meeting Highlights: Radiation Oncology October 7, 2016 - October 7, 2019, Total AMA PRA Category 1 Credit(s) TM Awarded: 5.00, CertificateNumber: 170544C_U61704_A5449_O2_T1, ASCO University. [10] Certificate of Continuing Medical Education Credit, Metastatic Melanoma: Molecular Oncology Tumor Boards, June 28, 2017 - June 28, 2020. Total AMA PRA Category 1 Credit(s) TM Awarded: 1.00, CertificateNumber: 601898C_U61704_A5631_O2_T1, ASCO University.

321

[11] Certificate of Continuing Medical Education Credit, Acute Myeloid Leukemia: Molecular Oncology Tumor Boards, November 9, 2016 - November 9, 2019, Total AMA PRA Category 1 Credit(s) TM Awarded: 1.00, CertificateNumber: 997047C_U61704_A5575_O2_T1, ASCO University.

[12] Certificate of Continuing Medical Education Credit, Lung Cancer (BRAF Mutation): Molecular Oncology Tumor Boards, October 26, 2016 - October 26, 2019, Total AMA PRA Category 1 Credit(s) TM Awarded: 1.00, CertificateNumber: 605568C_U61704_A5450_O2_T1, The American Society of Clinical Oncology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. All educational activities were planned and produced in accordance with the ACCME Essential Areas and Policies.

[13] Certificate of Continuing Medical Education Credit, Hormone Sensitive Metastatic Disease: ASCO Tumor Boards, October 19, 2016 - October 19, 2019, Total AMA PRA Category 1 Credit(s) TM Awarded: 1.00, CertificateNumber: 744384C_U61704_A5499_O2_T1, ASCO University.

[14] CERTIFICATE OF COMPLETION, Observational Studies in Cancer Research, CertificateNumber: 955738C_U61704_A5500_O2_T4, ASCO University.

[15] Certificate of Continuing Medical Education Credit, Myeloproliferative Neoplasms: Molecular Oncology Tumor Boards, July 27, 2016 - July 27, 2019, Total AMA PRA Category 1 Credit(s) TM Awarded: 1.00, CertificateNumber: 426506C_U61704_A5415_O2_T1, ASCO University.

[16] Certificate of Continuing Medical Education Credit, Head and Neck Cancer: Molecular Oncology Tumor Boards, August 24, 2016 - August 24, 2019, Total AMA PRA Category 1 Credit(s) TM Awarded: 1.00, CertificateNumber: 194743C_U61704_A5435_O2_T1, ASCO University.

322

[17] CERTIFICATE OF COMPLETION, Designing Patient Decision Aids 101 – Capture, Certificate Number: 987675C_U61704_A5628_O2_T4, ASCO University.

[18] Certificate of Participation, Cultural Competence for Oncology Practice December 11, 2016 - December 11, 2019, Certificate Number: 244679C_U61704_A3799_O2_T2, The American Society of Clinical Oncology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. All educational activities were planned and produced in accordance with the ACCME Essential Areas and Policies.

[19] Certificate of Continuing Medical Education Credit, Melanoma (BRAF/NRAS Mutations): Molecular Oncology Tumor Boards, October 30, 2015 - October 30, 2018, Total AMA PRA Category 1 Credit(s) TM Awarded: 1.00, The American Society of Clinical Oncology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. All educational activities were planned and produced in accordance with the ACCME Essential Areas and Policies, Certificate Number: 177545C_U61704_A4900_O2_T1.

[20] Certificate of Continuing Medical Education Credit, Acute Myeloid Leukemia (MLL Rearrangement): Molecular Oncology Tumor Boards, September 23, 2015 - September 23, 2018, Total AMA PRA Category 1 Credit(s) TM Awarded: 1.00, The American Society of Clinical Oncology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians, All educational activities were planned and produced in accordance with the ACCME Essential Areas and Policies. Certificate Number: 80891C_U61704_A4896_O2_T1.

[21] CERTIFICATE OF COMPLETION, Synthesis of Knowledge with Direct Meta-analysis – Capture, CertificateNumber: 737304C_U61704_A5414_O2_T4, ASCO University.

323

[22] Certificate of Continuing Medical Education Credit, Non-small Cell Lung Cancer (PD-L1 Expression): Molecular Oncology Tumor Boards, April 27, 2016 - April 27, 2019, The American Society of Clinical Oncology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. All educational activities were planned and produced in accordance with the ACCME Essential Areas and Policies. CertificateNumber: 189209C_U61704_A5058_O2_T1.

[23] Certificate of Continuing Medical Education Credit, Breast Cancer (Triple- Negative, AR+): Molecular Oncology Tumor Boards, February 24, 2016 - February 24, 2019, Total AMA PRA Category 1 Credit(s) TM Awarded: 1.00, The American Society of Clinical Oncology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. All educational activities were planned and produced in accordance with the ACCME Essential Areas and Policies. Certificate Number: 0747467C_U61704_A5037_O2_T1.

[24] Certificate of Continuing Medical Education Credit, PEComa (TSC2, TFE3): Molecular Oncology Tumor Boards, January 27, 2016 - January 27, 2019, Total AMA PRA Category 1 Credit(s) TM Awarded: 1.00, The American Society of Clinical Oncology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. All educational activities were planned and produced in accordance with the ACCME Essential Areas and Policies. Certificate Number: 172439C_U61704_A5028_O2_T1.

[25] Certificate of Continuing Medical Education Credit, Focus Under Forty: Fertility Preservation Issues in AYA Males and Females, December 16, 2015 - December 16, 2018, Total AMA PRA Category 1 Credit(s) TM Awarded: 3.00, The American Society of Clinical Oncology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. All educational activities were planned and produced in accordance with the ACCME Essential Areas and Policies. Certificate Number: 538303C_U61704_A4932_O2_T1.

324

[26] Certificate of Continuing Medical Education Credit, Focus Under Forty: Survivorship, December 16, 2015 - December 16, 2018, Total AMA PRA Category 1 Credit(s) TM Awarded: 4.50, The American Society of Clinical Oncology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. All educational activities were planned and produced in accordance with the ACCME Essential Areas and Policies. Certificate Number: 39632C_U61704_A4897_O2_T1.

[27] Certificate of Continuing Medical Education Credit, Lung Cancer (EGFR Mutation): Molecular Oncology Tumor Boards, December 16, 2015 - December 16, 2018, Total AMA PRA Category 1 Credit(s) TM Awarded: 1.00, The American Society of Clinical Oncology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. All educational activities were planned and produced in accordance with the ACCME Essential Areas and Policies. Certificate Number: 423711C_U61704_A4934_O2_T1.

[28] Certificate of Continuing Medical Education Credit, Acute Myeloid Leukemia: ASCO Tumor Board, November 18, 2015 - November 18, 2018, Total AMA PRA Category 1 Credit(s) TM Awarded: 1.00, The American Society of Clinical Oncology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. All educational activities were planned and produced in accordance with the ACCME Essential Areas and Policies. Certificate Number: 239704C_U61704_A4901_O2_T1.

[29] Certificate of Continuing Medical Education Credit, Thyroid Cancer (BRAF V600E): Molecular Oncology Tumor Boards, November 19, 2015 - November 19, 2018, Total AMA PRA Category 1 Credit(s) TM Awarded: 1.00, The American Society of Clinical Oncology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. All educational activities were planned and produced in accordance with the ACCME Essential Areas and Policies. Certificate Number: 604823C_U61704_A4929_O2_T1.

325

[30] CERTIFICATE OF COMPLETION, Qualitative Methods of Research – Capture, Certificate Number: 750589C_U61704_A4931_O2_T4, ASCO University.

[31] Certificate of Continuing Medical Education Credit, Uterine Cancer: ASCO Tumor Boards, September 16, 2015 - September 16, 2018, Total AMA PRA Category 1 Credit(s) TM Awarded: 1.00, The American Society of Clinical Oncology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. All educational activities were planned and produced in accordance with the ACCME Essential Areas and Policies. Certificate Number: 876492C_U61704_A4848_O2_T1.

[32] Certificate of Continuing Medical Education Credit, Carcinoma of Unknown Primary (August 2015): Molecular Oncology Tumor Boards, August 26, 2015 - August 26, 2018, Total AMA PRA Category 1 Credit(s) TM Awarded: 1.00, The American Society of Clinical Oncology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. All educational activities were planned and produced in accordance with the ACCME Essential Areas and Policies. Certificate Number: 399544C_U61704_A4834_O2_T1.

[33] Certificate of Continuing Medical Education Credit, Prostate Cancer (AR-V7): Molecular Oncology Tumor Board, July 29, 2015 - July 29, 2018, Total AMA PRA Category 1 Credit(s) TM Awarded: 1.00, The American Society of Clinical Oncology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. All educational activities were planned and produced in accordance with the ACCME Essential Areas and Policies. Certificate Number: 766874C_U61704_A4746_O2_T1.

326

[34] Certificate of Continuing Medical Education Credit, Metastatic Melanoma: ASCO Tumor Boards, July 22, 2015 - July 22, 2018, Total AMA PRA Category 1 Credit(s) TM Awarded: 1.00, The American Society of Clinical Oncology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. All educational activities were planned and produced in accordance with the ACCME Essential Areas and Policies. Certificate Number: 275051C_U61704_A4745_O2_T1.

[35] Certificate of Continuing Medical Education Credit, Ovarian Cancer (BRCA1 Mutation): Molecular Oncology Tumor Board, June 24, 2015 - June 24, 2018, Total AMA PRA Category 1 Credit(s) TM Awarded: 1.00, The American Society of Clinical Oncology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. All educational activities were planned and produced in accordance with the ACCME Essential Areas and Policies. Certificate Number: 0289655C_U61704_A4744_O2_T1.

[36] Certificate of Continuing Medical Education Credit, Locally Advanced Breast Cancer: ASCO Tumor Boards, August 19, 2015 - August 19, 2018, Total AMA PRA Category 1 Credit(s) TM Awarded: 1.00, The American Society of Clinical Oncology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. All educational activities were planned and produced in accordance with the ACCME Essential Areas and Policies. Certificate Number: 712894C_U61704_A4748_O2_T1.

[37] Certificate of Continuing Professional Development (CPD) scheme for the year 3 November 2016 - 2 November 2017, Royal Society of Biology.

[38] Certificate of Participation, ASCO Tumor Boards: Metastatic Colon Cancer, Total Hours: 1.50, ASCO Tumor Boards: Metastatic Colon Cancer March 29, 2018 - March 29, 2020. Certificate Number: 74413C_U61704_A6252_O2_T2.

327

[39] Certificate of Continuing Medical Education Credit, Electronic Health Records: Morbidity and Mortality Series, Total AMA PRA Category 1 Credit(s) TM Awarded: 4.00, Electronic Health Records: Morbidity and Mortality Series February 14, 2018 - February 14, 2021, Certificate Number: 702896C_U61704_A6251_O2_T1.

[40] Certificate of Continuing Medical Education Credit, Introduction to Common Cancer Therapies, Total AMA PRA Category 1 Credit(s) TM Awarded: 4.00, Introduction to Common Cancer Therapies April 18, 2018 - April 18, 2021 CertificateNumber: 116088C_U61704_A6532_O2_T1.

[41] Certificate of Continuing Medical Education Credit, Toxicities in Immunotherapy: Morbidity and Mortality Series, Total AMA PRA Category 1 Credit(s) TM Awarded: 5.00, Toxicities in Immunotherapy: Morbidity and Mortality Series December 13, 2017 - December 13, 2020, CertificateNumber: 790249C_U61704_A6191_O2_T1.

[42] Certificate of Continuing Medical Education Credit, ASCO Tumor Boards: AYA B Cell Acute Lymphoblastic Leukemia CAR T Cell, Total AMA PRA Category 1 Credit(s) TM Awarded: 1.50, ASCO Tumor Boards: AYA B Cell Acute Lymphoblastic Leukemia CAR T Cell May 16, 2018 - May 16, 2020, CertificateNumber: 780964C_U61704_A6584_O2_T1.

[43] Certificate of Continuing Medical Education Credit, Molecular Oncology Tumor Boards: Lung Cancer (ALK), Total AMA PRA Category 1 Credit(s) TM Awarded: 1.00, Molecular Oncology Tumor Boards: Lung Cancer (ALK) April 25, 2018 - April 25, 2020, CertificateNumber: 212789C_U61704_A6559_O2_T1.

[44] Certificate of Continuing Medical Education Credit, Survivorship Program, Total AMA PRA Category 1 Credit(s) TM Awarded: 2.50, Survivorship Program January 19, 2018 - January 19, 2021, CertificateNumber: 218807C_U61704_A6189_O2_T1.

328

[45] Certificate of Continuing Medical Education Credit, ALL and Cellular Therapy: Molecular Oncology Tumor Boards, Total AMA PRA Category 1 Credit(s) TM Awarded: 1.00, ALL and Cellular Therapy: Molecular Oncology Tumor Boards June 27, 2018 - June 27, 2020. CertificateNumber: 823018C_U61704_A6632_O2_T1.

[46] CERTIFICATE OF COMPLETION, THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY CERTIFIES THAT Sorush Niknamian Has Successfully Completed The E-Learning CourseTitled Overview of Design Options for Pragmatic Clinical Trials-Capture on 7/1/2018, Overview of Design Options for Pragmatic Clinical Trials Capture, CertificateNumber: 990628C_U61704_A6256_O2_T4.

[47] Institute of Natural Science and Advanced Technology, Prostate Cancer: Molecular Oncology Tumor Boards October 25, 2017 - October 25, 2020, Total AMA PRA Category 1 Credit(s) TM Awarded: 1.00, CertificateNumber: 718389C_U61704_A6173_O2_T1

[48] CERTIFICATE OF COMPLETION, ASCO Tumor Boards: 2017 Hodgkin Lymphoma on 8/12/2018, Certificate Number: 208622C_U61704_A6202_O2_T4.

[49] CERTIFICATE OF COMPLETION, Medical Cost Research Using Observational Data- Capture, THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY, Certificate Number: 243093C_U61704_A6199_O2_T4.

[50] Certificate of Continuing Medical Education Credit, Stage III Colon Cancer: ASCO Tumor Boards October 18, 2017 - October 18, 2020, Total AMA PRA Category 1 Credit(s) TM Awarded: 1.00, Certificate Number: 960934C_U61704_A6156_O2_T1.

[51] Certificate of Continuing Medical Education Credit, Head and Neck: Molecular Oncology Tumor Boards September 27, 2017 - September 27, 2020, Certificate Number: 952363C_U61704_A6144_O2_T1.

329

[52] Certificate of Continuing Medical Education Credit, 2017 Annual Meeting Highlights: Radiation Oncology, Total AMA PRA Category 1 Credit(s) TM Awarded: 5.00, 2017 Annual Meeting Highlights: Radiation Oncology August 30, 2017 - August 30, 2020, Certificate Number: 1454C_U61704_A6113_O2_T1.

[53] Certificate of Continuing Medical Education Credit, Sorush Niknamian, Business of Healthcare Fundamentals, Total AMA PRA Category 1 Credit(s) TM Awarded: 2.00, Business of Healthcare Fundamentals July 26, 2017 - July 26, 2020, Certificate Number: 923482C_U61704_A6052_O2_T1.

[53] Certificate of Continuing Medical Education Credit, Sorush Niknamian, Glioblastoma: ASCO Tumor Boards, Total AMA PRA Category 1 Credit(s) TM Awarded: 1.00, Glioblastoma: ASCO Tumor Boards August 23, 2017 - August 23, 2020, Certificate Number: 309054C_U61704_A6099_O2_T1.

[54] Certificate of Continuing Medical Education Credit, Sorush Niknamian, Prostate Cancer (BRCA2): Molecular Oncology Tumor Boards, Total AMA PRA Category 1 Credit(s) TM Awarded: 1.00, Prostate Cancer (BRCA2): Molecular Oncology Tumor Boards August 22, 2018 - August 22, 2020, Certificate Number: 312594C_U61704_A6660_O2_T1.

[55] Certificate of Continuing Medical Education Credit, Fundamentals of Clinical Trials (2016 Update), Total AMA PRA Category 1 Credit(s) TM Awarded: 6.50, Fundamentals of Clinical Trials (2016 Update) June 29, 2016 - June 29, 2019.

[56] Certificate of Continuing Medical Education Credit, Evaluation of the Scientific Literature, Total AMA PRA Category 1 Credit(s) TM Awarded: 1.00, Evaluation of the Scientific Literature May 17, 2017 - May 17, 2020.

[57] Certificate of Continuing Medical Education Credit, Immuno-Oncology Program, Total AMA PRA Category 1 Credit(s) TM Awarded: 8.00, Immuno- Oncology Program December 16, 2015 - May 18, 2020.

[58] CERTIFICATE OF COMPLETION, Secondhand Smoke Exposure in Children and the Risk for Lung Death, October 13, 2018, Medscape, LLC designates this

330 enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™, Certificate Number: 70183579, Kathy Geissel, Vice President, Editorial Operations, Medscape, LLC.

[59] Certificate of Completion, Continuing Professional Development (CPD) scheme, year 3 November 2016 - 2 November 2017, Royal Society of Biology.

[60] Certificate of Completion, Continuing Professional Development (CPD) scheme, year 3 November 2017 - 2 November 2018, Royal Society of Biology.

[61] Certificate of Completion, Case Studied in Melanoma: an Immersive Learning Experience, Medscape LLC, November 2, 2018, 2.00 AMA PRA Category 1 CreditsTM. Certificate Number: 70468228.

[62] Publons Academy Graduation Certificate, Certified Publons Academy Peer Reviewer. 10th of December 2018.

[63] CERTIFICATE OF PARTICIPATION, Cancer Summaries and Commentaries™: Update from Munich: Advances in the Treatment of Gastrointestinal Cancers, Release Date: November 30, 2018 Expiration Date: November 30, 2019, on December 13, 2018. Physicians' Education Resource®, LLC.

[64] CERTIFICATE OF PARTICIPATION, Burst CME™ – Cancer Summaries and Commentaries: Update from Toronto: Advances in the Treatment of Lung Cancers, Release Date: November 30, 2018 Expiration Date: November 30, 2019 on December 13, 2018, Physicians' Education Resource®, LLC.

[65] Certificate of CME Credits, International Meeting on Emerging Diseases and Surveillance - IMED 2018 - November 9-November 12, 2018, Vienna, Austria, CME Activity IMED 2018 - November 9 – November 12, 2018, Vienna, Austria. Congress language: English, CME Provider International Society for Infectious Diseases, 9 Babcock Street, Unit 3, Brookline, MA 02446, USA. European Union of Medical Specialists (UEMS) European Accreditation Council on CME (EACCME®). 09/11/2018-12/11/2018 has been accredited by the European

331

Accreditation Council for Continuing Medical Education (EACCME®) with 18 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity. The EACCME® is an institution of the European Union of Medical Specialists (UEMS).

[66] LETTER OF COMPLETION, Novel Therapies for AML: Expanding Future Options, January 18, 2019, Medscape, LLC designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity, Kathy Geissel, Vice President, Editorial Operations Medscape, LLC, Certificate Number: 71847720.

[67] CERTIFICATE OF PARTICIPATION, certifies that Sorush Niknamian, PhD has participated in the enduring material titled: Oncology Briefings™: New Frontiers in the Treatment of MSI High Endometrial Cancer, Release Date: December 31, 2017 Expiration Date: December 31, 2018. Physicians' Education Resource®, LLC.

[68] CERTIFICATE OF PARTICIPATION, Oncology Briefings™: Exploring the Role of PI3K Inhibitors for the Treatment of Hematologic Malignancies, Release Date: January 30, 2019 Expiration Date: January 31, 2019, Physicians' Education Resource®, LLC.

[69] CERTIFICATE OF PARTICIPATION, Cancer Summaries and Commentaries™: Update from Munich: Advances in the Treatment of Gastrointestinal Cancers, Release Date: November 30, 2018 Expiration Date: November 30, 2019, Physicians' Education Resource®, LLC.

[70] CERTIFICATE OF PARTICIPATION, Burst CME™ – Cancer Summaries and Commentaries: Update from Toronto: Advances in the Treatment of Lung Cancers, Release Date: November 30, 2018 Expiration Date: November 30, 2019. Physicians' Education Resource®, LLC.

332

[71] CERTIFICATE OF PARTICIPATION, Community Practice Connections™: 13th Annual New York Lung Cancers Symposium, Release Date: January 30, 2019 Expiration Date: January 30, 2020, Physicians' Education Resource®, LLC.

[72] CERTIFICATE OF PARTICIPATION, Community Practice Connections™: 3rd Annual International Congress on Immunotherapies in Cancer™: Focus on Practice–Changing Application, Release Date: February 28, 2019 Expiration Date: February 28, 2020, Physicians' Physicians' Education Resource®, LLC.

[73] CERTIFICATE OF PARTICIPATION, Community Practice Connection™ 2nd Annual Precision Medicine Through Plasma: Using Liquid Biopsies in Contemporary Oncology Care, Release Date: February 28, 2019 Expiration Date: February 28, 2020, Physicians' Education Resource®, LLC.

[74] International Meeting on Emerging Diseases and Surveillance - IMED 2018 - This is to certify that Dr. Sorush Niknamian attended the IMED 2018 in Vienna, Austria from November 9 - November 12, 2018, Vienna, Austria. The above named delegate spent 15 hours on educational activities. Certified by: Larry Madoff, Britta Lassmann Executive Directors, ISID, CME Activity IMED 2018 - November 9 – November 12, 2018, Vienna, Austria. Congress language: English. CME Provider: International Society for Infectious Diseases, 9 Babcock Street, Unit 3, Brookline, MA 02446, USA. (European Union of Medical Specialists (UEMS) European Accreditation Council on CME (EACCME®)). Credits: 18 European CME credits.

[75] CERTIFICATE OF PARTICIPATION, Rapid Reviews in Oncology®: Practice-Changing Data in Acute Myeloid Leukemia: A Rapid Update from Atlanta – Online Release Date: December 21, 2017, Expiration Date: December 21, 2018.

[76] Certificate of Continuing Medical Education Credit, Ovarian Cancer: ASCO Tumor Boards, Total AMA PRA Category 1 Credit(s) TM Awarded: 1.50, Ovarian Cancer: ASCO Tumor Boards November 14, 2018 - November 14, 2020.

[77] CERTIFICATE OF COMPLETION, Modern Psychometrics-Capture, Certificate Number: 126353C_U61704_A6811_O2_T4.

[78] Certificate of Continuing Medical Education Credit, Lymphoma: Multidisciplinary Molecular Tumor Boards, Total AMA PRA Category 1 Credit(s)

333

TM Awarded: 1.00, Lymphoma: Multidisciplinary Molecular Tumor Boards February 20, 2019 - February 20, 2022. Certificate Number: 392003C_U61704_A7086_O2_T1

[79] Certificate of Continuing Medical Education Credit, Breast Cancer (HER2): Molecular Oncology Tumor Boards, Total AMA PRA Category 1 Credit(s) TM Awarded: 1.00, Breast Cancer (HER2): Molecular Oncology Tumor Boards October 31, 2018 - October 31, 2020, Certificate Number: 728539C_U61704_A6803_O2_T1.

[80] Certificate of Continuing Medical Education Credit, Breast Cancer (HER2): Molecular Oncology Tumor Boards, Total AMA PRA Category 1 Credit(s) TM Awarded: 1.00, Breast Cancer (HER2): Molecular Oncology Tumor Boards October 31, 2018 - October 31, 2020, Certificate Number: 979022C_U61704_A6803_O2_T1.

[81] CERTIFICATE OF COMPLETION, Introduction to Network Meta-Analysis, Certificate Number: 388059C_U61704_A6755_O2_T4.

[82] Certificate of Continuing Medical Education Credit, Quality Oncology Practice Initiative (QOPI ®)-2018 Term, Total AMA PRA Category 1 Credit(s) TM Awarded: 20.00, Certificate Number: 0482247C_U61704_A6260_O2_T1.

[83] Certificate of Continuing Medical Education Credit, 2018 Quality Care Symposium Abstract Submission, Total AMA PRA Category 1 Credit(s) TM Awarded: 20.00, Certificate Number: 138334C_U61704_A6629_O2_T1.

[84] Certificate of Continuing Medical Education Credit, Multidisciplinary Molecular Tumor Boards: Borderline Resectable Pancreatic Cancer, Total AMA PRA Category 1 Credit(s) TM Awarded: 1.50, Multidisciplinary Molecular Tumor Boards: Borderline Resectable Pancreatic Cancer January 16, 2019 - January 16, 2021, Certificate Number: 665056C_U61704_A6816_O2_T1.

[85] CERTIFICATE OF PARTICIPATION, Community Practice Connections™: Differentiating Diagnosis and Treatment to Fit the Patient With Hemolytic Anemia: A Case-Based Approach, Release Date: January 30, 2019, Expiration Date: January 30, 2020, on May 4, 2019, Physicians' Education Resource®, LLC, Certificate ID:

334

00170591-00985. Physicians' Education Resource®, LLC | 2 Clarke Drive, Suite 110 | Cranbury, NJ 08512.

[86] CERTIFICATE OF PARTICIPATION, Cancer Summaries and Commentaries™ Update from Stockholm: European Perspectives on the Future Application of CAR T–Cell Therapies, Release Date: February 28, 2019 Expiration Date: February 28, 2020, Certificate ID: 00170591-001013.

[89] CERTIFICATE OF PARTICIPATION, Sorush Niknamian, PhD, MPH has participated in the journal-based CME activity titled: X-Linked Hypophosphatemia: Diagnosing and Addressing the Underlying Cause of the Disease, Release Date: December 31, 2018 Expiration Date: December 31, 2019, Physicians' Education Resource®, LLC | 2 Clarke Drive, Suite 110 | Cranbury, NJ 08512, Certificate ID: 00170591-00959.

[90] CERTIFICATE OF PARTICIPATION, Medical Crossfire®: Addressing Uncertainties in Oncology Biosimilars, Release Date: April 30, 2019, Expiration Date: April 30, 2020, Physicians' Education Resource®, LLC. Certificate ID: 00170591-001062, 1.50 AMA PRA Category 1 Credits™.

[91] CERTIFICATE OF PARTICIPATION. Community Practice Connections™ Coffee Talk: How to Best Apply PARP Inhibition Strategies in Patient Care, Release Date: May 31, 2019, Expiration Date: May 31, 2020, Physicians' Education Resource designates this enduring material for a maximum of 2.00 AMA PRA Category 1 Credits™. Physicians' Education Resource®, LLC | 2 Clarke Drive, Suite 110 | Cranbury, NJ 08512 Tel: (609) 716-7777 | Fax: (609) 716-4747 | www.gotoper.com Certificate ID: 00170591-001095.

[92] CERTIFICATE OF PARTICIPATION, Clinical Practice Connections™: From Diagnosis to Emerging Immunotherapeutic Options: Understanding the Burden and Risks in Peanut Allergy, Release Date: September 28, 2018, Expiration Date: September 28, 2019, Physicians' Education Resource designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians' Education Resource®, LLC | 2 Clarke Drive, Suite 110 | Cranbury, NJ 08512 Tel:

335

(609) 716-7777 | Fax: (609) 716-4747 | www.gotoper.com Certificate ID: 00170591- 00895.

[93] CERTIFICATE OF PARTICIPATION, Oncology Briefings™: How Can Nurses Make the Biggest Impact in Melanoma Treatment and Management? Release Date: May 31, 2019, Expiration Date: May 31, 2020, Physicians' Education Resource designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians' Education Resource®, LLC | 2 Clarke Drive, Suite 110 | Cranbury, NJ 08512 Tel: (609) 716-7777 | Fax: (609) 716-4747 | www.gotoper.com Certificate ID: 00170591-001082.

[94] CERTIFICATE OF PARTICIPATION, Prostate Cancer Tumor Board: Integration of Recent Data Sets Across Lines of Care, Release Date: April 30, 2019, Expiration Date: April 30, 2020, Physicians' Education Resource designates this enduring material for a maximum of 2.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians' Education Resource®, LLC | 2 Clarke Drive, Suite 110 | Cranbury, NJ 08512 Tel: (609) 716-7777 | Fax: (609) 716-4747 | www.gotoper.com Certificate ID: 00170591-001059.

[95] Certificate of Participation, Biomarker Testing for Immunotherapy, completed on Oct 30, 2019 This activity was designated for 0.50 AMA PRA Category 1 Credit(s)™, Provided by: National Comprehensive Cancer Network, 3025 Chemical Road, Suite 100, Plymouth Meeting, PA 19462 In support of improving patient care, National Comprehensive Cancer Network is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

[96] Certificate of Participation, Approaches to Individualized Treatment for Chronic Lymphocytic Leukemia: Expert Guidance on Sequencing Therapy, Novel Agents, and their Combinations, completed on Oct 30, 2019 This activity was designated for 1.00 AMA PRA Category 1 Credit(s)™, Provided by: National Comprehensive Cancer Network, 3025 Chemical Road, Suite 100, Plymouth

336

Meeting, PA 19462 In support of improving patient care, National Comprehensive Cancer Network is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

[97] CERTIFICATE OF ATTENDANCE, Liquid biopsy in lymphoma, Milan, 13.11.2019, European School of Oncology (ESO), Italy.

[98] CERTIFICATE OF PARTICIPATION, Neurology Consultations„¢: Coordinating Care Between the Neurologist and Pharmacist in Multiple Sclerosis Treatment, Release Date: October 23, 2019 Expiration Date: October 23, 2020, Physicians' Education Resource®, LLC, Physicians' Education Resource is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Physicians' Education Resource designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians' Education Resource®, LLC | 2 Clarke Drive, Suite 110 | Cranbury, NJ 08512 Tel: (609) 716- 7777 | Fax: (609) 716-4747 | www.gotoper.com Certificate ID: 00170591-001191.

[99] Autism Spectrum Disorder: Comprehensive Assessment and New Treatment Developments, December 02, 2019, and is awarded 0.50 AMA PRA Category 1 Credit(s) TM. The American Psychiatric Association is accredited by the ACCME to provide continuing medical education for physicians. The APA designates this Enduring Material for a maximum of 0.50 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. American Psychiatric Association | Department of Continuing Medical Education, 800 Maine Avenue SW, Suite 900 | Washington, DC 20024 | Telephone: 1-888-357-7924 or 202-559-3900. Serial Number: 266605C_U154800_A6946_O2_T2.

337

[100] CERTIFICATE OF PARTICIPATION, Key Highlights from the 2019 European Oncology Meeting: Focus on Emerging Strategies for Solid Tumors, Release Date: October 31, 2019 Expiration Date: October 31, 2020, Physicians' Education Resource®, LLC, Physicians' Education Resource is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Physicians' Education Resource designates this enduring material for a maximum of 2.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians' Education Resource®, LLC | 2 Clarke Drive, Suite 110 | Cranbury, NJ 08512 Tel: (609) 716-7777 | Fax: (609) 716-4747 | www.gotoper.com. Certificate ID: 00170591-001201.

[101] CERTIFICATE OF PARTICIPATION, Medical Crossfire®: Understanding the Complexities of Chronic Kidney Disease in Type 2 Diabetes, Release Date: October 31, 2019 Expiration Date: October 31, 2020, Physicians' Education Resource®, LLC, Physicians' Education Resource is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Physicians' Education Resource designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians' Education Resource®, LLC | 2 Clarke Drive, Suite 110 | Cranbury, NJ 08512 Tel: (609) 716-7777 | Fax: (609) 716-4747 | www.gotoper.com, Certificate ID: 00170591-001190.

[102] LETTER OF COMPLETION, At the Intersection of Cardiometabolic Health and HIV: Opportunities to Improve Care, Medscape, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Certificate Number: 76266362.

[103] CONTINUING MEDICAL EDUCATION CERTIFICATE, Current and Emergent Therapies for Advanced Metastatic Urothelial Cancer: What Do You Know? December 27, 2019, This program has been reviewed by the Faculty of Pharmaceutical Medicine and approved for CPD. This program has been allocated 0.75 CPD credit, For information on applicability and acceptance of continuing

338 education credit for this activity, please consult your professional licensing board. Certificate Number: 76563018.

[104] Medscape Physician Business Academy, Telemedicine, Course material developed by Medscape, LLC, December 28, 2019.

[105] Medscape Physician Business Academy. How to Become an Effective Medical Leader. Course material developed by Medscape, LLC. December 28, 2019.

[106] CONTINUING MEDICAL EDUCATION CERTIFICATE, 2019 Updates in Hematologic Malignancies and Disorders, December 28, 2019, and is awarded 1.00 AMA PRA Category 1 Credit(s)™. Medscape, LLC designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board. Certificate Number: 76587826.

[107] CERTIFICATE OF PARTICIPATION, Medical Crossfire®: Forefronts in the Treatment of Hereditary Angioedema: A Patient-Focused Approach to Improve Quality of Life, Release Date: December 13, 2019 Expiration Date: December 13, 2020. Physicians' Education Resource is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Physicians' Education Resource designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians' Education Resource®, LLC | 2 Clarke Drive, Suite 110 | Cranbury, NJ

339

08512 Tel: (609) 716-7777 | Fax: (609) 716-4747 | www.gotoper.com, Certificate ID: 00170591-001259, Physicians' Education Resource®, LLC.

[108] CERTIFICATE OF PARTICIPATION, The Impact of PI3K Inhibitors for the Treatment of Patients with Breast Cancer, Release Date: January 9, 2020 Expiration Date: January 9, 2021, Physicians' Education Resource is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Physicians' Education Resource designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians' Education Resource®, LLC | 2 Clarke Drive, Suite 110 | Cranbury, NJ 08512 Tel: (609) 716-7777 | Fax: (609) 716-4747 | www.gotoper.com, Certificate ID: 00170591-001284.

[109] CERTIFICATE OF PARTICIPATION, Haymarket Medical Education. Case Clinic 1: Total Laparoscopic Hysterectomy, this activity is designated for AMA PRA Category 1 Credit(s)™. Haymarket Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians, 140 East Ridgewood Ave., Suite 370S | Paramus, NJ 07652 | 201-799-4800 (Phone) | 201-799-4820 (Fax).

[110] CERTIFICATE OF PARTICIPATION, Haymarket Medical Education, Getting It Right: Optimizing Guideline-Directed Medical Therapy for Heart Failure—Effective Care Coordination: Collaboration Within the Multidisciplinary Team - Issue 3, This activity is designated for AMA PRA Category 1 Credit(s)™. Haymarket Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians, 140 East Ridgewood Ave., Suite 370S | Paramus, NJ 07652 | 201- 799-4800 (Phone) | 201-799-4820 (Fax).

[111] The Academy for Continued Healthcare Learning, Assessing Emerging Data on Approaches to Reduce Recurrent C. Difficile Infection: Understanding the Microbiome and Gut Microbiota, this activity was designated for AMA PRA Category 1 Credit(s)™, 230 W. Monroe St., Suite 2300, Chicago, IL 60606-3548. Phone: 877.444.8435 | Fax: 877.872.2544 | www.achlcme.org

340

[112] The Academy for Continued Healthcare Learning, Breaking the Cycle of Recurrent C. difficile: Update on Recent Data and Implications in Clinical Practice, this activity was designated for AMA PRA Category 1 Credit(s)™, 230 W. Monroe St., Suite 2300, Chicago, IL 60606-3548. Phone: 877.444.8435 | Fax: 877.872.2544 | www.achlcme.org.

[113] The Academy for Continued Healthcare Learning. Recurrent C. difficile Infection: it’s a Problem, Let's Get Serious, This activity was designated for AMA PRA Category 1 Credit(s)™, 230 W. Monroe St., Suite 2300, Chicago, IL 60606-3548. Phone: 877.444.8435 | Fax: 877.872.2544 | www.achlcme.org.

[114] CERTIFICATE OF PARTICIPATION, The American College of Cardiology Foundation (ACCF), Special Considerations for Women and Communities of Color: Monologues to Dialogues—A 52-Year-Old Native American Woman with HFrEF, This enduring material was designated for a maximum of AMA PRA Category 1 Credits™, The American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by the ACCME. The American College of Cardiology Foundation is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. [115] Confirmation of Participation, Participant's Name: Sorush Niknamian ACP Customer Number: 03860312 Claim Date: February 23, 2020 Number of credits claimed: 1, The American College of Physicians is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. For Physicians: The American College of Physicians certifies that the learner named above has participated in the Internet Enduring Material, Core IM Podcast 2019-11-13 Release: Heparin-Induced Thrombocytopenia 5 Pearls Segment. The number of AMA PRA Category 1 Credits™ claimed are listed above. For Non-Physicians: The American College of Physicians certifies that the learner named above has participated in the Internet Enduring Material, Core IM Podcast 2019-11-13 Release: Heparin-Induced Thrombocytopenia 5 Pearls Segment. This activity was designated for the number of AMA PRA Category 1 Credits™ listed above.

[115] Confirmation of Participation, Participant's Name: Sorush Niknamian ACP Customer Number: 03860312, Claim Date: February 23, 2020 Number of credits

341 claimed: 0.5, The American College of Physicians is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. For Physicians: The American College of Physicians certifies that the learner named above has participated in the Internet Enduring Material, Core IM Podcast 2020-02-04 Release: Coronavirus: What the Clinician Needs to Know. The number of AMA PRA Category 1 Credits™ claimed are listed above. For Non-Physicians: The American College of Physicians certifies that the learner named above has participated in the Internet Enduring Material, Core IM Podcast 2020-02-04 Release: Coronavirus: What the Clinician Needs to Know. This activity was designated for the number of AMA PRA Category 1 Credits™ listed above.

[116] Confirmation of Participation Participant's Name: Sorush Niknamian ACP Customer Number: 03860312 Claim Date: February 23, 2020 Number of credits claimed: 0.5, The American College of Physicians is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. For Physicians: The American College of Physicians certifies that the learner named above has participated in the Internet Enduring Material, Novel Coronavirus: A Physician's Guide. The number of AMA PRA Category 1 Credits™ claimed are listed above. For Non-Physicians: The American College of Physicians certifies that the learner named above has participated in the Internet Enduring Material, Novel Coronavirus: A Physician's Guide. This activity was designated for the number of AMA PRA Category 1 Credits™ listed above.

[117] MEDICAL SOCIETY OF THE STATE OF NEW YORK, Certificate of Attendance, Sorush Niknamian This will serve to verify your attendance at the CME activity Anthrax, February 27, 2020, The Medical Society of the State of New York is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The Medical Society of the State of New York designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. PLEASE RETAIN THIS ATTENDANCE CERTIFICATE AS A RECORD OF YOUR PARTICIPATION.

342

[118] MEDICAL SOCIETY OF THE STATE OF NEW YORK, Certificate of Attendance. Sorush Niknamian This will serve to verify your attendance at the CME activity Botulism and SEB, February 27, 2020, The Medical Society of the State of New York is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The Medical Society of the State of New York designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. PLEASE RETAIN THIS ATTENDANCE CERTIFICATE AS A RECORD OF YOUR PARTICIPATION.

[119] MEDICAL SOCIETY OF THE STATE OF NEW YORK, Certificate of Attendance, Sorush Niknamian This will serve to verify your attendance at the CME activity Veterans Matters: Suicide in Veterans, February 27, 2020, The Medical Society of the State of New York is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The Medical Society of the State of New York designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. PLEASE RETAIN THIS ATTENDANCE CERTIFICATE AS A RECORD OF YOUR PARTICIPATION.

[120] MEDICAL SOCIETY OF THE STATE OF NEW YORK. Certificate of Attendance, Sorush Niknamian This will serve to verify your attendance at the CME activity Veterans Matters: Substance Use Disorders in Veterans, February 27, 2020, The Medical Society of the State of New York is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The Medical Society of the State of New York designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. PLEASE RETAIN THIS ATTENDANCE CERTIFICATE AS A RECORD OF YOUR PARTICIPATION.

Inventions and Discoveries

343

[1] Discovering the Selonoid Valves Physical Formula for Better Returns for Manzoumeh Sanat Co., the Rights Reserved by Manzoumeh Sanat Co., This Formula has made the company to produce high amounts of Selonoid Valves in Return., 2008.

[2] Discovering the Evolutionary Cell Memory Hypothesis (ECM), Supported by Max Planck Institute, Germany. 2016.

[3] Discovering the Evolutionary Metabolic Hypothesis of Cancer (EMHC), Supported by Boston University, Berlin University, Weston A. Price Foundation at Washington DC, United States. Published: Somayeh Zaminpira and Sorush Niknamian. “Evolutionary Metabolic Hypothesis of Cancer (EMHC)”. EC Pulmonology And. Respiratory Medicine 5.4 (2017): 167-179.

[4] Discovering the PMMH Hypothesis of Cancer Metastasis, supported by Boston University and Cambridge University, Publishing Citation: Soroush Niknamian* and Somayeh Zaminpira, Introducing the Prodotis M1-Macrophage Hypothesis of Cancer Metastasis (PMMH), EC Cancer 2.6 (2018): 261-285.

[5] Discovering and Introducing the Butterfly Effect in Theoretical Physics in the Cause of Cancer, Supported by Boston University, MIT University and South Florida University, Citation: Somayeh Zaminpira and Sorush Niknamian, How Butterfly Effect or Deterministic Chaos Theory in Theoretical Physics Explains the Main Cause of Cancer, 2(5): 227-238., Published: November 22, 2017.

[6] Introducing New Field of Study in Biological and Medical Sciences, Supported by MIT and Boston University, Publishing and Citation: Dr. Somayeh Zaminpira and Dr. Sorush Niknamian., Introduction to the Evolutionary Metabolic Medicine Based on Mitochondrial Dysfunction, EC Pulmonology and Respiratory Medicine, Special Issue, SI.01 (2017): 25-30. Published: November 27, 2017.

[7] Discovering and Introducing Cancer Treatment Methodology in the Treatment of Cancer by Using Specific Ketogenic Diet Plus Special Dosage of Ozone Therapy, Supported by Max Planck Institute in Germany, South Florida University, MIT University, Weston A. Price Foundation (WAPF) and Gurdon Institute, Cambridge, United Kingdom., Citations and Publishing Data: [1] Somayeh Zaminpira, Sorush

344

Niknamian. The Main Treatment of Cancer. Open Access J Surg. 2017; 6(3): 555687., Submission: September 28, 2017; Published: October 16, 2017. [2] Sorush Niknamian, Nutritional Ketosis Condition and Specific Ketogenic Diet, May Benefit Cancer Patients as an Alternative Treatment by Sudden Change in the Metabolic State of Cancer Cells, International Journal of Biochemistry & Physiology., Research Article, Volume 1 Issue 1, Received Date: November 08, 2016 Published Date: November 15, 2016. [3] Somayeh Zaminpira, Sorush Niknamian, Introducing the Evolutionary Cell Memory (ECM) Hypothesis, International Journal of Biochemistry & Physiology, Research Article, Volume 3 Issue 1, Received Date: December 11, 2017 Published Date: January 08, 2018. [4] Sorush Niknamian, Nutritional ketosis condition and specific ketogenic diet, may benefit cancer patients as an alternative treatment by sudden change in the metabolic state of cancer cells, International Journal of Development Research, Vol. 06, Issue, 11, pp.10355-10363, November, 2016. [5] Somayeh Zaminpira and Sorush Niknamian. “Evolutionary Metabolic Hypothesis of Cancer (EMHC)”. EC Pulmonology And. Respiratory Medicine 5.4 (2017): 167-179. [6] Dr. Somayeh Zaminpira and Dr. Sorush Niknamian. “How Bohr Effect Admits the Ozone Therapy Plus Specific Keto-Diet in the Treatment of Cancer”. EC Pulmonology and Respiratory Medicine SI.01 (2017): 06-09.

[8] Introducing Sorush Cancer Treatment Protocol (SCTP) supported by Weston A Price Foundation in Washington DC, Massachusetts Institute of Technology (MIT), Boston College and South Florida Morsani College of Medicine, Registered in US Department of Health and Human Services, www.ahrq.gov, RoPR Id: 36793, Client Id: 55555, PRS Code: R0036792, Section Completion: [DPCRLOISBNMGEH] - 14/14, [L, P, H]: [2, 1, 0], 2018.

Honors and Awards

[1] Honorary Member of Weston A. Price Foundation (WAPF), Washington DC. USA, Awarded by Sally Fallon Morell the President of Weston A. Price Foundation.

[2] Nominee of Thomas J. Bardos Awards in Cancer by American Association for Cancer Research (AACR), 2017.

345

[3] Ambassador of European Association for Cancer Research (EACR) in Iran, by Professor Sir Anton Berns the President of EACR.

[4] Honorary Board Member of Weston A. Price Foundation Gifted by Sally Fallon Morell the President of WAPF, Washington DC., USA

[5] Nominee of Board of Directors at International Association for the Study of Lung Cancer (IASLC), 2017.

[6] Nominee of Royal Golden Medal in Biology at Royal Society of England 2017.

[7] Top Elite Researcher at Islamic Azad University, Central Tehran Branch, Biology Department, 2016.

[8] Nominee of the "General Practice with Primary Healthcare Section: GP Forum Medical Student and Trainee Poster Prize." 2017, Royal Society of Medicine (RSM), England.

[9] Certificate of Appreciation, In Recognition of Outstanding Dedication and Commitment for Researches in Cancer Crisis, Infectious Diseases and Bio-threads, AERC, 1st of April, 2017.

[10] Certificate of Appreciation, For the Precious Efforts and Researches with the Help of Prof. Thomas N. Seyfried Ph.D. in Reducing Cancer Crisis and Analysis and New Hypothesis: "On the Evolutionary Metabolic Hypothesis of Cancer", AERC, 7th of April, 2017.

[11] Certificate of Appreciation, For the Meta-Analysis of the Skyscraper's Fire in History Including Plasco Fire in Tehran, Iran, AERC, 10th of April, 2017.

[12] Certificate of Appreciation, For the Outstanding Researches on the Ketogenic Diet in Reducing the Incidence of Cancer and Cancer Crisis, AERC, 5th November, 2016.

[13] Certificate of Recognition, In Recognition of the Outstanding Researches and Meta-Analysis of the Prime Cause of Multiple Sclerosis and Cancer Crisis, AERC, 4th of June, 2016.

[14] Nominee of Research and Development Award at American Society of Federal Health Professionals, Military Medicine, Application: 3562, This award recognizes

346 a team or individual that has made a significant discovery or contribution in federal health research and development, 2017.

[15] Nominee of Andrew Craige Allied Health Professional Award for outstanding accomplishments and contributions in the field of Cancer Biology, Cause and Prevention of Cancer Disease, American Society of Federal Health Professionals, 2017.

[16] Top Member of the International Association for the Study of Lung Cancer, 2017.

[17] Becoming as the AMRSB at the Royal Society of Biology (RSB), United Kingdom, 2018.

[18] Nominee for the Sjöberg Prize 2019, The Royal Swedish Academy of Sciences, worldwide by European Association for Cancer Research, The Sjöberg Prize for cancer research is awarded to scientists who have made major contributions to our knowledge about disease mechanisms, risk factors, or the treatment or prevention of cancer.

[19] Nominee of International Collaboration Awards 2017, IC170158 On the Evolutionary Metabolic Hypothesis of Cancer (EMHC) Niknamian, Soroush | MRC National Institute for Medical Research (NIMR).

[20] Nominee of Top Care Team, 2018, International Association for the Study of Lung Cancer.

[21] Nominee of 2019 Global Oncology Young Investigator Award, Conquer Cancer Foundation, Submit Full Application - GO YIA, Violet Cancer Institute, Project ID: 14610, Name: Dr. Sorush Niknamian, PhD, Institutional Approver Nancy Anoruo George Washington University Mentor michael adeyanju, abiodun Federal Medical Centre. Institutional Approver: Nancy Anoruo, George Washington University, Mentor: michael adeyanju, abiodun, Federal Medical Centre.

[22] Nominee of 2018 John Maddox Prize for Standing up for Science. The John Maddox Prize recognizes the work of individuals who promote sound science and evidence on a matter of public interest, facing difficulty or hostility in doing so. The prize is a joint initiative of Sense about Science and the science journal Nature. The late Sir John Maddox, FRS, was editor of Nature for 22 years and a founding trustee

347 of Sense about Science. His daughter Bronwen Maddox is the patron of the prize. The Kohn Foundation supported the prize from 2012-2017.

[23] Nominee of 2019 National Academy of Sciences Award. The National Academy of Sciences (NAS) is a private, non-profit society of distinguished scholars. Established by an Act of Congress, signed by President Abraham Lincoln in 1863, the NAS is charged with providing independent, objective advice to the nation on matters related to science and technology. Scientists are elected by their peers to membership in the NAS for outstanding contributions to research. The NAS is committed to furthering science in America, and its members are active contributors to the international scientific community. Nearly 500 members of the NAS have won Nobel Prizes, and the Proceedings of the National Academy of Sciences, founded in 1914, is today one of the premier international journals publishing the results of original research.

[24] Nominee of Clinical Neurosciences Section: President's prize 2018, RSM Prize submission title: THE MAIN CAUSE AND PREVENTION OF MULTIPLE SCLEROSIS AND ITS RELATION TO CANCER, Royal Society of Medicine. Nomination ID: A4187918.

[25] Nominee of The Sartorius & Science Prize for Regenerative Medicine & Cell Therapy, American Association for Advancement of Science (AAAS), The Sartorius & Science Prize for Regenerative Medicine & Cell Therapy is an annual prize geared toward researchers focused on basic or translational research that advances regenerative medicine and cell therapy; for example, cell-, gene-, or immunotherapy, tissue engineering, and materials engineering. Established in 2017, the prize is awarded for outstanding research performed by the applicant and as described in a 1,000-word essay. The winner of the Sartorius & Science Prize for Regenerative Medicine & Cell Therapy is awarded US$25,000 and publication of his or her essay in Science. The Grand Prize essay and that of the Runner-up are also published on Science Online. The award is announced and presented at a ceremony for which Sartorius will provide financial support to help enable the grand prize winner to attend the ceremony.

[26] Nominee of Premier's Awards for Health and Medical Research (2019 Premier's awards), Nomination ID: 113 Clinical Researcher, Since 1995, the Premier's Awards have been awarded annually in partnership with the Australian Society for Medical Research, to recognize the exceptional contributions made by early career health and medical researchers in their PhD studies. The Awards are a joint initiative of the Victorian Government and the Australian Society for Medical Research. The

348

Victorian Premier's Awards for Health and Medical Research launched in 1995 and is a joint initiative of the Victorian Government and the Australian Society for Medical Research (ASMR).

[27] Nominee of International Research Travel Award Program Fall 2018, American Physics Society. IRTAP promotes international scientific collaborations between physicists in developing and developed countries. Grant recipients receive up to $2,000 USD to help support travel for the developing or developed country scientist to visit their collaborator abroad for a minimum of one month. APS Headquarters: 1 Physics Ellipse, College Park, MD 20740, Editorial Office: 1 Research Road, Ridge, NY 11961, Office of Government Affairs: 529 14th St NW, Washington, D.C. 20045. Nominee Qualification ID: 156781

[28] Selected Nominee of the Harvey Prize, Royal Society of Medicine, 2018, Organized by Vascular Medicine Section. The Harvey Prize rewards excellence by recognizing breakthroughs in science and technology. The monetary Prize is a banner of recognition for men and women who have truly contributed to the progress of humanity. No less, however, the Prize is a source of inspiration. Serving as stimulus, the award urges scientists and scholars forward to further accomplishment.

[29] Nominee of The Brain Prize 2019, Federation of European Neuroscience, The Brain Prize recognizes highly original and influential advances in research on the nervous system, covering all aspects from fundamental studies to research related to understanding and treatment of diseases of the brain and other parts of the nervous system. The Prize may be awarded to one or shared by two or three scientists who have distinguished themselves through publication of outstanding results in the field of brain research. The prize may in extraordinary cases be awarded to four or more researchers. Nomination ID: R295-2018-2647.

[30] Nominee of Newton Advanced Fellowships 2019 Round 1, Royal Society of Great Britain, Nomination ID: NAF\R1\191143, Applicant: Niknamian, Sorush Organisation: University of Cambridge, United Kingdom, Project: The Positive Effect of SKD Plus IOT and HBO2T in the Treatment of Cancer.

[31] Nominee of Grant: International Collaboration Awards 2017, Project: On the Evolutionary Metabolic Hypothesis of Cancer (EMHC), Applicant: Soroush Niknamian, Organisation: MRC National Institute for Medical Research (NIMR), Nomination ID: IC170158.

349

[32] Nominee of Grant: International Collaboration Awards 2018, Applicant: Sorush Niknamian, Organisation: The Royal Society (Science Policy Centre), Nomination ID: ICA\R1\180346.

[33] Nominee of Lisa Jardine History of Science Award 2018, Grant: Lisa Jardine History of Science Award 2018, Project: The Positive Effect of SKD Plus IOT and HBO2T in the Treatment of Cancer, Applicant: Sorush Niknamian Organisation: Violet Cancer Institute/Weston A Price Foundation (WAPF), Royal Society of Great Britain, Nomination ID: LJ\R1\181032.

[34] Nominee of the Dickson Prize in Medicine 2019, The Dickson Prize in Medicine is awarded annually to a leading American by the University of Pittsburgh School of Medicine investigator who is engaged in innovative, paradigm-shifting biomedical research.

[35] Nominee of Allen S. Lichter Visionary Leader Award, American Society of Clinical Oncology Special Awards, 2019.

[36] Nominee of American Cancer Society Award and Lecture, American Society of Clinical Oncology Special Awards, 2019.

[37] Nominee of B. J. Kennedy Award and Lecture for Scientific Excellence in Geriatric Oncology, American Society of Clinical Oncology Special Awards, 2019.

[38] Nominee of David A. Karnofsky Memorial Award and Lecture, American Society of Clinical Oncology Special Awards, 2019. [39] Nominee of Distinguished Achievement Award, American Society of Clinical Oncology Special Awards, 2019.

[40] Nominee of Edison Award 2019, Innovation: Sorush Cancer Treatment Protocol, The Edison Awards are a set of 16 awards that honor excellence in technological innovation, new product and service development, marketing, and human-centered design. The Edison awards are sometimes referred to as "The Oscars of Innovation" and are given annually by Edison Universe, a non-profit 501(c)(3) organization dedicated to fostering innovators. The Awards are named after innovator Thomas Alva Edison (1847-1931) and symbolize the persistence and excellence in innovation personified by him. Award winners represent game- changing products, services and excellence and leadership in innovation around four criteria: Concept, Value, Delivery and Impact. Additionally, Edison Green Awards and Edison Achievement Awards are bestowed each year. Originally established in

350

1987 by the American Marketing Association, The Edison Awards became an independent organization and part of the Edison Universe non-profit organization in 2008., Awarded for: Honoring excellence in new product and service development, marketing, human-centered design and innovation. Country: United States, first awarded 1987. Annually, beginning in September, nominations are sought from product and service innovators in fifteen categories. A nomination fee of ~$1000 is required, and then nominations are vetted by members of the Edison Award Steering Committee, who present a slate of finalists to the Panel of Judges. The panel is composed of over 3,000 senior business executives and academics from across the nation, whose votes acknowledge excellence in meeting the award criteria - concept, value, delivery and impact. Awards are presented at an annual black-tie gala event, usually held each April. Past gala events have been held in New York, NY, Chicago, IL, and San Francisco, CA. Gold, Silver, and Bronze awards are given in each category.

[41] The Royal Society of Medicine invited Nominee of the Vanessa Moss annual prize, Royal Society of Medicine, ID: 4233054, RSM Oncology Section, RSM Prize submission title: The Positive Effect of SKD Plus IOT and HBO2T in the Treatment of Cancer [Introducing Sorush Cancer Treatment Protocol (SCTP)], Prize: £250 for the winner of the oral presentation, November 2018, Building collaborations in global cancer care: From fragile conflict ecosystems to emerging economies' meeting.

[42] Nominee of Sartorius & Science Prize for Regenerative Medicine & Cell Therapy. Nomination Award ID: 7470, American Association for the Advancement of Science (AAAS).

[43] Nominee of 2019 Science & PINS Prize for Neuro-modulation (Main), ID: 8596, American Association for the Advancement of Science (AAAS).

[44] Nominee of the position of the EDITOR-IN-CHIEF - The NEW ENGLAND JOURNAL of MEDICINE at Massachusetts Medical Society. The Journal was established more than 200 years ago and today is widely accepted as the world’s preeminent biomedical publication. A candidate for this position must be a licensed physician with significant achievement in scientific investigation and research, demonstrated editorial experience and expertise, and an understanding of digital publishing. Proven leadership and administrative skills and the presence and ability to speak effectively in the public forum are essential. Recognized achievement within the medical community is expected.

351

[45] Nominee of the 2019 Science & PINS Prize for Neuromodulation, The Science & PINS Prize for Neuromodulation is awarded for innovative research that modulates neural activity through physical (electrical, magnetic, optical) stimulation of targeted sites in the nervous system with implications for translational medicine. Established in 2016, the prize is awarded annually for outstanding research as described in a 1,500-word essay based on research performed in the past three years. The winner is awarded US$25,000 and publication of his or her essay in the journal Science. The Grand Prize essay and that of the Runner-up are also published on Science Online. Presented by: Science AAAS, Science Translational Medicine.

[46] Nominee of American Physical Society (APS) Fellowship, 2019, Fellowship Nomination Number: 5070864300.

[47] Honorary Nominee for the place of Full-Time Editor-In-Chief in New England Journal of Medicine in Boston. The New England Journal of Medicine is a weekly medical journal published by the Massachusetts Medical Society. It is among the most prestigious peer-reviewed medical journals as well as the oldest continuously published one. Impact factor: 79.258 (2017), ISO 4: N. Engl. J. Med, Editor: Jeffrey M. Drazen, Bluebook: mw-parser-output. small caps, New Eng. J. Med, Open access: Delayed (6 months), Publisher: Massachusetts Medical Society (United States), ISSN: 0028-4793 (print); 1533-4406 (web). Nominated by: Alexis H. Stiles, Kathryn S. Sugerman, Gregory J. Vaughn, M.D and Raquel Lentnek.

[48] Nominee of RSB Travel Grant 2019: Early Career MRSB, 21 January 2019 Requested: £500, Reference Code: 86425.

[49] Nominee of American Physics Society Medal for Exceptional Achievement in Research, Reference ID: N-9082486009, 2020. The APS Medal for Exceptional Achievement in Research recognizes contributions of the highest level that advance our knowledge and understanding of the physical universe in all its facets. This is a Society-wide award that honors researchers across all fields of physics.

[50] Nominee of Award for Outstanding Doctoral Thesis Research in Biological Physics, Reference ID: N-8353718107, 2019.

[51] Nominee of EACR Travel Fellowships Award, 2020, Amount of Award: 3000 Euro. Application has been sent and reviewed by Roger Doxat-Pratt, Conference and Fellowships Officer, [email protected], Phone: +44 (0)11595 15065.

352

[56] Nominee of Dannie Heineman Prize for Mathematical Physics, 2019, APS. Reference ID: N-5850397679.

[57] Nominee of Andrei Sakharov Prize in Physics, APS, 2019, Reference ID: N- 2558275302.

[58] Nominee of The Gorden and Betty Moore Foundation Convening Awards, 2019, Reference ID: 11094638.

[59] Nominee of Altmetric 2019 Research Grant. Description: At Altmetric, we’re keen to see our data used to make advances in scholarly communication. To that end, we offer an annual research grant of up to $2,000 USD for a project that makes new discoveries about how research is shared and discussed online.

[60] Nominee of PENN STATE AIChE Regionals, Student Paper Competition- Kaylee Ermine and Jen Burke. Proposed by: Anika (Anni) Ko, Penn State University, Chemical Engineering 2021, Regionals Chair, American Institute of Chemical Engineers, P: (412) 436-6058, E: [email protected], [email protected].

[61] Selected as Competition Judge for AIChE 2019 Student Regional Conferences: 1. Southern – Mississippi State University, March 28-30, 2019 2. Southwest – Texas Tech University, March 29-30,2019 3. Eckhardt Northeast – University of Massachusetts, Amherst, March 29-31, 2019 4. Western – University of Southern California, April 5-6, 2019 5. Rocky Mountain – Colorado School of Mines, April 5-6, 2019 6. Mid Atlantic – Penn State University, April 5-7, 2019 7. North Central – University of Toledo, April 12-13, 2019 8. Mid America – Missouri S&T, April 12-14, 2019 9. Pacific Northwest – University of Idaho, April 26-28, 2019

[62] Nominee of 2019 Giants of Cancer Care, Event: OncLive®'s Giants of Cancer Care® Winners' Reception, Date & Time: Thursday, May 30, 2019 7:00 PM-10:00 PM CST, Location: Adler Planetarium Museum Campus 1300 S. Lake Shore Drive Chicago, IL 60605, Event Overview: The Giants of Cancer Care® recognition program honors renowned physicians and researchers who have devoted their time, talent, and resources to improving the care for patients and families who are affected by cancer. Their discoveries have propelled the field forward and established the building blocks for future advances. Recipients demonstrate the qualities that distinguish this award from others: unlimited selflessness, compassion for their

353 patients, and a desire to understand and develop life changing treatments against a disease that affects so many. Invited by: George D. Demetri, MD, Dana-Farber Cancer Institute, Harvard Cancer Center, Boston, MA

[63] Nominee for an APS Committee on Fellowship, 2019.

[64] Nominee of George R. Lippert Memorial Award 2019, The George R. Lippert Memorial Award, founded in 1989, is named in honor of George R. Lippert, who dedicated more than 20 years of his life to the security industry and SIA. When evaluating candidates nominated for the award, the SIA Lippert Award Committee considers their long-term service to SIA and the security industry, the impact of their efforts on behalf of SIA and the industry, and their integrity, leadership, and diplomacy as demonstrated in industry dealings. The Lippert Memorial Award is presented at SIA Honors Night.

[65] Nominee of SIA Progress Award 2019, The SIA Progress Award, presented by the Security Industry Association's Women in Security Forum, celebrates an individual who is advancing opportunities and paving the way to success for women in the security industry. Each recipient is determined based on the following criteria: Contributions to advancing women in the security industry within the past three years (e.g., volunteer activities and/or grassroots efforts, new programs, new company policies to promote a more diverse workforce and thought leadership) Promoting women’s professional growth through mentorship and/or sponsorship Recognitions and/or awards for related activities Demonstration of the highest levels of professionalism and integrity in the security industry. All nominees must be employees of SIA member companies, and each nomination must include a letter from a colleague in the security industry on why the candidate deserves the award.

[66] Nominee of John J. Carty Award for the Advancement of Science, 2020 NAS Awards (Main), ID: 858, Honors noteworthy and distinguished accomplishments in any field of science within the National Academy of Sciences charter. The 2020 Award will be presented in the physical sciences with a medal, and a $25,000 prize.

[67] Nominee 0f NAS Award in Molecular Biology, 2020 NAS Awards (Main), ID: 859. Honors a recent notable discovery in molecular biology by a young scientist (no older than 45) who is a citizen of the United States. Presented with a $25,000 prize.

354

[68] Nominee of NAS Prize in Food and Agriculture Sciences, 2020 NAS Awards (Main), ID: 1006. Honors mid-career individual researcher at a U.S. institution who has made an extraordinary contribution to understanding the fundamental biology of an agriculturally important species and/or has had a major impact on agriculture. Presented with a $100,000 prize.

[69] Nominee of Riegelman Award for Excellence in Undgraduate Public Health Education, nomination confirmation number: 7ML6K7QZML. URL: https://www.cvent.com/c/abstracts/c1b62a9b-4460-4a1e-8d0f-147aa8efd254/ Description: The Riegelman Award is awarded annually to one full-time public health faculty member recognized for his or her excellence in undergraduate teaching. Named for Dr. Richard and Mrs. Linda Riegelman, the award is given to recognize superb faculty members who have garnered respect and enthusiasm from undergraduate students for demonstrating exceptional teaching.

[70] Nominee of The American Pharmacists Association 2020 (APHA) Immunization Champion Award, Description: The American Pharmacists Association established these special awards in 2008 to recognize the value and extraordinary contributions pharmacists provide to improving the vaccination rates in their communities. Across the country, more than 320,000 pharmacists have completed training as immunization providers. In all 50 states, the District of Columbia, and Puerto Rico, pharmacists have the authority to administer vaccines. Pharmacists and student pharmacists have assumed one or more roles as immunization educators, facilitators, and vaccine administrators, thereby reducing vaccine-preventable morbidity and mortality across the lifespan. Pharmacists, in collaboration with physicians, public health officials, and other immunization stakeholders, are recognized as important members of the immunization neighborhood and are developing solutions to increase access to vaccines and other public health services. Millions of vaccines are administered by pharmacists each year. The profession’s dedication to meeting the public’s immunization needs and protecting people from vaccine-preventable diseases is evident in the work of this year’s nominees and the many thousands of immunizing pharmacists practicing in communities nationwide.

[71] Nominee for Subramanian Innovation Award 2020, The Subramanian Innovation Award was created through a generous donation to the ISMICS Research and Education Fund made by ISMICS Past President and Founding Member Dr. Valavanur A. Subramanian. The winner of the Subramanian Innovation Award shall receive a $5,000 grant to be used toward taking their innovation and bringing it to reality for implementation. ID: 20-A-39-ISMICS.

355

[72] Nominee for Gründeman Scientific Research Award 2020, The award is granted for demonstration of basic research or an early clinical concept that outlines a new innovation suited to Minimally Invasive Cardiothoracic Surgery (MICS).

[73] Nominee for The Cardiac Robotic Young Investigator Award 2020, This annual award is granted by ISMICS through a generous donation by a grateful patient from the Robotic Cardiac Surgery Program at the University of Chicago Medicine in an effort to support robotic cardiac surgical research and training worldwide. The best abstract related to robotic cardiac surgery will be chosen and announced at the annual ISMICS meeting. The author will receive a $3,000 award which will be used to cover travel expenses to the ISMICS meeting as well as a visit to the Robotic Cardiac Surgery Program at the University of Chicago Medicine for a week long traveling fellowship for case observation and training within a year after the annual meeting. After this visit the recipient will provide ISMICS leadership with a correspondence summary of their educational experience and progress.

[74] Winner of NSF grant (registration only) to attend FEW Nexus 2019, 2019 Food- Energy-Water Nexus Conference | NYIT, New York, NY | Dec. 5-6, 2019, Grant Code: code FEW1900, AIChE Technical Entities, 120 Wall St. 23rd Fl. New York, NY 10005. URL: https://www.aiche.org/ifs/conferences/food-energy-water- nexus/2019.

[75] Nominee of Nominate a HighScope Hero, In honor of HighScope’s upcoming 50th anniversary, we want to recognize the educators, administrators, and families who have been essential to the growth and success of HighScope's curriculum and approach. We're looking for exceptional individuals who consistently exemplify HighScope's values. Please nominate a person who is An educator who continuously gives their all to reach every child, so every child can reach their potential. A student who attended a HighScope program or HighScope's Demonstration Preschool and has gone on to achieve notable success in school or in life. An educator or administrator who inspires and empowers early educators through support, mentorship, and guidance. A passionate advocate who is working to lift communities by fighting for equitable, high-quality early childhood education. HighScope Heroes will be selected and featured throughout 2020 as part of our yearlong celebration of HighScope’s 50th anniversary.

[76] Nominee for MSc in Clinical Trials. European Heart Academy for an ESC Educational Grant.

356

[77] Winner of Top Ten Articles at SSRN: "FUZZY LOGIC CONTROLLER FOR PARALLEL PLUG-IN HYBRID VEHICLE", was recently listed on SSRN's Top Ten download list for: EngRN: Energy Transportation (Topic). As of 27 November 2019, your paper has been downloaded 24 times. You may view the abstract and download statistics at: https://ssrn.com/abstract=3203963.

[78] Winner of NSF Grant, Grant Code: FEW1900, 2019 Food-Energy-Water Nexus Registration Info, Conference Dates: December 5-6, 2019, NYIT Auditorium on Broadway, New York, NY, Detail: How do we provide and maintain the food, energy and water supplies in urban environments as the population continues to increase? Obstacles and initiatives are the focus of this conference, and attendees will leave with new ideas and new collaborators to focus on this imminent issue. 019 Food-Energy-Water Nexus Conference | NYIT, New York, NY | Dec. 5-6, 2019, www.aiche.org/few19.

[78] Winner of Breast Cancer Now the Research and Care Charity, for Introducing Sorush Cancer Treatment Protocol. Website: https://grants.breastcancernow.org/Login.aspx?ReturnUrl=%2f/, Research Grants Officer, Breast Cancer Now, Ibex House, 42-47 Minories, London, EC3N 1DY [email protected], +44 (0) 207749 4121. Breast Cancer Now is a company limited by guarantee registered in England under company number 9347608. It is a charity registered with the Charity Commission of England and Wales under number 1160558. Registered Office: Ibex House, 42-47 Minories, London EC3N 1DY.

[79] Nominee of David K. Wagner Award of AAEM. As an organization, AAEM recognizes Dr. Wagner's contributions to the specialty by offering an award named in his honor to individuals who have had a meaningful impact on the field of emergency medicine and who have contributed significantly to the promotion of AAEM's goals and objectives. Dr. Wagner himself was given the first such award in 1995.

[80] Nominee of an International Achievement Medal (ISSN), The ISSN Awards is a Private Society of Distinguished Scholars, Professionals and Researchers. The ISSN is charged with providing independent, objective advice to the world on matters related to Science and Technology. Scientists are elected by their peers to membership in the ISSN for outstanding contributions to Research. www.issnawards.com. ISSN Awards 2020.

[81] Certified Nominee of ISSN AWARD, https://issnawards.com/.

357

[84] Nominee of Emergency Ultrasound Section of AAEM (EUS-AAEM) Council, Position: Section Chair-Elect, Office: American Academy of Emergency Medicine, 555 East Wells Street, Suite 1100, Milwaukee, WI 53202-3823 USA Tel: (800) 884-2236 or (414) 276-7390, Fax: (414) 276-3349, Email: [email protected], Web: www.aaem.org.

[85] Nominee of Vice Chair in Federal Planning Division, Invited by: Andrew Wright, AICP Chair, FPD, Address: WASHINGTON, D.C. American Planning Association, 1030 15th St., NW Suite 750 West, Washington, DC 20005-1503.

[86] Nominee of UNIVANTS of Healthcare Excellence Award, About the award: A prestigious team award for integration across healthcare disciplines. It's About Unity. The UNIVANTS of HealthCare Excellence award recognizes those who step up as Unifiers to drive collaboration and persevere as a cross-disciplinary team, working together to achieve common goals. By pushing beyond convention, these teams have unified across silos, transformed healthcare delivery, and ultimately, patients' lives. It's About Being Avant-Garde, What makes the award even more meaningful is that it honors Unifiers who are also Avant-Garde in their approach to solving problems—using laboratory intelligence to achieve measurably better outcomes. It is this combination that makes the UNIVANTS of Healthcare Excellence Award unlike any other. It's About Partnering To Drive Change And Measureable Impact, Abbott has partnered with leading professional societies, institutions and organizations in the fields of healthcare, laboratory medicine, economics and quality to offer this prestigious award. It's About Healthcare Excellence, The UNIVANTS of Healthcare Excellence Award recognizes integrated clinical care teams that are breaking down silos and driving measurably better healthcare performance for patients, clinicians, payors and entire health systems. Distinguished Program Partners: Leading professional societies, institutions and associations across healthcare disciplines are program partners in offering this prestigious award. The International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) is advancing excellence in laboratory medicine for better healthcare worldwide. AACC is a global scientific and medical professional organization dedicated to better health through laboratory medicine. The European Health Management Association (EHMA) is a non-profit membership organization that focuses on enhancing the capacity and capability of health management to deliver high quality healthcare. Modern Healthcare is a leading source of healthcare business and policy news, research and information, reporting on important healthcare events and trends as they happen. HIMSS is a global advisor and thought

358 leader supporting the transformation of health through the application of information and technology. NAHQ (National Association for Healthcare Quality) is the only organization dedicated to healthcare quality professionals and defines the standard of excellence for the profession. The IHE (Institute of Health Economics) is a trusted, independent, globally networked organization for high-quality research in health economics and health technology assessment to assist policy making and best medical practices. What Do Winning Teams Receive? Award-winning teams for the UNIVANTS of Healthcare Excellence Award will be recognized for their contributions in multiple ways, locally and globally. Award Title and Prestigious Unifying Award: This is an earned honor—assessed and awarded by world- renowned organizations, societies and leaders from across healthcare. A custom award will be presented to each core member of the winning clinical care teams. Leadership Celebratory Event. A local event honoring members of the winning care team, along with executive leadership across teams, partners, and Abbott. World lab 2020 Educational Workshop/ Representatives from the winning teams will have the opportunity to present their best practices, including at the 2020 IFCC World Lab in Seoul, South Korea. Spotlight In Modern Healthcare Winning teams will be featured in a best practice supplement within Modern Healthcare, a leading healthcare magazine. Opportunities to participate in additional events involving media, think tanks and partner networking may also be available. https://www.ihe.ca/about/careers-awards/univants-of-healthcare-excellence-award. Email: [email protected].

[87] First Nominee of ePoster Competition at the Annual Scientific Meeting to be held at the Hilton Warsaw Hotel & Convention Centre, in Warsaw, Poland, from 4 - 6 June, 2020. Poster Title: Introducing The Sorush Cancer Treatment Protocol, Sponsored by: International Society for Minimally Invasive Cardiothoracic Surgery, Abstract Reference I.D. #: 39. E-POSTER COMPETITION DETAILS: The ePoster Competition is divided into two parts. The First Round includes all accepted posters that are assigned to general topic groups with a total of 11 groups. Presentations are sequential within each group with groups running concurrently. Presentations in the First Round are limited to a maximum of 3-minutes, followed by 2-minutes for questions/discussion from the audience. Times are strictly enforced. Your poster will first be featured during ePoster Session: Education, Imaging and Facilitating Technologies, which will be held on Thursday 4 June from 17.45 – 18.45, at the Hilton Warsaw Hotel and Convention Centre. Peer scoring supplemented by other physician attendees will be done for each group. The top- scoring eposter from each group becomes a finalist and will proceed to the Final Round. Final Round presentations will be made in the main Scientific Session Hall by the finalists. Finalist presentations will again be limited to a maximum of 3-

359 minutes, followed by 2-minutes for audience questions/discussion. Presenters will speak from the main podium using PowerPoint Slides for support, NOT the e-poster. Finalist posters will be moved to the Scientific Session Hall for display beginning Friday morning. Poster Session: Final Round is scheduled for Saturday 6 June from 15.00 – 16.00. Moderators from the First Round will score, with the winner announced at the Attendee Reception held Friday Evening. INTERNATIONAL SOCIETY FOR MINIMALLY INVASIVE CARDIOTHORACIC SURGERY, 2020 Annual Scientific Meeting ▪ 4 – 6 June, 2020, Hilton Warsaw Hotel & Convention Centre ▪ Warsaw, Poland.

[88] Nominee of The Spinoff Prize, The Spinoff Prize aims to encourage and give visibility to academic entrepreneurs and their companies. The judging panel will look for spinoffs that translate original, high-quality scientific research into products and services that address market problems and are well positioned to make a positive impact on society. In its first year, The Spinoff Prize will focus on companies commercializing research in four broad categories: pharmaceuticals, agriculture, chemicals and digital technologies. A long list of highly commended spinoffs will be profiled in a special report published in Nature. Shortlisted spinoffs will pitch in front of a live audience at the Curious2020 – Future Insight Conference, after which one winner will receive a €30,000 cash prize. https://go.nature.com/bpdm,

[89] Nominee of Resident Heidelberg Ion Therapy (HIT) Scholarship for Heidelberg Ion Therapy Center, Heidelberg University Hospital has long been a leader in advancements in clinical, physics, and radiobiological research. The HIT itself is a world class ion therapy center originally opened in 2009 that is one of very few centers in the world treating patients with both proton and carbon ion therapy. The HIT treats a diverse group of patients from Germany, elsewhere in Europe, and around the world. These patients often arrive at the HIT with radioresistant tumor histologies, locally advanced tumors, and/or tumors adjacent to radiosensitive critical structures in the CNS, head & neck, and pelvis. Additionally, a large cohort of pediatric patients is treated at HIT with a variety of rare malignancies. The American College of Radiation Oncology (ACRO) in collaboration with Heidelberg University Hospital, Heidelberg Ion Therapy Center (HIT), and the ACRO Resident Committee have offered a unique opportunity for a 1-month international elective rotation at the Heidelberg Ion Therapy center in Heidelberg, Germany. Details: ACRO will provide three $2,000 travel grants for radiation oncology residents or young practitioners for a 1-month elective at the HIT in Heidelberg, Germany. For more information, please review the application details.

360

[90] Nominee of 2020 APhA Immunization Champion Awards, The APhA Immunization Champion Awards recognizes individuals and organizations within the profession of pharmacy who have made extraordinary contributions towards improved vaccination rates within their communities. Award Categories Community Outreach: Practitioner or pharmacy that has conducted activities and provided education within the communities they serve to increase immunization awareness and delivery. This category recognizes individuals and organizations that have successfully embraced the key elements of the “immunization neighborhood” (collaboration, coordination, and communication) among immunization stakeholders (between pharmacies/pharmacists and immunization coalitions, physicians, nurses, public health departments) and are dedicated to meeting the immunization needs of the patient and protecting the community from vaccine- preventable diseases. Corporation/Institution: Community pharmacies, hospital pharmacies, long-term care pharmacies, clinics, government entities, corporations, institutions, etc., that have established, facilitated, and/or collaborated with their community to provide services to improve vaccination rates. These entities should address and incorporate key elements of the “immunization neighborhood” within their submitted activities. Friend of Pharmacy: An individual who is a non- pharmacist and has supported, facilitated, or advocated for pharmacists’ role in immunizations. Individuals could include a coalition leader, community leader, policy maker, physician, public health official, reporter, etc. Individual Practitioners: A pharmacist who has established, facilitated, and/or collaborated within their community to provide services to improve vaccination rates. These individuals should exemplify key elements of the “immunization neighborhood” within their submitted activities. Pharmacy Team Member: An individual who is not a pharmacist or student pharmacist, who has advocated for immunizations, and who has proactively identified at-risk patients for vaccination. Individuals could include a pharmacy technician, store manager, store cashier, etc. Activities could include conducting or coordinating community outreach, patient education campaigns, managing or delivering immunization services, or supporting pharmacists in the provision of immunization services. Travel Health: Practitioner or pharmacy that has established, facilitated, and/or collaborated within their community to offer travel health services, which include, but are not limited to, consultations, medications, and comprehensive travel vaccines. The awards will be presented at the APhA Annual Meeting, March 20–23, 2020 at the Gaylord National Resort & Convention Center, located in National Harbor, MD. Each award category includes a national winner, and may include honorable mention recipients. National winners receive: Travel to Washington D.C. (coach airfare up to pre-determined amount), Lodging (up to 2 nights) Annual Meeting Registration, $500 honorarium, Crystal award, Honorable

361 mention recipients receive: Annual Meeting Registration, $100 honorarium, Award plaque. https://www.pharmacist.com/.

[91] Nominee of Richard Neubauer Advocate for Internal Medicine Award, The annual Richard Neubauer Advocate for Internal Medicine Award recognizes the Advocate member who has made exceptional contributions to advance the College's public policy agenda. Advocates communicate as constituents with their members of Congress on issues of importance to internists, their patients and to medical students. The College has over 15,000 Advocates who partner with ACP's Washington office. The award recipient is chosen based on the quality and quantity of responses to ACP's congressional Legislative Alerts, writing editorials and letters to the editor, meeting with his or her members of Congress, expanding chapter federal advocacy efforts, recruiting Advocates, organizing and attending Leadership Day, attending Town Hall meetings, and/or otherwise seeking to engage with their elected officials over the course of the year on federal legislative issues of importance to the College. Dr. Neubauer was a phenomenal and passionate advocate for internal medicine. He was a member of the Board of Regents, a former Alaska Chapter Governor, and 2004 recipient of the Key Contact of the Year Award. We are honored to have this prestigious award in his name. The Richard Neubauer Advocate for Internal Medicine Award is presented during the College's annual Leadership Day held in Washington, DC. In addition, the recipient is recognized at the following year's Convocation. Staff in the ACP Washington office selects the Richard Neubauer Advocate for Internal Medicine Award recipient. Nominations may be submitted by chapters or members by filling out this brief online form. Please contact Shuan Tomlinson, Senior Analyst, State Health Policy and Grassroots, at [email protected] if you have questions. The deadline is March 13. Nominees must be a registered ACP Advocates for Internal Medicine who has actively participated in federal advocacy during the past year.

[92] Nominate for The MMUF Travel & Research Grants, The MMUF Travel & Research Grants are available to graduate students who participated in the Mellon Mays Undergraduate Fellowship Program. The grants provide eligible graduate students with the financial means to complete their research prior to the start of dissertation writing. Funding is for one summer or one semester of travel and/or research support. Awards are based on the scholarly merit of the individual applications received. Funded by the Andrew W. Mellon Foundation, the grant supports the Mellon Foundation's mission to strengthen, promote, and, where necessary, defend the contributions of the humanities and the arts to human flourishing and to the well-being of diverse and democratic societies. The MMUF Travel & Research grants provide up to $5,000 for a period of one summer or one

362 semester. Grants may be used to cover dissertation research, travel to/from research sites, and photocopying of documents and/or the purchase of access to databases for research purposes.

REFERENCES (People Who Know Me Well:

[1] Professor Thomas N. Seyfried Ph.D., Morrissey College of Arts and Sciences Gasson Hall, 140 Commonwealth Avenue, Chestnut Hill, MA 02467, Contact Higgins Hall 514, Telephone: 617-552-3563, Email: [email protected], ORCID 0000-0003-1491-3989, Education: Ph.D., University of Illinois, Urbana- Champaign, URL: https://www.bc.edu/bc- web/schools/mcas/departments/biology/people/faculty-directory/thomas- seyfried.html.

[2] Professor Stephanie Seneff Ph.D., Senior Research Scientist at the MIT Computer Science and Artificial Intelligence Laboratory. ,URL: https://en.wikipedia.org/wiki/Stephanie_Seneff, Email: [email protected], Phone: 253-0451, Room: 32-G438, Massachusetts Institute of Technology Computer Science & Artificial Intelligence Laboratory, 32 Vassar St, Cambridge MA 02139.

[3] Sally Fallon Morell, Weston A. Price Foundation (WAPF) President, Email: [email protected]. URL: https://en.wikipedia.org/wiki/Weston_A._Price_Foundation, https://www.westonaprice.org/about-us/board-of-directors/, The Weston A. Price Foundation, PMB 106-380, 4200 Wisconsin Avenue, NW, Washington, DC 20016 USA, Phone: (703) 820-3333, Email Addresses: Questions, general information: [email protected], chapter questions: [email protected], Website: problems or questions: [email protected].

[4] Professor Dominic D'Agostino, Research Scientist, Inst. Human and Machine Cognition, Associate Professor, College of Medicine Molecular Pharmacology & Physiology, Contact Info: Morsani College of Medicine, Molecular Pharmacology & Physiology 12901 Bruce B. Downs Blvd. MDC 8, FL 33612, Academic Email: [email protected], Academic Phone: (813) 396-9628, URL: https://health.usf.edu/medicine/mpp/faculty/24854/D%27Agostino.

[5] Professor David Ludwig, MD, PhD, Co-director, New Balance Foundation Obesity Prevention Center; Attending Physician, Division of Endocrinology

363

Professor of Nutrition, Harvard School of Public Health; Professor of Pediatrics, Harvard Medical School. Email: [email protected]. 300 Longwood Avenue, Boston, MA 02115, 617-355-6000, Boston Children's Hospital. URL: https://en.wikipedia.org/wiki/David_Ludwig_(physician).

[6] Professor Michael J Gonzalez DSc, NMD, PhD, FANMA, FACN, Universidad de Puerto Rico Rio, Public Health, Faculty Member, URL: https://upr.academia.edu/MichaelJGonzalez. Telephone: (787) 758-2525 Ext. 1405, Fax: (787) 759-6719, Email: [email protected], Address: Michael J. González, N.M.D., D.Sc., Ph.D., F.A.C.N., Professor, University of Puerto Rico Medical Sciences Campus, School of Public Health, Department of Human Development Nutrition Program, GPO Box 365067, San Juan, Puerto Rico 00936- 5067, Website: http://www.conem.org/people/gonzalezbio/.

[7] Senator Mark Robert Warner (Senate Intelligence Committee), an American businessman and politician serving as the senior United States Senator from Virginia, a seat he was first elected to in 2008. He is a member of the Democratic Party and currently a Vice Chair of the Senate Democratic Caucus and the Vice Chair of the Senate Intelligence Committee. Prior to his congressional career, Warner was the 69th Governor of Virginia holding the office from 2002 to 2006, and is the honorary chairman of the Forward Together PAC. Warner delivered the keynote address at the 2008 Democratic National Convention. Apart from politics, Warner is also known for his involvement in telecommunications-related venture capital during the 1980s; he founded the firm Columbia Capital. In 2006, he was widely expected to pursue the Democratic nomination in the 2008 U.S. presidential election; however, he announced in October 2006 that he would not run, citing a desire not to disrupt his family life. Warner was considered to be a potential vice presidential candidate, until he took himself out of consideration after winning the Democratic nomination for the U.S. Senate. Running against his gubernatorial predecessor, Jim Gilmore, Warner won his first election to the Senate in 2008 with 65% of the vote. Warner won reelection in 2014, narrowly defeating Ed Gillespie. Address: Washington, DC Office, 703 Hart Senate Office Building, Washington, DC 20510, Toll Free: 1-877-676-2759, (VA residents only) Phone: 202-224-2023. URL: https://www.warner.senate.gov/public/. https://en.wikipedia.org/wiki/Mark_Warner. [8] Congressman (Representative) Ben Cline (Benjamin Lee Cline), Member of the U.S. House of Representatives from Virginia's 6th district URL: https://cline.house.gov/, Washington Office: 1009 Longworth House Office Building, Washington, DC 20515, Phone: (202) 225-5431, Fax: (202) 225-9681.

364

TAKING ACTIONS ACTIVITY AS AN ACTIVIST:

[1] Stop Bombing Hospitals: Secure Justice for Medical Workers and Civilians in Syria 2020. Details: Physicians for Human Rights and our network of medical professionals and researchers are using the unassailable facts of forensic medicine and scientific investigation to document human rights crimes. We've been documenting the purposeful, illegal, and brutal strategy by the Syrian government to target health workers and hospitals, effectively criminalizing the delivery of health care. We work to ensure that the powerful evidence we collect can be used for justice and accountability. signed the petition to the United Nations to demand truth and accountability for attacks on health in Syria.

[2] oppose these recommended cuts and instead support an increase in colorectal cancer research funding. ACS CAN. Wednesday, February 12, 2020, American Cancer Society Cancer Action Network, 555 11th St, NW, Suite 300, Washington, DC, 20004 1.888.NOW.I.CAN.

[3] Parity for Oral Cancer Drugs H.R. 1730 / S. 741 CURRENT LEGISLATION: The Cancer Drug Parity Act H.R. 1730/ S. 741 has recently been introduced by Representatives Brian Higgins (D-NY-26), Brett Guthrie (R-KY-2), Doris Matsui (D-CA-6), Gus Bilirakis (R-FL-12)), and Senators Jerry Moran (R-KS), Tina Smith (D-MN), Chris Murphy (D-CT), and Roger Wicker (R-MS). The legislation requires private health insurance plans offering intravenous cancer drug benefits to provide parity in patient cost sharing for orally administered and self-injectable cancer drugs. BACKGROUND: ASCO strongly supports requiring private health insurance plans offering intravenous (IV) cancer drug benefits to provide parity inpatient cost sharing between traditional IV drugs and oral anticancer drugs Scientific advancements increasingly allow oncologists to treat cancer with oral anti-cancer medications that often provide clinical advantages over traditional forms of cancer medication Some health plans impose higher cost-sharing requirements (copayments, coinsurance, etc.) on cancer patients for oral cancer drugs.

[4] Medicaid Coverage of Routine Care Costs of Clinical Trials H.R. 913 Legislation: The CLINICAL TREATMENT Act, H.R. 913, was introduced by Representatives Ben Ray Lujan (D-NM-03) and Gus Bilirakis (R-FL-12) to guarantee coverage of the routine care costs of clinical trial participation for Medicaid enrollees with a life-threatening condition. Background: Medicaid insures nearly one-fifth of the U.S. population and is the only major payer that is not required

365 by federal law to provide coverage of the routine care costs for participating in a clinical trial. Medicare has paid for these services since a 2000 National Coverage Decision. Private payers are required to provide coverage under the provisions of the Public Health Service Act section 2709, enacted as part of the Affordable Care Act. Clinical trial participation benefits cancer patients in ways that go beyond the value of the research data generated within the trial, and clinical trials often provide individuals with cancer with their best clinical option. Improving representation improves the validity of clinical research data and quality of new treatments. Medicaid serves a large portion of under-represented minorities and ethnicities that are not well represented in clinical trial enrollment. Failure to address the coverage barrier that Medicaid patients face could further exacerbate existing disparities and prevents researchers from obtaining optimal results in clinical trials. Providing coverage for the routine costs of clinical trials is affordable for states as several studies have demonstrated a minimal effect on overall care costs. Because in most cases, this is coverage for care that patients would be receiving anyway. Routine care costs include the non-experimental costs of treating a patient who is participating in a clinical trial, such as physician visits and laboratory studies. The cost of the investigational device or drug would still be covered by the trial sponsor. Take action today! Urge your Representative and Senators to support Medicaid coverage of routine care costs in clinical trials.

[5] Prior Authorization Protections and Transparency in Medicare Advantage H.R. 3107 Legislation: The Improving Seniors' Timely Access to Care Act, H.R. 3107, was introduced by Representatives Suzan DelBene (D-WA-1), Mike Kelly (R-PA-16), Dr. Ami Bera (D-CA-7), and Dr. Roger Marshall (R-KS-1) to streamline prior authorization practices within the Medicare Advantage program. Background: Prior authorization practices that create delays in care can have severe negative impacts on patients with cancer. It is important that Congress take steps to streamline the prior authorization process, as well as create more transparency around the use of prior authorization to help understand how it can be improved to reduce delays in care for patients.

[6] Increase Funding for Cancer Research. BACKGROUND: Over the last five years, there has been bipartisan support for increasing the National Institutes of Health (NIH) funding; in fact, the NIH has received approximately $11.6 billion in funding increases over the last five years, which includes a $2.6 billion increase in fiscal year (FY) 2020. Even with bipartisan support over the last few years, once adjusted for inflation, NIH and NCI funding is still catching up with pre-recession levels. Additionally, any potential for NIH

366 increases this year is seriously constrained by budget limitations, making continued advocacy all the more necessary. CURRENT STATUS:Congress is working on funding bills for FY2021, which begins on October 1, 2020. For FY2021, ASCO and the larger biomedical community are asking Congress to increase funding for the NIH by $3 billion, to a total of $44.7 billion. For FY2021, ASCO and the cancer community have agreed on asking Congress for an increase of $460 million for NCI, to a total of $6.9 billion.

[7] Establish Guardrails for Step Therapy in Federally Regulated Plans H.R. 2279/S. 2546. New Legislation: The Safe Step Act, H.R. 2279, was introduced by Representatives Raul Ruiz (D-CA-36) and Brad Wenstrup (R-OH-2) putting reasonable guardrails and timelines around the utilization management practice known as "step therapy" or "fail first". Background: ASCO strongly supports limiting a payer’s ability to require fail first protocols Advancements in the diagnosis of cancer allow oncologists to determine the best treatment approach for each individual patient Many health plans require patients to try and fail medications chosen by the plan before they will cover the medication originally prescribed by their health care provider.

[8] Congress: Reject proposed cuts to cancer research funding. Message: * Subject: Dear [Decision Maker], As a constituent and a volunteer for the American Cancer Society Cancer Action Network, I'm asking you to please reject these proposed cuts in the FY2021 budget, and save more lives from cancer. The Administration's recently proposed budget for FY2021 calls for an over $3 billion cut to medical research at the National Institutes of Health(NIH), including nearly $500 million in cuts for the National Cancer Institute (NCI). The budget also calls for almost $43 million in cuts to important cancer screening and prevention programs at the Centers for Disease Control and Prevention. As a constituent and volunteer with the American Cancer Society Cancer Action Network, I ask that you reject these cuts in the FY2021 budget. Please reject these proposed cuts in the FY2021 budget, and save more lives from cancer.

[9] I pledge to action in 2020 to help save the lives of millions of women who are needlessly dying from cervical cancer. I want to help end death from cervical cancer ... everywhere. Cervical cancer deaths are preventable. With vaccination, screening and treatment, no woman needs to die from this disease. I will make sure my lawmakers hear from me in 2020 about making sure every woman everywhere has access to lifesaving cervical cancer prevention, screening and treatment services.

367

I’m ready to take action in 2020, because where you live should not determine if you live.

[10] Protect and Improve Access to Quality, Affordable Healthcare, Our country can never return to a time when cancer patients and survivors were denied health insurance due to a pre-existing condition, had limits placed on their care, or were unable to afford the care that could save their lives. More adults in America are insured today than in 2010, but over 27 million are still uninsured and struggling to afford health care. Uninsured people are more likely to be diagnosed with cancer at more advanced stages, when treatment is more expensive and patients are more likely to die from the disease. Recent government regulations have promoted the expansion of health plans that can deny coverage for pre-existing conditions like cancer and do not offer the kind of coverage sick people need. I'm asking all the Presidential candidates to tell us how they will ensure people with serious illnesses like cancer have access to quality, affordable healthcare.

[11] Protect and Improve Access to Quality, Affordable Healthcare, Our country can never return to a time when cancer patients and survivors were denied health insurance due to a pre-existing condition, had limits placed on their care, or were unable to afford the care that could save their lives. More adults in America are insured today than in 2010, but over 27 million are still uninsured and struggling to afford health care. Uninsured people are more likely to be diagnosed with cancer at more advanced stages, when treatment is more expensive and patients are more likely to die from the disease. Recent government regulations have promoted the expansion of health plans that can deny coverage for pre-existing conditions like cancer and do not offer the kind of coverage sick people need. I'm asking all the Presidential candidates to tell us how they will ensure people with serious illnesses like cancer have access to quality, affordable healthcare.

[12] Protect and Improve Access to Quality, Affordable Healthcare, Our country can never return to a time when cancer patients and survivors were denied health insurance due to a pre-existing condition, had limits placed on their care, or were unable to afford the care that could save their lives. More adults in America are insured today than in 2010, but over 27 million are still uninsured and struggling to afford health care. Uninsured people are more likely to be diagnosed with cancer at more advanced stages, when treatment is more expensive and patients are more likely to die from the disease. Recent government regulations have promoted the expansion of health plans that can deny coverage for pre-existing conditions like cancer and do not offer the kind of coverage sick people need. I'm asking all the

368

Presidential candidates to tell us how they will ensure people with serious illnesses like cancer have access to quality, affordable healthcare.

[13] GRASSROOTS: Access to Student Loans and Loan Repayment Programs are at Risk! Tell your members of Congress to oppose these Dangerous Cuts Today! The administration has released its most recent budget plan for consideration by Congress, and it contains $60 billion in cuts that could affect your education, your practice, and your patient's ability to access care. If adopted, these cuts would have a devastating impact on the osteopathic profession and our patient's ability to access care. The proposal would: Eliminate the public service loan forgiveness program, ending an important incentive for new physicians to practice in rural and underserved areas; and, Cap graduate student loans at $50,000 annually or $100,000 in total, and consolidate graduate student borrowing under a single program with the same terms as Graduate PLUS loans. Tell your members of Congress to reject these dangerous cuts today! Select Recipients: Sen. Mark Warner, Sen Tim Kaine, Rep. Ben Cline R-VA-6.

[14] Telling FDA Patient Safety Cannot Be Compromised, The Food and Drug Administration (FDA) Proposed Rule: Importation of Prescription Drugs, Comment Tracking Number: 1k4-9f3d-3eku, FDA recently published a proposed rule that would allow importation of certain prescription drugs from Canada. FDA’s proposed drug importation program introduces unnecessary risks to patient safety and threatens our ability as pharmacists to provide high-quality patient care. FDA is seeking comments from the public on this proposed rule. APhA and the National Alliance of State Pharmacy Associations (NASPA) encourage pharmacists to tell FDA that patient safety cannot be compromised. To help you provide comments to FDA, we created a template letter and three easy ways to use it. https://www.regulations.gov/comment?D=FDA-2019-N-5711-0001&p=1.

[15] FAMILY MEDICINE ACTION CENTER The Teaching Health Center Graduate Medical Education program’s funding will expire May 22 unless Congress takes action, and the delay of its long-term reauthorization threatens to undermine this month's residency match process. The Academy and AAFP state chapters are again urging Congress to pass long-term Teaching Health Center funding immediately, and the time to add your voice is now. Ask your legislators to reauthorize the THCGME program by passing the Training the Next Generation of Primary Care Doctors Act. End the standstill. No More Patches! Reauthorize THCGME! Action to: US Senators and US Representative. https://www.votervoice.net/AAFP/campaigns/.

369

[16] Congress: Support legislation to help end the youth vaping epidemic, Subject: Support legislation to help end the youth vaping epidemic, Recipients: Your Representative, Cancer Action Network. ACS CAN. To: Senator Mark Warner, Senator Tim Kaine, Representative Ben Cline.

[17] AAFP Brief Activities:

1. You sent a message to Senator Mark Warner regarding No More Patches! Reauthorize THCGME! on 2/19/2020 5:32 AM 2. You sent a message to Senator Tim Kaine regarding No More Patches! Reauthorize THCGME! on 2/19/2020 5:32 AM 3. You sent a message to Representative Ben Cline regarding No More Patches! Reauthorize THCGME! on 2/19/2020 5:32 AM 4. You created your profile on 1/28/2020 4:42 PM 5. You sent a message to Delegate Wendell Walker regarding Help the VAFP Advance Immunization Requirements for School Aged Children on 1/28/2020 10:42 AM

[18] Pancreatic Cancer Action Network's FY 2021 Legislative Priorities Dear [Decision Maker], Welcome back to the 116th Congress! I am one of your constituents and a supporter of the Pancreatic Cancer Action Network (PanCAN). Thank you for working in a bipartisan manner last year to prioritize lifesaving research for pancreatic cancer - the world's toughest cancer. Pancreatic cancer is the third leading cause of cancer- related death in the United States. While survival rates for many other cancers have improved, the pancreatic cancer five-year survival rate in the U.S. is just 10%. This year, nearly 58,000 Americans will be diagnosed with pancreatic cancer, more than ever before. There is no early detection method, and there are few effective treatment options for patients. However, progress for patients is being made thanks in large part to the investment Congress has made to advance the research. Research funding is key to solving this challenging disease and with 80% of funding for pancreatic cancer research coming from the federal government, you have the power to advance policies that will change the lives of current and future patients. As my member of Congress, I urge you to support PanCAN's legislative priorities in fiscal year 2021:1. Make the nation's toughest cancer a priority and provide $10 million for the pancreatic cancer research program at the Department of Defense. Ensure lifesaving medical research continues and support $44.7 billion for NIH, including $6.9 billion for the NCI. Increase awareness of the nation's deadliest cancers and join the Congressional Caucus on the Deadliest Cancers. look forward to working with you to improve patient outcomes and to ensure that vital cancer research continues.

370

Recipients: US Senator Tim M. Kaine, US Senator Mark R. Warner, US Representative Ben Cline.

[19] Subject: Support SB 172 to End Surprise Billing, To: Senator Steve Newman, Message: Please support SB 172 (Favola) to end surprise billing. These bills would protect patients as well as the health care safety net. The two bills establish a regional commercial average, a payment standard that would prevent individual health plans from driving down reimbursements to unsustainable levels, and therefore jeopardizing health care access. In an emergency, your physician's priority is your health. It is the insurer's responsibility to handle costs so patients and their physicians can focus on healing. Any solution that gives health insurers to power to indiscriminately set prices is not a patient-focused solution. As a health care provider, I urge you to support SB 172 (Favola). From: American College of Cardiology Foundation.

[20] 5 Taking Actions for ACP Releases New Vision for U.S. Health Care! Advocates for Internal Medicine Network. Recipient: Del. Eleanor Norton (D-DC). Time of taking actions: 1. 02/23/2020 07:40 PM, 2. 02/23/2020 07:46 PM, 3. 02/23/2020 07:54, 4. 02/23/2020 07:59 PM, 5. 02/23/2020 08:01.

[21] Protect and Improve Access to Quality, Affordable Healthcare, our country can never return to a time when cancer patients and survivors were denied health insurance due to a pre-existing condition, had limits placed on their care, or were unable to afford the care that could save their lives. More adults in America are insured today than in 2010, but over 27 million are still uninsured and struggling to afford health care. Uninsured people are more likely to be diagnosed with cancer at more advanced stages, when treatment is more expensive and patients are more likely to die from the disease. Recent government regulations have promoted the expansion of health plans that can deny coverage for pre-existing conditions like cancer and do not offer the kind of coverage sick people need. I'm asking all the Presidential candidates to tell us how they will ensure people with serious illnesses like cancer have access to quality, affordable healthcare.

[22] Pledge to take action in 2020 to help end all deaths from cervical cancer worldwide, I pledge to action in 2020 to help save the lives of millions of women who are needlessly dying from cervical cancer. I want to help end death from

371 cervical cancer ... everywhere. Cervical cancer deaths are preventable. With vaccination, screening and treatment, no woman needs to die from this disease. I will make sure my lawmakers hear from me in 2020 about making sure every woman everywhere has access to lifesaving cervical cancer prevention, screening and treatment services. I’m ready to take action in 2020, because where you live should not determine if you live.

[24] To my U.S. Senators: Cervical cancer shouldn't be a death sentence for any woman ... anywhere! Where you live shouldn’t determine if you live. But, when it comes to preventing and surviving cervical cancer, it makes all the difference in the world. The facts are clear: We have the vaccine and simple screening and treatment tools to end all deaths from cervical cancer. 90% of all women who die from cervical cancer are from low and middle-income countries because they don’t have reliable access to these resources. If we do nothing, the number of cervical cancer deaths will increase by nearly 50% in the next 20 years, totaling almost 450,000 women and girls. Cervical cancer shouldn't be a death sentence for any woman in any country. Please support dedicated funding in this year’s budget to help eliminate deaths from cervical cancer worldwide.

[25] Congress: Improve the quality of life for cancer patients and survivors,

[26] To my U.S. Senators: Increase funding for breast cancer research, Millions of women are alive today thanks to previous investments in breast cancer research. The facts are clear: Breast cancer research and prevention programs save lives. Despite our progress, more than 41,000 women in the U.S. are projected to die from breast cancer this year alone. Every major breast cancer breakthrough in the past 50 years can be traced back to federally-funded research. Please support a strong increase in funding for breast cancer research and lifesaving breast cancer prevention programs.

[27] End Family Separation, The U.S. is forcibly separating children from their parents at the border: evidence from PHR shows its torture. The evidence is clear: The Trump administration’s coercive, discriminatory practice of family separation constitutes torture. Despite claims that the practice has stopped, more than 1,100 children have been separated from their parents since a court order demanded the administration stop this harmful practice. Your response to this crisis is urgently needed. Please, send your message today demanding that the Trump administration end the cruel, forcible separation of families seeking asylum. Physicians for Human Rights. 256 West 38th Street, 9th Floor, New York, NY 10018, ©2020 Physicians for Human Rights.

372

[28] Promoting awareness-raising, education and training as part of a comprehensive approach to ensuring access to and the availability of controlled substances for medical and scientific purposes and improving their rational use, Detail: The 63rd session of the Commission on Narcotic Drugs (CND) will take place in Vienna from March 2-6. CND member states will discuss and approve a number of draft resolutions, including one proposed by Belgium, Australia and the European Union regarding the urgent need to improve global access to internationally controlled essential medicines such as those used for palliative care, the treatment of severe pain, substance use disorder, and other conditions. The resolution is focused on education and health system strengthening, including training and upskilling of personnel who oversee the procurement, distribution, and prescription of opioids. All UN resolutions begin with preambular paragraphs that sum up the situation addressed by the resolution and that lay out the normative framework in which it has been developed. These preambular paragraphs are followed by operational paragraphs that include recommendations to member states about how they should proceed to remedy the situation addressed in the preambular paragraphs. Both the preambular and operational paragraphs of this resolution are excellent. We are requesting that all our members and partners support this resolution by asking your national palliative care association to send a letter by electronic mail to your ambassador or head of mission in Vienna. This letter should be sent on letterhead and signed by a senior executive of the organization. The letter need not be long, but should include the following: 1. An introduction and brief presentation of the Association, its mission, and the country you work in, describing some of the challenges your members face in accessing controlled medicines for patients. 2. Reference the CND63 meeting to take place in Vienna and Draft Resolution, L4. 3. Emphasise your organization’s support for Draft Resolution L4. 4. Emphasise the work your Association is doing to comply with the recommendations of Chapter 2 of the UNGASS Outcome Document and the UN Conventions. 5. Respectfully request your Vienna mission to support the Draft Resolution and co-sponsor it with Australia, Belgium and the EU. 6. Offer any other support or information that might be required. Please contact me, Katherine Pettus [email protected] if you have any questions at all regarding this. The following text can serve as a guide for this request on letterhead. Please adapt as you see fit. Your Excellency (protocol for addressing Ambassadors) My name is XXX, and I am XXX (officer) of XXX Palliative Care Association, whose mission is the promotion and development of palliative care in XXX (country). We are an association of palliative care professionals who work with patients and families facing severe health related suffering. One of the pillars that we work on as a civil

373 society organization is the availability of and access to internationally controlled essential palliative care medicines, in particular opioids for the control of severe pain and breathlessness. The 63rd Session of the Commission on Narcotic Drugs will consider Draft Resolution L4, sponsored by Australia, Belgium and the European Union. This resolution is entitled Promoting awareness-raising, education and training as part of a comprehensive approach to ensuring access to and the availability of controlled substances for medical and scientific purposes and improving their rational use We have analyzed the document and consider that it is excellent. It emphasises the most important issues that affect access for rational medical use and outlines the necessary steps and solutions member states can adopt to overcome existing barriers. We are writing this letter to request that your mission support this resolution and add our country as a co-sponsor. Our palliative care patients need to be able to access opioid medicines to relieve severe pain; scarcity, stockouts, high prices, and unduly restrictive regulations cause great suffering and have created a global public health crisis. Please confirm receipt of this letter and feel free to contact us for any further information regarding our work.

[29] PanCAN: Ask Your Members of Congress to Join the Caucus - Urge your members of Congress to show their support for the pancreatic cancer community by joining the Congressional Caucus on the Deadliest Cancers.

[30] PanCAN: Our message to Congress: Make Pancreatic Cancer a National Priority! Let Congress know PanCAN's 2020 legislative priorities. Message Detail: Pancreatic Cancer Action Network's FY 2021 Legislative Priorities Dear [Decision Maker], Welcome back to the 116th Congress! I am one of your constituents and a supporter of the Pancreatic Cancer Action Network (PanCAN). Thank you for working in a bipartisan manner last year to prioritize lifesaving research for pancreatic cancer - the world's toughest cancer. Pancreatic cancer is the third leading cause of cancer-related death in the United States. While survival rates for many other cancers have improved, the pancreatic cancer five-year survival rate in the U.S. is just 10%. This year, nearly 58,000 Americans will be diagnosed with pancreatic cancer, more than ever before. There is no early detection method, and there are few effective treatment options for patients. However, progress for patients is being made thanks in large part to the investment Congress has made to advance the research. Research funding is key to solving this challenging disease and with 80% of funding for pancreatic cancer research coming from the federal government, you have the power to advance policies that will change the lives of current and future patients. As my member of Congress, I urge you to support PanCAN's legislative priorities in fiscal year 2021: 1. Make the nation's toughest cancer a priority and provide $10 million for the pancreatic cancer research program at the

374

Department of Defense. 2. Ensure lifesaving medical research continues and support $44.7 billion for NIH, including $6.9 billion for the NCI. 3. Increase awareness of the nation's deadliest cancers and join the Congressional Caucus on the Deadliest Cancers. I look forward to working with you to improve patient outcomes and to ensure that vital cancer research continues.

[31] Thanking members of Congress for Stepping Up for Pancreatic Cancer Research, thank your members of Congress for creating a dedicated pancreatic cancer research program at the DoD and increasing funding for the NIH. 2020. Message Body: Thank You for Prioritizing Medical Research, Dear [Decision Maker], As your constituent, I'm thankful that Congress worked in a bipartisan manner and passed an FY20 appropriations package that includes $6 million for a new, dedicated pancreatic cancer research program at the Department of Defense. These research dollars are critical as we push for progress against the world's toughest cancer. Additionally, I am appreciative of the $2.6 billion increase for the National Institutes of Health, which includes a $296 million increase for the National Cancer Institute. Pancreatic cancer is the third leading cause of cancer-related death in the United States and has a five-year survival rate of just 9 percent. The pancreatic cancer research field continues to grow, and we have the opportunity to see accelerated progress in creating new treatment options and early detection strategies when Congress prioritizes cancer research. As someone who has been impacted by pancreatic cancer, I care deeply about the future of pancreatic cancer patients and recognize the critical role the federal government has in funding lifesaving research. Thank you for recognizing the importance of increasing medical research funding at the DoD and the NIH.

[32] PanCAN: Increase Pancreatic Cancer Research Funding at the DoD, Urge the House to provide $10 million for the dedicated pancreatic cancer research program at the Department of Defense. Message Detail: Dear [Decision Maker], As your constituent, and someone who is committed to improving outcomes for pancreatic cancer patients and their families, I urge you to sign the Eshoo-McKinley- Kennedy Dear Colleague letter to the House Appropriations Subcommittee on Defense. Your support for the Pancreatic Cancer Research Program at the Department of Defense (DoD) will lead to advancements in research for the world's toughest cancer. In FY20, Congress took a crucial step and created a dedicated pancreatic cancer research program at the DoD. I applaud Congress's bipartisan effort. This is a critical research investment for a disease with a five-year survival rate of only 10% in the U.S., and 65% of patients die within their first year of diagnosis. There is an urgent need for more research efforts to change these statistics for patients. Research shows that within a cohort of U.S. veterans, there is direct

375 evidence for increased risk of death from pancreatic cancer. Veterans often have known risk factors for pancreatic cancer, including environmental exposure, other medical conditions such as diabetes, and lifestyles factors such as smoking and obesity. I urge you to sign the Dear Colleague letter spearheaded by Representatives Anna Eshoo (D-CA), David McKinley (R-WV), and Joe Kennedy (D-MA). The letter to the House Appropriations Defense Subcommittee requests $10 million for the dedicated pancreatic cancer research program. While the number of researchers focused on pancreatic cancer is growing, thanks in part to you and your colleagues, we must make sure they have the adequate resources necessary to accelerate progress. I ask that you sign this letter by March 13 to ensure its consideration during the FY21 appropriations process. Please contact Rachel Fybel ([email protected]) with Rep. Eshoo, Katie Brown ([email protected]) with Rep. McKinley or Naomi Plaskey ([email protected]) with Rep. Kennedy to sign on in support of all those impacted by this devastating disease. I stand with the Pancreatic Cancer Action Network (PanCAN) and the patients, caregivers, families and researchers across the country in asking for your support and commitment to greatly improving patient outcomes.

REFERENCES AS AN ACTIVIST, (Advocacy Membership and Taking Actions in US Governments (Senators, Representatives, Congress and Whitehouse)

[1] American Cancer Society, ACS CAN

[2] American Planning Association

[3] Federal Planning Association

[4] ACP Internal Medicine Network: The Advocates for Internal Medicine Network (AIMn) is a program for ACP members interested in participating in federal advocacy. It is designed to help members engage with their federal lawmakers on policy issues important to ACP and internal medicine, using a platform that is user- friendly. As key issues approach the decision-making stage on Capitol Hill, the College emails or faxes legislative updates and alerts to AIMn members, who we call Advocates. Legislative alerts include all of the necessary information (including sample messages that can be easily personalized) to make informative contacts with

376 members of Congress, and ACP staff is always available to provide support and answer legislative questions.

[5] American Society for Clinical Oncology

[6] Physicians for Human Rights

377